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Abstract 
Martin Latterich, B.Sc. (Dunelm) 
Osmohomeostasis and Vacuole Biogenesis Genes in the Yeast Saccharomyces 
cerevisiae 
A thesis submitted for a Ph.D., 1992. 
The putative role of the S. cerevisiae vacuole in osmohomeostasis, as well as its 
biogenesis was analysed by taking a mutational approach. 97 mutants unable to tolerate 
high concentrations of salt were isolated and examined for aberrant vacuolar 
phenotypes. A comprehensive phenotypic analysis was able to demonstrate that apart 
from osmosensitivity most mutations conferred other properties such as altered vacuolar 
morphology, the inability to perform gluconeogenesis and/or the mislocalization of 
vacuolar proteins to the cell surface. The mutants fall into at least 20 complementation 
groups, termed ssv for ^alt sensitive vacuolar mutants, of which 3 genetically overlap 
with complementation groups isolated by others. This analysis provides evidence that in 
S. cerevisiae correct vacuolar biogenesis is required for osmotolerance as well as other 
important cellular processes. To elucidate vacuolar osmohomeostasis at the molecular 
level, one gene, SSV7, was cloned from a genomic DNA library by complementation of 
a ssv7-\ mutation and its sequence determined. It encodes a novel 927 amino acid 
protein with limited structural homology to the functional domains of two nucleotide 
exchange factors from 5. cerevisiae, namely CDC25 and BUDS. A mutation in the 55V7 
gene confers a pleiotropic phenotype including fragmented vacuoles and the absence of 
a nucleus. The mutation apparently uncouples mitosis from cell growth, which results in 
an increased cell size of a ^5v7-l mutant. The role of 551^7 in the general concept of 
vacuole biogenesis is discussed, as is the observed fact that a number of mutants in 
intermediate biosynthetic pathways confer a vacuolar protein sorting defect. 
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ABBREVIATIONS 
All abbreviations other than those recommended by the lUPAC-IUB 
(Biochemical Nomenclature and related Documents, 1978) were avoided when 
possible. However, some abbreviations for frequently used terms for enzymes and some 
chemicals were thought to be an aid to the reader and are listed below. Other 
abbreviations for biological terms are defined at their first occurrance in the text. 
API 
APCo 
BCIP 
BSA 
Aminopeptidase I 
Aminopeptidase Co 
Bromochloroindolyl phosphate 
Bovine serum albumin 
CDCFDA 5(6)-carboxy-2',7'-diclilorofluorescein diacetate 
CIP Calf intestinal phosphatase 
CPY Carboxypeptidase Y 
CPS Carboxypeptidase S 
DAPI 4',6-diamino-2-phenylindole 
dH20 Distilled water 
DPAP A Dipeptidyl aminopeptidase A 
DPAP B Dipeptidyl aminopeptidase B 
EDTA Ethylenediaminetetraacetic acid 
EtOH Ethanol 
vu 
FITC 
GlcNAc 
IPTG 
NBT 
OD600 
Pi 
PBS 
PEG 
PrA 
PrB 
RT 
TE 
Tris 
V M M 
Fluorescein isothiocyanate 
N-Acetylglucosamine 
Isopropylthiogalactopyranoside 
Nitro blue tetrazolium 
Optical density (absorbance) at a wavelength of 600 nm 
Inorganic phosphate 
Phosphate buffered saline 
Polyethylene glycol 
Proteinase A 
Proteinase B 
Room temperamre (20°C) 
10 mM Tris pH 8.0, 1 mM EDTA buffer 
Tris-(hydroxymethyl)-methylamine-[2-amino-2-(hydroxymethyl)-
propane-l,3-diol (tris)] 
Yeast minimal medium 
vui 
MEMORANDUM 
The following publications have been achieved as a result of this research: 
Latterich, M . and Watson, M.D. (1991) Isolation and characterization of osmosensitive 
vacuolar mutants in 5. cerevisiae. Mol. Microbiol. 5, 2417-2426. 
Latterich, M. , Hartley, C.A. and Watson, M.D. (1992) The plasticity of vacuole 
biogenesis in the yeast Saccharomyces cerevisiae. J. Exp. Botany, in press. 
Latterich, M. , Hartley, C.A. and Watson, M.D. (1992) A mutation in 55^7, a CDC25 
homologue, confers a viable anuclear phenotype. Manuscript in peparation. 
Latterich, M . and Watson, M.D. (1992) A dual osmoregulatory mechanism in 5. 
cerevisiae. Manuscript in preparation. 
Latterich, M . and Watson, M.D. (1992) Osmoregulation in the y^dtsi Saccharomyces 
cerevisiae (Review). Manuscript in preparation. 
IX 
T A B L E OF CONTENTS 
Page 
CHAPTER 1 
Introduction 1 
1.1. General Introduction 1 
1.2. Protein Import into the Nucleus 3 
1.3. Protein Import into Mitochondria 6 
1.4. Protein Import into Chloroplasts 8 
1.5. Protein Import into Peroxysomes 10 
1.6. The Secretory Pathway 11 
1.6.1. Endoplasmic Reticulum 12 
1.6.2. ER to Golgi Transport 21 
1.6.3. Golgi Apparatus 25 
1.6.4. Transport from Golgi to Vacuoles/Lysosomes 33 
1.6.5. Secretion 36 
1.7. Endocytosis 40 
1.8. Osmohomeostasis in S. cerevisiae 42 
1.9. Aim of Thesis 44 
CHAPTER 2 
Materials and Methods 45 
2.1. Materials 45 
2.1.1. Reagents and Supplies 45 
2.1.2. Phage Strains 46 
2.1.3. Bacterial Strains 46 
2.1.4. Yeast Strains 47 
2.1.5. Plasmids 47 
2.1.6. Buffers and Stock Solutions 50 
2.1.7. Growth Media 54 
2.2. General Methodology 58 
2.2.1. Sterile Working Practices 58 
2.2.2. Sterilisation Techniques 58 
2.2.3. Polylysine Coating of Microscope Slides 58 
2.2.4. Treatment of Dialysis Tubing 58 
2.2.5. Maintenace of Stock Cultures - Bacterial Strains 59 
2.2.6. Maintenance of Stock Cultures - Yeast Strains 59 
2.2.7. Measurement of Growth - Phage Titration 59 
2.2.8. Measurement of Growth - Bacteria 60 
2.2.9. Measurement of Growth - Yeast 60 
2.3. Classical Yeast Genetics 61 
2.3.1. Drop-overlay Complementation 61 
2.3.2. Sporulation of Diploids and Random Spore Isolation 62 
2.3.3. Testing for Mating Type 62 
2.3.4. EMS - Mutagenesis 63 
2.3.5. UV - Mutagenesis 63 
2.3.6. Selection for NaCF mutants 64 
2.4. DNA Manipulation 64 
2.4.1. Plasmid DNA Preparation from E. coli - Large Scale 65 
2.4.2. Plasmid DNA Preparation from E. coli - Mini Preps 66 
2.4.3. Genomic DNA Isolation Irom S. cerevisiae - Large Scale 67 
2.4.4. Isolation of Plasmid DNA from 5. cerevisiae 69 
2.4.5. Determination of the DNA Concentration 69 
2.4.6. Phenol/Chloroform Extraction of DNA 69 
2.4.7. DNA Precipitation from Aqueous Solutions 70 
2.4.8. Restriction Digests 71 
2.4.9. DNA Molecular Weight Markers 71 
2.4.10. Dephosphorylation of Termini 72 
Page 
2.4.11. Ligation Reactions 72 
2.4.12. Klenow Filling-in of Cohesive Termini 72 
2.4.13. Exo ni/Mung Bean Nuclease Deletion 73 
2.4.14. Agarose Gel Electrophoresis 74 
2.4.15. DNA Fragment Isolation 74 
2.5. DNA Sequencing 75 
2.5.1. Procedure for Obtaining Single Stranded DNA from Bluescriptf 
Vectors 75 
2.5.2. Preparation of ds Plasmid DNA Template for Sequencing 76 
2.5.3. Alkaline Denaturation of dsDNA Sequencing Templates (Yanisch-
Perronetal., 1985) 76 
2.5.4. DNA Sequencing Reaction 77 
2.5.5. Denaturing Gel Electrophoresis 78 
2.5.6. DNA Sequence Analysis 78 
2.5.7. Deduced Protein Sequence Analysis 79 
2.6. Transformation 79 
2.6.1. Transformation of E. coli - Ultra High Efficiency 79 
2.6.2. Transformation of E. coli - RbCl Competent Cells 80 
2.6.3. Transformation of S. cerevisiae Sphaeroplasts 81 
2.6.4. Lithium Acetate Transformation of 5. cerevisiae 81 
2.6.5. Transformation of Yeast by Electroporation 84 
2.7. Protein Biochemistry Methods 85 
2.7.1. Lowry Determination of Protein Concenfrations 85 
2.7.2. Lammli SDS Polyacrylamide Gel Electrophoresis 85 
2.7.3. Electrophoretic Blotting of Proteins 86 
2.7.4. Non-lysing Colony Immunoblot Assay 87 
2.7.5. Pulse-labelling and Immunoprecipitation of Yeast Proteins 88 
2.7.6. Immunoprecipitation of CPY in Intra- and Extracellular Yeast 
Fractions 89 
2.7.7. Expression and Isolation of Recombinant Proteins 90 
2.7.8. Production of Polyclonal Antisera in Rabbits 92 
2.7.9. Adsorption of Antibodies 93 
2.7.10. Enzyme-Linked Imm unoadsorbent Assay (ELISA) 94 
2.8. Enzyme Assays 94 
2.8.1. Invertase assay 94 
2.8.2. a-glucosidase Assay 95 
2.8.3. a-mannosidase Assay 96 
2.9. Light Microscopy 97 
2.9.1. Normarski Contt-ast 97 
2.9.2. Fluorescence Microscopy 97 
2.9.3. Indu-ect Immunofluorescenece Microscopy 98 
2.10. Electron Microscopy 100 
2.10.1. Enhancement of Yeast Vacuoles and Double Membranes 100 
2.10.2. Fixation after Byers and Goetsch 102 
CHAPTER 3 
Raising Polyclonal Antisera Against Recombinant Carboxypeptidase Y 103 
3.1. Introduction 103 
3.2. Results 106 
3.2.1. hiduction of CPY Antigen Expression in MC1061 (pCKRlOS) 106 
3.2.2. Production of Polyclonal Antiserum Against CPY 106 
3.3. Discussion 114 
C H A P T E R 4 
Isolation and Characterization of Salt-Sensitive Vacuolar Mutants 116 
4.1. Infroduction 116 
4.1.1. Vacuolar Ion Transport and Storage 119 
4.1.2. Amino Acid Storage 121 
4.1.3. Carbohydrate Storage 123 
4.1.4. Homeostasis Function of the Vacuole 124 
XI 
Page 
4.1.5. Vacuole Inheritance 125 
4.1.6. Synthesis and Processing Pathway of Vacuolar Proteins 126 
4.1.7. Sorting of Soluble Vacuolar Proteins 130 
4.1.8. Sorting of Membrane Associated Proteins 134 
4.1.9. Endocytosis and Protein Degradation Pathways 138 
4.1.10. Biosynthesis of Soluble Vacuolar Proteins 143 
4.1.11. Biogenesis of Vacuolar Membrane Associated Proteins 149 
4.1.12. Mutants Defective for Vacuolar Biogenesis 156 
4.1.13. Isolation and Characterization of Vacuolar Protein Sorting Mutants 
157 
4.1.14. Mutants Deficient in the Maturation of Vacuolar Proteinases 163 
4.1.15. Endocytosis Mutants 163 
4.1.16. Acidification Defective Mutants 164 
4.1.17. Calcium Sensitive Mutants 164 
4.1.18. Amino Acid Storage Mutants 165 
4.1.19. Vacuolar Morphology Mutants 166 
4.1.20. Vacuolar Segregation Mutants 166 
4.1.21. Vacuole Biogenesis Genes 167 
4.1.22. The Isolation and Characterization of Salt-Sensitive Vacuolar 
Mutants 175 
4.2. Results 178 
4.2.1. Mutagenesis of SEY6210 and SEY6211 178 
4.2.2. Complementation Analysis 180 
4.2.2. Vacuolar Morphological Analysis 205 
4.2.2.1. Light and Fluorescence Microscopy 205 
4.2.2.2. Indirect Immunofluorescence Microscopy 206 
4.2.2.3. Electron Microscopy 206 
4.2.3. Morphological Features 210 
4.2.4. Sensitivity to other high osmotic strength compounds 216 
4.2.5. Differential Growth Inhibition by NaCl and Sorbitol 217 
4.2.6. Ca2+-Sensitive Alleles Among ssv Mutants 218 
4.2.7. Growth on Non-fermentable Carbon Sources 221 
4.2.8. Temperamre Sensitive Alleles 222 
4.2.9. Secretion of Vacuolar Proteinases 223 
4.2.10. Cosegregation of Mutant Phenotypes 232 
4.2.11. Dominace/Recessiveness of Phenotypes 237 
4.2.12. Comparison With Other Osmosensitive Alleles 237 
4.2.13. Other Associated Phenotypes 240 
4.2.14. Mutants in Metabolic Pathways 240 
4.3. Discussion 243 
CHAPTER 5 
Construction of Plasmid Based Yeast Genomic DNA Library 261 
5.1. Introduction 261 
5.2. Results 263 
5.2.1. Isolation of SEY6210 Genomic DNA 263 
5.2.2. Plasmid Bank Construction 264 
5.2.3. Optimal Conditions for Tranformation of the Gene Bank 265 
5.2.4. Maintenance of the Gene Bank in HBlOl 271 
5.2.5. Efficiency of Transformation for S. cerevisiae 273 
5.3. Discussion 275 
CHAPTER 6 
Characterization of the 55V7 Gene 278 
6.1. Introduction 278 
6.2. Results 279 
6.2.1. Morphological Features Conferred by the ssv7-l Allele 279 
6.2.2. vps phenotype of ssv7-\ 282 
6.2.3. Growth Behaviour of ssv7-1 282 
xu 
Page 
6.2.4. Molecular Cloning and Characterization of the SSV7 Locus 283 
6.2.5. The SSV7 Gene Encodes a Protein Whose C-terminus has Significant 
Sequence Similarity to the S. cerevisiae Cdc25p 289 
6.3. Discussion 308 
CHAPTER 7 
Characterization of AR07-OSM2 312 
7.1. Introduction 312 
7.2 Results 315 
7.2.1. Eleco-on Microscopic Examination of the aro7-1 Mutant 315 
7.2.2. Indirect Immunofluorescence 315 
7.2.3. Missorting of Carboxypeptidase Y 316 
7.2.4. Examination of Other Mutants in the Aromatic Amino Acid Pathway 
316 
7.3. Discussion 320 
CHAPTER 8 
Final Discussion 323 
8.1. Osmohomeostasis and the Vacuole 323 
8.2. Protein Traffic to the Vacuole 325 
8.3. Sttucmral Integrity of the Vacuole 328 
8.4. EpUogue 328 
R E F E R E N C E S 336 
xm 
CHAPTER 1 
INTRODUCTION 
1.1. General Introduction 
One of the features that distinguishes eukaryotic cells from prokaryotes is that in 
eukaryotes many cellular processes are compartmentalized in distinct membrane bound 
organelles. These organelles are composed of a set of unique proteins, most of which 
are synthesized in the cytoplasm and co- or post-translationally targeted to the correct 
subcellular locus. This process is highly specific and requires specialized targeting 
mechanisms and signals which have to discriminate between different destinations or in 
case of the secretory pathway confer retention (Warren, 1987). A great deal of interest 
has focussed upon unravelling the targeting and sorting signals of proteins that are 
localized to organelles or secreted from the cell, and understanding the sorting 
mechanism. Another area of interest is the assembly, maintenance and partitioning of 
these organelles during the cell cycle. Daughter buds must inherit a minimal number of 
all organelles and cytoplasmic constituents necessary for independent survival (Yaffe, 
1991). The segregation of organelles has to precede a phase of protein and lipid 
biosynthesis to provide sufficient material for segregation to occur. Except 
mitochondria and chloroplasts, which possess their own genome and are capable of 
synthesising part of their protein constituents autonomously, other organelles, such as 
the nucleus, the endoplasmic reticulum, the Golgi apparatus, the lysosome in animal 
cells, or the vacuole in yeast and plants derive all their protein constituents from the 
cytoplasm. The biogenesis of the Golgi apparatus, the vacuole and the plasma 
membrane all depend upon delivery of proteins via branches of the secretory pathway. 
Thus the majority of their constituents have to be translocated into the ER and 
fransported to subsequent locations. 
The vacuole of the yeast Saccharomyces cerevisiae has become a recent focus of 
investigation, partly because of its comparative homology to mammalian lysosomes and 
its easy amenability to genetic and biochemical analysis (Achstetter and Wolf, 1985; 
Klionsky et ai, 1990; Raymond et al., 1992). It represents a prominent organelle which 
participates in a series of important cellular processes, as diverse as proteolytic 
processing and degradation of vacuolar as well as cytoplasmic proteins (Achstetter and 
Wolf, 1985; Chiang and Schekman, 1991), nitrogen metabolism (Jones, 1982), amino 
acid, carbohydrate and ion storage (Klionsky et al., 1990), sporulation (Teichert et al., 
1989) and ion and osmohomeostasis (Klionsky et al., 1990). While many studies have 
addressed particular aspects of the vacuolar function in vivo and in vitro, its biogenesis 
is stiU poorly understood. The present study intends to examine two related aspects of 
its biogenesis, namely is morphological integrity and its role in osmoregulation, of 
which the latter has been hypothesized to be essential to allow survival under 
unfavourable environmental conditions (Banta et al., 1988; Klionsky et al., 1990), 
In the following introduction some general features of organelle biogenesis are 
reviewed to allow a comparison between the biogenesis of the vacuole with that of other 
organelles. Numerous studies in the past decade have focussed on various aspects of 
organelle inheritance and biogenesis in different organisms, and a complete review of 
the literature would easily exceed the number of pages of this thesis several-fold. 
Therefore, only the most important features are mentioned. Also, since many 
mechanisms of protein targeting and organelle biogenesis are conserved across species, 
it was decided to concentrate describing these processes in Saccharomyces cerevisiae, 
lastly because this simple model system has contributed to the undestanding of many 
cellular processes due to its biochemical as well as genetical amenability. However, 
when basic featores differ from mammalian and plant systems they are briefly outlined 
to allow a distinction. Protein sorting in plants has not received as much attention as in 
mammalian cells or yeasts. Recent studies show that the sorting machinery is conserved 
between plants, yeasts and mammalian cells. Therefore it was decided that unless plants 
have unique features in organelle biogenesis, other comparatative features such as 
protein import into the ER (Iturriaga et al., 1989), Golgi processing and morphology 
(Moore et al., 1991a), vacuolar protein sorting (Sturm et al, 1988) and endocytosis 
(Horn et al., 1992) will not be mentioned. They are outlined in some excellent reviews, 
mostly by Maarten J. Chrispeels and collaborators (Chrispeels, 1991; Chrispeels and 
Raikhel, 1992; Chrispeels and Tague, 1991; Vitale and Chrispeels, 1992; Harris and 
Watson, 1991). 
1.2. Protein Import into the Nucleus 
One of the most obvious distinctive features that discriminates eukaryotes from 
prokaryotes is the nucleus. The nucleus represents a double bilayer membrane enclosed 
compartment in which chromosomes and the ribosome assembly take place separated 
from the remaining cytoplasm. During mitosis the 5. cerevisiae nucleus elongates, and 
part of it migrates into the newly formed bud. The morphological changes during 
mitosis differ from that in other eukaryotes in that it remains intact during the whole 
cell cycle (closed mitosis), whereas it fragments or vesicularizes in other eukaryotes. 
The nucleus, ER and Golgi complex disassemble during mitosis in mammalian cells 
(Fry, 1976; Zeligs and WoUman, 1979; Lucocq et al., 1987) and membranes derived 
from these organelles are dispersed through the cytoplasm until the end of mitosis to 
ensure partitioning of the organelles during cell division. At the end of mitosis these 
membraneous compartments reassemble by fusion, a process which might be regulated 
by the same factors that mediate vesicle budding and fusion in interphase cells (Warren, 
1985). Nuclear vesicles will bind to chromatin, and after a step involving GTP 
hydrolysis will fuse to form a nuclear envelope in the presence of cytoplasm (Boman et 
al., 1992; Newport and Dunphy, 1992). The assembly of the nuclear membrane is 
independent of the availability of lamins (Newport et al., 1990). Karyogamy (nuclear 
fusion) after successful mating occurs and preceeds the formation of diploid S. 
cerevisiae (Rose, 1991). During mating cells of opposite mating type exchange peptide 
mating pheromones. Responding cells arrest in Gl of the cell cycle and develop cellular 
projections termed shmoos, after which cell walls dissolutions and plasma membrane 
connections allow the cells to fuse and form the zygote. The haploid nuclei associate by 
interdigitating cytoplasmic microtubules arising from the two spindle pole bodies 
present in die nuclear envelope and fuse together by an unknown mechanism in 
proximity of the spindle pole body. 
The nuclear membrane is stabilized by the karyoskeleton, the nuclear lamina, a 
network of intermediate filaments which attach to the intranuclear membrane and are 
thought to be associated with chromatin. Much knowledge about the karyoskeleton 
comes from amphibian and mammalian systems, where different lamins have been 
identified (Krohne et al., 1987). While lamin B is constitutively expressed and present 
in all cells, lamin A and C are differentially expressed. It has been proposed that lamin 
A participates in early differentiation by reorganizing chromatin that is followed by 
expression of a differential phenotype (CoUard et al., 1992; Wolin et al., 1987). The 
search for evolutionary conserved yeast lamins so far has been unsuccessful (M.N. Hall 
and K. Weber to M.D. Watson, personal communication) despite one initial report that 
lamin A, lamin B and a lamin B receptor had been identified in yeast based on 
immunological cross reactivity (Georgatos et al., 1989). A gene showing sequence 
homology to the lamin B receptor has recently been identified (Shimanuki et al., 1992). 
The apparent lack of evolutionary conserved lamin homologues can be explained 
because yeast does not differentiate. Other structurally similar intermediate filament-
like proteins such as Nuflp have been identified which could be part of the 
karyoskeleton (Mirzayan et al., 1992). Lamins A and C are not essential proteins in 
mammals since cell lines lacking both lamins remain viable (Guilly et al., 1987). The 
nuclear membrane possesses pore complexes (125,000 kDa) to facilitate the selective 
uptake of cytoplasmic proteins. Its structure is conserved between mammalian species 
and yeast (Aris and Blobel, 1989; Goldfarb and Michaud, 1991; Wozniak et al., 1989). 
Nuclear specific import is determined by nuclear localization sequences, which are 
characterized by small positively charged stretches of amino acids that are not 
proteolytically removed (Dingwall and Laskey, 1986). WhUe the nuclear localization 
signals do not have a common consensus, there can be more than one signal in a nuclear 
protein. The yeast repressor a2 contains two putative nuclear localization signals, of 
which one is important in nuclear import, while the other appears to facilitate binding to 
the nuclear pore complex (Hall et al., 1990). Nuclear uptake of proteins is highly 
selective (Dingwall and Laskey, 1986). The size of proteins imported varies from small 
histones to the large (2800 kDa) 60S ribosomal subunit which requires a mechanism of 
dilation of the relatively small (9-11 nm diameter) nuclear pore (Goldfarb and Michaud, 
1991). 
Nuclear import in mammalian cells requires soluble cytoplasmic factors, ATP and 
lastly the presence of a nuclear localization signal in the protein to be imported into the 
nucleus (Adam et al., 1990; Halleck and Rechsteiner, 1990). In the absence of ATP or 
at low temperature nuclear proteins were localized to the nuclear membrane but failed 
to be imported. An N-ethylmaleimide-sensitive cytosolic factor is required in signal 
mediated binding to the nuclear pore (Newmeyer and Forbes, 1990). Nucleoplasmin, a 
nuclear protein, complexed with gold particles will bind to eight distinct features to the 
nuclear pore complex around the periphery of the transporter and also over the center of 
the nuclear pore complex (Akey and Goldfarb, 1989). The nucleoplasmin-gold particles 
are then translocated through the nuclear pore into the nucleus. Proteins that have 
entered the nucleus are generally accumulated against a concentration gradient and 
retained in the nucleus and cannot easily diffuse out, suggesting the existence of a 
separate retention mechanism (Dingwall and Laskey, 1991). The transport efficiency of 
a given nuclear protein depends on the number of nuclear localization signals present 
(Dworetzky et al., 1988). There is evidence that a number of nuclear localization signal 
binding proteins associate with proteins and shuttle between the cytoplasm and 
nucleolus (Meier and Blobel, 1990; L i and Thomas, 1989; Silver et al., 1989; Stochaj 
and Silver, 1992). Spliced mRNA is exported from the nucleus, probably also through a 
nuclear pore by an unknown mechanism, which has to control the selective export of 
spliced but not unspliced mRNA (Goldfarb and Michaud, 1991). Also, nuclear U 
snRNAs are exported from and imported into nuclei via the nuclear pore complex by a 
mechanism that requires a different receptor to that of nuclear proteins (Michaud and 
Goldfarb, 1992; Goldfarb and Michaud, 1991). A DnaJ protein homologue, YDJl, has 
been reported to be localized in a perinuclear fashion as well as in the cytoplasm and 
associated with the ER. A deletion of the gene confers a conditional lethal phenotype 
(Caplan and Douglas, 1991), suggesting that it is required for some essential cellular 
function. 
A number of proteins have to enter the nucleus during the cell cycle in a regulated 
fashion such as the tanscription factor SWI5 which is accumulated in the cytoplasm and 
is then taken up during the Gl phase of the cell cycle (Henkel et al., 1992; Nasmydi et 
al., 1990). Whether this factor is degraded in the nucleus or exported to a cytoplasmic 
location is not clear. 
1.3. Protein Import into Mitochondria 
Although mitochondria have their own genome and protein synthesis machinery, 
the biogenesis of the organelle relies on the import on nuclear encoded proteins. Very 
early in the cell cycle a portion of a mitochondrion migrates into the developing bud, a 
process dependent on the presence of actively growing mitochondria and possible 
cytoskeletal elements (Yaffe, 1991). Many mitochondrial proteins are synthesized as 
larger precursors with transient N-terminal peptide extensions (Geli and Click, 1990; 
Glick and Schatz, 1991; Neupert et al., 1990). These extensions contain several basic 
amino acids, lack acidic amino acids and are processed during or after import. The |3-
subunit of the mitochondrial FpATPase has a 27 amino acid N-terminally located 
sequence which is necessary and sufficient for import into the organelle (Emr et al., 
1986). Although mitochondrial signal peptides have no common consensus, the signal 
cleavage site is predictable and often represents RXXS/A (Gavel and von Heijne, 1990). 
As little as 12 N-terminal amino acids suffice to target fusion peptides to the 
mitochondrion (Hurt et al., 1985). However, the pre-sequence processing is impeded, 
which indicates that further sequence information is necessary for correct proteolytic 
processing to occur. Different mitochondrial proteins are imported via a common 
translocator present on "contact sites" of outer with inner membrane (Pfaller et al., 
1988; Pon et al., 1989; Roise, 1992) although different import receptors exist for two 
subclasses of mitochondrial proteins in a common receptor complex (Geli and Glick, 
1990; SoUner et al., 1990; Sollner et al., 1992; Stuart et al., 1990). In case of 
apocytochrome c, the precursor form of cytochrome c, there is no receptor/translocator 
present on the outer mitochondrion membrane and insertion into the membrane is 
spontaneous (Stuart et al., 1990). The receptor complex in the outer membrane consists 
of several preprotein receptors, Isp49p and Mas70p (S. cerevisiae) or MOM72 and 
M0M19 {N. crassa), close to the insertion site in conjunction with low molecular 
weight proteins (Isp42, MOM38, MOM30, MOM22, MOMS and M0M7). The binding 
of preproteins to MOM72 occurs outside of the complex, upon which it associates with 
the translocation complex. Preproteins accumulating at the import site are partially 
exposed to the intermembrane space. Subsequent translocation across or into the inner 
membrane requires a membrane potential A\|/ and the mhsplO protein in the matrix. It 
has been suggested that the positively charged amino acid residues respond to the 
membrane potential and are transported across the inner membrane upon which 
proteolytic processing of the import sequence occurs (Neupert et al., 1990). The 
proteolytic processing is mediated by the MASl and MAS2 gene products, two soluble 
matrix proteins (Yaffe et al., 1985; Geli and Glick, 1990). These form a protein, called 
Mpl, of approximately 115 kDa (Achstetter and Wolf, 1985). The protein import across 
the mitochondrial membrane is facilitated by sequential action of two heat shock related 
proteins, mhsplO and hsp60 (Glick and Schatz, 1991; Manning-Krieg et al., 1991; 
Scherer et al., 1990) and also depends on the conformation of the protein to be 
translocated because unfolding prior to translocation is essential for successful 
translocation to occur (Nye and ScarpuUa, 1990a; Nye and Scarpulla, 1990b; Rassow et 
al., 1989; Vestweber and Schatz, 1988). The mhsplO chaperone probably plays an 
important part in the translocation process and after ATP dependent release of the 
imported protein hsp60 mediates correct folding of the protein, also connected with 
hydrolysis of ATP. Some of the proteins participating in the import of nuclear encoded 
proteins into mitochondria are encoded by the mitochondrial genome (Myers et al., 
1985). 
Some mitochondrial proteins destined for the inter-membrane space enters 
mitochondria by different mechanisms. Cytochrome c enters the mitochondrium 
independent of a translocation apparatus (Glick and Schatz, 1991). Other proteins have 
a bipartite pre-sequence containing an amino terminal matrix targeting signal, followed 
by a stretch of hydrophobic amino acids. The mechanism by which the proteins enter 
first the matrix and processed to be released into the intermembrane space is not clear. 
Proteins are either completely localized into the matrix and after signal peptide cleavage 
are then exported mediated by their hydrophobic pro-sequence. Alternatively, the 
hydrophobic sequence could act as a stop-transfer sequence during translocation, and 
proteolytic cleavage in the iimer membrane space could release the protein. Inter-
membrane space proteins undergo two proteolytic events. The fu-st is accomplished by 
the matrix protease (Bohni et al., 1983), the second by the PET2858 gene product, 
IMPl, which shows sequence similarity to the E. coll leader peptidase and might be 
evolutionally conserved (Behrens et al., 1991). Targeting of proteins to the inner 
membrane is more complex and might involve stop-transfer signals (Glick and Schatz, 
1991). The assembly of outer membrane proteins is at present unknown and does not 
involve obvious mitochondrial signal sequences but requires specific receptors (Geli 
and Glick, 1990; Glick and Schatz, 1991). 
1.4. Protein Import into Cliloroplasts 
Chloroplasts are organelles which multiply by fission after replication of their 
genomes. Chloroplasts interact with microfilaments and are subject to movement along 
these filaments depending on light conditions (Haupt and Scheuerlein, 1990). 
Chloroplasts, like mitochondria, import a large number of proteins, although they have 
their own genome and protein synthesis machinery. The chloroplast is surrounded by a 
two membrane envelope separated by an intermembrane space except for "contact 
points" where membranes are fused or in close proximity (DeBoer and Weisbeek, 
1991). The inner membrane surrounds the stroma where CO2 fixation and most 
biosynthetic pathways occur. The stroma also contains thylakoids which are membranes 
participtating in the photosynthetic electron transfer and surroimd the thylakoid lumen 
where water splitting and oxygen evolution take place. The thylakoid lumen is highly 
acidic due to the H"*" pumping activity during photosynthesis. Nuclear encoded 
chloroplastic proteins are synthesized cytoplasmically as precursors with a N-terminal 
extension. This transit peptide contains sufficient and necessary information for import 
into the chloroplast (Keegstra and Olsen, 1989; von Heijne et al., 1989). Transit 
peptides are characterized by high amounts of hydroxy amino acids and the lack of 
tyrosine and acidic amino acids (DeBoer and Weisbeek, 1991). A typical transit peptide 
represents an amino-terminal domain of 10 amino acids with no proline, glycine or 
charged amino acids followed by a central region with high amounts of hydroxy amino 
acids and containing positively charged amino acids, and lastly a C-terminal 10 amino 
acids with a predicted P-sheet forming capacity. Proteins destined for the stroma only 
require the transit peptide for correct import and localization (Hand et al., 1989). The 
targeting information of proteins to be imported into the thylakoid lumen is present in 
the form of a bipartite transit peptide, a transit domain for import into the chloroplast 
and a separate domain destining the peptide for import into the thylakoid (Ko and 
Cashmore, 1989). Analysis of protein import of plastocyanin (PC), a chloroplast 
lumenal thylakoid protein, revealed that transport occurs in two steps: import across the 
chloroplast envelope into the stroma, followed by transfer across the thylakoid 
membrane into the lumen (Hageman et al., 1990). The N-terminal peptide of PC is 
removed by two separate processing proteases, the first which removes the chloroplast 
import signal and the second which removes the thylakoid routing signal. The thylakoid 
targeting sequence is short and similar to a bacterial signal sequence (DeBoer and 
Weisbeek, 1991). It contains a few positively charged N-terminal amino acids, a central 
hydrophobic domain then a region containing small uncharged amino acids in -3 and -1 
positions relative to the protease processing site. 
Protein transport into or across the thylakoid membrane is protein specific and 
depends solely on the presence of a trans-thylakoid ApH for some proteins (0E17, 
OE23), or dependent on ATP and ApH (OE33) or ATP only (PC) (Cline et ah, 1992). 
The study of the protein targeting step with gene fusions in vitro is complicated by the 
fact that proper localization only occurs in vivo (DeBoer et al., 1991) which questions 
some of the experimental results on thylakoid import in earlier studies. Proteins located 
in the thylakoid membrane exhibit the same charge assymmetry as other transmembrane 
domain proteins and generally have the more highly charged regions facing the stromal 
site (Gavel et al., 1991). Whether the chloroplast chaperonin 60 functions in unfolding 
of proteins before import into the thylakoids is not known (Lubben et al., 1989). The 
precise import apparatus required for the recognition of chloroplasmic enzymes and 
translocation across into the stroma and sometimes thylakoid has not been 
unambiguously identifed and is thought to be similar to mitochondrial import of 
proteins (de Boer and Weisbeek, 1991). The chloroplast import receptor has been 
identified as an integral membrane protein (Schnell et al., 1990). It also appears that 
different proteins are imported by different mechanisms. 
1.5. Protein Import into Peroxysomes 
The peroxysome, glyoxysome, glycosome and glucosome (microbodies) are small 
related organelles bound by a single membrane which undergo fission or budding to 
multiply. Peroxysomes carry out different metabolic functions that grossly depend on 
cell type and metabolic state of the cell, including catalase dependent reactions, P-
oxidation of fatty acids, the glyoxalate cycle, alcohol oxidation, transaminations and 
purine and polyamine catabolism (Lazarow and Fujiki, 1985). Proliferation of the 
organelle is inducible during certain growth conditions (Erdmann et al., 1991), and 
proliferation occurs by posttranslational import of proteins which divide and form 
daughter peroxysomes. The origin of the membrane is not known, but is probably not 
derived from the endoplasmic reticulum as has been suggested before (Trelease, 1984). 
Peroxysomes are probably degraded in the vacuole (H.L. Chiang, personal 
communication). Peroxysomal proteins are synthesized on free polysomes and most are 
imported posttranslationally not involving any obvious modification (Lazarow and 
Fujiki, 1985; Subramani, 1992). The mechanism of translocation is conserved between 
yeast, plants, insects and mammals and in different microbodies providing evidence for 
a common evolutionary conservation between species and classes of microbodies 
(Gould et al., 1990; Keller et al., 1991; Subramani, 1992). Most peroxysomal proteins 
in insects have the C-terminal tripeptide SKL (Gould et al., 1988; Gould et al., 1989) 
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which is also conserved in mammalian cells (Gould et al., 1990a; Gould et al., 1990b). 
Zellweger cell lines from patients with a peroxysomal disorder are unable to import 
proteins with the SKL targeting signal caused by mutations in different 
complementation groups (Santos et al., 1992; Walton et al., 1992). Another class of 
peroxysomal proteins do not have the C-terminal SKL tripeptide and are not imported 
into peroxysomes by the same mechanism (Kamijo et al., 1992). 3-ketoacyl-CoA 
thiolase has a N-terminal peroxysomal import signal which is cleaved upon 
translocation into the peroxysome, arguing for distict import pathways (Swinkels et al., 
1991). Two mutants have been isolated which are deficient in the assembly of 
peroxysomes (Tsukamoto et al., 1990). 
1.6. The Secretory Pathway 
The secretory pathway in 5. cerevisiae has been defined by the isolation and 
characterization of conditionally lethal mutations in which protein transport is arrested 
intracellularly because surface growth and secretion are linked (Deshaies and 
Schekman, 1987; Ferro-Novick et al., 1984; Holcomb et al., 1988; Novick and 
Schekman, 1979; Novick and Schekman, 1983; Novick et al., 1980; Schekman et al., 
1983). Biochemical and morphological examination of the sec (secretory) mutants 
allowed the classification of the compartments that were affected by each mutation and 
to establish the order of events in secretion (Esmon et al., 1981; Ferro-Novick et al., 
1984; Novick et al., 1981; Kaiser and Schekman, 1990). These pioneer studies 
established unequivocally the proposed secretory pathway from the ER to Golgi to the 
plasma membrane or vacuole. Subsequent studies demonstrated that all secretory and 
plasma membrane proteins travel via the same vesicular intermediates (Brada and 
Schekman, 1988; Holcomb et al., 1988; Tschopp et al., 1984). 
Not all proteins exit the cell by migration through compartments of the secretory 
pathway (Muesch et al., 1990). The a-mating factor is not imported into the ER but 
modified cytoplasmically by proteolytic processing and famesylation and methylation 
of its C-terminal Cys residue (Schafer et al, 1989). The peptide hormone exits the 
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cytoplasm via a putative protein translocation channel encoded by the STE6 gene 
product (Kuchler et al., 1989). A ste6 mutant can be functionally complemented by a 
mammalian multidrug resistance gene which leads to a restoration of a-factor export 
(Raymond et al., 1992). Recent evidence points towards a second late secretory 
pathway from the yeast Golgi apparatus in yeast which is different from the constitutive 
pathway (Lupashin et al., 1992). A 400 kDa heat shock induced glycoprotein has been 
identified whose export to the plasma membrane is dependent on Secl8p but not on 
Sec7p. The protein also does not comigrate with the secretory acid phosphatase in the 
same secretory vesicles. 
A number of heritable pathological defects are caused by perturbations in the 
secretory process, such as the mutation induced misfolding and subsequent retention of 
the type IIA von Willebrand factor involved in haemostasis (Lyons et al., 1992) and the 
tissue dependent missorting of lysosomal proteins in I-cell disease resulting from a 
defective phosphotransferase (Komfeld, 1986). 
1.6.1. Endoplasmic Reticulum 
The endoplasmic reticulum (ER) is a network of interconnected membrane 
lamellae supported by microtubules (Lee et al., 1989). The ER is divided into two 
subsets, the smooth ER and the rough ER where ribosome binding and protein transport 
occurs (Sanderson et al., 1990; Sanderson and Meyer, 1991). The ER is the major site 
of membrane phospholipid biosynthesis, and ER membranes can proliferate in the 
presence of certain protein factors that presumably induce lipid biosynthesis (Schunck 
et al., 1991; Wright et al., 1988). The ER and nuclear envelope are connected to each 
other, a fact that probably ensures partitioning of the ER during mitosis (Yaffe, 1991). 
Protein import into the ER is a multistep process, which requires a number of cytosolic 
and ER membrane factors (Walter and Lingappa, 1986; Walter et al., 1984). Proteins 
destined for the ER, analogous to nuclear encoded mitochondrial proteins, usually have 
a N-terminal signal peptide carrying a positive sorting sequence. Analysis of secretory 
routing signals of different proteins showed that a N-terminal hydrophobic region 
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preceeded by one to three positively charged amino acids contains the necessary 
information. Fusion of N-terminal signal peptides to cytoplasmic proteins showed that 
they were sufficient to cause targeting into the ER. The specificity of the pre-sequence 
appears to be low in yeast, since a significant amount of random sequences can act as a 
secretory pathway routing signal (Kaiser and Botstein, 1990). Carboxypeptidase Y and 
acid phosphatase can even be partially translocated without functional pre-sequence 
(Blachly-Dyson and Stevens, 1987; Haguenauer-Tsapis, 1992). In mammalian cells the 
functional efficiency of a signal peptide is related to its hydrophobicity (Bird et al., 
1990). For instance the yeast vacuolar protein carboxypeptidase Y can only be 
translocated into mammalian microsomes i f one glycine is substituted by leucine which 
increases the hydrophobicity of the signal peptide. Functional signal peptides can adopt 
several structures: highly ordered before association with the signal recognition particle, 
or less ordered when in a lipid environment (Caulfield et al., 1991). Complex 
membrane proteins having several transmembrane domains in E. coli can adapt a 
correct conformation in the absence of a N-terminal export signal (Ehrmann and 
Beckwith, 1991). Thus the first signal does not dominate the insertion process, and there 
are further putative topological signals promoting the assembly of surrounding amino 
acids. Proteins anchored in the ER membrane by an uncleaved signal peptide can 
assume two orientations. Type I signal anchor sequences translocate the N-terminus 
across the membrane, while type 11 signal anchors translocate the C-terminus, using the 
same translocation apparatus (High et al., 1991a). The orientation of the protein in the 
membrane appears to be determined by the charge distribution. Signal anchoring 
sequences occur in the form of a tripartite structure: a hydrophobic core region that 
mediates targeting to and insertion into the ER membrane and flanking hydrophilic 
segments that determine the orientation of the protein in the membrane (Haeuptle et al., 
1989). Not all ER membrane associated proteins have N-terminal transmembrane 
anchors. The nontransmembrane tyrosine phosphatase PTP-IB can localize to the ER 
via its 35 C-terminal amino acids (Frangioni et al., 1992). 
The signal recognition particle (SRP) is an essential component for protein 
translocation (Meyer, 1991; Rapoport, 1991; Walter and Lingappa, 1986). It associates 
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with ribosomes to facilitate the recognition of signal sequences. Upon emergance of the 
signal peptide translocational artest occurs until the ribosone/SRP/nascent protein 
complex is bound to the ER by sequential interaction with the SRP receptor (Meyer, 
1991) . The SRP receptor binds GTP to mediate the release of the signal peptide. 
Subsequent GTP hydrolysis enables the release of the SRP from the SRP receptor 
(Rapoport, 1990). A signal recognition particle is found in yeast. Several of its subunits 
have been identified (Amaya et al., 1990; Hann and Walter, 1991; Stirling and Hewitt, 
1992) . The 54 kDa SRP subunit homologue from mammalian cells has been cloned 
from yeast (Amaya et al., 1990; Hann et al., 1989). It is a 59.6 kDa protein essential for 
efficient cell growth in most yeast strains, and is also highly homologous to the SecY 
protein in E. coll. SRP54 is responsible for both interaction with the signal peptide and 
binding to the RNA of the SRP (High and Dobberstein, 1991; Romisch et al., 1990; 
Walter and Blobel, 1982). It has a GTP binding site, but whether or not GTP hydrolysis 
is associated with signal recognition or assembly of the SRP is not known. This is 
despite the GTP requirement for translocation in mammalian cells (High et al., 1991a; 
Rapiejko and Gilmore, 1992). Another subunit, the SRP19 homolog, has been cloned 
from 5. cerevisiae and characterized (Reid, 1991; Stirling and Hewitt, 1992; Stirling et 
al., 1992). It is encoded by the SEC65 gene and represents a 31.2 kDa protein which is 
responsible for the stable association of the SRP54p with the SRP (Hann et al., 1992). 
The yeast SRP represents a 16S particle that apart from its protein constituents contains 
a small cytoplasmic RNA scRl (Hann and Walter, 1991). Both protein subunits of the 
yeast SRP identified so far are not absolutely necessary for cell growth in certain S. 
cerevisiae strains, although cells with deletions in the cortesponding genes grow pooriy 
(C.S. Stirling, personal communication). 
The affmity of the signal recognition particle for the signal peptide depends on the 
nascent chain length and drops with increasing length (Siegel and Walter, 1988). There 
is evidence that not all proteins that enter the ER are imported via SRP mediated 
translocation, which is cortoborated by the subsequent finding that there are two 
translocation pathways (Greene et al., 1992; Rapoport, 1990; Rapoport, 1991). The 
hypothesized role of the SRP in translational arrest of nascent secretory proteins has 
14 
been suggested to be an artefactual observation in wheat germ cell-free systems (Meyer, 
1985), although subsequent investigations could show that translational arrest was not 
unique to wheat germ translation extracts and was mediated by the SRP (Wolin and 
Walter, 1989). In vivo evidence for translational arrest has been provided by analysis of 
a mutation in the 7S RNA of the SRP of Yarrowia lipolytica which arrests translation 
(Yaver et al., 1992). Translocation in yeast of some proteins (e.g. a-mating factor) can 
occur post-translationally and not involving SRP. It is not known whether this process is 
mediated by polypeptide chain binding proteins (Rothman, 1990). 
Ribosome binding to the ER is dependent on a protease-sensitive factor and is 
believed to be mediated by a ribosome acceptor which so far has escaped successful 
purification (Collins and Gilmore, 1991; Meyer, 1991; Nunnari et al., 1991; Rapoport, 
1991). The SRP receptor located in the ER membrane consits of two subunits. The 
aSRP receptor subunit has an essential GTP binding site participating in efficient 
translocation (Rapiejko and Gilmore, 1992; Wiedmann et al., 1987). This subunit has 
also been hypothesized to represent part of the protein conducting channel based on its 
electric properties (Simon and Blobel, 1991). The assembly of the a and P subunits of 
the SRP receptor on the ER membrane in mammalian cells are independent of SRP 
mediated targeting. It occurs in a two-step mechanism involving the targeting and 
subsequent anchoring of the a subunit to the ER membrane (Andrews et al., 1989). 
Ribophorins I and 11 are believed to be in close proximity to the site of translocation but 
not part of the translocation channel (Rapoport, 1991; Yu al., 1990). 
In vitro translocation assays demostrated that ATP, membrane proteins and 
cytosolic proteins are necessary for translocation into the ER (Hansen et al., 1986; Sanz 
and Meyer, 1989; Waters and Blobel, 1986; Waters et al., 1986). ATP is necessary for 
assembly but not required for the translocation process itself (Levy et al., 1991). Four 
translocation deficient mutants have been isolated (Deshaies and Schekman, 1987; 
Deshaies and Schekman, 1989; Deshaies et al., 1989; Rothblatt et al., 1989; Stirling et 
al., 1992; Toyn et al., 1988). Further analysis established that they are associated in a 
complex, also with two other protein species (Deshaies and Schekman, 1990; Deshaies 
et al., 1991). In yeast, BiP function is required for complete translocation of proteins 
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into the ER (Nguyen et al., 1991). Sec61p, Sec62p and Sec63p are associated with the 
ER membrane (Stirling et al., 1992; Deshaies and Schekman, 1990; Sanders et at., 
1992). Coprecipitation data suggest that Sec62p and Sec63p exist together in a complex 
with a 31.5 kDa glycoprotein and a 23 kDa protein (Deshaies et al., 1991). Biochemical 
coss linking revealed that Sec61p also exists in a complex with the proteins. In addition 
the heat shock proteins Ssalp, Ssa2p and BiP participate in translocation. A recent 
study addressing the molecular basis of the translocation process in yeast dissected 
several sequential processes before and during translocation of polypeptides (Miisch et 
al., 1991; Saunders et al., 1992). The precursor protein makes contact via its signal 
peptide to Sec61p in an ATP dependent manner. Contact with Sec62p, Sec63p and BiP 
occurs simultaneously or just prior to that process. BiP functions a second time to 
advance the secretory protein from an immature complex with Sec61p to a mature 
complex, resulting in translocation across the ER membrane. These findings corroborate 
previous observations that nascent chain translocation, targeting and signal sequence 
insertion are independent processes (Nicchitta and Blobel, 1989). Not all proteins that 
are translocated into the ER depend on Sec61p and Sec63p (Green et al., 1992). Initial 
mutations in SEC61, SEC62 and SEC63 are not impaired in the assembly and 
glycosylation of type n membrane proteins (Stirling et al., 1992). A different approach 
screening for import defective integral membrane proteins also identified SEC6J and 
and a new gene, SEC65 (see above). 
Studies in mammalian cells by cross-linking of secretory proteins in transit 
revealed that the 34 kDa signal sequence receptor (SSRa) identified previously 
(Hartmann et al., 1989; Ichimura et al., 1992; Prehn et al., 1990) is not involved in 
signal sequence recognition but defines the translocation site together with the 22 kDa 
SSRP (Gorlich et al., 1990; Rapoport, 1991). Cross linking of nascent signal peptides 
with controlled reconstituted microsomal membranes identified a 36 kDa protein termed 
TRAM (for translocating chain-associating membrane protein) in close contact with the 
translocating signal peptide. Whether this protein is identical to the previously 
identified 37 kDa protein associated with type I signal anchor domains (High et al., 
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1991b) or the 39 kDa protein encoding the putative translocation mnnel (Krieg et al., 
1989; Thrift et a/., 1991) is not known. 
Removal of the signal sequence occurs upon or immediately after translocation 
and is catalyzed by a signal peptidase located in the ER lumen. The yeast signal 
peptidase is a multimeric complex consisting of the SEC 11 gene product and at least 
one glycoprotein with a molecular mass of 25 kDa (Bohni et al., 1988; YaDeau et al., 
1991) . 
Proteins entering the ER exhibiting the Asn-X-Thr/Ser (X all amino acids but Pro) 
N-linked glycosylation consensus motif are modified by the addition of a complex 
oligosaccharide to the amino group of asparagine (Abeijon and Hirschberg, 1992; 
Komfeld and Komfeld, 1985). Other important glycosylation reactions also are located 
in the ER, such as the addition of glucose residues to high-mannose glycoproteins 
(Hirschberg and Snider, 1987; Kukuruzinska et al., 1987; Trombetta et al., 1991), the 
addition of N-acetylglucosamine residues to Ser or Thr (0-lmked glycosylation) 
(Abeijon and Hirschberg, 1988; Strahl-Bolsinger and Tanner, 1991), and lastly the 
incorporation of glucosamine and mannose into the glycosylphosphatidylinositol (GPI) 
anchor of membrane associated proteins (Conzelmann et al., 1990; Conzelmann et al., 
1992; Doering et al., 1990). The dolichol-linked oligosaccharide precursor is 
synthesized on the cytoplasmic orientated ER membrane (Abeijon and Hirschberg, 
1992) . The stepwise addition of GlcNAc and Man to the dolichol-lipid anchor occurs 
until GlcNAc2Man5 is formed. The oligosaccharide is attached to the dolichol via a 
diphosphate linkage. At this stage translocation into the ER lumen occurs. The 
GlcNAc2Man9Glc3 core-oligosaccharide is synthesized in the ER lumen by addidion of 
four more mannose residues and subsequent addition of three glucose residues. The 
dolichol-P-P-GlcNAc2Man9Glc3 acts as donor of the oligosaccharide to the nascent 
protein, after which the remaining dolichol-P returns to the cytoplasmic side of the ER 
membrane. Three yeast ER glycosyl transferases as well as the Sec59 protein have a 13 
amino acid membrane spanning peptide in common that specifically recognizes the 
isoprenoid region of dolichol phosphate (Albright et al., 1989). The fact that mutations 
in SEC53 and SEC59 are conditionally lethal suggests that some aspect of glycosylation 
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is an essential process (Bernstein et al., 1989b; Feldman et al., 1987). Sec59p is located 
in the ER membrane and is involved in the folding and glycosylation of proteins in the 
ER lumen. The core oligosaccharide is modified by glucosidases I and n which trim the 
mannose linked glucose, and subsequently by an a-mannosidase which trims 1 mannose 
residue (Roth et al., 1990). The removal of the glucose residues from the core 
oligosaccharide is an essential reaction in mammalian cells, but is not essential in yeast 
(Esmon etal, 1984). 
In mammals, 0-linked glycoproteins receive N-acetylglucosamine from N-
acetylglucosamine transferases on the cytoplasmic as well as the lumenal side of the ER 
membrane using UDPGlcNac as a donor. In yeast the first mannose is transferred from 
dolichol-P-Man to serine or threonine residues, and up to 4 additional mannose residues 
are transferred from GDP-Man in the Golgi (Kukuruzinska et al., 1987). A number of 
cell surface proteins are attached to the membrane via a GPI anchor. This consists of 
phosphatidylinositol-glucosamine-mannose3-ethanolamine phosphate of which the 
ethanolamine component is linked to the a-carboxyl group of the C-terminal amino acid 
of the protein. The mannose constituents of the GPI anchor are synthesized and attached 
involving phosphomannomutase, an essential yeast protein (Sec53p) (Conzelmann et 
al., 1990). The phosphatidylinositol lipid moiety of the anchor is exchanged with a 
ceramide in a post ER compartment during protein traffic (Conzelmann et al., 1992). 
The fate of most proteins entering the ER is secretion. Resident ER proteins can 
exit the ER but are retrieved from a subsequent compartment, probably identical with 
the cis Golgi compartment (Hsu et al., 1991; Pelham, 1988; Pelham, 1989a). Retention 
of resident ER enzymes is cell type dependent, and certain cell lines have normally ER 
located enzymes present in a post Golgi compartment (Brada et al., 1990). In S. 
cerevisiae, the C-terminal tetrapeptide HDEL functions as an ER retention signal that is 
necessary and sufficient for localization of proteins in the ER (Pelham et al., 1988; 
Pelham, 1990; Warren, 1990a). HDEL carrying proteins are able to exit the ER and are 
retrieved from an early Golgi department judged by their Golgi specific carbohydrate 
modification by al-6 mannosyl transferase but not by al-3 mannosyl transferase (Dean 
and Pelham, 1990). Since retention is a saturable event, it is likely to be mediated by a 
18 
specific sorting receptor. Two mutants defective in ER retention, erdl and erdl, have 
been isolated (Pelham et al., 1988). Erdlp acts in the Golgi compartment and is 
required for correct glycoprocessing in the Golgi apparatus. The Golgi defect probably 
accounts for its erd phenotype and provides indirect evidence that the retrieval of ER 
proteins occurs in the Golgi apparatus. The protein product encoded by ERD2 
represents the sorting receptor for luminal ER proteins. The binding specificity of the 
sorting apparatus has been altered by introducing point mutations into the putative 
binding site of Erd2p (Semenza and Pelham, 1992). Expression of the Kluyveromyces 
lactis ERD2 gene in S. cerevisiae allows the retention of proteins with C-terminal 
DDEL, usually not recognized by the 5. cerevisae ERD2 encoded receptor (Lewis et al., 
1990; Semenza et al., 1990). A human homolog, hERD2, with similar properties has 
been identified (Lewis and Pelham, 1992) which differs from a 72 kDa protein also 
believed to participate in retention (Vaux et al., 1990). Mutations in the hERD2 receptor 
alter its ligand specificity providing further evidence that hERD2 protein is the KDEL 
receptor and not a protein disturbing the sorting process. C-terminal KDEL sequences 
do not absolutely retain proteins in the ER but retard their secretion several-fold 
(Zagouras and Rose, 1989). 
Membrane associated proteins usually resident in the ER have different signals 
present in the form of complex spatial arrangements and charged residues adjacent to 
transmembrane spanning domains, including a conserved Lys in the -3 position and a 
positively charged amino acid in the -4 or -5 position from the C-terminus (Gabathuler 
and Kvist, 1990; Jackson et al., 1990). Unlike the retention of soluble ER proteins, the 
retention of transmembrane ER proteins is not saturable, arguing against a receptor 
mediated process (Jackson et ah, 1990). So far only one transmembrane ER protein, 
Sec20p, has been analyzed in yeast which has the C-terminal consensus HDEL and is 
sorted by the HDEL retrieval system (Sweet and Pelham, 1992). It has been suggested 
that the protein acts in ER to Golgi transport and subsequently is retrieved from the 
Golgi to function in a subsequent round of vesicle traffic. Why is Sec20p retrieved from 
the Golgi apparatus rather than retained like other transmembrane proteins resident in 
the ER? One possible explanation is that Sec20p associates with the cytoskeleton to 
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mediate efficient transport to the Golgi and then is retrieved by the HDEL receptor 
(Sweet and Pelham, 1992). Annother possibility is that Sec20p functions in the retrieval 
or budding of retrograde transport vesicles from the Golgi. This may occur by 
associating with filaments because a genetic interaction between sad and sec20 has 
been shown (Cleves et al., 1989). This hypothesis would explain the erd pheneotype 
observed in sec20 mutants at the non-restrictive temperature. 
The ER is involved in degradation of aberrant proteins in an orderly, Ca^ "*" 
dependent fashion (Tsao et al., 1992). The selective breakdown of newly synthesized 
proteins retained within the ER is mediated by the specific recognition of structural 
features by components of the degradative system (Bonifacino et al., 1991; Stafford and 
Bonifacino, 1991). The introduction of two basic amino acids in certain positions into 
the transmembrane domain of the a chain of the multi-subunit T cell antigen receptor 
wil l result in retention and rapid degradation of the protein in the ER. These and similar 
studies (Cosson et al., 1991) have shown that membrane protein association can occur 
by adequately located opposite intramembrane charge pairs. Some cell lines have 
specific resident ER proteins that bind to protein monomers and protect them from 
proteolytic cleavage before they form homopolymers (Clarke et al., 1991) or that the 
formation of heteropolymers prevents the degradation of labile proteins (WUeman et al., 
1990a; Wileman et al., 1990b; WUeman et al., 1991a; Wileman et al., 1991b). The 
correct folding of proteins seems to be crucial for subsequent transport from the ER 
(Rose and Doms, 1988). Misfoided proteins are bound to binding protein (BiP) and are 
selectively retained in the ER until proteins adopt the correct folded conformation (de 
Silva et al., 1990; Dorner et al., 1987; Hurtley and Helenius, 1989; Marquardt and 
Helenius, 1992; Navarro et al., 1991; Singh et al., 1990; Suh et al., 1989; Taniyama et 
al., 1992). BiP can exist in three diffemt modified forms depending on the metabolic 
state of the cell, complexed to other proteins, as free unmodified monomer or as free 
phosphorylated aggregates (Freiden et al, 1992). This indicates a putative modulation 
other than by induction of biosynthesis in the presence of incorrectly folded proteins in 
the ER. There is evidence that Ca2+ acts in the retention of reticuloplasmins in 
mammalian cells, and the infroduction of Ca2+ ionophores will result in the secretion of 
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reticuloplasmins rather their selective retention in the ER (Booth and Koch, 1989). Ca^ "*" 
also can change the oligomerization properties of ER proteins (Poruchynsky et al., 
1991; Sambrook, 1990). A decrease in Ca2+ levels can also dissociate proteins bound to 
BiP and thus no longer prevent the retention of incorrectly folded proteins (Suzuki et 
al., 1991). Depletion of Ca^^ can also accelerate protein degradation in the ER 
(WUeman et al., 1991a; Wielean et al., 1990c). 
BiP mediated retention of misfolded or incompletely assembled proteins involves 
the exit from the ER and subsequent retrieval from the cis Golgi compartment (Hsu et 
al., 1991). The problem of how BiP can distinguish folded from unfolded proteins has 
been directly addressed by identifying peptide sequences that BiP binds to (Flynn et al., 
1991) . Heptameric random polypeptides bound preferentially but not exclusively to BiP 
when alipathic amino acids were present. A comparison of energy fingerprints between 
the heptamers and proteins suggests that BiP will bind to stretches of amino acids 
usually found inside folded proteins but also with smaller affinity to other random 
peptide sequences. The ATP requirement for activation of BiP is matched by 
translocation of ATP into the ER lumen via a specific translocator (Clairmont et al., 
1992) . 
1.6.2. ER to Golgi Transport 
Transport from ER to Golgi is mediated by vesicular intermediate transport 
vesicles (Beckers et al., 1990; Groesch et al., 1990; Hicke and Schekman, 1990; 
Holcomb et al., 1987; Kaiser and Schekman, 1990; Lodish et al., 1987; Rexach and 
Schekman, 1991; Warren, 1990b; Wilson et al., 1991) and can be divided into at least 
three distinct steps: vesicle budding, vesicle targeting and vesicle fusion which are all 
defined by distinct gene products and requirements in an in vitro assay. Epistasis 
analysis identified mutants which are defective in budding off vesicles from the ER 
{secll, secl3, secl6 and sec23) and fusion of vesicles with the Golgi (seel?, secl8 and 
sec22) (Kaiser and Schekman, 1990). Several mutations are lethal in combination, 
suggesting cooperation between different gene products. ER derived vesicles (EDVs) 
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bud off from the endoplasmic reticulum in a defined manner involving several gene 
products (d'Enfert et al., 1991a; Melan9on et al., 1991; Rexach an Schekman, 1991). 
The function of Secl2p and Sarlp has been closer examined. Secl2p is a type n 
integral membrane protein resident in the ER which genetically and physically interacts 
wih Sarlp (d'Enfert et al., 1991b; Nakano et al., 1988). Sarlp attaches to the membrane 
via Secl2p and mediates vesicle budding during or immediately before GTP hydrolysis 
(d'Enfert et al., 1991b). Detailed insight about the secretory pathway comes from in 
vitro reconstitution assays allowing the dissection of individual steps of vesicle budding 
and fusion (Baker et al., 1988; Baker et al., 1990; Beckers et al., 1990; Balch et al., 
1987; Haselbeck and Schekman, 1986; Oka et al., 1991; Rexach and Schekman, 1991; 
Ruohola et al., 1988; Schwaninger et al., 1991). Whether an intermediate functional 
compartment exists between the ER and the cis Golgi compartment (Schweizer et al., 
1991), or whether transport vesicles represent this compartment is not known. Transport 
is dependent on ATP, cytosol and is inhibited by GTPyS. It also depends on functional 
SEC gene products (Baker et al., 1988; Baker et al., 1990; Rexach and Schekman, 
1991). A number of GTPases have been found to regulate specific stages of vesicle 
budding, targeting and fusion in the secretory pathway by a mechanism that is different 
from that of signal transduction (Balch, 1990; Bourne, 1988). The transport steps from 
ER to Golgi are no exception, involving Arf lp , Betlp, Boslp, Bos2p, Sarlp and Yptlp 
(Nakano and Muramatsu, 1989; Newman and Ferro-Novick, 1987; Nigam, 1990; Oka et 
al., 1991; Shim et al., 1991). Excepting Sarlp, these small GTP binding proteins (smgs) 
have not been studied in detail. Based on the genetic interaction between their structural 
genes, Betlp, Boslp and Sec22p probably interact to promote transport from the ER to 
the Golgi complex (Newman et al., 1990). GTPases have a conserved structure and 
function associated with conformational changes during GTP hydrolysis (Downward, 
1990; Jumak et al., 1990; Prive et al., 1992; Uhl et al., 1990; Wittinghofer and Pai, 
1991). Most undergo isoprenylation dependent membrane attachment via their C-
terminal CXXX tefrapeptide (Kinsella and Maltese, 1991; Spiegel et al., 1991). It has 
been suggested that smgs participate in conferring directionality of the reaction step 
they mediate similar to the action of EF-Tu in protein synthesis (Bourne et al., 1990; 
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Bourne et al., 1991; Limmer et al., 1992; Plumer et al., 1991). This hypothesis has not 
been tested yet since no in vitro system was available to follow the proposed molecular 
switch of the smgs. 
Yptlp, a ras-like small OTP binding protein whose OTP binding domain is 
essential for functioning probably confers targeting information to the EDVs (Segev et 
al., 1988; Wagner et al., 1987). yptl mutants are defective in transport between ER to 
Golgi and loss of Golgi function (Bacon et al., 1989). While the loss of Yptlp function 
in vivo is repressible by the addition of Ca2+ the Yptlp function in an in vitro transport 
reaction can only be restored by the addition of cytosol by not by Ca^ "*". This argues for 
the primary function of Yptl protein in transport (Bacon et al., 1989; Baker et al., 1990) 
rather than the regulation of Ca2+ levels (Schmitt et al., 1988) or the cell cycle (Segev 
and Botstein, 1987). The yptl mutation can also be suppressed by mutations in ATPases 
reducing the cytoplasmic Ca2+ concentration (Rudolph et al., 1989). Yptlp GTPase 
activity is regulated by a specific effector, yptGAP, a protein interacting with the 
effector domain of Yptlp (Becker et al., 1991). The yptGAP has not been identified, but 
a homologous isolate from mammalian cells is active with Yplp or rablp as specific 
substrates. There is evidence that p21' '^ is affected by different GAP activities (Bollag 
and McCormick, 1991). Whether GTP hydrolysis in smgs in the secretory pathway are 
subject to stimulation by GAPs is not known, nor is the function of GAPs in the 
secretory pathway. Four suppressors of a A.yptl strain, SLYl, SLY2, SLY12 and SLY41, 
have been isolated and characterized (Dascher et al., 1991). While SLY12 is identical to 
BETl a gene involved in vesicle transport and fusion, the nature of the other suppressor 
genes in not known although they might function in the regulation of Yptlp activity and 
genetically interact (Ossig et al., 1991). sly2 mutants accumulate aberrant ER structures 
at a non-permissive temperature. 
Sec7p, a protein previously reported to act within vesicular Golgi traffic, has 
recently been shown to be involved in ER to Golgi fransport (Franzusoff et al., 1992). 
Sec7p coats ER to Golgi intermediate transport vesicles and anti-Sec7p antisera 
inhibited ttansport in an in vitro ttansport reaction. sec7 mutants accumulate Golgi 
sfructitfes at the nonpermissive temperature indicative of a Golgi transport defect which 
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has been confirmed by a biochemical Golgi analysis (Franzusoff and Schekman, 1989). 
The combined results suggest that Sec7p acts at multiple stages in vesicular transport 
including the step from ER to Golgi, and that there may be a bypass for ER to Golgi 
transport because Golgi compartments accumulate despite the transport defect from ER 
to Golgi. Alternatively, the anti-Sec7p antisera could recognize features of ER to Golgi 
intermediates by cross-reactivity or by direct association with phospholipid epitopes. 
For instance, Usolp is a protein hypothesized to function in the ER to Golgi transport 
pathway (Nakajima et al., 1991). The protein is very similar in size to Sec7p and also is 
a highly charged protein. Since highly charged regions in proteins are likely to be 
highly antigenic, antibodies binding to Sec7p could recognize other proteins with 
similar regions, although in case of Sec7p the antibody was raised against a region of 
the protein which did not include the extremely acidic N-terminal region of Sec7p 
(Franzusoff et al., 1991a). This hypothetical cross-reactivity of the antibody between 
Sec7p and Usolp could account for the immuno-isolation of EDVs. 
Sec23p acts in the cytoplasm as a member of a multiprotein complex to promote 
protein fransport from the ER to the Golgi (Hicke and Schekman, 1989; Orci et al., 
1991a). Other cytosolic factors in the intermediate transport have been identified 
(Wattenberg et al, 1990). Efficient ER to Golgi traffic requires K+ ions for fusion of 
EDVs with the Golgi apparatus (Judah et al., 1989), as well as Ca2+ ions and ATP 
(Kuznetsov et al., 1992; Rexach and Schekman, 1991). The molecular function 
underlying the cation requirements remains obscure. There is evidence that efficiency of 
transport is determined by cytoskeletal factors such as Usolp (Nakajima et al., 1991). 
Whether such proteins act as a motor from the ER to Golgi as basis for vesicle transport 
is unlikely because transport reactions can be reconstituted in vitro in the absence of 
microtubules. It appears likely that Usolp is a coat protein of EDVs or involved in 
scision processes. Evidence from mammalian cells suggests that a 58 kDa Golgi 
membrane protein migrates along microtubules from ER to Golgi and might bind ER 
and Golgi vesicles to microtubules to allow efficient transport (Saraste and Svensson, 
1991; Saraste fl/., 1987). 
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Fusion of EDVs with the Golgi apparatus requires the presence of the SEC 18 gene 
product, the yeast equivalent of the N-ethylmaleimide sensitive factor (NSF) (Beckers 
et al., 1989; Wilson et al., 1989). The same fusion protein is required for subsequent 
fusion events within the Golgi apparatus (Malhofra et al., 1988) and endocytic vesicle 
fusion events (Diaz et al., 1989). There is evidence that SeclSp might be required for 
transport of some proteins but not for others. The transport of the high glucose affinity 
carrier depends on functional SEC gene products and is not localized to the plasma 
membrane in a number of sec mutants with the exception of sec!8 cells (Bisson, 1988). 
Not all vesicles derived from the ER are transported to the Golgi but some 
participating in cholesterol transport can bypass the Golgi apparatus and fuse with the 
plasma membrane directly (Urbani and Simoni, 1990). 
1.6.3. Golgi Apparatus 
The Golgi represents a defmed structure in mammalian and plant cells with 
several cistemae arranged in an orderly fashion (Rambourg et al., 1981; Rothman, 
1981). The Golgi in yeast cannot be visualized by electron microscopy under 
physiological conditions in wild type cells, probably because the membrane traffic 
occurs at a high turnover rate. It does, however, form cistemae in sec7 and secM 
mutants at a non-permissive temperature in low glucose medium. Using antibodies 
against Sec7p and Kex2p, the Golgi apparatus has been immunolocalized in S. 
cerevisiae (Franzusoff et ah, 1991b). The molecular mechanism of transport through the 
Golgi complex is higly conserved between yeast and mammalian cells as demonstratd 
by the rescue of in vitro intercompartmental transport of cytosol deprived Golgi 
membranes from mammalian cells by yeast cytosol (Dunphy et al., 1986). The kinetics 
of glycoprotein as well as glycolipid transport are very similar and thought to occur by 
the same mechanism (Dawidowicz, 1987; Wattenberg, 1990). 
A novel 58 kDa protein has been identified in mammalian hepatocytes that is 
located on the Golgi membrane and associates with microtubules in vitro and in vivo 
(Bloom and Brashear, 1989). Although microtubules maintain structural integrity of the 
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Golgi compartment, they are not required in the determination of polarity or vesicular 
fraffic (fida and Shibata, 1991; Kreis, 1990; Skoufias et al., 1990; Turner and Tartakoff, 
1989). Time lapse photography revealed that tubulovesicular processes emerge from the 
trans Golgi and migrate along microtubules to link with other trans Golgi elements. At 
the same time vesicular structures bud off the Golgi and migrate along microtubules at a 
comparable rate (Cooper et al., 1990). These tubules do not inter-connect ER, cis and 
middle Golgi, imposing the question why heterologous compartments are unable to fuse 
in a comparable manner. 
The Golgi apparatus in eukaryotes undergoes mitosis dependent reorganization to 
ensure its inheritance (Warren, 1989). It vesicularizes during mitosis and the second 
meiotic metaphase, and processes such as secretion are arrested (Colman et al., 1985). 
However, transport from ER to Golgi is not disabled (Ceriotti and Colman, 1989). This 
implies that the structural feature "Golgi" is not important at least in accepting ER 
derived transport intermediates and fusion still can faithfully occur in a vesicularized 
Golgi. Why do cells have a highly structured Golgi i f certain reactions can be 
maintained in vesicular Golgi compartments, like in S. cerevisiael One possibility is 
that transport between stacked compartments is more efficient and allows the stepwise 
progression of secretory enzymes more quickly than would be the case in randomly 
distributed organelles. The mechanism underlying the vesicularization of the Golgi 
apparatus is speculative at present. A 57 kDa Golgi associated protein has been 
identified that undergoes mitosis dependent phosphorylation and relocation (McMorrow 
et al., 1990). The phosphorylation is mediated by p34^^'^, and a model has been 
proposed that relies on the continuation of budding of Golgi vesicles while fusion is 
inhibited as a result of the phosphorylation (Warren, 1989). Fragmented rat Golgi can 
reassemble in Xenopus oocytes raising hopes that the assembly process can be 
reconstituted (Paiement etal., 1989). 
The Golgi apparatus in yeast has been examined biochemically and represents at 
least three distinct membrane enclosed compartments (Franzusoff and Schekman, 
1989b). The cis and trans compartments are defmed by al-6 mannosyltransferase I 
activity and Kex2p activity (Julius et al., 1983; Redding et al., 1991; Wilcox and Fuller, 
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1991), respectively, and can be separated by density gradient fractionation 
(Cunningham and Wickner, 1989). A number of sequential glycosylation reactions 
involving a number of al-6, a l-2 and al-3 mannosyltransferases occur in the Golgi but 
whether each requires a separate membrane enclosed compartment is not known 
(Farquhar, 1985; Fransuzoff and Schekman, 1989; Hirschberg and Snider, 1987; 
Komfeld and Komfeld, 1985; Kukuruzinska et al., 1987; Tanner and Lehle, 1987). In 
mammals and yeasts, core glycosylated glycoproteins are terminally modified by 
galatosyltransferases located in a late Golgi compartment (Chappell and Warren, 1989; 
Watzele et al., 1991). Also, tyrosine sulfation, a modification promoting efficient 
transport, takes place in the trans Golgi compartment (Friederich et al., 1988). The 
trans Golgi in yeast represents the compartment where the sorting of vacuolar proteins 
takes place. The maturation of the a-factor precursor involving the excision of the four 
repeated peptide sequences representing the mature peptide (Kurjan and Herskowitz, 
1982) is catalyzed by the KEX2 protein product (Achstetter and Wolf, 1984; Julius et 
al., 1984), a reaction which has been localized to a late Golgi compartment. Dipeptidyl 
aminopeptidase A, another enzyme participating in the proteolytic processing of the a-
factor, is localized in the Golgi apparatus, as is carboxypeptidase ysca (Achstetter and 
Wolf, 1984). Together the three proteinases process the a-factor precursor to the mature 
13 amino acid secreted polypeptide. DPAP A and Kex2p are localized in the late Golgi 
and are retained in this compartment by a retention signal (Raymond et al., 1992). The 
Kex2p compartment has been identified to be the sorting compartment where vacuolar 
proteins are sorted from secretory proteins (Graham and Emr, 1991). Recycling of 
resident Golgi proteins might occur analogously to the ER recycling pathway and there 
is evidence that Kex2p is recycled from an intermediate compartment between the trans 
Golgi and secretory vesicles, possibly involving clathrin coated vesicles (Bowser and 
Novick, 1991; Payne and Schekman, 1989). Whether the recycling occurs via the 
plasma membrane or through an intermediate vesicular recycling compartment is not 
known. 
Intra Golgi traffic has been reconstituted in vitro (Pfeffer and Rothman, 1987; 
Rothman and Orci, 1992). It is mediated by non-clathrin coated vesicular transport 
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intermediates that bud off and fuse with the subsequent comparment and is dependent 
on a number of proteinous factors, GTP, ATP and Ca^^ (Farquhar, 1985; Kobayashi 
and Pagano, 1988; Malhotra et al., 1989; Orci et al., 1989; Persson et al., 1988; Persson 
et al., 1992; Rothman and Orci, 1992). It shares the requirement for SeclSp and Sec23p 
with the transport from ER to Golgi, indicative that the two protein products mediate 
processes common to general budding and fusion processes in different compartments 
(Graham and Emr, 1991). Infra Golgi vesicles have been purified and their coat proteins 
isolated (Malhofra et al., 1989; Serafmi et al., 1991). The coat proteins (COPs) include 
a-COP (170 kDa), P-COP (110 kDa), y-COP (98 kDa), 5-COP (61 kDa) and the smg 
ARFlp (21 kDa). Purification of native p-COP showed that it existed in an 
approximately 700 kDa complex, the coatomer, which promotes vesicle budding 
(Rothman and Orci, 1992). The protein also shares homology with P-adaptin (Duden et 
al., 1991b). Coat proteins are found in yeast, including a-COP (Secl6p), P-COP (pl05 
bound to Sec23p), y-COP (Sec23p), 5-COP (Sec21p), p36 (Secl3p), p20 (Secl2p) and 
ARFl , arguing for a conserved mechanism of non-clathrin coated vesicle formation 
(Rothman and Orci, 1992). Clathrin coated vesicles associated with the Golgi apparatus 
link the clathrin coat to membrane associated proteins via a y-adaptin/P'-adaptin dimer. 
Based on protein sequence analysis the y-adaptin is similar to a-adaptin mediating 
binding of clathrin to coated pits (Robinson, 1990) and probably performs a similar 
function. 
Selective depletion with controlled reconstitution of Golgi membranes has 
identified three peripheral membrane proteins required for vesicular transport including 
NSF and two fractions of 500 kDa (Frl) and 40 kDa (Fr2) (Clary and Rothman, 1990). 
The fusogenic activity has been attributed to three individual closely related proteins of 
35, 36 and 39 kDa, a-SNAP, P-SNAP and y-SNAP, respectively (SNAP for soluble 
NSF attachment proteins) which is capable of binding to Golgi membrane as well as an 
integral membrane receptor (Clary et al., 1990; Weidman et al., 1989). NSF only binds 
to SNAPs in the presence of the integral receptor to form a 20S multisubunit protein 
complex (Wilson et al., 1992). y-SNAP has a distinct binding site to that of a- and p-
SNAP, which themselves are equivalent, alternative subunits of the particle. The correct 
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assembly of this protein complex preceeds the actual fusion process. Also, fatty 
acylation promotes the budding and fusion of transport vesicles with Golgi cistemae by 
an unknown mechanism (Pfanner et ah, 1989; Pfaimer et al., 1990). The fatty acyl-CoA 
is required after uncoating and NSF binding but before the actual fusion process. The 
same pathway operates in yeast based on the fmding that Secl7p and a-SNAP are 
exchangeable. In Golgi membranes a- and P-SNAP bind competetively to a common 
site, whUe y-SNAP binds to a different site (Rothman and Orci, 1992). The a/p-SNAP 
membrane protein receptor is either the same protein as the y-SNAP receptor or is non-
covalently associated with it. Upon Golgi membrane association the SNAP complex can 
associate with NSF to form a fusogenic complex which disassociates after ATP 
hydrolysis, possibly of the NSF bound ATP. The molecular mechanism of membrane 
fusion is not understood, and it appears that a number of proteins have to lower the 
repulsive forces between different membrane compartments (Stegmann et al., 1989). 
smgs also perform an essential role in 5. cerevisiae and mammalian inter Golgi 
transport (Goud et ah, 1990). rab6p and ARFlp are two mammalian smgs hypothesized 
to act within the Golgi stack to promote some unknown function (Rothman and Orci, 
1992). It can be envisaged that they act analogously to Sarlp in ER to Golgi vesicle 
budding. ARFlp has been suggested to cycle between membrane bound (myristoylated) 
and cytosolic forms dependent on the uptake or hydrolysis of GTP. It might associate 
and disassociate coat proteins during this cycle. Al l rab homologues are hypothesized to 
bear targeting information. Trimeric G-proteins are also involved in the formation of 
secretory vesicles from the trans Golgi network as has been examplified by [A1F4]" 
inhibitor studies (Barr et ah, 1991; Kahn, 1991) and exert inhibitory control on transport 
vesicle coating and vesicle formation. 
The fact that Secl4p (Bankaitis et al., 1989), a protein blocking intra Golgi 
transport, is identical to a phospholipid transfer protein (Bankaitis et al., 1990) suggests 
that either Secl4p involves the retrieval of acidic phospholipids and relocalization to 
the ER, or that the protein delivers phosphatidyinositol (PI) and/or phosphatidylcholine 
(PC) to the late Golgi. Mutations in specific aspects of phosphatidyl choline 
biosynthesis can bypass the essential requirement for Secl4p (Cleves et al., 1989; 
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Cleves et al., 1991) suggesting that a reduction of PC in the Golgi is required to permit 
secretion to occur (Cleves et al, 1991). The whole story is even more complicated by 
the fact that a genetic repressor of a ts actin mutation, a sad mutation, also suppresses 
the cell's requirement for functional Secl4p. Saclp is an actin bundling protein 
organizing the cytoskeleton and acts as an antagonist to Secl4p function and actin 
assembly. It is an integral membrane protein (Cleves et al., 1989) of the ER and Golgi 
(A.E. Cleves, unpublished results). The mammalian actin binding proteins profilin and 
gelsolin have a higher affinity for PI 4-phosphate and PI 4,5-bisphosphate than actin 
(Goldschmidt-Clermont et al., 1990). It has been proposed that such actin binding 
proteins sequester phosphoinositides, and that this interaction of actin binding proteins 
with phospholipids represents an important aspect of a mechanism by which actin 
polymerization and phospholipid mediated signalling may be regulated. 
Studies addressing the selective retention of Golgi proteins suggest that C-
terminal cytoplasmic polypeptides (Armstrong and Patel, 1991; Hopkins, 1992) as well 
as transmembrane domains (Armsfrong et al., 1990; Machamer and Rose, 1987; 
Machamer et al., 1990; Swift and Machamer, 1991; Wong et al., 1992) are responsible 
for the correct retention in the Golgi compartment. The first 44 amino acids of a-2,6-
sialyltransferase, a type n resident Golgi protein, specifies retention in the trans Golgi 
and TGN (Munro, 1991). Both the transmembrane domain as well as adjacent 
cytoplasmic regions are involved in the selective retention. Whether these retention 
patches are recognized by a protein mediating retention or function in the formation of 
homomultimers is not known at present. The release of dimers/multimers during mitosis 
could be mediated by phosphorylation of the cytoplasmically orientated accessory 
domains which subsequently dissociate because of repulsive equal charges (G. Warren, 
op. citation). The cytoplasmic transmembrane spanning domains and 10 amino acids of 
the lumenal domain of P-l,4-galactosyltransferase are sufficient to retain a protein 
fusion in the Golgi apparatus (Nilsson et al., 1991). The cytoplasmic domain plays an 
accessory role in the retention of the Golgi protein but not in determining 
compartmental specificity of retention. A 58 kDa transmembrane protein located in the 
cis Golgi of hepatocytes is not terminally glycosylated by the trans Golgi glycosyl 
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transferases. This provides evidence that it is not recycled from a trans Golgi 
compartment but never exits the cis Golgi compartment (Hendricks et al., 1991). 
Brefeldin A (BFA), a fungal metabolite, disrupts the Golgi stack by an unknown 
mechanism (Lippincott-Schwartz et al., 1990) involving the selective dissociation of a 
110 kDa pripheral membrane protein identical to P-COP and a so far unknown 200 kDa 
protein from the Golgi apparatus (Burgess et al., 1991; Donaldson et al., 1991; 
Klausner et al., 1992; Lippincott-Schwartz et al., 1989; Narula et al., 1992; Orci et al., 
1991b) during which resident Golgi proteins are relocalized to the ER in a reversible 
reaction and budding from the ER is inhibited (Ulmer and Palade, 1989; Ulmer and 
Palade, 1991). Proteins retained in the ER were not sialic acid modified, although they 
acquired the conversion from high mannose forms to complex type structures 
characteristic for early and middle Golgi modifications (Doms et al., 1989; Lippincott-
Schwartz et al., 1989). These findings together with the fact that sialyltransferase is not 
relocated to the ER suggest that enzymes in the trans Golgi and/or trans Golgi network 
are not affected by brefeldin A in the same way the cis and medial Golgi are (Chege and 
Pfeffer, 1990). BFA exerts a similar membrane rearrangement within the 
endosomal/lysosomal fransport system involving the selective fusion of the central 
vacuolar system via tubule formation of the TGN and subsequent fusion with 
endosomes (Lippincott-Schwartz et al., 1991; Reaves and Banting, 1992; Wood et al., 
1991). The association/dissociation process of the 110 kDa P-COP with the Golgi 
apparams is regulated by AIF4" sensitive GTPases and perturbed by BFA by 
interference of the association process (Donaldson et al., 1991). ATP also participates 
in the association of the 110 kDa protein with the Golgi, and a depletion led to the 
release of the 110 kDa protein without fiision of the Golgi with the ER (Donaldson et 
al., 1990). GTPyS treatment could reverse ATP depletion induced disassociation of the 
110 kDa protein (Donaldson et al., 1991) and antagonize BFA induced retrograde 
fransport (Tan et al., 1992). Mastoparan, an activator of heterotrimeric GTPases, 
promotes the binding of P-COP to Golgi membranes and antagonizes the effect of BFA 
(Ktistakis et al., 1992). Together with the fact that A1F4- promotes the binding of p-
COP to the membrane these data suggest that the membrane association of P-COP is 
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regulated by heterotrimeric GTPases, possibly ARFl (Klausner et al., 1992). The 
failure to form non-clathrin coated vesicles might be accompanied by NSF mediated 
fusion of Golgi compartments with each other to allow the formation of a network (Orci 
et al., 1991). The fusion of the BFA induced Golgi network with the ER might rely on 
the formation of retrograde tubules. Whether these tubules represent exaggerated 
retrograde tubules present in all cells (Klausner et al., 1992; Lippincott-Schwartz et al., 
1990) or aberrant strucmres resulting from the missing association of the Golgi 
coatomer (Pelham, 1991) is not clear. It seems plausible that the coatomer in untreated 
cells will prevent the fusion of bulk membranes with compatible membranes and also 
mediate controlled vesicular budding. In BFA treated cells the coatomer is not 
associated with the Golgi compartments any more, and normal budding is no longer 
possible. The now mbular extention where vesicle budding previously occurred will 
fuse with a compatibele membrane in a reaction that requires ATP. This model awaits 
stepwise analysis in vitro as does identifying the target of BFA. The fusion of the 
central vacuolar system is not dependent on the provision of ATP (Reaves and Banting, 
1992) which can be explained by the analogy that Golgi to vacuole in yeast does not 
require the SEC18 encoded general fusion protein (Graham and Emr, 1991). 
The validity of the above suggested pathway has been questioned because a 
disorganization of both cis/middle and trans Golgi after brefeldin A treatment was 
observed (Alcalde et al., 1992). Upon removal of brefeldin A the cis/middle located 
proteins exit the ER from the cis/middle compartment via a vesicular intermediate. The 
reorganization of the trans Golgi compartment was dependent on the presence of the 
earlier Golgi compartments through which translocated proteins have to migrate. Since 
the latter studies were based on morphological observations whereas the others were 
based on biochemical studies this apparent discrepancy can be explained by assuming 
that forward fransport from frans Golgi through the TGN to the cell surface still can 
occur thus depleting the structural feature independent of BFA action. Other evidence 
suggests that BFA acts selectively in some cell lines, because MDCK cells did not show 
the BFA dependent dissociation of the 110 kDa P-COP and subsequent morphological 
changes (Hunziker et al., 1991). BFA has no obvious effects on protein trafficking in 
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the secretory pathway in yeast (R.W. Schekman, personal communication), possibly 
because of the limited host range of BFA or differences in the molecular target of BFA. 
1.6.4. Transport from Golgi to Vacuoles/Lysosomes 
The majority of S. cerevisiae vacuolar protein constituents described so far are 
delivered to the vacuole in transit through the secretory pathway (Klionsky et al., 1990; 
Raymond et al., 1992; Schekman, 1982; Stevens et al., 1982). The details of sorting, 
delivery and function of the constituents as well as the integrated role of the vacuolar 
compartment will be described in more detail in Chapter 4. 
The mechanism by which soluble vacuolar yeast proteins are sorted to the vacuole 
differs from that from mammalian cells. The recognition and receptor binding of the 
protein to be sorted does not depend on the recognition, binding and retrieval of 
proteins labelled with a mannose 6-phosphate (Komfeld and Mellman, 1989; see 
Chapter 4). On the other hand only three proteins were examined for sorting and there 
might be other vacuolar proteins that are sorted by a mannose 6-phosphate retrieval 
system, since many vacuolar proteins in yeast are also phosphorylated (Raymond et al., 
1992). Recognition of lysosomal proteins preceeds phosphorylation of high-mannose 
type N-linked oligosaccharides on the 6-carbon position of specific mannose residues. 
This recognition is mediated by N-acetylglucoseamine-1-phosphotransferase suggesting 
the presence of intrinsic peptide signals in lysosomal enzymes (Komfeld and MeUman, 
1989). This domain has no conserved homology between different lysosomal proteins 
of the same organism and most likely represents a signal patch (Baranski et al., 1990). 
Thus, lysosomal proteins differ from secretory proteins in the presence of a targeting 
domain which is recognized and modified by the phosphofransferase to generate a new 
signal (mannose 6-phosphate) and subsequently recognized by mannose 6-phosphate 
sorting receptors (Komfeld, 1989; Komfeld and Mellman, 1989). Vacuolar protein 
sorting signals of three soluble vacuolar proteins in yeast differ in primary peptide 
sequence, and it has been suggested that similar signal patches might form a consensus 
for vacuolar targeting (Klionsky et al., 1990). This has recently been questioned in 
33 
experiments addressing the specificity of sorting (Paravicini et al., 1992) and it appears 
that different vacuolar proteins are sorted by different pathways, possibly involving 
different sorting receptors (Stevens et al., 1986). Mammalian cells express two mannose 
6-phosphate receptors with different molecular mass (46 kDa and 300 kDa, also 
referred to as 275 and 215 kDa) which are dimerized and bind two ligand molecules per 
dimer (Koster et al., 1991; Komfeld and Mellman, 1989; Pfeffer, 1988; von Figura and 
Hasilik, 1986). The receptors are indentical in ligand binding and are co-expressed in 
the same cells (Bleekemolen et al., 1988). The 300 kDa receptor additionally binds to 
the insulin-like growth factor n in a number of species (Morgan et al., 1987) and also 
mediates endocytosis of mannose 6-phosphate containing ligands (Gartung et al., 1985), 
a function that cell surface localized 46 kDa receptor cannot perform, possibly because 
it adopts a different conformation (Chao et al., 1990; Hille et al., 1990; Stein et al., 
1987). Studies involving the selective overexpression of either receptor led to the 
proposal that the 46 kDa receptor releases the ligand at a site from which secetion can 
occur while the 300 kDa receptor quantitatively retrieves the ligand and localizes it to 
the lysosome (Chao et al., 1990). Both receptors recycle to the Golgi involving the 
same endosomal compartments although their distribution among these compartments is 
different in that the 46 kDa receptor is almost exclusively found in the Golgi complex 
(Matovcik et al., 1990; Messner et al., 1989). Both receptors are specifically 
redistributed upon hormonal stimuli and thus are also under endocrinal control (Damke 
et al., 1992). 
Recent evidence suggests that the mannose-6-phosphate / mannose 6-phosphate 
receptor mediated sorting is not the only sorting mechanism in mammalian cells (Tsuji 
et al., 1988). Glucerobrosidase, a membrane associated lysosomal enzyme from human 
skin fibroblats, does not undergo oligosaccharide phosphorylation, and is still faithfully 
localized to the lysosome (Aerts et al., 1988). Humans with I-cell disease lack mannose 
6-phosphate as a result of a defective phosphotransferase. However, they only show a 
tissue dependent, selective secretion of a subset of lysosomal enzymes, sfrongly 
suggesting that certain proteins in certain tissues only rely on mannose 6-phosphate 
dependent lysosomal protein sorting (Komfeld, 1986). Integral (see below) and 
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membrane associated proteins are sorted by a different mechanism not relying on 
phosphorylation. This seems to suggest that a number of mechanisms exist to ensure the 
correct localization of lysosomal proteins, some of which are tissue specific. In 
mammalian cells lysosomal membrane associated proteins such as acid phosphatase 
(LAP) are localized to lysosomes via the cell surface (Braun et al., 1989), although 
other reports provide evidence that two other transmembrane glycoproteins are sorted in 
the TGN and fransported directly to the lysosome thus not involving endocytosis from 
the plasma membrane (Green et al., 1987; Matter et al., 1990). The retrieval of LAP 
from the cell surface occurs efficiently, and is mediated by a refrieval signal located in 
the cytoplasmic domain of the receptor (Dintzis and Pfeffer, 1990; Peters et al., 1990). 
Upon arrival in the lysosome, LAP is sequentially processed by two proteolytic events 
(Gottschalk et al., 1989). The first cleavage removes most of the C-terminal 
cytoplasmic domain, while the second cleavage occurs in the lysosomal lumen to 
release LAP from the fransmembrane domain. The second proteolytic event depends on 
the cleavage of the C-terminal cytoplasmic domain, possibly because the C-terminus 
controUs the homodimer formation of LAP and i f not cleaved prevents accessibility of 
the lumenal domains. There is evidence that the introduction of a positively charged 
amino acid into the first membrane spanning domain of Rous Sarcoma Virus Envelope 
Glycoprotein will result in the lysosomal localization of the protein rather than cell 
surface expression (Davis and Hunter, 1987). The studies did not address whether the 
protein was localized to the plasma membrane and rapidly endocytosed or migrated 
directly to the lysosome. The 300 kDa mannose 6-phosphate receptor's C-terminal 
domain contains signals for rapid endocytosis and efficient lysosomal targeting (Lobel 
et al., 1989). Lysosomal membrane associated proteins have a Tyr-containing 
intemalization signal in their cytoplasmic domain which is part of a p-tum in solution 
(Bansal and Gierasch, 1991; Eberle et al., 1991; Lobel et al., 1989). The aromatic 
amino acid is presented to the cytoplasmic receptor in the stmctural context of a tight 
turn. 
The formation of autophagic vacuoles is different to that of lysosomes and is 
induced in hepatocytes by the depletion of nitrogen (Dunn, Jr., 1990a). Autophagic 
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vacuoles are derived from the smooth ER and represent a smooth double membrane 
enclosed vesicle. Cytoplasmic contents are engulfed by the ER during autophagy and 
soon after generation recruit lysosomal enzymes in transition to an acidic proteolytic 
compartment (Dunn, Jr., 1990b; Ueno et ai, 1991). 
1.6.5. Secretion 
Secretion is the default pathway in mammalian cells, yeasts and plants (Denecke 
et ai, 1990). Secretion in S. cerevisiae is polarized, and closely coupled to cell surface 
growth and budding. It involves the polarized deposition of new cell surface material 
associated with a highly assymmetric disposition of the actin cytoskeleton. Factors 
establishing cell polarity have been identified by isolating mutants unable to bud at a 
restrictive growth temperature of 37°C (Adams et al., 1990; Chenevert et al, 1992). 
Their analysis showed that bud site selection are Ca2+ and GTP dependent processes 
(Chant et al., 1991; Johnson and Pringle, 1990; Johnson et al., 1990; Miyamoto et al., 
1987; Ruggieri et al., 1992), and proteins participating in bud site selection and bud 
formation have been identified (Chant and Herskowitz, 1991; Chant et al., 1991; 
Chenevert et al., 1992). One protein, Bemlp, has been suggested to link the actin 
cytoskeleton to morphogenetic determinants on the cell surface (Chenevert et al., 1992). 
A 85 kDa actin binding protein has been located to the yeast cortical actin patches at 
growing surfaces of the yeast cell (Drubin et al., 1988). Overproduction of the 85 kDa 
protein results in bud formation at adjacent sites. 
The actin cytoskeleton and the Ca2+ binding protein calmodulin colocalize with 
the site of bud emergence and cell growth (Adams and Pringle, 1984; KUmartin and 
Adams, 1984; Sun et al., 1992). While the actin cytoskeleton is essential for cell 
growth, factors such as Cap2p regulating actin filament distribution are not essential 
(Amatruda et al., 1990). The MY02 encoded myosin promotes vectorial vesicle 
transport to the bud site probably by acting as a cytoskeletal motor to transport secretory 
vesicles along actin cables to the site of bud development (Johnston et al., 1991). This 
process is required for high efficiency but is not absolutely necessary for secretory 
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vesicle transport. Cytoplasmic dynein has been identified as a coat protein on synaptic 
vesicles suggesting a role for the microtubule based motor protein (Lacey and Haimo, 
1992). Actin filaments have been attributed a different role in baseline secretion in 
intestinal goblet cells where they form a physical barrier to slow constitutive secretion 
(Oliver and Specian, 1990) 
10 SEC genes iSECl, SEC2, SEC3, SEC4, SEC5, SEC6, SEC8, SEC9, SEC 10 and 
SEC15) have been identified so far that regulate the secretory pathway from the Golgi 
to the plasma membrane. SEC 15 encodes a 116 kDa hydrophilic protein that associates 
with the plasma membrane by binding directly to a protein complex located on the 
cytoplasmic side (Bowser and Novick, 1991). Preliminary evidence suggests that both 
the SEC8 and the SEC 10 gene products participate in attachment of SeclSp to the 
membrane or a protein complex. SeclSp might function in the attachment or 
aggregation of vesicles coated with Sec4p to the plasma membrane (Salminen and 
Novick, 1989), Sec4p, a small GTP binding protein, regulates secretion in S. cerevisiae 
by cycling between an active and inactive state (Salminen and Novick, 1987; Walworth 
et al, 1989). GTPase activity of Sec4p is modulated by an GTPase-activating protein 
(GAP) which so far has evaded detection (Walworth et al., 1992). A Sec4p functional 
and structural homologue, Ypt2p, has been identified in Schizosaccharomyces pombe 
(Haubruck et al., 1990). The SEC2 gene product, a 368 amino acid protein with an 
essential coiled coil domain and similarity to cytoskeletal proteins, probably functions 
in conjunction with Sec4p and SeclSp to control vesicle fusion (Nair et al., 1990). 
Three proteins common to different secretory vesicles in exocrine, endocrine, 
neural and constitutive secretion have been identified in rat (Brand et al., 1991). The 
secretory carrier membrane proteins (SCAMPs) have an apparent molecular mass of 31, 
33 and 35 kDa and are unglycosylated transmembrane proteins throughout. A ras-
related GTPase has been found to function at a late step in secretion (Wilson and 
Wilson, 1991). Their identity to known S^C gene products is not known. 
The rate of bulk flow from the Golgi apparatus to the plasma membrane has been 
determined in mammals to be 14 minutes at 30°C following the transport of truncated 
sphingomyelin from the cis Golgi to the plasma membrane (Karrenbauer et al., 1990). 
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An ER lumenal marker is secreted with a half time of 18 minutes under identical 
conditions, allowing 4 minutes for ER to Golgi transport. 
Epithelial cells have often polarized regions of the plasma membrane differing in 
their protein constituents. The plasma membane polarity is maintained by intracellular 
sorting of apical protein constituents in the trans Golgi network from the default 
basolateral transport pathway (Griffith and Simons, 1986; Salamero et ah, 1990) or the 
selective retrieval of transmembrane proteins destined for the apical membrane from the 
basolateral membrane (Simons and Wandinger-Ness, 1990). It appears that some 
proteins located to the basolateral membrane have positive localization information 
present (Hopkins, 1992). The lipid polarity observed in polar epithelial cells is 
maintained by sorting before reaching the membrane surface (van't Hof and van Meer, 
1990). There is evidence that a subset of apical proteins recycle through the trans Golgi 
network in MDCK cells although its physiological function is so far subject to 
speculation and might aid the efficient receptor mediated sorting (Brandli and Simons, 
1989; Simons and Wandinger-Ness, 1990). Also, the developmental remodeling of 
membrane protein distribution and subsequent sorting involves transcytosis as well as a 
new specificity of apical membrane protein sorting (WoUner et al., 1992). 
Unlike S. cerevisiae which only exhibits polarized constitutive secretion, neural 
and endocrine cells exhibit regulated and constitutive secretion, which requires a more 
sophisticated machinery for sorting in the TGN and regulated release of vesicle contents 
in secretion (Brion et al., 1992; Burgess and Kelly, 1987; Koedam et al., 1992; Sossin 
et al., 1990; Spom et al., 1989). PC12 cells have two distinct regulated secretory 
pathways mediated by large dense secretory compartments related to chromaffin 
granules and by small electron-lucent vesicles (Cutler and Cramer, 1990). Acidophilic 
cells of the cow anterior pituitary are able to sort three secretory proteins to different 
secretory granules (Hashimoto et al., 1987), suggesting the existence of regulated 
sorting and traffic pathways. In cytolytic lymphocytes the regulated secretory vesicles 
have characteristics of both secretory vesicles and lysosomes in terms of protein 
constituents emphasizing the diversity of membrane enclosed compartments in 
specialized cells (Burkhardt et al., 1990). A related process occurs in Alzheimer brains 
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where lysosomal contents are released into the extracellular medium contributing to 
certain physiological defects (Cataldo et al., 1991). Unlike in cytolytic lymphocytes, 
however, a general leakage of lysosomal emzymes might be primarily responsible for 
the deleterious defects. There is also evidence that oxysterol induced association of an 
oxysterol binding protein with the Golgi complex modulates transport (Ridgway et al., 
1992), Constitutive secretion in many cell types is the default late secretory pathway. 
Most vesicle intermediates in regulated secretion are coated, and their contents are 
sorted in the trans Golgi network (TGN) by selective aggregation (Burgess and Kelly, 
1987; Tooze et al., 1987). The formation of secretory vesicle subpopulations depends 
on ATP (Tooze and Hutmer, 1990). Aggregation of specific proteins is mediated by the 
low pH and high Ca2+ environment in the TGN which permits segregation from 
constitutively secreted proteins (Chanat and Hutmer, 1991). The release of regulated 
secretory vesicles depends on an external stimulus, and requires Ca2+. In pancreatic 
acini cells the release of amylase is induced by a rab3a effector, providing evidence that 
the GTPases involved in membrane transport are subject to functional modulation to 
control transport (Padfield et al., 1992), Vesicle transport in neuronal cells is subject to 
modulation by Ca2+ and the phosphorylation of rap-lb (Sahyoun et al., 1991). It also 
depends on the function of a small GTPase, which dissociates from synaptic vesicles 
during exocytosis (von MoUard et al., 1991). 
Vesicle aggregation on the plasma membrane is thought to be mediated by 
annexin, cytoplasmic Ca2+ binding proteins and phospholipid binding proteins. 
Annexins I and I I promote contact between vesicles via an N-terminal repeat and 
engage in mediating contact between phospholipid bilayers (Ernst et al., 1991), The 
Ca^ "*" requirement could not be shown to be essential in an in vitro assay where 
exocytosis was dependent on ATP, GTP and N-ethylmaleimide sensitive factors (Miller 
and Moore, 1991; DeLisle and Williams, 1986; Tatham and Gomperts, 1991). There is 
evidence in a number of organisms that prepositioning of regulated secretory vesicles 
and organelles onto the plasma membrane occurs as part of a mechanism to ensure the 
rapid release in case of stimulation. The effector pathways regulating secretion involve 
different mechanisms depending on species and tissue. They include Ca^ "*", contractile 
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cytoskeleal proteins, protein kinases, phosphatases and a number of cytoplasmic 
proteins. 
Modulation of secretion can be achieved by transporting newly synthesized 
secretory proteins to lysosomes for degradation rather than secretion via secretory 
vesicles (Lenk et al., 1991). 
1.7. Endocytosis 
The most compelling studies describing fluid phase and receptor mediated 
endocytosis and the endocytic organelles comes from specialized mammalian cells 
(Griffith, 1989). Mammalian cells internalize a variety of growth factors, nutrients and 
viruses through receptor mediated endocytosis (Goldstein et al., 1985). Endocytosed 
ligands can be routed intracellularly by several ways. Epidermal growth factor (EGF) is 
directed to the lysosome together with its receptor, while transferrin is released from its 
receptor and the receptor is recycled back to the plasma membrane (Salzman and 
Maxfield, 1989). In polarized epithelial cells there is documented evidence for 
transcytosis, the transport of ligands and their receptors from the apical site of the 
membrane to the basolateral (Fuller and Simons, 1986; Sztul et al., 1991). Studies 
involving fluorescent labeled transferrin and low density lipoprotein (LDL) colocalized 
the two ligands in the same endocytic compartment, but could demonstrate that they are 
differentially sorted (Dunn et al., 1989). Endocytic vesicles fuse with an endosomal 
compartment in which LDL accumulates, but transferrin is sorted away. Recent 
evidence indicates that transferrin is processed intracellularly via small coated 
endosomal vesicles and is not delivered into large tubular endosomes, characteristic for 
ligand traffic to lysosomes. The small coated endosomal vesicles have sorting and 
recycling properties and might represent branchpoint vesicles where differential sorting 
of endocytosed material takes place (Eskelinen et al., 1991). It has been suggested that 
endocytosed receptor containing vesicles preferentially fuse with the early endosome 
and conversely vesicles budding from tubular extensions of early endosomes 
preferentially fuse with the plasma membrane. Early endosomes mature during this 
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process and lose their competence for interaction with the plasma membrane. Instead 
fusion of TGN vesicles with the late endosome increases as does a recycling pathway 
(Stoorvogel et al., 1989). The actin cytoskeleton plays a role in the rapid turnover of 
short lived membrane proteins in astrocytes as a result of hormonal stimulation (Harwell 
et al., 1990). Reconstitution of the endocytic pathway following vesicular transport of 
the 300 kDa marmose 6-phosphate receptor from late endosomes to the TGN is 
dependent on GTP and soluble cytosolic proteins sensitive to N-ethylmaleimide 
(Gruenberg and Howell, 1989). The cytosolic factor termed ETF-1 differs fi-om the NSF 
required for transport fi-om ER to Golgi and intercompartmental transport (Goda and 
Pfeffer, 1991). It has been suggested that the "pre-lysosomal" compartment receives 
material from the TGN and early endosomes and somehow passes it on to the lysosome 
(Griffiths, 1989). The recycling of transferrin receptors occurs with a half-time of 15 
minutes (Yamashiro et al., 1984) while the recycling of endocytosed material has a 
half-time of 40 minutes, demonstrating the efficiency conferred by the clustering of 
receptors in coated pits (Koval and Pagano, 1989). Transcytosis in MDCK cells is 
sensitive to BFA treatment at an early step, indicative of a BFA-sensitive coat present 
on endocytic compartments (Hunziker et al., 1991). Endocytosis occurs from both 
apical and basolateral surfaces of MDCK cells, and endocytosed material from both 
membrane domains are targeted to a common endosomal compartment (Parton et al., 
1989). Endosomes also may participate in the uptake of membrane impermeable 
components directly from the cytoplasm (Steinberg et al., 1988). 
Comparatative studies on the endosomal system of Paramecium provided 
evidence for a highly conserved endocytic pathway, including the coating of the phago-
/pinocytotic vesicles, their uncoating and subsequent fusion with early endosomes 
(Allen et al., 1992). The sorting of endocytosed material from plasma membrane 
components has been located to an endosomal compartment having striking similarity 
to the same process in mammalian systems. Receptor mediated endocytosis in S. 
cerevisiae does occiu: and plays an important role in the selective uptake of mating 
pheromones (Singer and Riezman, 1990; see Chapter 4). Like the analogous process in 
mammalian cells it is temperature dependent and requires ATP. Whether endocytosis in 
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yeast is coupled to the targeting of membrane associated enzymes by retrieval from the 
plasma membrane is not known. 
WhUe clathrin represents the major coatomer for endocytotic vesicles in species 
as diverse as mammals, Paramecium and plants (Coleman et al., 1988; Gruenberg and 
Howell, 1989; Robinson and Depta, 1988), the clathrin homologues in yeast are 
dispensable for that function (Payne et al., 1988; Silveira et al., 1990). Studies on 
mammalian coated vesicle formation suggests that receptor bound ligands are 
spontaneously invaginated into a coated pit and the coated vesicles are detached in a 
reaction involving ATP, Ca2+ and cytosolic factors (Lin et al., 1991; Moore and 
Anderson, 1989; Schmid and Smythe, 1991). Not all endocytosis is mediated by 
clathrin coated pits. Enzymes involved in the uncoating of clathrin coated vesicles 
present in brain exfracts as well as in yeast have been identified (Gao et al., 1991). 
Preliminary evidence suggests that clathrin directly mediates vesicle fusion in 
mammalian cells (Maezawa and Yoshimura, 1991). 
The membrane protein composition of different endosomal compartments varies 
which is consistent with the view that membrane protein recycling takes place between 
different compartments (Beaumelle et al., 1990). The endosome and lysosome differ 
quite drastically in protein composition suggesting the unrelatedness of the two 
compartments. While the processing pathways within the endosomal system have been 
described for different systems, one trend observable is that not all pathways are 
common to all cell lines. Endocytosis might very well serve a specialized function in 
different cells and might utilize a slightly different mechanism adapted to the function. 
There is also still a debate on whether endocytic transport is vesicularized similar to ER 
to Golgi fransport or takes place by compartmental progression (Gruenberg and Howell, 
1989). 
1.8. Osmohomeostasis in 5. cerevisiae 
Only little information on the osmohomeostasis in 5. cerevisiae is available, and 
although the vacuole has been suggested to participate in osmoregulation (Banta et al.. 
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1988) no further details of the osmoregulatory mechanism are known. A number of 
studies concentrated on the elucidation of the glycerol mediated osmoadaptive pathway 
(Andre et al., 1991; Blomberg and Adler, 1989; Larsson et al., 1990; Reed et al., 1987; 
Singh and Norton, 1991). While most exponentially growing cells are sensitive to a 
reduced water potential in the form of a 1.4 M NaCl supplement to the medium, cells 
that enter the stationary phase are generally more resistant to the osmotic shock and 
remain viable, as are cells that were conditioned with 0.7 M NaCl before plating out 
onto YPD agar supplemented with 1.4 M NaCl. The conditioning is dependent on de 
novo protein biosynthesis and can be prevented in the presence of cycloheximide 
(Blomberg and Adler, 1989). The process of conditioning is referred to as acquired 
osmotolerance and is accompanied by the acumulation of glycerol. Glycerol and 
glycerol 3-phosphate dehydrogenase, an enzyme in glycerol production, show an 
osmotically inducible increase irrespective of the carbon source used for cell growth 
(Andre et al., 1991). Although the enzyme levels are lower and subject to glucose 
repression if cells are grown in glucose medium, they are elevated compared to cells 
grown in the absence of an osmotically active component. Removal of glycerol by 
repeated washing with water will reduce the osmotolerant fraction by 50% as 
determined by survival on YPD supplemented with 1.4 M NaCl (Blomberg and Adler, 
1989) . Other eukaryotes, such as Neurospora crassa, accumulate glycerol and marmitol 
as a response to low water pressure (Ellis et al., 1991; van Zyl et al., 1990). Glycerol 
and arabinitol accumulate in Debaryomyces hansenii, a salt-tolerant yeast, to maintain a 
positive turgor balance at high salinity (Larsson et al., 1990). A physiological overlap 
between osmotolerance and thermotolerance has been observed in S. cerevisiae 
(TroUmo et al., 1988). Salt-sensitive mutants isolated from Zygosaccharomyces rouxii 
were defective in glycerol catabolism and accumulation (Yagi and Tada, 1988). Any 
vacuolar defects in these mutants were not reported. 
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1.9. Aim of Thesis 
The study of certain aspects of vacuolar biogenesis in yeast, namely vacuolar 
morphogenesis and the so far unknown role of the vacuole in cellular osmohomeostasis, 
were subject of this thesis. Based on the finding that some vacuolar protein sorting 
mutants lacked a structurally intact vacuole and were also osmosensitive (Banta et ah, 
1988), a scheme was devised to isolate osmosensitive mutants which also have vacuolar 
defects. After initial characterization of the mutations conferring an osmosensitive 
vacuolar phenotype, it was intended to clone and sequence the genes corresponding to 
the mutations to be able to analyse certain aspects of vacuolar biogenesis on the 
molecular level. 
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CHAPTER 2 
MATERIALS AND METHODS 
2.1. Materials 
2.1.1. Reagents and Supplies 
All chemicals and reagents used in this study were obtained from Sigma 
Chemicals pic, Poole, Dorset, UK, or BDH Chemicals Ltd, Poole, Dorset, UK, unless 
stated otherwise. Restriction enzymes and T4 ligase were from NBL, Cramlington, 
Northumberland, UK. Caesium chloride, calf intestinal alkaline phosphatase and 
Klenow enzyme were from Boehringer Mannheim Diagnostics and Biochemicals 
(England) Ltd, Lewes, East Sussex, UK. Sequenase Version 2.0 sequencing kits and 
mung bean deletion kits were from Stratagene, La Jolla, CA 92037, USA. Agarose and 
LMP agarose were from Bethesda Research Laboratories Inc, Gaithersburg, MD 20877, 
USA. Zymolyase 100-T was from Seikagaku Kogyo Co, Ltd, Tokyo, Japan. Peptone, 
nutrient broth, and yeast nitrogen base without amino acids were from Difco 
Laboratories, Detroit, MI 48232-7058, USA, and agar and yeast extract were from 
Oxoid Ltd, Basingstoke, UK. Tran[35s]-label was from ICN Biomedicals Ltd, High 
Wycombe, Buckinghamshire, UK; a-^^S-ATP and silica fines were from Amersham 
International pic, Amersham, Buckinghamshire, UK. Filterpaper was purchased from 
Whatman International Ltd, Maidstone, Kent, UK. Hybridization membranes were from 
Schleicher and Schuell, Dassel, FRG. Polaroid 667 film was from Polaroid (UK) Ltd, 
St, Albans, Hertfordshire, UK. Unless stated otherwise, photographic materials were 
from Kodak Ltd, Liverpool, UK. 
Antisera to CPY, Pho8p, and the 60 kDa subunit of the vacular membrane 
ATPase were a gift from Tom Stevens, Oregon, USA, and antisera to PrA and PrB were 
a gift from Dieter Wolf, Stuttgart, FRG. 
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2.1.2. Phage Strains 
Bacteriophage R408 (Stratagene, La JoUa, CA 92037; Russel, M. et al., 1986) 
was used in this study as helper phage for recovering single stranded DNA from the 
Stratagene Bluescript™ vectors pKS and pSK for sequencing. 
2.1.3. Bacterial Strains 
The bacterial strains used in this study were all Escherichia coli and are listed in 
Table 2.1. All strains represented laboratory stocks, or for XLl-Blue, were purchased 
from commercial sources. 
Strain Genotype Reference 
HBlOl supEAA hsdSlO (TQ mg") recAl3 ara-U Bolivar and Backman, 
proAl lacYl galKl rpsL20xyl-5 mtl-l 1979. 
MC1061 hsdR mcrB araDl39 A(araABC-leu)1619 Meissner a/., 1987 
MacXlA galU galK rpsL thi 
XLl-blue recAl lac endAl gyrA96 thi hsdRll Stratagene Manual. 
supEAA relAl 
[FproAB /aclQ /acZAM15 TnlO] 
Table 2.1: Bacterial strains used in this study. 
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2.1.4. Yeast Strains 
The yeast strains used in this study are listed in Table 2.2 and were 
Saccharomyces cerevisiae throughout. Whenever possible, sfrains quoted in the 
literature were obtained from the authors, and the reference describing their 
construction is given. A collection of all up to date identified vps mutant type alleles 
were obtained from Tom Stevens, Eugene, Oregon, USA, and are not necessarily all 
published. 
2.1.5. Plasmids 
All plasmids used in this study were maintained in either HBlOl or MCI061. 
HBlOl was always used to maintain yeast plasmids or plasmids containing yeast 
genomic DNA sequences, since the recA^ host MCI061 can lead to recombination 
between repeated sequences. Plasmids and their most prominent features are listed in 
Table 2.3. 
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Strain Genotype Reference 
05149 MATa leu2-3,112 ura3-A52 his3-A200 trpl-A901 Robinson 
lys2-801 SUC2-A9 GAL vps5 et al., 1988. 
05201 MATa leu2-3.112 ura3-A52 his3-^200 trpl-A901 Robinson 
lys2-801 SUC2-A9 GAL vpsl8 et al., 1988. 
0531 MATa leu2-3,112 ura3-A52 his3-A200 trpl-A901 Robinson 
lys2-801 suc2-b9 GAL vps33 etal., 1988. 
0552-11 MATa leu2-3,112 ura3-A52 his3-A200 trpl-A901 Robinson 
lys2-801 SUC2-A9 GAL vpsll etal., 1988. 
0570 MATa leu2-3,112 ura3-A52 his3-A200 trpl-A901 Robinson 
lys2-801 SUC2-A9 GAL vpsl6 et al., 1988. 
0572 MATa leu2-3,112 ura3-A52 his3-A200 trpl-A901 Robinson 
lys2-801 suc2-A9 GAL vpsl7 et al., 1988. 
14121-26 MATsi leu2-3,112 ura3-A52 his3-A200 trpl-A901 Robinson 
ade2-101 suc2-A9 GAL vpsl etal., 1988. 
15113-8 MATa leu2-3,112 ura3-A52 his3-A200 trpl-A901 Robinson 
ade2-101 suc2-/S9 GAL vps8 etal., 1988. 
B-6164 MATa cycl-367 arg4-17 osm2 Singh and Sherman, 
1978. 
D-597-6D MATa cycl-1 trpl-1 aro7-l leu2-l osml Singh and Sherman, 
1978. 
DBY1373 MATu his4 ura3-52 tub2-104 Thomas et al., 
1985. 
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Strain Genotype Reference 
DBY1691 MATsihis4-619actl-l Novick and 
Botstein, 1985. 
MWYIOO MATa adel M.D. Watson, lab 
strain. 
MWYlOl MATa adel M.D. Watson, lab 
strain. 
RH1330 MATa aro3-2 aro4-l M. Kunzler, 
Zurich. 
RH1610 MATa Aura3 aro2::URA3 M. Kunzler, 
Ziirich. 
S5 MATsi adel adel ural his? tyrl lys7 
gall gutl 
Sprague and 
Cronan, 1977. 
S22 MATsi adel ade2 ural his? tyrl lys? 
gall gut2 
Sprague and 
Cronan, 1977. 
SEY6210 MATa leu2-3,112 ura3-A52 his3-A200 trpl-A901 
lys2-801 SUC2-A9 GAL 
Robinson 
etal., 1988. 
SEY6211 MATa leu2-3,112 ura3-A52 his3-A200 trpl-A901 
ade2-101 suc2-A9 GAL 
Robinson 
etal., 1988. 
SF838-1D MATa ade6 his4-519 ura3-59 leu2-3 leu2-112 
pep4-3 gal 
T.H. Stevens, 
lab strain. 
vpsl to 47 T.H. Stevens 
Table 2.2: Yeast strains used in this study. 
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Plasmid Comments Reference 
pBluescript™ bla^ Stratagene Manual. 
pCKR108 bla"", carboxypeptidase Y C.K. Raymond, Eugene, 
fusion plasmid Oregon. 
pCYI433 hlaF, URA3 Bankaitis etal., 1986. 
pEXPl-3 hW, lacZ promoter Muchmore et al., 1989. 
expression vector 
pRS316 blar, URA3 Sikorski and Hieter, 1989. 
pUC18/19 Messing, 1983. 
YCp50 tet^ bla ,^ URA3 Rose era/., 1987. 
Table 2.3: Plasmids used in this study. 
2.1.6. Buffers and Stock Solutions (Listed in Alphabetical Order) 
Amino Acids Stock Solutions 
Stock solutions of individual amino acids or amino acid mixtures were prepared at 
2 mg/mL and then autoclaved, except for tryptophan, which was sterile filtered. They 
were used at a final concentration of 20 \ig/mL as supplements of yeast minimal 
medium as required. 
Antibiotic Stock Solutions 
Antibiotic stock solutions were prepared and used as shown in Table 2.4. All 
stocks were kept at -20°C. 
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Antibiotic Stock Solvent Final Concentration 
Ampicillin 25 mg/mL 70%Ethanol 50[igJmL 
Chloramphenicol 20 mg/mL 100% Ethanol lO^tg/mL 
Tetracyclin 5 mg/mL 50% Ethanol lO^ig/mL 
Table 2.4: Antibiotic stock solutions and their effective final working concentration. 
Blocking BufTer 
Gelatin 10 g 
lOx Tris.HCL-Salt 100 mL 
in 1 L dH20. 
Carbonate Buffer pH 9.2 
NaHCOj 2.1 g 
in 1 L dH20. The solution was adjusted to pH 9.2 with 1 M NaOH. 
Coomassie Blue Stain Solution 
Coomassie Brilliant Blue 0.2% (w/v) 
Methanol 50% (v/v) 
Glacial Acetic Acid 7% (v/v) 
in aqueous solution. 
Ethidlum Bromide Stock 
Ethidium Bromide 50 mg 
in 10 mL dH20. The solution was stored in the dark. 
Gel Destaining Solution 
Methanol 40% (v/v) 
Glacial Acetic Acid 10% (v/v) 
in aqueous solution. 
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6x Gel Loading BuiTer (Agarose Gel Electrophoresis) 
Bromophenol Blue 25 mg 
Xylene Cyanol 25 mg 
Sucrose 4 g 
in 10mLdH2O. 
lOx PAGE Buffer 
Glycine 141 g 
Tris.HCl 30 g 
SDS 10 g 
in 1 L dH20. 
20x PBS (Phosphate Buffered Saline) 
NaCl 160 g 
KCl 4 g 
Na2HP04 28.8 g 
KH2PO4 4.8 g 
in 1 L dH20. The solution was adjusted to pH 7.4 with HCl. 
Protein Sample Buffer 
Glycerol 1 mL 
10% SDS 4 mL 
0.5 M Tris.HCl pH 6.8 500 ^iL 
250 mM EDTA 40 ^iL 
0.05% bromophenol blue 500 ^iL 
in 10 mL dH20. P-mercaptoethanol was added prior to use to 5% (v/v). 
50x T A E Buffer 
Tris.HCl 242 g 
EDTA 18.5 g 
Glacial Acetic Acid 57.1 ml 
in 1 L dH20 
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lOx T B E Buffer 
Tris.HCl 121.1 g 
Boric Acid 51.35 g 
EDTA 3.72 g 
in 1 L dH20. 
T E Buffer pH 8.0 (10 mM Tris.HCl, 1 mM EDTA) 
1 M Tris.HCl pH 8.0 10 mL 
250 mM EDTA pH 8.0 4 mL 
in 1 L dH20. 
Transfer Buffer 
Tris.HCl 6.06 g 
Glycine 28.8 g 
Methanol 400 mL 
in 2 L dH20. 
5x Tris-Glycine Buffer 
Tris.HCl 15.1 g 
Glycine 94 g 
SDS 5g 
in 1 L dH20. 
lOx Tris-Salt Buffer 
Tris.HCl 24.2 g 
NaCl 90.0 g 
in 1 L dH20. The solution was adjusted to pH 7.2 with HCl. 
Tween-20 Precoat Buffer 
1 M NaH2P04 pH 7.5 10 mL 
NaCl 8.2 g 
5% (v/v) Tween-20 10 mL 
in 1 L dH20. 
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2.1.7. Growth Media (Listed in Alphabetical Order) 
Al l growth media described below can be used as liquid media, or can be 
solidified by the addition of 2% agar. 
Luria-Bertani Broth (Luria Broth) 
Bacto-Tryptone 10 g 
Yeast Extract 5 g 
NaCl 5 g 
in 1 L dH20. 
Plate Agar (Sphaeroplast Transformation) 
Sorbitol 218.6 g 
Yeast Nitrogen Base w/o amino acids 6.7 g 
Glucose 20 g 
Amino acids 20 |Xg/mL 
Agar 20 g 
in 1 L dH20. 
Presporulation Agar 
Yeast Extract 10 g 
Nutrient Broth 30 g 
Glucose 50 g 
Adenine 50 mg 
Uracil 5 mg 
Agar 20 g 
in 1 L dH20. 
Regeneration Agar (Sphaeroplast Transformation) 
Sorbitol 218.6 g 
Yeast Nitrogen Base w/o amino acids 6.7 g 
Glucose 20g 
Amino acids 20 )Xg/mL 
Agar 30 g 
in 1 L dH20 
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SOB Medium 
Tryptone 20 g 
Yeast Extract 5 g 
NaCl 0.6 g 
KCl 0.5 g 
in 1 L dH20. Autoclave and add 10 mL 2 M Mg2+ stock (1 M MgCl2 and 1 M MgS04, 
filter sterilized) just prior to use. 
Sporulation Agar 
Yeast Extract 1 g 
Glucose 0.5 g 
Potassium acetate 10 g 
Agar 20 g 
in 1 L dH20. Essential amino acids were added after autoclaving to a final 
concentration of 20 |xg/mL. 
Superbroth 
Bacto-Tryptone 3 3.0 g 
Yeast Extract 20 g 
NaCl 7.5 g 
Glucose 1.0 g 
in 1 L dH20. The medium was adjusted to pH 7.0. 
2x TV broth 
Trypticase 16 g 
Yeast Extract 10 g 
NaCl 10 g 
in 1 L dH20. The medium was adjusted to pH 7.2 to 7.4. 
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Wickerham's Minimal Medium (Wickerham, 1946) 
Glucose 10 g 
Proline 5 g 
Na2S04 0.71 g 
1 M K P O 4 pH 5.7 10 mL 
1 Ox Salts 50 mL 
1,000x Vitamins 0.5 mL (added after autoclaving) 
lO.OOOx Minerals 50 \iL 
10 mg/mL Amino acids 1 mL 
in 500 mL dH20. 
lOx Salts (two components) 
Solution 1: K H 2 P O 4 4.38 g 
K 2 H P O 4 0.63 g 
in250mLdH2O. 
Solution 2: MgS04.7H20 2.5 g 
NaCl 0.5 g 
CaCl2.2H20 0.5 g 
in 250 mL dH20. 
Equal volumes of solutions 1 and 2 were mixed just prior to use to yield lOx salts. 
LOOOx Vitamins 
Biotin 0.2 mg 
Ca-panthothenate 40 mg 
Inositol 200 mg 
Niacin 40 mg 
p-aminobenzoic acid 20 mg 
Pyridoxine.HCl 40 mg 
Thiamine.HCl 40 mg 
Riboflavin 20 mg 
in 100 mL dH20. The solution was 
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10,000x Minerals 
Boric acid 0.5 g 
MnS04 0.4 g 
ZnS04 0.4 g 
FeCl2.6H20 0.2 g 
(NH4)6M07024.4H20 0.2 g 
Nal 0.1 g 
CUSO4.5H2O 0.04 g 
Citric Acid 1 g 
in 100 mL dH20. 
Yeast Minimal Medium 
Yeast Nitrogen Base w/o amino acids 6.7 g 
Glucose 20 g 
in 1 L dH20. Required amino acids were added after autoclaving to the desired 
concentration. 
YPD(A) 
Yeast Extract 10 g 
Bacto Peptone 20 g 
Glucose 20 g 
(Adenine 20 mg) 
in 1 L dH20. 
YPSA Bromocresol Purple Medium 
Yeast Extract 10 g 
Bacto Peptone 20 g 
Sucrose 20 g 
0.4% Bromocresol purple in ethanol 5 mL 
in 1 L dH20. Just prior to inoculation, 0.01 mg antimycin A in ethanol was added per 
mL medium. 
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2.2. General Methodology 
2.2.1. Sterile Working Practices 
A microbiological, sterile working practice was maintained throughout. Al l media 
or materials used in the maintenance or recovery of cultures, transformants, etc. were 
sterilized by diverse suitable means. I f a laminar-flow hood was not available, it was 
attempted to keep the surrounding free of possible contaminants by repeated wiping of 
bench surfaces with 70% ethanol, flaming the necks of culture flasks, and immediate 
sealing of culture vessels after inoculation. 
2.2.2. Sterilisation Techniques 
All media, buffers, solutions, glassware and plasticware that were resistant to heat 
treatment were autoclaved at 15 p.s.i., 123°C, for 20 minutes. Heat sensitive solutions 
were filter sterUized by passing through a 0.22 jxm nitrocellulose membrane filter. Heat 
sensitive plasticware was left overnight in 70% ethanol and dried in a laminar-flow 
hood. I f sterility was an absolute necessity (e.g. electroporation cuvettes), items were 
irradiated with y-rays from a ^^Co source for 24 hours (4 Mrad). 
2.2.3. Polylysine Coating of Microscope Slides 
Microscope slides were coated by covering each slide with 1 mg/mL polylysine. 
After 20 seconds, the slides were washed six times with dH20 and allowed to air dry. 
For welled slides 20 | i L 1 mg/mL polylysine was added to each well. 
2.2.4. Treatment of Dialysis Tubing 
Dialysis tubing was boiled in a solution containing 2% (w/v) Na2C03 and 1 mM 
EDTA (pH 8.0) for 10 minutes. The tubing was rinsed five times in sterile dH20, 
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followed by another 20 minutes autoclaving. Finally, the tubing was rinsed several 
times in sterile dH20 and then stored at 4°C in TE buffer. 
2.2.5. Maintenace of Stock Cultures - Bacterial Strains 
Strains harbouring no plasmids or selectable markers were cultured in Luria broth 
or on Luria agar plates without antibiotics. Strains containing plasmids and/or selectable 
markers were grown in medium under selective conditions. A master stock was 
maintained in 40% (v/v) glycerol at -84°C. For glycerol stocks, 10 mL Luria broth was 
inoculated with a colony from the respective strain and incubated at 37 °C overnight 
with agitation. The culture was centrifuged at 3,000 g for 5 minutes, the pellets 
resuspended in 1 mL Luria broth and transferred to a 2 mL glass or plastic vial 
containing 1 mL 80% (v/v) sterile glycerol. The vial was frozen in liquid nitrogen, and 
placed in a freezer at -S4^C. 
2.2.6. Maintenance of Stock Cultures - Yeast Strains 
A stock culture of all yeast strains was maintained in glycerol at -840C. A single 
colony of each yeast strain was used to inoculate 10 mL YPDA. The culture was grown 
to saturation at 30°C with agitation for 48 to 72 hours, dependent on the growth rate of 
the strain concerned. The cells were sedimented by centrifugation at 1,500 g for 10 
minutes, resuspended in 0.75 mL YPDA and added to 1.25 mL 80% (v/v) glycerol in a 
2.5 mL glass vial. The glycerols were frozen in liquid nitrogen and stored at -84°C until 
further use. Great care had to be taken when material was taken from the glycerol not to 
let the glycerol thaw, since yeast glycerols could not be frozen a second time after the 
initial freezing. 
2.2.7. Measurement of Growth - Phage Titration 
20 \iL phage suspension was diluted with 180 | J L SM buffer (5.8 g/L NaCl, 2.0 
g/L MgS04, 50 mL/L 1 M Tris.HCl pH 7.5, 5 mL/L 2% (w/v) gelatin) in a serial 
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dilution series until the desired dilution was reached. After the addition of 1(X) ^ L 
appropriate log-phase host cells to 1(X) f j L of the above dilution, phage and host cells 
were incubated at 37°C for 20 minutes. An additional 200 \xL of host cells were added, 
and the suspension was mixed with 3 mL top agar (same as Luria-agar, except with 
0.7% (w/v) agarose) at 420C and poured immediately onto an agar plate. The plates 
were incubated at 31°C overnight. The phage concentration in plaque forming units 
(p.f.u.) could be calculated by the formula: p.f.u. / mL = plaques/plate x 1/dilution x 
100. 
2.2.8. Measurement of Growth - Bacteria 
Bacterial growth was either determined spectrophotometrically by measuring the 
ODgoo i f a correlation between die number of bacteria and the optical density was 
known, or by viable cell counts. For the latter, a known volume of the culture was 
diluted down in Ix PBS in decimal steps, and 100 | J L of each dilution was plated out in 
duplicates onto Luria agar plates under the correct selective conditions. The plates were 
incubated at 37°C for 12 hours, and the plates showing between 15 and 200 colonies 
were used for the assessment of the number of bacteria present in the original culture. 
2.2.9. Measurement of Growth - Yeast 
Total cell counts of yeast cultures were done with a Coulter® Multisizer n fitted 
with a 37 | im aperture and adjusted to take account of all particles between 0.748 and 
9.957 \Lm (window option). A sample of the yeast culture was diluted 20 times with 
Isoton® electrolyte solution, and two counts were done per sample, subtracting the 
blank value. The cell number could be calculated as follows: 
Total Cell Count/mL = Cell Count (for 25 |aL) x 40 x Dilution Factor 
Viable counts were done as described for bacteria, with the only difference that 
dH20 was used for dilutions, and YPDA agar plates to plate out the dilutions. 
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2.3. Classical Yeast Genetics 
2.3.1. Drop-overlay Complementation of Auxotrophic Haploid Yeast Strains 
Complementation of yeast strains of opposite mating type was done in a drop-
overlay complementation test as described in Spencer et al, 1989. Complementation, 
that is the restoration of the wild type phenotype of two complementing mutations in 
diploid cells, is an indication that the mutations are affecting different genes. I f two 
mutations fail to complement, it indicates that the two mutations have affected the same 
gene, or one affects a regulatory site for the other gene, or at least one mutation yields 
an inhibitory gene product. 
Al l auxotrophic haploid strains of opposite mating types having complementary 
nutritional requirements were grown in 5 mL YPDA at 30°C for 48 hours with 
agitation. 100 | J L aliquots of each culture were taken and added to 900 | iL dH20. After 
centrifugation at 12,000 g in a microfuge for 5 minutes, the pellets were washed once 
with 1 mL dH20, and were resuspended in 100 |J,L dH20 each. 5 ^iL aliquots of each a 
strain were dotted onto yeast minimal medium agar plates supplemented with all 
essential amino acids common to both a and a strains, leaving out those which are 
required by only one strain. After the plates were sufficiently dry, 5 ^ L aliquots of each 
a strain were applied onto all different spots of a strain mutants. 5 | J L aliquots of all 
strains were also individually dotted onto the selective yeast minimal medium agar 
plates as controls. Plates were dried at room temperature and subsequently incubated at 
300C for 4 days. Viable auxotrophy-complementing diploids will be able to grow on the 
selective medium, whereas haploids will not grow since one or several nutritional 
requirements were missing. The patches of diploid cells could be replica-plated to 
screen for complementation of mutations like NaCF growth, or growth at high 
temperature of ts strains on other selective media or conditions. 
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2.3.2. Sporulation of Diploids and Random Spore Isolation 
Diploids heterozygous for the ADE locus were patched out onto presporulation 
agar and were incubated at 30°C for 48 hours. Al l the material from the patch was 
scraped off the plate and patched out onto a sporulation agar plate. The plate was 
incubated at 30°C for 5 days, or until about 95% of all diploids formed tetrads as 
detectable by light microscopic analysis. A loopful of the sporulated diploid (about the 
size of a matchhead) was resuspended in 200 )iL glusulase. The suspension was 
incubated at 30°C for 2 hours with agitation. Sterile glass beads were added to about 
half the volume of the digest, the mix was vortexed vigorously for 1 minute and 1 mL 
sterile water was added. The sample was diluted down to 1 x 10"^ in a decimal dilution 
series. 100 |J,L aliquots of each dilution was plated out onto YPD agar plates, which 
were incubated at 30®C for 72 hours. Al l red colonies (representing ade haploids) or 
small white colonies (generally representing ADE haploids) were picked and purified in 
a fractional streak. The isolated haploids were tested for various markers and also for 
the mating type, so that mutants of opposite mating type could be isolated. 
2.3.3. Testing for Mating Type 
Testing of mating type was done as described in Spencer et al., 1989, using strains 
MWYlOOa and M W Y l O l a as mating type testers. These strains carry a mutation in the 
ADEl locus, but are wild type for all other genetic markers concerned. This allows the 
testing for mating type of all but adeJ strains on unsupplemented yeast minimal 
medium. 
The two tester strains were streaked onto a yeast minimal medium plate parallel to 
each other, and the strain to be tested was streaked perpendicular to each of the two 
streaks. The plates were incubated at 30°C for 4 days, and colonies that were able to 
grow only on one overlapping cross were recorded as the mating type opposite to the 
tester strain. 
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2.3.4. EMS - Mutagenesis 
Yeast strains were mutagenized with ethanemethylsulphonate (EMS) at 50% 
killing after the method of Fink, G.R., 1970. 
A medium size colony of the yeast strain to be mutagenized was used to inoculate 
10 mL YPDA, which was incubated at 30oC for 24 hours with agitation (140 rpm). The 
cells were centrifuged at 1,500 g for 10 minutes, the pellets were resuspended in 10 mL 
dH20, and it was centrifuged as above. The cells were resuspended in 10 mL 0.1 M 
sodium phosphate buffer pH 8.0, and 0.3 mL EMS was added to each tube. The tubes 
were vortexed vigorously to disperse the EMS, and the suspension was incubated at 
30°C without agitation for exactly 50 minutes. The cells were centrifuged at 1,500 g for 
10 minutes, were resuspended in 10 mL dH20 and then transferred to a new sterile tube. 
This washing process was repeated twice, and the cells were resuspended in 10 mL 
dH20 after the third wash. The cell suspension was diluted down to 1 x 10'^ in a serial 
dilution, and 100 [iL aliquots were plated out onto YPDA agar plates. The plates were 
incubated at 30°C for 48 hours, and then could be replica-plated onto the selective 
medium or screened in dot blot hybridization tests. 
2.3.5. UV - Mutagenesis 
Yeast strains were also subjected to mutagenesis by UV irradiation to induce a 
potentially different set of mutants to the ones generated by EMS mutagenesis. Since 
the degree of killing strongly depends on the light source and wavelength used, a dose-
response curve had to be constructed to allow mutagenesis at 5% survival. For that 
purpose a single yeast colony from a fresh YPDA agar plate was used to inoculate 10 
mL YPDA. The culture was incubated at 30°C and agitation (140 rpm) for 48 hours to 
saturation. The cells were harvested by centrifugation at 1,500 g for 10 minutes, the 
pellet was resuspended in 10 mL dH20 and cooled to 4°C to inhibit further cell 
division. The suspension was given into a 9 cm diameter petri-dish fitted with a 
magnetic stirrer (70 mm long; 9 mm diameter) which rotated at a speed-setting of 4 of a 
Gallenkamp Magnetic Stirrer Hotplate 400. The set-up was placed underneath a UV 
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lamp (CAMAG universal UV lamp TL900; 254 nm, 10 cm from the surface of the 
suspension). Irradiation of the cells was started by removing the lid from the petri-dish, 
and 100 | i L samples were taken in 15 second intervals for 450 seconds. The samples 
were diluted down to 1x10"^ in a decimal dilution series, and 100 ^ L aliquots of the 
1x10"^, 1x10"^, and 1x10"^ dilution were plated out in duplicates onto YPDA agar 
plates, which then were incubated at 30°C for 48 h. The percentage of survivors was 
plotted against the time (dose) of UV irradiation, and the dose which leads to 95% 
killing of the yeast cells originally present was used in subsequent mutagenesis events 
under the same conditions as described above. 
2.3.6. Selection for NaCl^ mutants 
Mutagenized yeast cultures were diluted with sterile dH20 in decimal steps and 
plated out onto YPDA agar plates. After incubation at 30°C for 48 hours, all plates 
which showed between 20 and 200 colonies were replica plated onto YPDA plates 
supplemented with 1.5 M NaCl using a wooden block covered with a sterile piece of 
velvet. The plates were sealed with Para-film™ and incubated at 30°C for 7 days. 
Master and replica were compared, and all colonies which were able to grow on YPDA 
but not on YPDA + 1.5 M NaCl were thought to be sensitive to high osmotic 
conditions, and were picked. The colonies were further purified in two successive 
fractional streaks, and after repeated testing for the inability to grow on YPDA + NaCl 
as before, stocks were produced. 
2.4. DNA Manipulation 
Al l methods described in the following section were adopted directly from 
Sambrook et al., 1989, or were modified protocols, which worked equally well under 
the conditions employed. Any of the following protocols which originated from another 
source are quoted from the literature. 
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2.4.1. Plasmid DNA Preparation from E. coli - Large Scale 
10 mL of Luria broth containing the appropriate antibiotic was inoculated with a 
colony of the bacterium harbouring the plasmid to be isolated, and then incubated at 
37°C for 16 hours with agitation. The culture was then used to inoculate 5(X) mL of 
superbroth containing antibiotic at the correct concentration, and then incubated at 37°C 
and 200 rpm for 6 hours, or until the OD^QO reached a value of 0.9 to 1.0, using 
superbroth as a blank. 100 mg solid chloramphenicol per 500 mL culture was added and 
the culture incubated for another 16 hours at 370C and 200 rpm. The chloramphenicol 
amplification step described here was optional, and unnecessary for high copy number 
plasmids (e.g. pUC derivatives). I f chloramphenicol was omitted, the cultures were 
incubated for 18 hours under the same conditions as described before. Cells were 
harvested by centrifugation in 250 mL centrifuge tubes at 3,500 g and 4^ for 1 minute. 
The peUet was washed once with 250 mL 25 mM Tris.HCl pH 8.0, 10 mM EDTA 
without resuspending the pellet. It was centrifuged under the same conditions as 
described above. The pellet of a 250 mL aliquot of the original culture was resuspended 
in 5 mL 15% (w/v) sucrose, 50 mM Tris.HCl pH 8.0, 50 mM EDTA (STE), and 
aliquots of 20 mL of this suspension were transferred to 100 mL centrifuge tubes. The 
tubes were frozen at -84°C for 30 minutes and were left at room temperature until 
completely thawed. 30 mL STE and 4 mL of a 10 mg/mL lysozyme solution in STE 
were added to each tube, which then were incubated at 37°C for 10 minutes, and a 
further 15 minutes on ice. 12 mL 5 M potassium acetate were added to each tube and 
left on ice for 15 minutes. 6 mL 10% (w/v) SDS each was added, and the tubes were 
gentiy mixed at room temperature for 10 minutes by slow inversion before they were 
left on ice for 60 minutes. The tubes were balanced and centrifuged at 12,000 g and 7°C 
for 20 minutes. The supernatant was aspirated and pooled. Solid NaCl was added to 36 
g/L supernatant and when completely dissolved, 50% (w/v) PEG-6000 was added to 
reach a final concentration of 10%. After mixing, this solution was left on ice for 14 to 
16 hours. The white sediment formed was resuspended and then centrifuged at 8,000 g 
and 4°C for 15 minutes. The pellets were slowly dissolved in a total of 18 mL TE (for 
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500 mL plasmid prep), and solid CsCl was added to a final concentration of 0.94 g per g 
sample. It was centrifuged at 2,500 g and 4°C for 20 minutes to float any residual PEG. 
PEG on top of the solution was removed, and 10 mg/mL ethidium bromide solution was 
added to give a final ratio of 10 \iL/mL sample. The sample was introduced into 
quickseal ultracentrifuge tubes, which after balancing were sealed and centrifuged at 
200,000 g (VTi70 rotor) at 15oC for 20 hours in a Sorvall OTP65B Ultracentrifuge. The 
tubes were carefully removed, DNA was visualized under U.V., and the lower visible 
band (plasmid DNA) was taken up with a syringe, after piercing the top of the tube. I f 
high purity of the plasmid preparation was essential, the samples containing the plasmid 
were given into a fresh 15 mL quickseal tube and then topped up with a 0.94 g/mL CsCl 
plus 30 ^iL/mL ethidium bromide solution. The tubes were centrifuged as before, and 
the plasmid DNA was carefully taken off the gradient with a syringe. The sample was 
extracted with an equal volume CsCl and TE buffer saturated isopropanol about 4 to 5 
times to remove the ethidium bromide, and it was dialysed against a total of 4 L TE 
with four changes of buffer for 12 hours between each buffer change. The concentration 
of the plasmid DNA was determined, and the DNA was stored at -84°C. 
2.4.2. Plasmid DNA Preparation from E. coli - Mini Preps 
A method for the isolation of small amounts of plasmid DNA (4 to 10 ^ g) from E. 
coli using silica fines was employed throughout (Amersham). 
5 mL Luria broth containing the appropriate antibiotic were inoculated with a 
single bacterial colony, and incubated at 31°C overnight with vigorous agitation (200 
rpm). 1.5 mL of the culture were transferred into a microcentrifuge tube and centrifuged 
for 1 minute at 12,000 g in a microfuge. The supernatant was removed by aspiration, 
leaving the bacterial pellet as dry as possible. The pellet was resuspended in 350 \LL of a 
sterile filtered solution containing 8% sucrose, 0.5% (v/v) Triton X-100, 50 mM EDTA, 
10 mM Tris.HCl pH 8.0. 25 | i L of a freshly prepared lysozyme solution (10 mg/mL 
lysozyme in TE buffer) was added, and it was vortexed for 3 seconds. The tube was 
incubated in a boiling waterbath for exactly 90 seconds. It was then immediately 
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centrifuged at room temperature for 10 minutes, and the pellet was removed from the 
tube with a sterile toothpick. To the supernatant 0.7 mL Nal solution (90.8 g Nal, 1.5 g 
Na2S03 in 100 mL dH20, filter sterilized, and 0.5 g Na2S03 added after filtering) was 
added and mixed by gentle vortexing. 20 ^ L of well resuspended, acid washed silica 
fines (silica 325 mesh, 50% (v/v) in dH20) were added to the tube, mixed by inversion, 
and the plasmid DNA bound to the glass by incubation at room temperature for 10 
minutes. The tubes were centrifuged for 15 seconds at 12,000 g and all of the 
supernatant aspirated off. The pellet was resuspended in 1 mL 70% (v/v) ethanol:30% 
(v/v) TE buffer, and then centrifuged as before. The ethanol was aspirated off, the 
pellets were dried under vacuum for 10 minutes, and the fines then resuspended in 50 
\iL TE buffer. DNA was eluted by incubating the tube at 370C for 10 minutes. The fines 
were pelleted by centrifugation as before, and the plasmid DNA containing supernatant 
was transferred to a fresh tube. The DNA was now ready for digestion with any 
restriction endonuclease or transformation without any further purification. 
2.4.3. Genomic DNA Isolation from S. cerevisiae - Large Scale (Rose et al, 1987) 
Two 10 mL YPDA starter cultures were inoculated with a medium size yeast 
colony, and incubated at 30°C for 36 hours with agitation. The contents of both starter 
cultures were transferred to 1 L YPDA and then incubated at 30oC and 140 rpm for 16 
hours until a cell density of 1 x 10^ cells/mL was reached. Cells were harvested by 
centrifugation at 7,500 g and A^C for 5 minutes. The pellets were resuspended in 50 mL 
50 mM EDTA pH 9.5 each, and the cell suspension centrifuged under the same 
conditions as above. Each pellet was resuspended in 25 mL ice-cold 50 mM Tris.HCl 
pH 9.5, 2% (v/v) |3- mercaptoethanol, pooled into a 250 mL centrifuge tube and left on 
ice for 15 minutes. The cell suspension was centrifuged as before and the pellet 
resuspended in 20 mL 1 M sorbitol, 1 mM EDTA pH 8.5 and then 500 ^iL of a 10 
mg/mL lyticase-100 solution in the same buffer was added. The cells then were 
sphaeroplasted at 37°C with gentle shaking (120 rpm) until more than 95% of the cells 
burst upon dilution of a 10 M,L sample in 1 mL 1% (w/v) sarcosyl (3.5 hours). The 
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suspension was centrifuged at 12,000 g and 4°C for 15 minutes. The pellet was 
suspended in 5 mL lysis buffer (0.1 M Tris.HCl pH 9.5, 0.15 M NaCl, 0.1 M EDTA, 
2% (v/v) p-mercaptoethanol), and the centrifuge tube was frozen in liquid nitrogen for 
about 15 to 30 minutes. The frozen sample was thawed at room temperature and 
transferred to a 100 mL conical flask (total volume approximately 10 mL). 20 mL lysis 
buffer, pH 9.4, with 4% (w/v) sarcosyl was added, and the lysis mixture was incubated 
at 450c for 20 minutes. 20 mL lysis buffer, pH 8.0, with 4% (w/v) sarcosyl was added 
to the flask, which was then incubated at 70°C for 15 minutes. DNAse free RNAse was 
added to a final concentration of 0.1 mg/mL, and then incubated at 4 5 ^ for 1 hour. 
Proteinase K (Type XI) was added to a final concentration of 0.8 mg/mL in two aliquots 
in hourly intervals. The mixture was incubated at SVC for a total of 2 hours, followed 
by incubation at 70°C for 15 minutes. 10 mL aliquots of the digest were transferred to 
30 mL cortex tubes. 10 mL of a phenol .'chloroform mixture (1:1) was added to each 
tube, the tubes were then sealed with cling film and slowly agitated until a white 
emulsion formed and no phase boundaries were visible anymore. Phases were separated 
by centrifugation at 5,000 g and 15°C for 15 minutes. The DNA containing top layer 
was extracted once more with phenol .-chloroform and twice with chloroform. The 
aqueous fractions were pooled and incubated at 4 5 ^ for 2.5 hours to remove traces of 
chloroform. The DNA was dialysed against 0.15 M NaCl, 10 mM Tris.HCl pH 8,0, 1 
mM EDTA at 4°C with continuous stirring. The dialysis buffer was changed twice after 
8 hours, and the DNA was pooled and the volume determined. Solid CsCI was added to 
reach a final concentration of 1 g CsCl/0,8 mL, The solution was filled into quickseal 
tubes which were topped up with CsCl solution of the same density, balanced and 
sealed. The tubes were centrifuged at 200,000 g and 150C in a Sorvall OTP65B 
centrifuge (VTi50 rotor) for 24 hours. The tubes were perforated with a wide gauge 
syringe needle, and 1 mL fractions were collected. The fractions were tested for DNA 
concentration, and the fractions which contained the DNA were pooled and dialysed 
against TE buffer in dH20 for 24 hours with three buffer changes. The DNA 
concentration was determined spectrophotometrically and then stored at -S4°C. 
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2.4.4. Isolation of Plasmid DNA from S. cerevisiae 
A single step purification protocol for shuttle plasmids from yeasts for 
transformation into E. coli was employed as described by Ward, 1990. The plasmid 
harbouring yeast strain was grown under selective conditions until saturation, usually 48 
hours at 30°C and 140 rpm, and cells were harvested by centrifugation of a 1.5 mL 
aliquot at 12,000 g for 30 seconds. The pellet was suspended in 100 | i L of LTTE (2.5 M 
LiCl, 50 mM Tris.HCl pH 8.0, 4% Triton X-100, 62.5 mM EDTA), 100 ^iL 
phenohchloroform (1:1), and 0.2 g acid washed glass beads were added. The mixture 
was vortexed at top speed for 2 minutes, and phases were separated by centrifugation at 
12,000 g for 1 minute. The upper phase was ethanol precipitated and the DNA was 
dried under vacuum and redissolved in 20 piL TE buffer. A l^iL aliquot of the DNA 
could be transformed into E. coli. 
2.4.5. Determination of the DNA Concentration 
The concentration of aqueous nucleic acid solutions was determined 
spectrophotometrically at a wavelength of 260 nm and 280 nm in a Philips UVA^isible 
PU8740 Spectrophotometer. An OD260 of 1.0 corresponds to about 50 ^ig/mL dsDNA, 
40 )Xg/mL ssDNA and RNA, and approximately 20 |ig/mL for single stranded 
oligonucleotides. The OD260/OD280 ratio could estimate the purity of the DNA/RNA 
measured. For pure nucleic acid the ratio is approximately 1.8 for DNA, and 2.0 for 
RNA. I f the preparation is contaminated with phenol or proteins, the ratio will be much 
smaller. 
2.4.6. Phenol:Chloroform Extraction of DNA 
The method makes use of the fact that proteins and DNA have different 
partitioning properties in a mixture consisting of an organic (phenol) and aqueous 
phase. 
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An equal volume of a 1:1 mixture of phenohchloroform, which before had to be 
buffer equilibrated to pH 8.0, was added to the nucleic acid sample to be extracted, and 
the contents of the tube was gently emulsified. The emulsion was centrifuged at 12,000 
g for 30 seconds in a microfuge, and the aqueous phase was transferred to a fresh tube, 
and the extraction process could be repeated until no precipitate at the interphase was 
formed. The aqueous phase was transferred to a new tube, an equal amount of 
chloroform was added, and the tubes were gently mixed until an emulsion was formed. 
The emulsion was centrifuged at 12,000 g for 30 seconds in a microfuge and the 
aqueous phase was transferred to a fresh tube. The DNA in the aqueous phase could be 
ethanol precipitated as described below. 
2.4.7. DNA Precipitation from Aqueous Solutions 
DNA could be precipitated with isopropanol or with ethanol in the presence of 
sodium acetate or lithium chloride. For isopropanol precipitation, 0.7 volumes 
isopropanol were added to the DNA solution and then immediately centrifuged for 30 
minutes at 12,000 g and room temperature. The supernatant was aspirated off, and the 
mostly invisible DNA pellet was washed with 1 mL ice-cold 80% (v/v) ethanol. After 
further centrifugation for 1 minute, the supernatant was aspirated off and the pellet dried 
either under vacuum for 1 to 2 minutes or by leaving the tubes inverted at room 
temperature. For ethanol precipitations, 1/10 volume of 5 M sodium acetate or 8 M LiCl 
were added to the DNA containing solution, and 2 volumes ice-cold ethanol were added 
to the solution. Tubes were left on ice for 15 minutes, and DNA was pelleted by 
centrifugation at 12,000 g for 15 minutes. Pellets were washed and dried as described 
for isopropanol precipitations. Generally, the addition of monovalent ions could be 
omitted, i f the DNA was in buffer containing high salt concentrations. 
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2.4.8. Restriction Digests 
Restriction digests were carried out using commercial sources of enzymes and 
their appropriate buffers from the same supplier. A typical digest was sequentially set 
up as described below: 
DNA X ^iL 
dH20 18-X^iL 
lOx Restriction Enzyme Buffer 2 | i L 
Restriction Enzyme 1 U/p,g DNA 
Digestion was carried out for 3 hours at the recommended temperature, usually 
37°C, except for Sma I where the temperature optimum was 25 ^ C. Double digests were 
carried out using the Boehringer buffer system, i f restriction enzymes were compatible, 
and both enzymes were added simultaneously to the digest. I f enzymes were 
incompatible in their buffer requirement, digestion was carried out with one enzyme, 
the digest was phenol:chloroform extracted, and DNA was precipitated and used in a 
subsequent restriction digest. I f larger amounts of DNA were required, the above 
reaction could be scaled up appropriately. 
2.4.9. DNA Molecular Weight Markers 
DNA molecular weight markers were prepared by digestion of phage A, DNA with 
Eco RI, Pst I or Hind I I I to completion. A typical preparative digest was performed in 
the following reaction: 
X DNA (300 |ig/mL) 166 ^ L 
dH20 624 |XL 
lOx Restriction Enzyme Buffer 90 | i L 
Restriction Enzyme (10 U/|iL) 20 \iL 
Digestion was carried out overnight at 37°C. 100 j iL 6x stop dye was added, and 
the molecular wight marker was dispensed into 100 ^.L aliquots and stored frozen at -
20°C. An equivalent of 20 to 25 )a.L was loaded onto agarose gels as a size standard. 
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2.4.10. Dephosphorylation of Termini 
Dephosphorylation of 5'-phosphate groups of linearized DNA was carried out 
with phenohchloroform extracted and ethanol precipitated DNA in the following 
reaction: 
Linearized DNA 45 |xL 
lOx CIP Buffer 5 ^iL 
Calf Intestinal Alkaline Phosphatase (CIP) 2 | i L 
Dephosphorylation was carried out at 37°C for 3 0 minutes. The phosphatase was 
inactivated by adding 5 )iL 0.1 M NTA, pH 8.0 and heating to 750C for 20 minutes. 
DNA was twice phenohchloroform extracted, and DNA was ethanol precipitated and 
could be used in ligation reactions. 
2.4.11. Ligation Reactions 
Ligation reactions of cohesive and blunt-ended termini were set up by placing an 
equivalent of 0.1 ^g vector DNA and an equimolar amount of the fragment to be ligated 
into the vector into a microcentrifuge tube, and adding water to a total volume of 18 ^iL. 
The mix was heated up to 45"^C for 5 minutes, and then placed on ice. 2 | J L lOx ligase 
buffer (200 mM Tris.HCl pH 7.6, 5 0 mM MgCl2, 5 0 mM dithiothreitol, 500 \Lg/mL 
BSA, 5 mM ATP) and 1 ^iL T 4 DNA ligase (1 Weiss unit) were added into the tube, 
and ligation was carried out at room temperature for 2 to 4 hours, or at 4 ^ overnight. 1 
to 1 0 | i L of the ligation reaction could be transformed into competent £. coli. 
2.4.12. Klenow Filling-in of Cohesive Termini 
Klenow filling-in of recessed 3' cohesive termini could be done immediately after 
restriction digestion without phenohchloroform extraction. 1 j j L of a solution of all 4 
dNTP's at a concentration of 1 mM was added to 2 0 \iL of the restriction digest, 1 unit 
Klenow fragment/^ig DNA was added, and the reaction was carried out at room 
temperature for 1 5 minutes. The reaction was terminated by adding an equal amount of 
TE buffer, phenohchloroform extraction and subsequent ethanol precipitation. 
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2.4.13. Exo III/Mung Bean Nuclease Deletion 
The Exo in/mung bean deletion system™ (Stratagene) has been designed to carry 
out unidirectional deletions of DNA of predictable sizes. The Exo HI nuclease will 
digest 3' termini from blunt and 5' protruding termini, but not 3' single strand termini. 
Deletions of an insert in the pBluescipt™ vectors proceeded according to the 
manufacturer's recommendations, using only reagents supplied with the kit 
(Bluescript™ Exo/Mung DNA Sequencing System Instruction Manual, Stratagene). 
The plasmid construct was double digested to completion with two restriction 
enzymes. One enzyme creates a 5'-protruding or blunt end, the other 3'-protruding 
termini. The 5'-protruding or blunt end is between the sequence to be deleted and the 3'-
protruding terminus. DNA was phenol:chloroform extracted, ethanol precipitated and 
dissolved in TE buffer. The Exo EI reaction was set up as follows for each time point: 
Double digested DNA 5 ^ig 
2x Exo Buffer 12.5 )iL 
100 mM P-mercaptoethanol (fresh) 2.5 |xL 
Exonuclease in 1 | i L 
dH20 to 25 ^iL 
The reaction was started by adding Exo HI, and incubation at the optimal 
temperature (Table 2.5) to yield the desired deletions. 25 | i L of the reaction mixture was 
removed at the appropriate time, and given into a tube containing 40 |xL 5x Mung Bean 
Buffer and 135 [iL dH20 and then placed on ice. When all aliquots were removed, 
tubes were heated to 68°C for 15 minutes and then placed on ice. 40 units Mung Bean 
Nuclease (diluted with Ix Mung Bean Dilution Buffer) was added to each tube, and 
then incubated at 30oc for 30 minutes, 4 |xL 20% (w/v) SDS, 10 ^ L 1 M Tris,HCl pH 
9,5, 20 | i L 8 M LiCl, and 250 [LL phenol:chloroform were added, mixed by vortexing 
thoroughly, and then centrifuged at 12,000 g for 1 minute. The aqueous layer was 
chloroform extracted, 0.5 mL ice-cold ethanol added and the DNA ethanol precipitated 
as described before. The now blunt ended deletions were self ligated, transformed into 
E. coli, and transformants were screened for the presence of the correct size deletion. 
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Temperature Exo m dsDNA to ssDNA 
conversion 
370c 400 bp/minute 
340c 375 bp/minute 
30OC 230 bp/minute 
230c 125 bp/minute 
Table 2.5: Progress of Exo I I I digestion at different incubation temperature. 
2.4.14. Agarose Gel Electrophoresis 
Agarose gel electrophoresis was performed in a Pharmacia mini-gel system, or a 
home made maxi gel apparatus. The open ends of the gel casting apparatus were sealed 
with autoclave tape, or a casting mold was placed onto a glass plate, and the casting 
mold was set on a horizontal place and combs inserted. Agarose was added to a 
measured quantity of Ix TAE buffer, usually to a concentration of 0.7% (w/v), and the 
suspension was boiled in a microwave oven until all the agarose had dissolved. After 
cooling down to approximately 60°C, ethidium bromide was added to a fmal 
concentration of 0.5 |j,g/mL and the agarose poured into the mold. Once the gel had set, 
the comb was removed and the gel placed into the electrophoresis apparatus. Ix TAE 
buffer containing 0.5 [Xg/mL ethidium bromide was added so that the surface of the gel 
was covered to a depth of 1 to 2 mm. DNA samples in 6x sample buffer were loaded 
and electrophoresis performed at 1 to 5 V/cm until the marker dyes had migrated to 
appropriate distances. The gel then was placed onto a UV illumination apparatus and 
photographed using a red-filter and a polaroid camera. 
2.4.15. DNA Fragment Isolation 
DNA fragments separated in a low melting point agarose gel were excised with a 
sterile razor blade, heated up to 70°C for 10 minutes and 700 ^iL Nal (see 2.4.2.) 
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solution added. After genUe mixing by inversion 10 )iL silica fines was added and the 
DNA was bound and eluted from the fines as described previously (2.4.2.). 
2.5. DNA Sequencing 
2.5.1. Procedure for Obtaining Single Stranded DNA from 
Bluescript™ Vectors 
A tube containing 10 mL Luria broth supplemented with ampicillin and 
tetracycline was inoculated with XLl-Blue harbouring recombinant pKS/pSK plasmid. 
After overnight incubation with agitation at 37°C, a 5 mL equivalent was transferred to 
50 mL 2x TY broth containing ampicillin and tetracycline and incubated for 4 to 6 
hours until an ODggo of 0,3 was reached (about 2,5 x 10^ cells/mL), Helper phage R408 
was added to the log-phase culture at a multiplicity of infection (m,o,i,) of 20:1 
(phage:bacteria). The culture was incubated for another 6 to 8 hours at 37°C with 
moderate (160 rpm) agitation. The culture was clarified by centrifugation at 17,000 g 
for 20 minutes and the supernatant transferred to a fresh tube. A 10 mL aliquot of the 
suspension was added to 2,5 mL 3.5 M ammonium acetate pH 7.5, 20% (w/v) 
polyethyleneglycol solution. It was mixed by inversion and incubated at room 
temperature for 15 minutes. Tubes were centrifuged at 11,000 g for 20 minutes and the 
supernatant thoroughly drained off. The pellet was resuspended in 0.5 mL TE buffer, 
0.5 mL buffer saturated phenohchloroform was added and then vortexed for 1 minute. 
The tube was centrifuged for 5 minutes, the supernatant transferred to a fresh tube and 
the procedure was repeated until no interphase was left (up to 5 times). 0.5 mL 
chloroform was added to the aqueous phase of the final phenohchloroform extraction, 
vortexed for 1 minute and then centrifuged for 2 minutes. The aqueous phase was 
transferred to a fresh tube. The ssDNA was precipitated by adding 375 )JL 7,5 M 
ammonium acetate pH 7,5, and 1,5 mL cold 100% ethanol in a 15 mL Corex tube. The 
mixture was left on ice for 15 minutes and then centrifuged at 4°C for 20 minutes. The 
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supernatant was aspirated off, the pellet washed with 80% (w/v) ethanol and dried under 
vacuum. The pellet was redissolved in 100 | i L dH20, and transferred to a fresh tube. 
2.5.2. Preparation of ds Plasmid DNA Template for Sequencing 
1.1 mL of an overnight culture in Luria Broth of the strain harbouring the desired 
plasmid was transferred to a microfuge tube and bacteria were pelleted by 
centrifugation at 12,000 g for 3 minutes. The pellet was resuspended in 110 | J L 8% 
(w/v) sucrose, 5% (v/v) Triton X-100, 50 mM Tris.HCl pH 8.0,50 mM EDTA, and then 
12 ^iL of a freshly prepared 5 mg/mL lysozyme solution was added and incubated at 
room temperature for 10 minutes. The tube was placed in a boiling waterbath for 2 
minutes, and centrifuged at 12,000 g for 15 minutes. The pellet was removed with a 
sterile toothpick, and 110 )xL isopropanol was added prior to centrifugation for 15 
minutes. The pellet was resuspended in 25 |xL TE buffer, extracted twice with 
phenohchloroform and once with chloroform. The aqueous phase was transferred to a 
new tube and 20 |xL 7.5 M ammonium acetate and 100 [LL ice-cold ethanol was added. 
The tube was placed on ice for 15 minutes and then centrrfuged for 20 minutes. The 
DNA pellet was washed with 1 mL 80% (v/v) ethanol and the pellet dried under 
vacuum. The DNA was dissolved in 15 | J L TE buffer. 5 )iL of the solution contains 
approximately 2 )ig DNA. 
2.5.3. Alkaline Denaturation of dsDNA Sequencing Templates (Yanisch-Perron et 
al,1985) 
A 5 |ig equivalent of the dsDNA to be sequenced was added to 45 \iL 0.2 M 
NaOH, 0.2 mM EDTA, and denaturation was performed by incubation for 30 minutes at 
37"C. The mixture was neutralized by the addition of 5 jxL 3 M sodium acetate pH 5.0 
and the DNA was precipitated by adding 150 | i L ethanol and incubation at -84°C for 15 
minutes, or at -20°C overnight. After centrifugation the pellet was washed with 1 mL 
70% (v/v) ethanol and dried under vacuum. It was resuspended in 7 j iL dH20 and used 
in the sequencing reaction described below. 
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2.5.4. DNA Sequencing Reaction 
The sequencing reactions were performed in accordance with the Sequenase 
Version 2.0™ protocol (Unites States Biochemical, Cleveland, Ohio, USA; 5th edition). 
In brief, for a typical non-extended sequencing reaction, the following were 
combined in a microcentrifuge tube: 
Template DNA (1 \ig ssDNA; 5 |xg dsDNA) 7 ^iL 
Reaction Buffer 2 f iL 
Primer (1 pM/|iL) 1 ^iL 
It was important to use an approximate equimolar ratio of template and primer for 
best results. A l l dsDNA to be sequenced had to be alkaline denatured and ethanol 
precipitated to allow primers to bind. The tube was incubated at 65 °C for 2 minutes and 
then cooled slowly to room temperature over a period of 30 minutes. This was done by 
placing the tubes in a beaker containing 5 mL water of 65°C, and leaving the beaker at 
room temperature. Once the temperature was below 30°C, tubes were placed on ice. 
The following components were added to the same tube: 
0,1 M dithiothreitol 1,0 \iL 
1X Labeling Mix (dGTP) 2,0 | i L 
[a-35S]dATP (10 ^iCi/|iL) 0.5 ^lL 
Diluted Sequenase/Pyrophosphatase 2.0 ^iL 
1 |xL Sequenase Version 2.0 T7 DNA Polymerase and 0.5 |xL pyrophosphatase 
were diluted in 6.5 \iL enzyme dilution buffer and left on ice no longer than 15 minutes. 
Once the Sequenase was added to the labelling reaction it was mixed and incubated at 
room temperature for 2 minutes. Four 3.5 j iL aliquots of the labelling reaction were 
transferred into four tubes labelled G, A, T and C, containing 2.5 | i L of the ddOTP, 
ddATP, ddTTP and ddCTP termination mixes, respectively. Tubes containing the 
termination mixes were pre-warmed to 38°C for at least 2 minutes in a heating block 
before the labeling reaction was added. The termination reaction was carried out for 5 
minutes at 38°C. 4 ^iL of stop solution was added to each of the four termination 
reactions. Samples could be stored at -20°C for up to one week, or could be loaded onto 
a pre-heated sequencing gel. Before loading the gel, samples were heated up to 80°C for 
2 minutes and loaded immediately. 
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2.5.5. Denaturing Gel Electrophoresis 
A Bio-Rad® 21 x 50 cm Sequi-Gen Nucleic Acid Sequencing Gel System was 
used to pour and run sequencing gels. Before pouring the gel, the glass plates were 
cleaned with ethanol and acetone, and one plate was siliconized with Repelcote and 
polished. The gel apparatus was assembled and ready for casting. 
To make the gel, 42 g urea, 10 mL lOx TBE buffer and 40 mL dH20 were heated 
to 65°C in a water bath, until the urea was completely dissolved. 12.5 mL of a 40% 
(w/v) acrylamide stock solution (380 g/L acrylamide, 20 g/L Bis-acrylamide) for a 5% 
gel was added, the volume made up to 100 mL and then filtered through a 22 |im 
Satorius membrane filter. 20 mL of the unpolymerized gel solution was transferred to a 
beaker, 140 ^iL 25% (w/v) ammonium persulphate solution and 100 | iL TEMED were 
added and the solution was poured into the casting fray onto filter paper, and the gel 
assembly was placed on top. After 5 minutes, the gel assembly was placed in a 
horizontal position. To the remaining 80 mL of unpolymerized gel solution, 117 pL 
25% (w/v) ammonium persulphate and 90 | i L TEMED were added, the gel was poured 
and an appropriate comb was inserted between the glass plates. After the gel had 
polymerized it was pre-run at 30 mA to a temperature of 55°C, using Ix TBE as the 
electrophoresis buffer. Before loading the samples, the wells were washed out with 
buffer. The gel was run at 30 mA and 55°C until the bromophenol blue marker was 
eluted off the sequencing gel. 
2.5.6. DNA Sequence Analysis 
Primary DNA sequence analysis was carried out by entering the DNA sequence 
into the DNA-Strider program (Marck, 1988), assembling the complementary strand, 
and analysing restriction sites, creating graphical maps of the sequenced fragments, and 
translating all six hypothetical reading frames, as described in the manual. Additionally, 
the DNA sequence was down-loaded to the Daresbury SERC SEQNET facility and an 
analysis using the UWGCG (Devereux et al., 1984) package was performed. This 
included database searches, determination of DNA sequence features, such as 
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terminators, start and stop codons, and codon preference comparisons. The most likely 
start codon was chosen, using a codon bias table, as described in Cavener and Ray, 
1991, and searching for upstream regulatory elements at the appropriate distance. 
Judged from the codon preference comparison, the most probable open reading frame 
was translated into protein code and further analyzed as described below. 
2.5.7. Deduced Protein Sequence Analysis 
The deduced protein sequence was compared to previously published sequences, 
searching the OWL non-redundant database on SEQNET with NEWSWEEP and a 
daily updated GenEMBL database with TFASTA and FASTA, alignment programs 
based on the algorithm of Lipman and Pearson, 1985, at a K-tuple of 1. Possible 
consensus sequences were determined by searching the LUPES and UWGCG 
consensus sequence libraries for matches. Secondary structure predictions were 
produced using the UWGCG program (all available on SEQNET), 
2.6. Transformation 
2.6.1. Transformation of E. coli • Ultra High Efficiency 
A modified version of the method described by Kushner et ah, 1978, for ultra 
high efficiency transformation (e,g, for libraries) was routinely used to transform E. 
coli. 
Cells were grown up in 10 mL Luria broth directly from a glycerol or from an 
overnight culture to a cell density of 2,0 x 10^ cells/mL, 1,4 mL aliquots of the culture 
were centrifuged in a cooled microfuge at 12,000 g for 30 s and the pellets gentiy 
resuspended in 500 ^iL 10 mM MOPS pH 7,0, 10 mM RbCl, The suspension was 
centrifuged for 15 s at 12,000 g and the pellets resuspended in 500 ^iL 100 mM MOPS 
pH 6,5,10 mM RbCl, 50 mM CaCl2 and held on ice for 90 minutes. Cells were pelleted 
in a 10 second spin and were resuspended in 150 |i.L of the same buffer, 3 |xL DMSO 
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and up to 100 \lL of the D N A solution (1 - 250 ng) were added consecutively. The 
transformation mixture was kept on ice for 60 minutes. The tubes were mixed by 
inversion, heat shocked at 55°C for 30 seconds and kept on ice for 1 minute. 1 mL pre-
warmed Luria broth was added to each tube and then incubated at 37<XZ for 1 hour. 100 
|xL aliquots of a decimal dilution series of the transformed cells were plated out onto 
pre-warmed antibiotic containing Luria agar plates. 
2.6.2. Transformation ofE. cott - RbCl Competent Cells (Hanahan, 1985) 
30 mL SOB was inoculated with a fresh colony of the strain to be transformed and 
the culture incubated overnight at 37°C with moderate agitation (160 rpm). 8 mL of the 
overnight culture were added to 200 mL SOB in a 2 L flask and incubated at 37 °C to an 
OD550 of 0.3. The culture was collected in four 50 mL polypropylene centrifuge tubes 
and left on ice for 15 minutes. Cells were centrifuged at A°C and 3,000 g for 5 minutes 
and the supernatant was aspirated off thoroughly. Pellets were gently resuspended by 
mild vortexing of each in 16 mL sterile filtered and pre-chilled transformation buffer 1 
(12 g/L RbCl, 9.9 g/L MnCl2.4H20, 30 mL/L 1 M potassium acetate pH 7.5, 1.5 g/L 
CaCl2.2H20, 150 g/L glycerol, pH 5.8 with acetic acid) and incubated on ice for 15 
minutes. Cells were pelleted as before and each pellet resuspended in 4 mL ice-cold 
sterUe filtered transformation buffer 2 (20 mL/L 0.5 M MOPS pH 6.8, 1.2 g/L RbCl, 
11.0 g/L CaCl2.2H20, 150 g/L glycerol), disfributed in 600 ^ L aliquots into sterile, ice-
cold microcentrifuge tubes and frozen in liquid nitrogen. Cells were stored at - 8 4 ^ 
until required. 
For transformation, tubes were thawed on ice and 300 ^iL aliquots of competent 
cells were transferred to pre-chilled tubes. 20 }JL of the D N A to be transformed was 
added whilst stirring the cells. The suspension was incubated on ice for 45 minutes and 
then heat shocked at 420C for 45 seconds without shaking the tube. The tubes were 
placed on ice for 5 minutes, 1 mL Luria broth added and fransformed cells were plated 
out onto selective medium after 1 hour incubation at 37°C. Transformants were 
obtained after 12 to 36 hours incubation at 37°C, dependent on the strain used. 
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2.6.3. Transformation of S. cerevisiae Sphaeroplasts 
The method described by Beggs, 1978, was used to transform yeast sphaeroplasts. 
An overnight culture of the yeast strain to be transformed was grown up in 5 mL 
YPDA to an OD^QO of 3,0, A 200 \iL aliquot was ti-ansferred to 200 mL YPDA which 
was incubated at 30°C and 140 rpm for 16 hours. The culture was centrifuged at 3,000 g 
for 5 minutes, washed once with dH20, and finally was resuspended in 35 mL 1,2 M 
sorbitol, 25 mM EDTA, 50 mM dithiothreitol, pH 8,0, The suspension was incubated at 
30°C for 10 minutes with gentie shaking, centrifuged as before, and washed twice with 
1,2 M sorbitol. The pellet was resuspended in 30 mL 1,2 M sorbitol, 10 mM EDTA, 0.1 
M sodium citrate pH 5.8, and 0.3 mL of a 10 mg/mL Zymolyase-IOOT solution was 
added. The suspension was incubated at 30°C for 1 hour and then washed three times 
with 1.2 M sorbitol. The pellet was resuspended in 15 mL 1.2 M sorbitol, 10 mM 
CaCl2, centrifuged and then resuspended in 1 mL of the same solution. 20 )xL DNA 
(approximately 2 )xg) was added to 200 \iL cells and left at room temperature for 15 
min. 1 mL 20% PEG-4000, 10 mM CaCl2,10 mM Tris.HCl pH 7.5 was added and left 
no longer than 10 minutes at room temperature. Cells were sedimented by 
centrifugation at 12,000 g for 5 seconds in a microfuge and resuspended in 100 | iL 1.2 
M sorbitol, 10 mM CaCl2 plus 50 ^ L YPD. The tubes were incubated at 300C for 20 
minutes and diluted 10^ fold in 1.2 M sorbitol and plated out in 6 mL regeneration agar 
onto selection agar plates. The plates were incubated 3 to 4 days at 30°C. 
2.6.4. Lithium Acetate Transformation of S. cerevisiae 
Three different methods, all derived form the method of Ito et ai, 1983, were 
used to transform 5. cerevisiae with plasmid DNA, the transformation frequencies 
depending on the plasmid class used. 
Conventional Lithium Acetate Method After Ito et ai, 1983 
2 mL of a late log phase starter culture were used to inoculate 100 mL of pre-
warmed YPDA. The initial cell density of the culture was determined with a Coulter 
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Counter, and from the initial density the approximate incubation time was estimated 
from a growth curve of the same strain under identical conditions to reach a fmal 
density of approximately 5.6 x 10^ cells/mL. The cells were harvested by centrifugation 
at 15°C and 1,500 g for 5 minutes in two 30 mL aliquots. Each pellet was washed with 
30 mL TE buffer pH 7.5, resuspended in 10 mL TE pH 7.5 and then 0.5 mL aliquots 
were fransferred to test tubes. The tubes were incubated at 30°C and agitation (140 rpm) 
after the addition of 0.5 mL 0.2 M LiAc to each tube. 100 | i L aliquots of the now 
competent yeast cells were mixed with no more than 15 ^ L plasmid DNA 
(approximately 10 \Lg DNA). It was important to include a positive and negative control 
at this step, i.e. a standard amount of plasmid DNA with known transformation 
frequency, and dH20 as a negative control. Al l tubes were incubated at 30°C for 30 
minutes without agitation. 110 )xL 70% (w/v) PEG-4000 was added to each tube and 
then the tubes were incubated at 30°C for 60 minutes without agitation. The 
transformation mixtures were heat shocked at 42°C for exactly 5 minutes and then left 
at room temperature to cool down. The cells were sedimented by centrifugation for 60 
seconds at 12,000 g in a microfuge, washed twice with 1 mL dH20 each and were 
finally resuspended in 1 mL dH20 each. 100 | i L aliquots were spread out onto selective 
medium to screen for transformants (e.g. yeast minimal medium supplemented with 
amino acids except the one whose auxofrophic requirement was complemented by the 
transformed plasmid). The agar plates were incubated at 30°C for at least 4 days. 
Transformant colonies were sfreaked out onto minimal medium for further purification. 
SimpUfied Lithium Acetate Method 
2 mL of a late log - phase starter culture were used to inoculate 100 mL pre-
warmed YPDA, the initial cell density of a 1 mL aliquot was determined with a Coulter 
Counter, and the culture was incubated at 30°C and 140 rpm, imtil an approximate cell 
concentration of 5.0 x 10^ was reached as determined from a growth ciu^e of the 
particular sfrain. Two 40 mL aliquots of the culture were centrifuged at 1,500 g and 5^ 
for 15 minutes. Each pellet was washed once with 10 mL dH20 and then resuspended 
in 1 mL 0.1 M LiAc, 10 mM Tris.HCl pH 7.5, and incubated at 30°C for 60 minutes 
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with agitation (140 rpm). 200 |a.L of the suspension was added to 10 jxg plasmid DNA in 
15 ILL T E buffer. A positive control with an amount of plasmid DNA of known 
transformation efficiency and a control omitting DNA were included at this step. The 
tubes were incubated at 30°C for 30 minutes and agitation (140 rpm). 1.2 mL 40% 
(w/v) PEG-4000 in 10 mM Tris.HCl pH 7.5, 0.1 M LiAc were added to each tube and 
then vortexed vigorously. The tubes were incubated at 30°C for 30 minutes with 
agitation (140 rpm), and subsequentiy heat shocked at 55°C for 1 minute and 37°C for 4 
minutes The cells were centrifuged for 1 second at 12,000 g in a microfuge, washed 
twice with 1 mL T E and finally resuspended in 1 mL TE. 100 )J,L aliquots were spread 
out onto selective medium as described above and incubated at 30°C for at least 4 days. 
Transformant colonies were streaked out onto minimal medium and the presence of the 
correct plasmid was checked as described before. 
Improved LiAc Method of Transformation (U. Certa, personal communication to 
M.D. Watson) 
400 )iL of a late log-phase starter culture was used to inoculate 25 mL pre-
warmed YPDA. The initial cell density of a 1 mL aliquot was determined with a Coulter 
Counter, and the culture was incubated at 30°C and 140 rpm, until an approximate cell 
concentration of 5,0 x 10^  was reached as determined from a growth curve of the 
particular strain. The culture was centrifuged at 10,000 g and 5°C for 5 minutes, and the 
pellet was washed once with 20 mL dH20, The cell pellet was finally resuspended in 20 
mL 0,1 M LiAc and incubated at 30°C with agitation (140 rpm) for 60 minutes. The 
competent yeast cells were centrifuged at 4,000 rpm and room temperature for 10 
minutes and then resuspended in 800 )iL 0,1 M LiAc. 75 )xL of the cell suspension was 
added to 10 jig plasmid DNA in 15 jxL TE. A positive control with an amount of 
plasmid DNA of known transformation efficiency and control omitting DNA were 
included at this step. The tiabes were incubated at 30°C for 30 minutes and agitation 
(140 rpm). The tubes were then vortexed gentiy, and 600 ^iL 40% (w/v) PEG-4000 in 
10 mM Tris.HCl pH 7.5 was added. The tubes were incubated at 30oC for a further 60 
minutes, and the cells were finally heat shocked at 42^ for 5 minutes. After 
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centrifugation at 12,000 g in a microfuge for 2 seconds, the ceils were washed with 1 
mL dH20 once and were finally resuspended in 1 mL dH20. 100 )iL aliquots were 
spread out onto selective medium as described above 
2.6.5. Transformation of Yeast by Electroporation (Meilhoc et ai, 1990) 
5 mL YPDA were inoculated with an average size colony of the yeast strain to be 
transformed. The culture was incubated at 30°C with agitation for 36 h. A 0.5 mL 
aliquot of this starter culture was inoculated into 100 mL pre-warmed YPDA and 
incubated at BO^ C and 140 rpm until a cell density of 1 x lO'' cells/mL was reached. The 
culture was centrifuged at 1,500 g and 4°C for 5 minutes and the pellets were 
resuspended in 1 mL 25 mM dithiothreitol, 10 mM Tris.HCl pH 8.0 in YPDA and 
statically incubated at 30°C for 10 minutes. The cells were washed twice with 1 mL 10 
mM Tris.HCl pH 7.0, 270 mM sucrose, 1 mM MgCl2 (electroporation buffer) by 
resuspending the pellets with gentle pipetting up and down in the buffer and spinning 
the cells down in a microfuge at 12,000 g for 15 seconds. Finally, the pellets were 
resuspended in 0.8 mL of the electroporation buffer (total volume with cells 
approximately 1 mL) and stored on ice until transformation. 48 |iL of the cell 
suspension and 2 jxL DNA solution (approximately 10 to 20 ng) were mixed in a 
microcentrifuge tube and transferred into a gene pulser cuvette (BioRad 0.2 cm 
electrode gap) and pulsed at 0.54 V (2.7 kV/cm) for about 15 to 20 ms (BioRad Gene 
Pulser). 1 mL YPDA was added to the transformation mix and it was incubated at 30*C 
for 1 hour to allow recovery and phenotypic expression of the selectable marker 
conferred by the plasmid (e.g. URA3 with YCp50). Cells were harvested by 
centrifugation for 15 seconds at 12,000 g, resuspended in KX) |iL dH20 and direcfly 
plated out onto selective medium. The plates were incubated at 30°C for at least 4 days. 
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2.7. Protein Biochemistry Methods 
2.7.1. Lowry Determination of Protein Concentrations (Lowry et al, 1951) 
100 )iL of protein sample were added to 100 (iL of a freshly prepared solution 
containing 0.5 mL 1% (w/v) CUSO4, 0.5 mL 2.7% (w/v) sodium potassium tartrate, 5 
mL 24% (w/v) Na2C03, 0.66 mL 1 M NaOH and incubated at room temperature for 10 
minutes. 500 |xL of 1:19 diluted Folin-Ciocalteu reagent (Sigma) was added and the 
samples were incubated at 37°C for 30 minutes. The absorbance was read at 578 nm 
and the concentration of the sample was determined using known concentrations of 
BSA as standard. 
2.7.2. Lammli SDS Polyacrylamide Gel Electrophoresis (Lammli, 1970) 
SDS polyacrylamide gel electrophoresis (SDS PAGE) was performed using the 
Protean® n xi Slab Cell apparatus (Bio-Rad), as described in the manual. 
SDS PAGE gels were prepared from an acrylamide/bis stock (30% T, 2.67% C) 
containing 292 g acrylamide and 8 g N'N'-bis-methylene-acrylamide in 1 L dH20 which 
was not older than 30 days (see Table 2.6). Acrylamide/bis, dH20, and buffer were 
combined, degassed imder vacuum for 5 minutes and the rest of the components added 
to the desired concentration. The gel apparatus was assembled for casting according to 
the manufacturers manual. After puoring, the gel was overlayed with dH20 saturated 
butanol and was allowed to polymerize at room temperature for about 30 to 45 minutes. 
Butanol and unpolymerized acrylamide were poured off, the gel surface was washed 
with dH20 and then the stacking gel was poured. The comb was inserted and the gel 
was allowed to polymerize for another 30 minutes. The comb was removed, the wells 
washed with dH20 and the apparatus assembled for electrophoresis, filling both top and 
bottom reservoir with Tris-glycine buffer. Samples were loaded and electrophoresed at 
30 mA/gel for 4 to 6 hour, using a Model 1000/500 power supply (Bio-Rad) at a 
constant current setting. 
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Separating Gel Stacking Gel 
Monomer Concentration 12% 10% 7.5% 4.0% 
Acrylamide/bis stock 40.0 mL 33.3 mL 25.0 mL 1.3 mL 
dH20 33.5 mL 40.2 mL 48.5 mL 6.1 mL 
1.5MTris.HCl pH8.8 25.0 mL 25.0 mL 25.0 mL 
0.5 M Tris.HCl pH 6.8 2.5 mL 
10% SDS 1.0 mL 1.0 mL 1.0 mL 100 ^ iL 
10% NH4persulfate 500 ^iL 500 [iL 500 ^iL 50\LL 
TEMED 50 ^iL 50|iL 50 ^iL 10 ^iL 
Table 2.6: Formulation for SDS separating and stacking gels. 
2.7.3. Electrophoretic Blotting of Proteins 
Electrophoretic blotting of proteins ("Western Blots") was done in a Trans-Blot® 
Electrophoretic Transfer Cell (Bio-Rad) according to the manufacturers specifications. 
The SDS PAGE gel to be blotted and a piece of nitrocellulose membrane of equal 
size were equilibrated in 100 mL ice-cold transfer buffer for 30 minutes. Two pieces of 
filter paper of equal size to the gel were also soaked in transfer buffer, the gel-holder 
was opened, and the gel/nitrocellulose sandwich could be assembled. One saturated 
filter was placed on the pre-wetted gray side of the assembly cassette, followed by the 
gel, the nitrocellulose membrane and the other filterpaper, avoiding the enclosure of air-
bubbles. The cassette was closed and inserted such that the gray side faced the cathode. 
Transfer was performed at 100 V, 0.36 A for 4 hours with cooling on ice. After 
electrophoresis, the sandwich was disassembled, and the nitrocellulose membrane used 
in subsequent experiments. The gel could be stained with Coomassie blue to verify 
efficient tranfer. 
The membrane was placed into a plastic box and approximately 20 mL blotting 
buffer was added, or until the blot was just covered. The membrane was incubated at 
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37''C for 75 minutes on a rotary shaker (50 rpm). It was then washed three times in 
blotting buffer for 10 minutes each at room temperature (50 rpm). 25 | J L of the primary 
antibody in 20 mL blotting buffer was added to the box and incubated at 37°C for 135 
minutes. The blot was washed three times in blotting buffer for 10 minutes at room 
temperature with gentie agitation. 20 | iL secondary antibody alkaline phosphatase 
conjugate in 20 mL blotting buffer (1:1,000 dilution) was added to the membrane in the 
box and incubated at 37°C and 50 rpm for 2 hours. The blot was washed three times in 
blotting buffer for 10 minutes each at room temperature and 50 rpm and then rinsed 
once with 20 mL Ix Tris.HCl-salt pH 7.2. 333 ^iL 10 mg/mL NBT in 70% (v/v) 
dimethylformamide and 66 |xL 25 mg/mL BCIP in 100% dimethylformamide was 
added to 10 mL alkaline phosphatase buffer (100 mM NaCl, 5 mM MgCl2, 100 mM 
Tris.HCl pH 9.5). The alkaline phosphatase substrate solution was added to the blot and 
developed at room temperature with gentle agitation until a positive control was 
obtained. The reaction was stopped by rinsing the filter in dH20,1 M EDTA, and dH20 
successively. The filters were photographed, dried and stored in the dark. A deep purple 
to black band suggests the presence of a immunoreactive protein in the original gel. 
2.7.4. Non-lysing Colony Immunoblot Assay 
Qualitative secretion of soluble vacuolar proteins was tested with a dot-blot 
colony hybridization method (Rothman et al., 1986). 
Freshly grown colonies of the strains to be tested for secretion were picked from 
YPDA agar plates not older than 72 hours and patched onto YPDA agar plates together 
with a positive and negative control. A nitrocellulose filter was pre-wetted with Ix 
Tris.HCl-Salt (500 | iL for a 8.5 cm filter) and placed onto the agar plate, the position of 
the filter was marked and the plate was incubated at 30°C for 8 hours, if secretion of 
PrA or PrB was tested, or for 14 hours if secretion of CPY was tested. After incubation, 
the filters were labeled and washed in a jet of dH20 water. Each filter was placed into a 
petri-dish and processed as Western blots. The filters were photographed, dried and 
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stored in the dark. A deep purple to black patch over the position of a former colony 
signaled the secretion of the protein concerned. 
2.7.5. Pulse-labelling and Immunoprecipitation of Yeast Proteins 
Sphaeroplasts were prepared and labelled as described before (Robinson et ai, 
1988), except that Zymolyase 100-T was used at 2 mg/mL instead of lyticase. 
Cells were grown to mid-logarithmic phase in yeast minimal medium 
supplemented with 0.2% yeast extract. Four absorbance units at ODggo were harvested 
by centrifugation at 12,000 g for 20 seconds and resuspended in 1 mL 0.1 M Tris.S04 
pH 9.4, 10 mM dithiothreitol and incubated at 30^C for 5 minutes. The cells were 
centrifuged again and resuspended in Wickerham's minimal medium adjusted to pH 7.4 
and supplemented with 1.3 M sorbitol. Zymolyase was added to a final concentration of 
1 mg/mL, and the cultures were incubated at 30°C for 45 minutes. Sphaeroplasts were 
pelleted by centrifugation at 5,000 g for 30 seconds, genUy resuspended in 1 mL 
Wickerham's minimal medium supplemented with 1.3 M sorbitol and pulse-labelled by 
adding Tran[35s]-label to 0.2 mCi/mL. The cells were incubated at 30°C for 20 minutes 
and chase was initiated by the addition of methionine to a final concentration of 50 
[ig/mL. After 30 minutes chase the culture was separated into sphaeroplast 
(intracellular) and supernatant (extracellular) fractions by centrifugation at 5,000 g for 5 
minutes. The pellet fi-action was washed once with Wickerham's medium containing 1.3 
M sorbitol. Sphaeroplasts were broken by adding 0.5 mL NP40 lysis buffer (1% (v/v) 
NP40, 0.5% (w/v) DOC, 0.1% (w/v) SDS, 10 mM Tris.HCl pH 7.5, 150 mM NaCl, 2 
mM EDTA, 0.4 M galactose and 40 |ig/mL PMSF). Tubes were left on ice for 30 
minutes, 0.3 g acid-washed glass beads were added and then vortexed for 30 seconds. 
Debris was sedimented by centrifugation at 10,000 g for 10 minutes. Both intracellular 
and extracellular fractions were mixed with an equal volume of 1% (v/v) NP40,10 mM 
Tris.HCl pH 7.5, 150 mM NaCl, 2 mM EDTA, 0.4 M galactose and 40 [Lg/rnL PMSF, 
then 50 \iL protein-A-sepharose slurry (1:1 in NP40 buffer) was added to each tube and 
left on ice for 30 minutes. After centrifugation at 10,000 g for 5 minutes, 2 |xL of 
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affinity purified rabbit antiserum against the appropriate vacuolar enzyme was added to 
the supernatant, followed by incubation for 1 hour at 4°C. 50 |jL protein-A-sepharose 
slurry (see above) was added and the mixture was incubated on ice for an additional 30 
minutes with occasional shaking. Beads were collected by centrifugation for 15 seconds 
and washed three times with 1 mL 0.2% NP40 buffer, twice with 0.2% NP40 buffer 
containing 0.5 M NaCl and once with 1.0 mL 10 mM Tris.HCl pH 7.5. The washed 
protein-A-sepharose antibody-antigen conjugates were resuspended in 50 pL SDS 
sample buffer (200 mM Tris.HCl pH 8.8, 0.5 M sucrose, 5 mM EDTA, 0.01% 
bromophenol blue, 1% (w/v) methionine, 4% (w/v) SDS, 10 mM dithiothreitol), boiled 
for 3 minutes and separated on a 7.5% acrylamide gel. Fluorography using PPO has 
been described elsewhere (Laskey and Mills, 1975). Pre-flashed Fuji-XR film was 
exposed to the dried gels at -84°C for 3 days for densitometric examination, and for 5 to 
7 days for photographic presentation. 
2.7.6. Immunoprecipitation of CPY in Intra- and Extracellular Yeast Fractions 
A simplified protocol could be used to immunoprecipitate CPY from culture 
supernatant and broken yeast sphaeroplasts, since the anti-CPY antibody used in this 
study was still able to bind to CPY under denaturing conditions where most other 
proteins could not bind non-specifically to the immuno-sorb matrix used (C.K. 
Raymond, unpublished observations). 
Cells were grown to an OD500 1-0 and the equivalent of one absorbance unit was 
harvested and resuspended in 1.0 mL yeast minimal medium, 50 mM K P O 4 pH 5.7, 2 
mg/mL BSA, and incubated at 30°C for 10 minutes. 500 jiL was transferred to a screw-
cap microfuge tube and Tran[35S]-label was added to a concentration of 100 ^Ci/tube. 
The tubes were incubated for 10 minutes at 30°C and then chased by adding 50 | iL 
methionine/cysteine (5 mg/mL each) and incubation for another 30 minutes. The pulse-
chase label reaction was stopped by adding 5 ^ L 1 M NaN3. Cells were harvested and 
the supernatant was transferred to new tubes containing 10 |i,L lOOx proteinase inhibitor 
cocktail (0.5 mM PMSF, 1 [ig/mL leupeptin, 1 \Xg/mL pepstatin A) each. This tube 
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represents the external fraction. 150 (JL freshly prepared sphaeroplast mix (1.4 M 
sorbitol, 50 mM Tris.HCl pH 7.4, 2 mM MgCl2, 10 mM NaNj, 3 ^iL/mL P-
mercaptoethanol, 15 |ig/mL zymolyase 100-T, 25 |iL/mL glusulase) was added to the 
cell pellet (internal fraction) and incubated at 30^ for 30 to 45 minutes. 100 ^iL lOx IP 
buffer (0.9 M Tris.HCl pH 8.0, 1% SDS, 1% Triton X-100, 20 mM EDTA) and 150 ^L 
dH20 was added to the external fraction and heated to lOO C^ for 5 minutes. The 
internal fraction was supplemented with 10 |xL lOOx proteinase inhibitor cocktail, 100 
^L lOx IP buffer and 519 )xL dH20 and also incubated at lOO C^ for 5 minutes. After 
cooling to room temperature, samples were preadsorped by adding 50 ^iL IgSorb and 
221 | iL dH20 to both samples and incubating them on ice for 15 minutes. The tubes 
were centrifuged for 5 minutes at 12,000 g and 950 ^iL supernatant was transferred to a 
new tube containing 10 \lL anti-CPY antiserum diluted 1:10 in Ix immunobuffer (10 
mM Tris.HCl pH 8.0, 0.1% SDS, 0.1% Triton X-100, 2 mM EDTA). After 1 hour 
incubation on ice with occasional mixing 50 | iL IgSorb was added and then incubated 
for another hour on ice. The CPY/anti-CPY/IgSorb complex was sedimented at 12,000 
g for 1 minute and pellets were washed twice in 1 mL immunobuffer. Washed pellets 
were resuspended in 40 \iL 2x SDS loading buffer and then electrophoresed as 
described above (2.7.2.). 
2.7.7. Expression and Isolation of Recombinant Proteins from E. coli 
The expression of recombinant proteins in E. coli was facilitated by cloning the 
open reading frame of interest into the expression vector series pEXPl-3. These vectors 
are designed to subclone blunt ended or cohesive termini fragments into the Sma I , Xba 
I , Sal I or Hind I I I sites of the multiple cloning site which are linked to the Pi^j. Pj^ ,^ 
promoters (Muchmore etal., 1989). 
The open reading frame of the protein of interest was cloned into the pEXP 
expression vector in frame with the N-terminus of T4 lysozyme encoded by the vector. 
Constructs were transformed into competent MCI061 and tested for expression by 
diluting an overnight culture of MCI061 harbouring the desired plasmid 100 fold into 
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fresh Luria broth containing ampicillin. The culture was grown at 37°C for 1 hour, 
IPTG added to 1-2 mM and incubated at 37°C for 3 hours to induce recombinant 
protein expression. A control, omitting IPTG, was included at that point to allow a 
comparison. 1.5 mL cells were harvested by centrifugation at 12,000 g for 1 minute, 
150 \iL protein sample buffer was added and samples were incubated at 100°C for 2 
minutes. The contents of the tubes were vortexed, centrifuged at 12,000 g for 5 minutes 
and then 5 |J,L of the sample was loaded onto a SDS PAGE gel and electrophoresed 
under standard conditions. The recombinant protein is normally well expressed and 
detectable on the gel in the inuced sample. Occasionally, as was the case for 
recombinant CPY, the recombinant protein was of identical size to abundant bacterial 
proteins and could not be detected by the rapid screening protocol described above. In 
this case, a small scale extraction of the recombinant protein was performed. 
50 mL Luria broth was inoculated with 0.5 mL of an overnight culture of the 
desired clone and then induced with IPTG to 2 mM after 1 hour as described above. A 
non-induced control was included at this point. The cultiu-es were incubated at 37°C for 
3 hours and then harvested by centrifugation at 3,000 g for 5 minutes. The pellets were 
frozen at -84°C, thawed and resuspended in 1 mL STEE (50 mM sucrose, 25 mM 
Tris.HCl pH 8.0, 5 mM EDTA, 5 mM EGTA) supplemented with 10 mg/mL lysozyme. 
This lysis mix was incubated 10-15 minutes at room temperature with occasional 
mixing. 40 mL distilled water was added and shaken at 200 rpm for 2 minutes. 1 mL 1 
M Tris.HCl pH 7.5, 1.6 mL lOOmM MgClz, 40 ^L IM PMSF, 200 ^iL of 
RNAse/DNAse (10 mg/mL RNAse, 1 mg/mL DNAse in 50% (v/v) glycerol, 10 mM 
Tris.HCl pH 7.5) was added and then agitated 10-15 minutes at room temperature. 
After centrifugation at 15,000 g for 10 minutes, the supernatant was saved and 2 mL of 
it was precipitated by adding 8 mL of acetone, mixing, chilling at -20°C for 2 hours, 
pelleting the precipitate at 15,000 g, removing the supernatant and resuspending the 
pellet in 200 fiL protein sample buffer. The pellet from above was resuspended in 20 
mL of 50 mM Tris.HCl pH 7.5, 4 mM MgC12, 1% (v/v) Triton X-100, 0.1 mL 
RNAse/DNAse solution (see above) and agitated 10 - 15 minutes. 20 mL 50 mM 
Tris.HCl pH 7.5, 20 mM EDTA, 1% (v/v) Triton X-100 was added and then shaken for 
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an additional 10 - 15 minutes. Samples were centrifuged as before. 2 mL of the 
supernatant was kept and acetone precipitated as before. The pellet ft-action, which 
should contain the foreign protein, was resuspended in 0.5 mL of protein sample buffer. 
An analytical SDS PAGE of the induced whole cell extracts, the first and second 
supernatant fractions, and the Triton X-100 washed pellet fraction was run. 
If the recombinant protein was to be expressed on a large scale, then usually a 250 
mL culture was induced and the above extraction procedure scaled up proportionally. If 
the analytical SDS PAGE revealed the presence of the recombinant protein, the 
corresponding fraction (always the Triton X-100 washed pellet) was taken and loaded 
onto a preparative SDS PAGE (15 x 15 x 0.5 cm). Electi-ophoresis was performed at 50 
mA constant current. The gel was stained with 250 mM KCl, 1 mM dithiothreitol at 4°C 
for several hours, or until bands were visible. It was often helpful to cut a slice from the 
preparative gel and stain it with Coomassie Blue in order to unambiguously identify the 
correct protein band. The band was excised with a razor blade and destained in distilled 
water for 1 hour. The slice was homogenized with a blender in 5 mL SDS elution buffer 
(2% (w/v) SDS, 50 mM Tris.HCl pH 6.8, 100 mM NaCl, 2mM EDTA, 1 mM 
dithiothreitol), and the slurry was transferred to a falcon tube. The homogenizer was 
rinsed with an additional 5 mL of the SDS elution buffer and the samples were pooled. 
Samples were shaken at 37°C for 4 hours. An additional 10 mL of the elution buffer 
was added to the slurry and extracted as before. Supernatant fractions were pooled and 
precipitated with 80 mL acetone at -20°C for 4 hours. The precipitate was centrifuged at 
-20°C and 15,0(X) g for 20 minutes and pellets dried and resuspended in 1 mL 1% (w/v) 
SDS. 1 ^ L of the protein sample was run on an analytical SDS PAGE, against a known 
standard (BSA) to assess yield and purity. 
2.7.8. Production of Polyclonal Antisera in Rabbits 
Usually two female New Zealand white rabbits, which were maintained on a yeast 
extract free RABMA rabbit maintenace diet (Special Diets Services), were immunized 
with one antigen to yield a polyclonal antibody response. 
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200 |Xg antigen in 1% (w/v) SDS, 2.7 mL Freunds complete (Sigma), 70 ^iL 20x 
PBS, dH20 to 4 mL were emulsified by repeated voxtexing for at least 10 minutes 
before injection, and each rabbit was injected intradermally at six locations on the back 
with 330 | iL of the emulsion. After 28 days, the first booster injection was given. 100 
\ig antigen in 1% (w/v) SDS, 2.7 mL Freund incomplete (Sigma), 70 | iL 20x PBS, 
dH20 to 4 mL were emulsified, and 330 | iL aliquots were injected as before at six 
locations per rabbit. After 12 days, the rabbits were test-bled, the blood was coagulated 
at 37°C for 30 minutes, and the serum supernatant was stored at 4°C. Aliquots were 
taken to determine Ab-titer and specificity in an ELISA and Western blot, respectively. 
After 28 days, the second booster was given by injecting 330 )xL aliquots of 50 \ig 
antigen in 1% (w/v) SDS, 70 ^iL 20x PBS, dH20 to 4 mL as before. After 10 days, the 
rabbits were test bled, and if the antibody titer was sufficienfly high as determined in an 
ELISA, the rabbits were terminated by cardiac puncture. Blood was allowed to clot at 
37°C, red blood cells were pelleted by centrifugation at 3,000 g for 10 minutes, and the 
serum supernatant was supplemented with NaN3 to 10 mM and stored at -840C in 5 mL 
aliquots. 
2.7.9. Adsorption of Antibodies 
Polyclonal antibodies raised by injection of rabbits with purified yeast proteins 
were purified by adsorption with yeast cells deleted for the corresponding gene to bind 
all non-specific antibodies. 
5 mL YPDA were inoculated with a fresh colony of the yeast strain and were 
incubated at 30°C for 6 hours with agitation. Four 1 mL aliquots were centrifuged at 
12,000 g in pre-weighted microcentrifuge tubes for 5 minutes and were washed with 1 
mL Tween-20 precoat buffer each. After thorough draining the weight of die pellets was 
determined. 30 |xL of the antibody to be purified was added per 1 mg pellet, mixed well 
and the tube left at room temperature for 30 minutes. Cells were pelleted by 
centrifugation at 12,000 g for 5 minutes and the supernatant transferred to another tube 
containing the yeast cells and the binding step was repeated. Finally, the supernatant 
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was taken off the pellet, 1 M NaN3 was added to a final concentration of 10 mM, the 
adsorbed antibody was dispersed in 25 ^iL aliquots and stored at -20°C. 
2.7.10. Enzyme-linked Immunoadsorbent Assay (ELISA) 
A 96 well cluster plate with flat bottom was coated with antigen by filling each 
well with 80 | iL 2 \ig/mL of the antigen in 50 mM carbonate buffer pH 9.2, as well as 
another cluster with 2 |J.g/mL BSA as non-specific antigen control. The clusters were 
incubated overnight in the dark at room temperature in a humid chamber. They were 
then washed 5 times witii Tris.HCl-Salt pH 7.2, 200 ^iL blocking buffer was added to 
each well and the clusters incubated at 31°C for 1 hour. The wells were washed 5 times 
with Tris.HCl-Salt buffer, and 100 |iL of a decimal dilution series of the antibody to be 
titrated was given into each well of both plates, leaving some wells with buffer only as 
controls. After incubation at 37°C for 90 minutes the wells were washed 5 times as 
before, and 100 )iL secondary antibody horseraddish peroxidase conjugate in a 1:1,000 
dilution in blocking buffer was added to each well. The cluster then was incubated at 
37°C for 90 minutes and then washed five times as before. 50 |xL of a peroxidase assay 
mix (1 mg/mL p-nitrophenoxyzol, 5 jiL/mL 30% (v/v) H2O2) were added to each well, 
and the absorbance was read at 495 nm immediately, after 10, and after 30 minutes. 
Results were corrected, taking account of controls and non-specific antigen binding. 
2.8. Enzyme Assays 
2.8.1. Invertase Assay (Johnson et ah, 1987) 
Yeast strains were grown in 3 mL MV-Pro-Fructose medium at 30°C for 72 
hours. 100 )xL of the initial culture was added to 3 mL MV-Pro-Fructose medium and 
incubated at 30°C for 36 hours. After centrifugation for 10 minutes at 3,000 g, pellets 
were washed with 3 mL 10 mM NaN3, and resuspended in 1.5 mL 0.1 M sodium 
acetate pH 5.5. A 0.5 mL aliquot of each sample was taken and used for the invertase 
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assay directly (periplasmic fraction). 50 | iL 10% (v/v) Triton X-100 was added to 
another 0.5 mL sample, which then was frozen in liquid nitrogen and subsequendy 
thawed and assayed for invertase (periplasmic and intracellular fraction). 25 |iL of the 
samples were given to 50 \iL sodium actate pH 4.9 in a test tube, and 25 ^iL 0.5 M 
sucrose were added to start the reaction. Tubes were incubated at 30°C for 10 minutes 
and then placed into a boiling water bath for 3 minutes to stop the reaction after the 
addition of 100 \iL 0.5 M KPO4 pH 7.0. Samples were cooled down to 30oC, and 1 mL 
of a freshly prepared solution containing 1 mL 84 |i.g/mL glucose oxidase, 10 \ig/mL 
horseradish peroxidase, 0.9 mL/mL 0.1 M KPO4 pH 7.0, 0.5 mL 0.3 mg/mL o-
dianisidine, and 8.5 mL 45% (v/v) glycerol was added to each tube. These were 
incubated at 300C for another 20 minutes. 0, 20, 40 and 60 |J,M/L glucose standards 
were included. 1.5 mL 6 M HCl was added to stop the reaction and the developed red 
colour was read at 450 nm in a spectrophotometer. This step measured the glucose 
released during the enzymatic hydrolysis of sucrose in the first step. A 100 pL sample 
of the cell suspension was taken for an estimate of the cell number. Another 100 jxL 
sample of the suspension was used for a protein estimation according to the method of 
Lowry. The secreted (periplasmic) and total invertase activity was related to the total 
protein concentration and cell number, and the relative degree of invertase secretion 
could be determined. 
2.8.2. a-glucosidase Assay 
Cells to be analyzed for a-glucosidase secretion were grown in 3 mL yeast 
minimal medium supplemented with all essential amino acid for 36 hours at 30°C. Cells 
were harvested by centrifugation at 3,000 g for 5 minutes, pellets were resuspended in 
1.5 mL 0.1 M NaP04 pH 7.0 and subdivided into two 0.5 mL fractions for the enzyme 
assay. The rest of the suspension was kept for protein estimations and cell counts. To 
determine the total fraction of a-glucosidase, 50 ^iL 10% (v/v) Triton X-100 was added 
to one aliquot of cells, followed by the addition of half the volume of acid washed glass 
beads and vigorous vortexing for 2 minutes. The debris was sedimented and the 
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supernatant kept for assaying the total a-glucosidase activity. The secreted 
(periplasmic) fraction of a-glucosidase was determined from the other, non Triton X-
ICX) treated corresponding cell suspension. 25 jiL of the crude cell extract was added to 
500 \iL of a solution containing 40 mM p-nitrophenyl-a-D-glucopyranoside, 40 mM 
sodium acetate pH 6.5. A control containing buffer only instead of the cell extract was 
included at that step. Tubes were incubated at room temperature for 15 minutes, and the 
reaction was terminated by the addition of 200 ^iL 10% (w/v) TCA. They were 
centrifuged for 10 minutes at 12,000 g in a microfuge and the supernatant mixed with 
0.5 mL 1 M glycine pH 10.4 and the absorbance measuerd at 400 nm. Assuming an 
extinction coefficient of 1.9 x 10 ,^ the activity was expressed in ^mol p-nitrophenyl 
librated per minute. 
2.8J. a-mannosidase Assay (Opheim, 1978) 
Cells to be analyzed for a-mannosidase secretion were grown in 3 mL yeast 
minimal medium supplemented with all essential amino acid for 36 hours at 30°C. Cells 
were harvested by centrifugation at 3,000 g for 5 minutes, pellets were resuspended in 
1.5 mL 0.1 M NaP04 pH 7.0 and subdivided into two 0.5 mL fractions for the enzyme 
assay. The rest of the suspension was kept for protein estimations and cell counts. To 
determine the total fraction of a-mannosidase, 50 | iL 10% (v/v) Triton X-100 was 
added to one aliquot of cells, followed by the addition of half the volume of acid 
washed glass beads and vigorous vortexing for 2 minutes. The debris was sedimented 
and the supernatant kept for assaying the total a-mannosidase activity. The secreted 
(periplasmic) fraction of a-mannosidase was determined from the other, non Triton X-
100 treated corresponding cell suspension. 25 ^iL of the crude cell extract was added to 
500 |J.L of a solution containing 40 mM p-nitrophenyl-a-D-mannopyranoside, 40 mM 
sodium acetate pH 6.5. A control containing buffer only instead of the cell extract was 
included at that step. Tubes were incubated at room temperature for 15 minutes, and the 
reaction was terminated by the addition of 200 ^iL 10% (w/v) TCA. They were 
centrifuged for 10 minutes at 12,000 g in a microfuge and the supernatant mixed with 
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0.5 mL 1 M glycine pH 10.4 and the absorbance measuerd at 400 nm. Assuming an 
extinction coefficient of 1.9 x 10'^ , the activity was expressed in .^mol p-nitrophenyl 
librated per minute. 
2.9. Light Microscopy 
2.9.1. Normarski Contrast 
Starter cultures of the yeast sd-ain to be examined were set up by inoculating 5 mL 
YPDA with a colony and incubation at 30°C with agitation for 48 hours. 100 pL of the 
stationary phase cells were used to inoculate 3 mL YPDA. The cultures were incubated 
at 24°C for 24 hours at 200 rpm. 5 | iL aliquots of each culture were transferred onto 
microscope slides, covered with a cover-slip and observed under l,000x Normarski 
contrast optics with a Nikon inverted microscope. A black and white photograph of a 
typical population of each strain was taken with an attached Olympus 0M2 camera onto 
T n ^ film (400 ASA). 
2.9.2. Fluorescence Microscopy 
Labeling of the mutants with FITC and quinacrine was performed as described in 
Bantaetai, 1988. 
5 mL YPDA were inoculated with a colony and incubatied at 30°C with agitation 
for 48 hours. 100 [LL of the stationary phase cells were used to inoculate 3 mL YPDA. 
The cultures were incubated at 24°C for 24 hours at 140 rpm. 1 mL of the cell 
suspension was centrifuged at 5,000 g for 20 seconds and resuspended in 1 mL YPDA 
supplemented with 50 mM sodium citrate pH 5.5 and 10 )ig/mL FTTC in DMSO. After 
10 minutes incubation at 25°C with agitation, cells were centrifuged as above, washed 
once with YPDA and resuspended in 100 |.iL 100 mM KPO4 pH 7.5, 2% glucose. Cells 
were mounted onto polylysine coated microscope slides and viewed under a 
fluorescence microscope. For quinacrine vital stainig of vacuoles, cells were grown as 
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above, and quinacrine was added to the culture to 175 jxM in YPDA pH 7.6. After a 5 
minute incubation period at 30°C, cells were centrifuged as above and mounted onto 
slides without washing. Specimens were observed under fluorescence microscopy using 
a blue-filter. 
2.9.3. Indirect Immunofluorescenece Microscopy 
Yeast cells were prepared for indirect immunofluorescence microscopy using a 
modified protocol to the one described in Roberts et al., 1991. 
Strains to be examined were sft-eaked out to near confluence on fresh YPD agar 
plates, unless plasmid selection needed to be maintained. After overnight incubation at 
30°C, colonies were taken off the siuface of the agar plate, resuspended to an OD^QQ of 
about 0.25 in 10 mL of YPD and agitated at 30°C for 2-4 hours. The cultures were pre-
fixed by the addition of 1.2 mL of 37% (v/v) formaldehyde and agitation at 30oC for 60 
minutes. Fixative was freshly prepared by adding 2 g paraformaldehyde to 50 mL dH20 
containing 375 )xL 6M NaOH and heating until the paraformaldehyde dissolves. The 
solution was neutralized with 0.68 g KH2PO4 and a pH of about 6.5 confirmed. Cells 
were centrifuged in a clinical centrifuge for 20 seconds and the supernatant was 
aspirated away. Pellets were resuspended in 2 mL fixative and shaken at room 
temperature to 30°C 12 to 18 hours. Cells were harvested in a clinical centrifuge, 
resuspended in 1 mL 200 mM Tris.HCl pH 8.0, 20 mM EDTA, 1% (v/v) p-
mercaptoethanol and were transfered to microcentrifuge tubes. After 10 minutes cells 
were sedimented by low speed centrifugation for 20 seconds and resuspended in freshly 
prepared sphaeroplast solution (1.2 M sorbitol, 50 mM KPO4 pH 7.3, 1 mM MgCl2, 15 
)Xg/mL zymolyase 100-T, 25 |J.L/mL glusulase). After 35 minutes incubation with gentie 
shaking, sphaeroplasts were pelleted at slow speed and washed once with 1.2 M 
sorbitol. Pellets were resuspended in 500 )iL 1.2 M sorbitol and treated with SDS. SDS 
denaturing conditions depended sti-ongly on the primary antibody used, and are shown 
in Table 2.7. 
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Primary antibody [SDS] added Incubation period 
a-Pho8p 500 )iL 10% (w/v) SDS 5 minutes 
a-60kD 125 \iL 2% (w/v) SDS 1 minute 
Table 2.7: Denaturing conditions for cells prepared for indirect immunofluorescence 
with specific primary antibodies. 
After denaturation, cells were washed twice in 1 mL 1.2 M sorbitol, and were 
finally resuspended in 1 mL 1.2 sorbitol. 40 jiL of cell suspension was added to each 
well of a polylysine coated microscope slide and allowed to settie for 15 minutes at 
room temperature in a moist chamber. The fluid was aspirated off and the slide washed 
twice with 20 ^iL PBS-BSA (Ix PBS, 5 mg/mL BSA, 10 mM NaNj). 20 ^iL PBS-BSA 
was added and the slides were left in a humid chamber for 15 minutes. The PBS-BSA 
was aspirated off and 10 [iL of the primary antibody solution added. For polyclonal 
antisera a 1:10 working solution was used; monoclonal antibodies were used in 
undiluted form. After 1 hour incubation in a humid chamber the wells were washed six 
times with PBS-BSA and the second antibody was added. In most cases, amplification 
of the flourescence signal was required. For amplification, 10 ^iL of a 1:1,000 dilution 
of goat anti-rabbit IgG or goat anti-mouse IgG were added and incubated for 1 hour. 
After six washes a 1:1,000 dilution of the third antibody (rabbit anti-goat IgG or mouse 
anti-goat IgG) was added and left for another hour. After six washes a 1:200 dilution of 
final antibody (FITC-goat anti-rabbit IgG or FTTC-goat anti-mouse IgG) was added and 
the slides were incubated for 1 hour as before. After nine washes, 20 ^iL of mounting 
medium (Citifluor containing 0.1 |ig/mL DAPI) per well was added and slides were 
covered with 24 x 60 mm coverslips. After 5 minutes two edges were sealed with 
fingernail polish to fix the coverslip into position. Slides were ready for viewing and 
can be stored successfully for 1 to 2 months at -20°C. 
Slides were examined under an Axioplan fluorescence photomicroscope (Carl 
Zeiss Inc, Thomwood, NY) fitted with filters for DAPI and FTTC fluorescence. Each 
99 
specimen was photographed under Normarski contrast (auto-setting), DAPI (2 seconds) 
and FITC (4, 8, and 15 seconds) fluorescence onto Tj„^ 400 film. 
2.10. Electron Microscopy 
Yeast cells were prepared for electron microscopy using a modified procedure to 
the one described in Banta et al., 1988. 
10 mL yeast minimal medium supplemented with all essential amino acids were 
inoculated with 200 ^iL of a stationary phase starter culture and grown at 24°C for 5 
hours on a rotary shaker (200 rpm), until an ODggo of 0.3 was reached. The cells were 
separated from the minimal medium by centrifugation (12 minutes at 1,500 g and room 
temperature), resuspended in 10 mL YPDA and allowed to grow for 1.5 hours under the 
same conditions as described above. The cells were harvested by centrifugation (see 
above), resuspended in 1 mL dH20, transferred to microcentrifuge tubes and 
centrifuged at 12,000 g for 2 minutes. The pellets were used in subsequent protocols to 
enhance different subcellular compartments. 
To assess the effect of high temperature on temperature sensitive strains, these 
strains were incubated at 37°C for 1.5 hours after shifting to YPDA medium. 
Furthermore, the first fixation step was carried out at 37°C rather than room 
temperature as for temperature resistant strains. 
2.10.1. Enhancement of Yeast Vacuoles and Double Membranes 
A ferrocyanide-reduced osmium - thiocarbohydrazide - ferrocyanide-reduced 
osmium fixation method (Willingham et ai, 1984) was employed to enhance yeast 
vacuoles and double-membrane structures. 
Cells prepared as above (2.10.) were fixed for 2 hours at room temperature in 0.5 
mL 3% (v/v) glutaraldehyde, 0.1 M sodiumcacodylate pH 6.8, 5 mM CaCl2. The fixed 
cells were centrifuged at 12,000 g in a microfuge for 20 seconds, washed in 0.5 mL 100 
mM Tris.HCl pH 8.0, 25 mM dithiothreitol, 5 mM EDTA, 1.2 M sorbitol (TDES), and 
finally were resuspended in 0.5 mL TDES and incubated for 10 minutes at 30°C. The 
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cells were centrifuged, washed once with 0.1 M KPO4 (pH 5.8 with solid citric acid), 
1.2 M sorbitol, and resuspended in the same buffer containing 4 mg/mL Zymolyase 
100-T. Sphaeroplasts were produced by incubation at 37°C for 45 minutes. The 
sphaeroplasts were centrifuged at 1,500 g for 30 seconds, washed once with 1 mL 0.1 M 
sodium cacodylate pH 6.8, 5 mM CaCl2 (cacodylate buffer), and finally were 
resuspended in 200 | iL 1% (w/v) OSO4, 1% (w/v) K-ferrocyanide in cacodylate buffer 
and incubated 30 minutes at room temperature. After four washes in 1 mL dH20, the 
sphaeroplasts were resuspended in 1 mL 1 % (w/v) thiocarbohydrazide (freshly made up 
at SS^ C, followed by sterile filtration through a 0.45 \im millipore filter after cooling 
down to room temperature immediately before use) and left at room temperature for 5 
minutes. The samples were washed four times with 1 mL dH20 and stained with 1% 
(w/v) OSO4, 1% (w/v) K-ferrocyanide in cacodylate buffer for 3 minutes at room 
temperature. After four washes with dH20, the fixed and stained sphaeroplasts were 
dehydrated through an ethanol series (12.5% (v/v), 12.5% (v/v), 25% (v/v), 25% (v/v), 
50% (v/v), 50% (v/v), 75% (v/v), 75% (v/v), 99% (v/v), 99% (v/v), dry 100%). The 
ethanol was changed after at least 30 minutes between each step by centrifugation for 
30 seconds at 12,000 g, resuspended, and finally left overnight in dry 100% ethanol. 
The samples were resuspended in 1 mL Spurr:dry ethanol (1:1) and were left for 8 
hours at room temperature. Cells were sedimented by centrifugation at 12,000 g for 45 
seconds, and were resuspended in Spurr resin. The resin was discarded after 24 hours, 
and fresh Spurr was added. The in Spurr resuspended sphaeroplasts were transferred to 
a 24 block casting mold and left to polymerize for 15 to 17 hours at 70°C. Ultra-
thinsections were cut on a Sorvall Ultramicrotome MT-2 with a freshly broken glass 
knife, mounted onto 200-mesh copper grids (no coating), and dried on filter-paper 
overnight. The sections were stained with lead citrate (Reynolds et al, 1963) for 45 
seconds in a CO2 free atmosphere, destained in 0.02 M NaOH for 2 seconds, and 
washed on a droplet of dH20 for 5 seconds. The sections were examined with a Philips 
TEM400 electron microscope after they were sufficiently dry. 
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2.10.2. Fixation after Byers and Goetsch, 1975 
Cells prepared as above (2.10.) were resuspended in 1 mL 3% (v/v) 
glutaraldehyde in 0.1 M sodium cacodylate pH 6.8, 5 mM CaCl2 at 200C for 30 
minutes, and at 0°C for 16 hours or overnight. The fixed cells were centrifuged at 
12,000 g in a microfuge for 20 seconds, washed in 0.5 mL 100 mM Tris.HCl pH 8.0, 25 
mM dithiothreitol, 5 mM EDTA, 1.2 M sorbitol (TDES), and finally were resuspended 
in 0.5 mL TDES and incubated 10 minutes at 30°C. The cells were centrifuged, washed 
once with 0.1 M KPO4 (pH 5.8 with solid citric acid), 1.2 M sorbitol, and resuspended 
in the same buffer containing 4 mg/mL Zymolyase 100-T. Sphaeroplasts were produced 
by incubation at 37°C for 45 minutes. The sphaeroplasts were centrifuged at low speed 
for 30 seconds, and incubated in 2% (w/v) osmium tetroxide in 0.1 M sodium 
cacodylate pH 6.8, 5 mM CaCl2 for 1 hour at 0°C. Post-fixed sphaeroplasts were 
washed once with dH20, resuspended in 1 mL 2% (w/v) uranyl acetate, dehydrated in 
an ethanol series as above, and were embedded in Spurr resin as described before. 
Ultra-thinsections were cut on a Sorvall Ultramicrotome MT-2 with a freshly broken 
glass knife, mounted onto 200-mesh copper grids (no coating), and dried on filter-paper 
overnight. The sections were stained with 2% (w/v) uranyl acetate for 45 seconds and 
lead citrate (Reynolds et al., 1963) for 45 seconds in a CO2 free atmosphere, and were 
dried on filter paper overnight and the sections were examined with a Philips TEM400 
electron microscope after they were sufficiently dry. 
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C H A P T E R S 
RAISING P O L Y C L O N A L ANTISERA AGAINST RECOMBINANT 
CARBOXYPEPTIDASE Y 
3.1. Introduction 
The yeast vacuole is considered to represent the major digestive compartment of 
the cell (Wiemken et al., 1979) and also to play an important role in the storage of 
metabolites and amino acids (Klionsky et al., 1990). Most of its soluble and membrane 
associated protein constitutents transit through the secretory path (reviewed in Klionsky 
et al., 1990), although some proteins are imported directly, such as fructose 1,6-
bisphosphatase (Chiang and Schekman, 1991) and a-mannosidase (Yoshihisa and 
Am-aku, 1990). The soluble vacuolar proteases have been characterized extensively in 
terms of cellular function and biosynthesis (Jones, 1991; Klionsky et al., 1990; Wolf, 
1986). A soluble vacuolar protein in the yeast S. cerevisiae which has received much 
attention and of which a great deal of information concerning transport, targeting and 
biological function is known, is carboxypeptidase Y (CPY). 
CPY is a serine protease involved in a series of proteolytic events in the vacuole 
(Achstetter and Wolf, 1985). The structural gene for CPY, PRCl, has been cloned 
(Stevens et al., 1986) and sequenced (Vails et al., 1987). It encodes a 58 kDa precursor 
protein, pre-pro-CPY (ppCPY), that is imported into the endoplasmic reticulum 
(Stevens et al., 1982). The pre-pro-protein undergoes signal peptidase dependent 
proteolytic processing (Stevens et al., 1982) and is core glycosylated in the ER (Ballou 
et al., 1990). The signal peptide is cleaved between Ala-20 and Ile-21 so the fu-st 
aminoacid of pro-CPY (plCPY) is amino acid 21 of the predicted amino acid sequence 
(Blachly-Dyson and Stevens, 1987). The core glycosylated pi CPY, which migrates at 
67 kDa on a denaturing SDS-PAGE (Klionsky et al., 1990), exits the ER and proceeds 
to the Golgi apparatus (Stevens et al., 1982). The core-glycosylated plCPY undergoes 
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further carbohydrate modification in transit through the Golgi (Ballou et al., 1990; 
Stevens et al., 1982) such that the CPY precursor now has a molecular weight of 
approximately 69 kDa (p2CPY) (Klionsky et al., 1990). It is thought that at some stage 
in the Golgi apparatus sorting to the vacuole occurs (Klionsky et al., 1990; Stevens et 
al., 1982). The signal responsible for correct targeting of pro-CPY to the vacuole is 
located within the first 30 amino acids of the N-terminus of the pro-peptide (Vails et al., 
1987), and is defined by the four successive amino acid residues QRPL (amino acids 24 
to 27 of the predicted amino acid sequence of PRCl) (Vails et al., 1990). On delivery to 
the vacuole, proteinase A (PrA) and proteinase B (PrB) dependent proteolytic 
processing of p2CPY to the mature 61 kDa form occurs (Ammerer et al., 1986; Jones, 
1991; Stevens et al., 1982). PrA was thought to be the major processmg enzyme in the 
maturation of CPY (Ammerer et al., 1986). However, the site-specificity of PrA, which 
preferentially cleaves peptide bonds between large hydrophobic amino acids (Dreyer, 
1989), does make the established cleavage of the CPY pro-peptide between Asn-111 
and Lys-112 by PrA alone unlikely. The current view on the vacuole dependent 
maturation of p2CPY to CPY suggests that both PrA and PrB are equally involved in 
the maturation and activation of p2CPY (Mechler et al., 1987). PrA will remove most 
of the CPY pro-sequence, and subsequently PrB will trim off the residual aminoacids of 
the propeptide (Jones, 1991). The CPY processing and transit pathway has been 
reconstituted in vitro (Vida et al., 1990). Although recent evidence suggests that 
different vacuolar proteases are sorted by different mechanisms (Klionsky et al., 1988; 
Paravicini et al., 1992; Raymond et al., 1992), the sorting pathway of CPY is well 
established and some mutants that missort vacuolar enzymes were isolated on the basis 
of secretion of CPY (Rothman et al., 1986) or secretion of a ppCPY-invertase fusion 
(Bankaitis et al., 1986; Robinson et al., 1988) which has the CPY signal peptide and the 
vacuolar sorting signal fused to the secretory enzyme invertase. The mislocalization of 
CPY into the periplasm has been attributed to defects in vacuolar protein sorting 
(Rothman et al., 1989a) and vacuole biogenesis (Banta et al., 1988). As described 
above, CPY is differentially modified in different compartments of the secretory 
pathway and upon delivery to the vacuole. The different forms of CPY can easily be 
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distinguished by their associated size difference on SDS-PAGE. In addition all forms of 
CPY as well as the secreted form of the enzyme can readily be retrieved by 
immunoprecipitation. These considerations led to the choice of CPY as a reporter for 
protein sorting and vacuole biogenesis defects in screening mutants in this study, as 
well as in a number of previous studies (for review see Klionsky et al., 1990; Raymond 
era/., 1992). 
The purification of yeast proteins for raising antibodies is often difficult because 
the presence of numerous proteolytic enzymes results in the degradation of proteins 
during the isolation process (Wiemken et al., 1979). Another problem is associated with 
the production of polyclonal antisera against glycoproteins, even after endomannosidase 
treatment, because residual carbohydrate residues provoke a strong antigenic response 
(Harlow and Lane, 1988). These problems can be circumvened by exclusive adsorption 
purification of the sera with carbohydrate columns, or yeast strains deleted for the PRCl 
gene. The latter has been attempted for polyclonal anti-CPY antiserum raised against 
purified yeast CPY available in this laboratory. Even after these procedures the 
unsatisfactory affinity of the antiserum to CPY and non-specific antigen binding to 
proteins other than CPY as judged by Western blotting and immunoprecipitation 
(results not shown) made the antiserum unsuitable for this study. 
Glycosylation and contamination of an antigen with other proteins from the same 
organism can be prevented by expressing the protein as a fusion in E. coli, if the 
structural gene and sequence encoding the protein are known. One expression system 
that allows the expression of foreign proteins in E. coli is that of Muchmore et al., 1989, 
which uses P^ ^^ , Pj^ .^ promoters linked to the pUC19 multiple cloning site and a 
transcriptional terminator region. Recombinant proteins are expressed as fusions with 
just 8 N-terminal amino acids from T4 lysozyme when induced by IPTG. The 
recombinant proteins expressed do not necessarily need to be purified to a large extent 
if in subsequent steps immunodetection of proteins in E. coli is not required. 
An approximately 900 bp BanMl fragment from PRCl has been cloned into the 
E. coli expression vector pEXP2 (Raymond et al., 1990) to yield CPY protein 
expression plasmid pCKRlOS. The plasmid was a kind gift of Dr. Chris Raymond 
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(University of Oregon, USA) and was used in this study to express CPY antigen in E. 
coli. The corresponding protein was purified as described by Roberts et al., 1989, and 
used to raise polyclonal antisera in New Zealand white rabbits. 
3.2. Results 
3.2.1. Induction of CPY Antigen Expression in MC1061 (pCKRlOS) 
The recombinant CPY antigen was expressed in E. coli MCI061 harbouring the 
plasmid pCKR108. The plasmid carries the 900 bp BarrML fragment from PRCl fused 
in frame into the BamWl site of the multiple cloning site of pEXP2. Expression was 
induced by the addition of IPTG to a final concentration of 2 mM and the corresponding 
protein was purified as described in Materials and Methods and could be recovered in 
the Triton X-100 washed pellet (Figure 3.1). A total of 2.5 mg recombinant protein 
which had a size of about 43 kDa was recovered from a 500 mL culture. It was 
contaminated with low molecular weight proteins from E. coli which were successfully 
removed after electrophoresis on a preparative SDS-PAGE (Figure 3.2). 
3.2.2. Production of Polyclonal Antiserum Against CPY 
Two female New Zealand white rabbits were injected with SDS denatured CPY 
antigen and it was boosted after 12 and 34 days from the initial injection. Test bleeds 
were performed after 18 and 45 days and the titer of anti-CPY specific antibody 
determined in an ELISA using recombinant CPY and BSA coated 96 well cluster plates. 
The specific antibody binding was determined by subtracting the non-specific binding 
of each antiserum dilution to BSA from the binding of the same dilution to the original 
antigen, CPY. Since equal amounts of both specific and non-specific antigen were used 
in each assay, the absorbance values obtained after developing the ELISAs were 
directly comparable, assuming that both antigens bound to the plates with the same 
efficiency. The ability to bind antigen was dependent on the dilution of the antiserum 
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and was different for sera obtained after the first and second booster injections. For 
antiserum obtained after the first booster the specific binding activity steadily increased 
from a 1:1x10"^  dilution to reach an optimum at a 1:1,000 dilution (Figure 3.3A). A 
further increase in the antiserum concentration resulted in a decrease in specific antigen 
binding activity. This was due to an increase in non-specific binding of the antibodies to 
BSA at a higher concentration rather than to a decrease of binding activity to CPY, 
since the specific antigen binding reached a saturation level at about tiie same 
concentration (data not shown). The specific antigen binding activity of diluted antisera 
obtained after the second booster increased from a 1:10"^  dilution to a 1:10 dilution, and 
appears to be saturated at about 1:20 (Figure 3.3B). Rabbit B had a marginally higher 
antibody titer than rabbit A. The different response of antigen binding is due to a lower 
non-specific binding activity of the antisera rather than an increase in absolute binding 
(data not shown). 
The antigenic responses of the two rabbits were comparable (Figure 3.4). The 
specific responses after the first booster were reduced after the second booster at a 
1:1000 dilution (Figure 3.4), but the specificity of the sera after the second booster was 
increased significantiy at higher antisera concentrations. 
Antigen specificity was determined on a Western blot using commercial CPY and 
total yeast extracts as antigens (Figure 3.5). Both rabbits produced a highly specific 
polyclonal antiserum which only detected one CPY band on a Western blot in total 
yeast extract and several bands in a commercial CPY preparation. Immunoprecipitation 
of CPY in cell and supernatant fractions of Tran[35S] labelled yeast sphaeroplasts with 
pre-immune serum obtained from a rabbit not immunized with CPY and 1 jxL of serum 
from rabbit A detected a 61 kDa radiolabelled protein in the cell fraction only when 
immune but not when pre-immune serum was used (Figure 3.6). This is characteristic 
for a specific antigenic response to the CPY antigen. Rabbits were terminated after 46 
days from the initial injection by cardiac puncture, the serum was separated from the 
clotted erythrocytes and aliquots of the sera were stored at -84°C. A total volume of 20 
mL serum from rabbit A and 23 mL serum from rabbit B were obtained. 
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Figure 3.1: Expression and purification of IPTG induced recombinant CPY in E. coli. 
Lanes 1, 3, 5 and 7 represent £. coli MC1061 harbouring pEXP2 as control; 
lanes 2,4, 6 and 8 represent MC1061 harbouring the pCKR108 CPY 
recombinant fusion plasmid. No IPTG induced recombinant CPY is detectable 
in a total cell extract from the pCKR108 containing sfrain (Lanes 1 and 2). A 
slightly more abundant protein of approximately 43 kDa is detectable in the first 
supernatant from the strain harbouring the recombinant plasmid (Lane 4) but not 
in MCI061 (pEXP2). This protein band does not appear r,n the second 
supernatant from either strain (Lanes 5 and 6). However, a 43 kDa protein band 
is highly enriched in the Triton X-100 washed pellet from MC1061 (pCKR108; 
lane 8) but not in the strain harbouring the control plasmid (lane 7). Since the 43 
kDa protein product is absent from a control and present in the Triton X-100 
washed pellet of an IPTG induced strain with the recombinant plasmid it is 
likely that it represents recombinant CPY. 
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Figure 3.2: Large scale induction of recombinant CPY and SDS PAGE gel purification 
of the 43 kDa protein species. A 5 ng protein sample recovered from the Triton 
X-100 pellet of an IPTG induced MCI061 (pCKR108) stiain was heavily 
contaminated with low molecular weight proteins (Lane 1) which successfully 
were removed after preparative SDS PAGE, excision and SDS elution of tiie 
appropriate band (Lane 2; 0.5 \ig protein). Lane 3 contains low molecular weight 
markers representing 66,45, 36, 29, 24 and 20.1 kDa from tiie start of the gel to 
the front. The excised and SDS eluted protein was pure and free of contaminant 
protein and was used without further purification for immunizations. 
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Figure 3.3: Optimal specific antigen binding activity of diluted antisera. Different 
dilutions of antisera obtained from rabbits A and B 12 days after the first booster 
injection (A) and 8 days after the second booster (B) were subjected to an 
ELISA using BSA (non-specific binding) and recombinant CPY at 0.16 ng 
protein per well as antigens. The absorbance of each dilution was determined at 
495 nm 30 minutes after starting the peroxidase assay reaction and was a direct 
measure of the specific antigen binding of the antisera after substraction of non-
specific (BSA) binding and a control reaction omitting the secondary anti-rabbit 
Ig-peroxidase conjugate antibody. 
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Figure 3.4: Specific antigenic response of a 1:1,000 antiserum dilution after the first 
and second booster injections. Antisera from both rabbits obtained 12 days after 
the first and 8 days after the second booster injection were subjected to an 
ELISA to determine the levels of specific antigen binding. BSA (non-specific 
binding) and recombinant CPY antigens were used at 0.16 ng protein per well. 
The absorbance of each well was determined at 495 nm 30 minutes after starting 
the peroxidase assay reaction and was a direct measure of the specific antigen 
binding of the antisera after substraction of non-specific (BSA) binding, and a 
control reaction omitting the secondary anti-rabbit Ig-peroxidase conjugate 
antibody. 
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Figure 3.5: Immunoblots of commercial CPY and total yeast cell extract with antisera 
from rabbit A and rabbit B. The equivalent of 1 | ig commercial CPY (Sigma; 
lane 1) and 5 |ig total yeast extract from strain SEY6210 (Lane 2) were 
separated on a 7.5% SDS PAGE and blotted onto nitrocellulose. The Western 
blot was developed using 0.1 |j,L/mL anti-CPY antiserum from rabbit A. The 
antibody recognizes several bands in a commercial CPY preparation, the more 
prominent band migrating at a molecular mass of 61 kDa (Lane3). The smaller 
size bands probably represent breakdown products of CPY. A single 61 kDa 
protein is recognized in total yeast extract from strain SEY6210 (Lane 4). The 
equivalent of 5 |ig and 0.05 fxg representing total yeast extract were separated on 
a 7.5% SDS PAGE and blotted onto nitrocellulose (Lanes 5 and 6, respectively). 
The Western blot was developed using 0.1 | iL/mL anti-CPY antiserum from 
rabbit B as primary antibody. The antibody recognizes a single 61 kDa protein in 
both corresponding lanes (Lanes 7 and 8). 
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Figure 3.6: Immunoprecipitation of pulse-chase labelled CPY present total yeast 
extract and culture supernatant with pre-immune serum and antiserum from 
rabbit A. Strain SEY6210 sphaeroplasts were labelled with Tran[35S] label and 
chased with cold methionine for 20 minutes. Both pellet (P) and supernatant (S) 
fractions were divided and incubated with 1 |xL pre-immune serum (PIS) and 1 
| i l immune serum (IS) to immunoprecipitate radiolabelled protein. While the 
pre-immune serum does not recognize any radiolabelled protein in pellet and 
supernatant fractions, the anti-CPY serum from rabbit A recognizes a single 61 
kDa protein in the pellet but not the supernatant fraction from wild type yeast. 
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3.3. Discussion 
Two polyclonal antisera against recombinant CPY expressed in E. coli were 
obtained from two rabbits. They had a high antigen binding titer to recombinant CPY 
and recognized one antigen of a molecular weight of 61 kDA in total yeast extracts on 
Western blots and in immunoprecipitations of pulse-chase labelled wild type yeast cells. 
The antisera also recognized commercial CPY which migrated at the same location on 
Western blots. This provides sufficient evidence to assume that the antisera are specific 
to CPY. The isolation of the antigen expressed in E. coli was unproblematic and the 
antibody of far better specificity than could have been obtained by using antigens 
isolated according to convenional protein purification procedures. It was decided not to 
further purify the antisera by ammonium sulfate precipitation and dialysis or by affinity 
purification because the sera were highly specific as judged by ELISA and Western 
blotting. Furthermore, immunoglobulins are generally less stable after purification, and 
affinity columns tend to bind the highest affinity antibodies irreversably (Harlow and 
Lane, 1988). 
It was decided not to use the traditionally recommended methods of 
immunodiffusion and other immunoelectrophoretic techniques to determine the 
antibody titer and mono-specificity of the antisera (Clausen, 1981). The Ouchterlony 
antibody-antigen diffusion technique is commonly employed to assess the titer of 
antibodies in test-bleeds, but the technique is hardly quantitative, requires large amounts 
of antigen and can take up to 5 days until precipitin lines are visible. Additionally, not 
all antibody-antigen interactions lead to detectable pecipitin lines. The ELISA technique 
used in this study can easily be quantified, and is more sensitive in that it can detect 
lower antibody titers. For example, a typical Ouchterlony plate displays visible 
precipitation of the antibody-antigen complex in a range from 1:10 to 1:1 fold dilutions 
of antiserum using 5 ^ig antigen (C.K. Raymond, open citation). The ELISA described 
here was able to detect antibodies in a 1:10,000 fold dilution of antiserum using 0.16 ng 
antigen, and also could assess non-specific binding. The antisera were also tested for 
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specificity under experimental conditions such as Western blotting and 
immunoprecipitations. The experimental results clearly indicate that the antisera 
exclusively recognize CPY but not other antigens present in total yeast extract. 
The antiserum from rabbit A has successfully been used in subsequent non-lysing 
colony hybridizations. Western blots and immunoprecipitations in this study, initially 
together with a small batch of affinity purified anti-CPY serum kindly provided by Tom 
Stevens (University of Oregon, USA), which was of equal purity and affinity. In 
immunoprecipitations i f Immunosorb is used to retrieve antibody bound CPY, the 
antiserum from rabbit A will precipitate some proteins of lower molecular weight than 
the different forms of CPY (results not shown). These bands are easily removed if care 
is taken to resuspend the Immunosorb pellet thoroughly in the wash buffer. 
Samples of antisera taken after the first and second booster reaction differed in 
their specific binding to CPY. Although the antibody titer of the two test-bleeds was 
lower after the second test-bleed, the specificity of binding at higher antibody 
concentrations was increased after the second booster injection. These fmdings are 
consistent with the current understanding of hyperimmunizations (Harlow and Lane, 
1988), where the average affinity of antibodies for a particular antigen increases with 
repeated injections. B-lymphocyes expressing the highest affinity antigen receptors will 
compete most successfully for low concentrations of antigen. Clones of B-lymphocytes 
secreting higher-affmity antibodies will thus be selected for proliferation. Since somatic 
mutations of variable region genes occur, there will be a selective pressure for higher 
affmity antibodies. The antisera produced after the second booster injection appear to 
represent the higher-affinity antibodies. Since only relatively few higher affinity 
antibody secreting B-lymphocyte clones are selected, the overall titer of the antibodies 
might be lower, but this is compensated by improved specificity of the antisera. 
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CHAPTER 4 
ISOLATION AND CHARACTERIZATION OF SALT-SENSITIVE 
VACUOLAR MUTANTS IN YEAST 
4.1. Introduction 
The yeast vacuole is an important acidic subcellular compartment involved in the 
homeostasis and storage of metabolites, including amino acids, polyphosphates, 
carbohydrates and ions. It contains a variety of hydrolytic enzymes which play an 
important role in proteolytic processing and intracellular macromolecular degradation, 
especially associated with nitrogen metabolism, the cell cycle and cellular control 
(Achstetter and Wolf, 1985; Klionsky et al., 1990; Raymond et ai, 1992). These 
features make the yeast vacuole show some homology to both mammalian lysosomes 
(Wiemken et al, 1979; Pisoni and Thoene, 1991) and plant vacuoles (Matile, 1978). 
Another function of the vacuole appears to be osmoregulation (Banta et al., 1988) and 
the maintenance of cytosolic ion and pH homeostasis (Klionsky et al., 1990). The 
vacuole can occupy 25 to 50% of the yeast cell and is known to undergo dynamic 
changes in response to growth conditions (Raymond et al., 1992). The vacuole does not 
have its own genome as for example mitochondria and it has to derive all its protein 
constituents directly from the cytoplasm (Kane et al., 1989a; Yoshihisa and Anraku, 
1990), as well as via the secretory pathway (Klionsky et al., 1990; Raymond et al., 
1992; Stevens et al., 1982; Vida et al., 1991) and the endocytotic pathway (Chvatchko 
et al., 1986; Jennes and Spatrich, 1986; Makarow, 1985a, 1985b; Riezman, 1985). 
Some recent experimental evidence also suggests that proteins can enter the vacuole 
directly for degradation (Chiang and Schekman, 1991). This is thought to occur by a 
mechanism where proteins destined for vacuolar degradation enter peroxysomes which 
then are localized into the vacuole via some novel mechanism (H.-L. Chiang, personal 
communication). The vacuolar morphology is plastic and depends very much on 
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external conditions such as the presence of nutrients or the cell cycle (Gomes de 
Mesquita et ai, 1991; Pringle et al, 1991; Wiemken et al, 1970). During mitosis, the 
vacuole buds off some of its material, which is transported into the daughter bud 
(Weisman and Wickner, 1987; Weisman et al., 1990) suggesting a mechanism for 
vacuole derived vesicle formation, scission and transport into the daughter bud. This is 
associated with some characteristic segregation pattern in the form of large vesicles or 
tubular structures (Gomes de Mesquita et al, 1991; S.D. Emr and T. Vida, personal 
communication; M.D. Watson, unpublished observation). Unlike for example the Golgi 
in mammalian cells, which cannot be synthesised de novo (G.R. Warren, open citation), 
vacuole biosynthesis does apparently not depend on inherited vacuolar material (Banta 
et al., 1988), although the experimental evidence suggesting de novo biogenesis is 
indirect. 
Table 4.1 lists a selection of the most important constituents of the yeast vacuole 
currently known. Whereas much information about most inorganic ions and storage 
metabolites exists, little is known about the vacuolar protein constituents. Only about 10 
to 20 vacuolar proteins have been described in the literature, whereas there are about 
100 proteins detectable by Coomassie staining of SDS-PAGE separated Na2C03 
washed vacuolar membranes alone (M.D. Watson, unpublished data). Little is known 
about the function of most proteins with the exception of a few vacuolar proteinases and 
the vacuolar membrane ATPase which have been studied in detail (Klionsky et al., 
1990; Raymond et al., 1992). In the following few sections an attempt is made to 
review various aspects of vacuole biogenesis according to the constituents involved, 
their synthesis and processing and their import pathway into the vacuole. 
Simultaneously, the present knowledge of organelle inheritance as well as the role of 
the vacuole as cellular compartment is summarized. However, the main theme to 
consider always is that the yeast vacuole is one organelle which carries out a number of 
overlapping, often related functions in concert, and the focus on only one aspect at a 
time can easily distort the actual image of vacuole maintenance and biogenesis. 
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Constitutent Function Reference 
Ions 
H+ Acidification Kancet al., 1989a 
Na+ ? Cramer and Davis, 
1984 
K+ Osmoregulation (?) Okorokov et al., 1980 
Mg2+ Okorokov et al., 1980 
Ca2+ Detoxification, storage Ohsumi and Anraku, 
1983 
Zn2+ Cofactor (?) (API) White and Gadd, 1987 
Sr2+ Detoxification White and Gadd, 1986 
Co2+ Detoxification (?) White and Gadd, 1986 
Pb2+ Detoxification White and Gadd, 1986 
Pi Storage; charge balance UTQchetal., 1978 
Amino Acids 
Arginine Nitrogen storage Kitamotoer al., 1988c 
Asparagine Storage Kitamoto a/., 1988c 
Glutamine Storage Kitamoto er a/., 1988c 
Histidine Storage Kitamotoer al., 1988c 
Isoleucine Storage Kitamoto et al., 1988c 
Leucine Storage Kitamoto et al., 1988c 
Lysine Storage, detoxification Kitamoto C M / . , 1988b 
Phenylalanine Storage Cooper, 1982 
Tryptophan Storage Cooper, 1982 
Tyrosine Storage Kitamoto a/., 1988c 
Metabolites (?) 
Trehalose Stress protectant De Virgilio etal., 1991 
Soluble Proteins 
Aminopeptidase I Proteolysis Frey and Rohm, 1978 
Aminopeptidase Co Proteolysis Achstetter and Wolf, 
1985 
Carboxypeptidase S Proteolysis Achstetter and Wolf, 
1985 
Carboxypeptidase Y Proteolysis Achstetter and Wolf, 
1985 
Polyphosphatases Degradation Wiemken etal., 1979 
Proteinase A Specific proteolysis Schwencke, 1991 
Proteinase B Specific proteolysis Schwencke, 1991 
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Constitutent Function Reference 
Soluble Proteins 
RNAse 7 Schwencke, 1991 
Trehalase Trehalose degradation Schwencke, 1991 
Membrane Associated Proteins 
a-mannosidase ? Opheim, 1978 
Alkaline phosphatase Wiemken er a/., 1979 
AMPase ? Wiemken era/., 1979 
ATPase (7 subunits) Acidification Kane et al, 1989a 
DPAP B Roberts et al., 1989 
Table 4.1: Major constituents of the yeast vacuole. 
4.1.1. Vacuolar Ion Transport and Storage 
The regulation of the cytosolic ion concentration in yeast as in any other cell is 
necessary, because some ions, such as Co2+, Pb^ "*" and Sr2+ are protein inhibitors and 
need to be removed from the cytosol (White and Gadd, 1986). Ions like Ca2+, Mg2+ and 
Zn2+ are required in physiological concentrations, but can be toxic to the cell when that 
concentration is exceeded (Cornelius and Nakashima, 1987; Ohya et al., 1986; Raguzzi 
et al., 1988). Furthermore, the concentration of Ca^ "*" has to be regulated because of its 
involvement in several regulatory processes and signalling pathways (Carafoli, 1987). 
Also, the vacuole has to import protons required for the acidification and certain 
transport processes coupled to the release of protons (Okorokov et al., 1985). The yeast 
vacuole plays a prominent role in the selective sequestration and regulated release of the 
above mentioned ions (Klionsky et al., 1990). The vacuole of Neurospora crassa, 
which is believed to have similar features to the S. cerevisiae vacuole, is impermeable 
to a variety of mono- and bivalent ions. Uptake of Mg2+, Ca^ "*", Na"*" and K"*", as well as 
basic amino acids, is highly selective and evidence suggests the involvement of an 
active process (Cramer and Davis, 1984). Recent evidence points towards an H"*" 
antiport involved in the selective uptake of Ca^* (Ohsumi and Anraku, 1983; Ohsumi et 
al., 1988) and Zn2+ (Okorokov et al., 1985) in 5. cerevisiae. Other cations are also 
taken up, but their transport properties have not been established yet (Okorokov et al., 
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1980, 1985; White and Gadd, 1986). It appears that the yeast vacuole is the main 
compartment ensuring homeostasis of Ca2+ ions in the cytoplasm of yeast cells 
(Ohsumi and Aiu-aku, 1983). A central role in vacuole acidification and uptake of other 
ions is played by the vacuolar membrane H'*'-ATPase, whose activity is stimulated by 
die presence of Ca2+ and Mg2+ (Ohsumi and Anraku, 1981; Ohsumi and Anraku, 1983) 
or other ions (Okorokov et al., 1985). The ability of the vacuole to store other 
metabolites and ions depends on presence of a proton gradient (Klionsky et al., 1988). 
In other eukaryotes the acidification of the vacuolar network is required for a variety of 
cellular processes, such as receptor-mediated endocytosis, protein sorting and targeting, 
activation of zymogens and the assembly of secretory granules (Mellman et al., 1986). 
Except zymogen activation, which in yeast does not depend on an acidic vacuole 
(Klionsky et al., 1992), other processes like efficient protein sorting to the vacuole 
(Klionsky et al, 1992), and amino acid and ion transport (Klionsky et al., 1990) depend 
on acidification. The vacuolar ATPase requires ATP as substrate for proton uptake 
(Ohsumi and Anraku, 1981). 
K+ might function as regulator of vacuolar ion pools (Ohsumi et ah, 1988) by 
maintaining the charge balance and triggering the release of other ions like Ca2+ or 
arginine (Eilam et ah, 1985). A membrane potential-dependent cation channel capable 
of conducting K"*" and other monovalent cations has been characterized by an 
electrophysiological method (Wada et al., 1987; Tanifuji et al., 1988). It appears that 
the channel is regulated by the membrane potential and the presence of Ca2+ on the 
cytoplasmic site. 
The major anion present in the vacuole is inorganic phosphate (Pj) in the form of a 
polymer, polyphosphate (Cramer and Davis, 1984; Urech et al., 1978), although the 
mechanism of uptake of the monomer and regulated polymerisation in the vacuole 
remains obscure. It is believed that polyphosphate is involved in the retention of basic 
amino acids and Ca2+ in the vacuole, although not exclusively, as Ca2+ can be readily 
released upon the addition of H+ or Ca2+ ionophores (Ohsumi and Anraku, 1983). It 
seems more likely that polyphosphate serves as a pimary store for phosphates in an 
osmotically inactive form, and as an overall charge balancing agent (Cramer and Davis, 
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1984), especially since it has been demonstrated that the vacuolar polyphosphate can 
polymerize and depolymerize rapidly (Langen et al., 1962; Pisoni and Lindley, 1992). 
The presence of a polymerized anion will help to balance the charge, and reduce the 
osmotic potential as would not be possible by monomeric anions. On the other hand, it 
has been demonstrated that when Ca^^ is sequestered in the vacuole in large amounts a 
Ca2+-polyphosphate inclusion was formed (Ohsumi et al., 1988). The vacuole appears 
to be the only compartment in yeast which accumulates polyphosphate (Urech et al., 
1978; Shanks and Bailey, 1990). The presence of an endopyrophosphatase and an 
exopyrophosphatase in the vacuole (Schwencke, 1991) suggests that its activity is 
regulated by some mechanism to avoid depolymerization of pyrophosphate under 
undesirable condition. There is no coherent knowledge about other anions inolved in 
maintaining the overall charge balance of the vacuole, but indirect evidence suggests 
that other anions must maintain this charge balance because polyphosphates only 
represent at most 75% of the anions present in the vacuole (Cramer and Davis, 1984). 
Also during the sudden release of some Ca^ "*" the polyphosphate pool does not undergo 
measurable change (Ohsumi and Anraku, 1983) arguing for the existence of another 
mechanism for rapid charge balance. 
The selective uptake of ions by the vacuole and their regulated release requires 
ion channels as well as a regulatory mechanism. The transmembrane subunits of the 
channel complexes have to be targeted to the vacuole. This requires mechanisms of 
targeting these proteins to the vacuolar membrane in the correct orientation. The 
selective sequesteration or release of ions also requires a regulatory mechanism that 
senses cytoplasmic ion concentrations and activates or deactivates channels according 
to the requirements of the cell. The vacuolar protein constituents contributing to ion 
storage and maintenance of ion gradients are described in later sections, 
4.1.2. Amino Acid Storage 
Comparatative analysis of cytoplasmic and vacuolar amino acid pools suggests 
that the yeast vacuole functions as a store for a number of amino acids (Kitamoto et al.. 
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1988c). Kinetic studies on isolated vacuolar vesicles demonstrated that eight 
independent amino acid transporter systems exist (Sato et al., 1984b). Transporters for 
arginine, arginine-lysine, histidine, phenylalanine-tryptophan, tyrosine, glutamine-
asparagine and isoleucine-leucine are H+ antiport systems (Sato et al., 1984b). An 
additional arginine-histidine exchanger that utilizes the chemical potential of a histidine 
gradient also exists (Sato et al., 1984a). Analysis of the vacuolar amino acid pools is in 
good agreement with the presence of the above amino acid transport systems (Kitamoto 
et al., 1988c). The sequesteration of certain amino acids in the vacuole is consistent 
with the idea that the vacuole acts as a storage organelle to allow survival of the yeast 
cell under unfavourable conditions such as nitrogen starvation. This is particularly the 
case for arginine which can reach intravacuolar concentrations of 430 mM. Indirect 
evidence for this hypothesis comes from the examination of the vacuole deficient 
mutant endl (vpsll). The mutant does not accumulate any polyphosphate or arginine, 
and as a consequence growth of the mutant strain ceases much earlier than the 
corresponding wild type strain (Westenberg et al., 1989). Another supplementary 
explanation for the accumulation of certain amino acids in the vacuole is the regulation 
of cytoplasmic amino acid concentrations. Kitamoto et al., 1988c, have shown that die 
cytoplasmic concentrations of amino acids remain constant, even when the growth 
medium was supplemented with individual amino acids. Lysine and histidine cannot be 
degraded by S. cerevisiae (Watson, 1976), and the uptake of any excess lysine and/or 
histidine is necessary because an excess of these amino acids can be toxic to the cell 
(Kitamoto et al., 1988b). This strategy has been employed to isolate mutants which are 
deficient in the vacuolar uptake of lysine (Kitamoto et al., 1988b). 
The presence of three independent arginine transport systems stresses the 
importance of arginine sequesteration in the vacuole. One of the three channels 
described is a H''"/arginine antiport driven by a proton motive force which is inhibited 
by Cu2+, Ca^ "*" or Zn2+ (Ohsumi and Am-aku, 1981). Arginine is the amino acid with the 
largest ammonium content per mole, and probably serves as the main nitrogen store of 
the yeast cell (Kitamoto et al., 1988c; Klionsky et al., 1990). Arginine represents about 
30% of the basic amino acid pool in S. cerevisiae (Diirr et al., 1979). The retention of 
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arginine and other basic amino acids, which under the vacuolar pH conditions are 
protonated, is thought to occur by polyphosphate acting as a cation trap, partly because 
of the stoichiometrical correlation between polyphosphate and arginine (Cramer and 
Davis, 1984; Diirr et al., 1979), The fact that both pools can be regulated independently 
(Cramer and Davis, 1984) indicates that there is no absolute requirement for 
polyphosphates to trap arginine in the vacuole, and any association in a complex may 
function in reducing the osmotic potential of the vacuole. Retention of amino acids in 
the vacuole is due to the impermeability of the vacuolar membrane to amino acids and 
an active mechanism to take up amino acids from the cytoplasm (Klionsky et al., 1990). 
Arginine is mobilized from the vacuole to the cytoplasm under certain nitrogen 
starvation conditions (Kitamoto et al., 1988c) in a reaction that might require energy to 
allow arginine efflux (Drainas and Weiss, 1982). The mechanism of efflux and the 
signalling path to initiate release of stored ions or amino acids are poorly understood 
(Klionsky a/., 1990). 
4.1.3. Carbohydrate Storage 
Relatively littie is known about the role of the yeast vacuole in carbohydrate 
metabolism. The presence of a trehalase in the vacuole (Wiemken and Schellenberg, 
1982) suggests that part of the trehalose metabolism is comparmentalized in the 
vacuole. Trehalose is a non-reducing disaccharide of glucose and is thought to be part 
of the primary heat shock response in 5. cerevisiae and also confers resistance to 
dessication (Hottiger et al., 1987). Trehalose accumulation in the cytoplasm is also 
believed to confer osmoresistance (Mackenzie et al., 1988). Trehalose-6-phosphate 
synthase and trehalose-6-phosphate phosphatase are osmotically induced in E. coli 
(Kaasen et al., 1992), but whether this is the case for S. cerevisiae is unknown and in 
addition trehalose might be located in the cytoplasm in S. cerevisiae (Keller et al., 
1982). 
Some recent results suggest an intriguing involvement of the vacuole in 
carbohydrate metabolism. Plankert et al., 1991, reported that the vacuolar alkaline 
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phosphatase (Pho8p) is identical to fiiictose-2,6-bisphosphate 6-phosphatase which 
converts fructose-2,6-bisphosphate to fructose-2-phosphate and Pj. The 
dephosphorylation of the 6-phosphate of fructose-2,6-bisphosphate is a key reaction in 
regulation of the carbohydrate metabolism in S. cerevisiae (Holzer, 1990). Fructose-2,6-
bisphosphate is produced as an indirect response to the presence of glucose and 
regulates the switch fi-om gluconeogenesis to glycolysis (Hers et al., 1988). This 
reaction has to occur in the vacuole because of the unique localization of the PH08 
gene product, and requires a transport mechanism for fructose-2,6-bisphosphate into the 
vacuole. An interesting question remains whether fructose-2-phosphate is released into 
the cytoplasm or remains vacuolar. Some mutants that mislocalize vacuolar proteins are 
defective in gluconeogenesis (Dulic and Riezman, 1989). This fact seems to suggest 
that the vacuole does regulate part of the gluconeogenetic pathway, and i f the vacuole 
or part of it is defective other functions will be affected. So far no experimental 
approach has concentrated on this intriguing phenomenon. 
4.1.4. Homeostasis Function of the Vacuole 
The selective accumulation of ions and the presence of a number of transport 
channels support the hypothesis that the vacuole is a homeostatic organelle (Klionsky et 
al., 1990). Its function in pH homeostasis has firsUy been suggested by Banta et al., 
1988, who found that a vacuolar biogenesis mutants were sensitive to variation in the 
pH of the surrounding medium. The fact that the vacuolar as well as the cytoplasmic pH 
undergo relatively small changes in response to larger alterations of the pH in the 
enviroimient has been attributed to the action of the vacuolar ATPase (Klionsky et al., 
1990). The fact that the plasma membrane ATPase is essential for growth under a 
number of unfavourable conditions including slight changes in environmental pH 
(McCusker et al., 1987) argues against the functioning of the vacuole in cellular pH 
homeostasis. The vacuolar acidification will secondarily contribute to an increase in 
cytoplasmic pH, but its prime function is in maintaining the vacuole an acidic 
environment. The fact that mutants lacking a vacuole are osmosensitive, has been 
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suggested to be caused by the absence of an osmoregulatory organelle or vacuolar 
components involved in osmoregulation (Banta et al., 1988; Klionsky et al., 1990; 
Latterich and Watson, 1991). These hypotheses are supported by the fact that the 
vacuole contains osmotically active components, such as polyphosphate, arginine and 
K"*" (Klionsky et al., 1990). The only conclusive evidence for a role of the vacuole in ion 
homeostasis has been demonstrated for Ca^^. Mutants sensitive to elevated 
concentrations of Ca^^ in the growth medium are almost exclusively defective in some 
vacuolar function, including vacuolar acidification (Ohya et al., 1986; Ohya et al., 
1991). The precise mechanism of ion uptake and release and charge balance is still 
poorly understood. The vacuole plays a similar role in amino acid homeostasis by 
selectively sequestering amino acids resulting in a constant concentration of these 
particular amino acids (Kitamoto et al., 1988b; Kitamoto et al., 1988c; Klionsky et al., 
1990). From the latter two examples it appears that the vacuole has the ability to 
selectively uptake components which would be toxic i f not removed from the 
cytoplasm, and thus to tightly regulate the cytoplasmic concentration of these 
components. The regulation of the homeostasis mechanism is not understood, but 
judging from the number of constituents accumulating in the vacuole it might be quite 
sophisticated. 
4.1.5. Vacuole Inheritance 
The vacuolar compartment is usually inherited from the mother cell into the 
daughter bud as soon as the daughter bud emerges (Weisman et al., 1987). Stable 
fluorophore labelling of the vacuolar compartment (Weisman and Wickner, 1988) and 
time lapse photography using confocal scanning laser microscopy (Gomes de Mesquita 
et al., 1991) have been used to assess the inheritance of vacuolar material from mother 
cell to the bud. The inheritance pattern is distinct in a number of different wild type 
strains examined (Gomes de Mesquita et al., 1991), but some general features do seem 
to exist. For the most commonly used wild type yeast strain X2180 the majority of buds 
aquire a vacuolar segregation structure within 15 minutes after bud emergence. The 
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separation structure has the form of a tubule or a vesicular stream (Gomes de Mesquita 
et al, 1991; S.D. Emr and T. Vida, personal communication; C.K. Raymond, personal 
communication). It also is observed in semi-permeabilized cells (T. Vida, personal 
communication). The vacuolar segregation structure originates from the mother 
vacuole, elongates and moves across into the bud before the tubule or stream 
disappears. This process is completed within 20 minutes after initial bud emergence and 
before nuclear division occurs. The segregation pattern observed is not disturbed by the 
presence of nocodazole, a microtubule disrupting drug, suggesting that microtubules do 
not actively participate in segregation. Nocodazole does, however, disrupt vacuole 
integrity in X2180 (Guthrie and Wickner, 1988), but even that does not prevent the 
formation of segregation patterns. The inherited vacuole continues to grow during the 
cell cycle, presumably by de novo synthesis via the secretory pathway. In X2180 the 
observed disruption of the vacuolar compartment in the presence of nocodazole might 
be a consequence of a destabilized cytoskeleton which might participate in confining 
the vacuole as a single compartment (Guthrie and Wickner, 1988). The budding off of 
vacuolar vesicles might be mediated by a local destabilization of the vacuole 
surrounding cytoskeleton permitting segregation to occur. 
4.1.6. Synthesis and Processing Pathway of Vacuolar Proteins 
A great deal of interest has focused on understanding the pathway for the delivery 
of vacuolar proteins to the vacuole (Rothman et al., 1989a; Stevens et al., 1982), the 
activation of vacuolar zymogens (Mechler et al., 1987), and the molecular mechanisms 
involved in the sorting process and vesicle budding and fusion (Klionsky et al., 1990; 
Raymond et al., 1992). A great deal of information about the synthesis and 
transportation of proteins into the vacuole has been derived by studying the biogenesis 
of the soluble vacuolar protein carboxypeptidase Y (Stevens et al., 1982). The fact that 
most vacuolar enzymes are glycoproteins (Hasilik and Tanner, 1978b) seems to suggest 
that these proteins share parts of the secretory pathway where glycosylation occurs 
(Esmon et al., 1981; Esmon et al., 1984). Since it is known that preproCPY (ppCPY) is 
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processed in two independent proteolytic events (Hasilik and Tanner, 1978a), the 
comparment dependent maturation of preproCPY was assessed (Stevens et ah, 1982). 
The isolation of conditionally lethal mutants in the secretory path, and the subsequent 
classification of the sec (secretory) mutants into groups which define at least three 
distict linear compartments in the secretory pathway (Novick et al., 1981; Deshaies and 
Schekman, 1987) showed that vacuolar proteins enter the secretory pathway and at 
some stage are sorted and routed to the vacuole. Different sec mutants interrupt 
transport in the secretory pathway at different steps at the non-permissive growth 
temperature (37 °C), and accumulated material is discharged in most mutants to the next 
successive step upon return to the permissive temperature (24°C). The presence of 
pulse-labeled CPY was detected by immunoprecipitation of total cell extracts from 
mutants grown at the restrictive temperature. This includes those that block the import 
into the ER, the budding of transport vesicles from the ER or the subsequent fusion with 
the Golgi apparatus, mutants that block within or after the Golgi, and mutants that block 
the fusion of Golgi derived secretory vesicles with the plasma membrane (Deshaies and 
Schekman, 1987; Stevens et al., 1982). Translocation deficient mutants sec61 and sec62 
accumulated the unglycosylated signal peptide containing form of CPY, preproCPY 
(Hasilik and Tanner, 1978a; Deshaies and Schekman, 1987), in the cytoplasm. In the 
wild type the signal peptide is cleaved during translocation into the ER by a signal 
peptidase (Blachly-Dyson and Stevens, 1987; Johnson et al., 1987). A thermoreversible 
accumulation of CPY precursors was detectable in mutants that block after the ER and 
the Golgi but not in mutants that block transport of secretory vesicles. Two CPY 
precursors were found to accumulate: plCPY (67 kDa) accumulated at 37°C in secJ8-\ 
and represents the core-glycosylated ER form of CPY, which also accumulates in all 
other ER blocked mutants. In sec7 and secM mutant strains, another CPY precursor (69 
kDa) could also be immunoprecipitated. This precursor was designated p2CPY and 
represents the fully glycosylated Golgi precursor of CPY. Secretory vesicle blocked 
mutants did not accumulate significant amounts of precursors but produced mature CPY 
(61 kDa) at the restrictive temperature. The maturation sequence of the two CPY 
precursors was assessed with the help of double mutants which were pep4 and either 
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seel8, sec7 or seel. secl8 and sec7 were epistatic to the pep4 mutation and mainly 
produced plCPY at 37°C. The p2CPY was observed in a pep4 or a pep4 seel double 
mutant. plCPY thus precedes p2CPY. These pioneer experiments showed that the 
maturation and vacuolar targeting of CPY required the ER and Golgi and several gene 
products defining these compartments in yeast. 
The increase in molecular mass of ppCPY to the ER form pi CPY is due to 
dolichol-mediated core glycosylation of the four Asn-X-Thr N-glycosylation sites. The 
added core oligosaccharides have the structure P2(GlcNac)2Man9Glc3 upon addition 
and are subsequently trimmed by glucosidase I and I I and an a-mannosidase to yield 
the 67 kDa plCPY (Esmon et al., 1984). Phosphorylation of the carbohydrate side 
chains occurs in the ER, unlike for the secreted enzyme invertase where the 
phosphorylation event occurs in the Golgi compartment (Hashimoto et al., 1981; 
Stevens et al., 1982; Trimble et al., 1983). plCPY exits the ER via a vesicular 
intermediate transport carrier (Kaiser and Schekman, 1990; Rexach and Schekman, 
1991) which is accumulated in restrictive seel 8 mutants because of their inability to 
fuse with the Golgi compartment (Wilson et al., 1989). Upon fusion of the ER derived 
transport intermediates with the cis Golgi, pi CPY is released into the Golgi lumen. At 
some stage in the Golgi outer chain carbohydrate modification occurs (Franzusoff and 
Schekman, 1989) by the addition of a-l,6-mannose linked carbohydrates and 
subsequent addition of a-l,3-mannose linked carbohydrates. Compared to the secreted 
form of invertase, which is extensively outer-chain glycosylated on seven of nine 
glycosylation sites during migration through the Golgi (Man>2oGlcNAc), CPY receives 
relatively few carbohydrate side chains (Man^j to Man^gGlcNAc) on three of the four 
core oligosaccharides on preCPY (Trimble et al., 1983). This difference is not due to 
the diffent nature of secretory and vacuolar enzymes or that the sorting of CPY from 
secretory enzymes occurs before extensive outer chain modification takes place. It 
rather is an intrinsic property of invertase and CPY, since preproCPY-invertase fusions 
which are correctly targeted to the vacuole in wild type strains receive extensive outer-
chain marmose addition on the invertase moiety which are indistinguishable from the 
mature secreted invertase (Johnson et al., 1987). Endo-p-N-acetylglucosaminidase H 
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(Endo H) digestion of native and denatured CPY and invertase revealed that one of the 
three high mannose oligosaccharides of CPY and two of nine oligosaccharides of 
invertase are inaccessible to Endo H treatment when in their native conformation. 
Denaturation of both proteins made all N-linked oligosaccharides accessible to Endo H 
treatment. The inaccessible N-linked oligosaccharides of both proteins have less outer 
chain mannose present and are devoid of phosphate which is associated with all the 
other oligosaccharides (Trimble et al., 1983). The fully glycosylated p2CPY precursor 
has a molecular mass of 69 kDa and is believed to leave the Golgi at the trans 
compartment where sorting occurs (Graham and Emr, 1991). The sorting of soluble 
vacuolar proteins from proteins with other destinations is believed to occur by an active 
process, where sorting signals present in the pro sequence of vacuolar proteins are 
recognized. Proteins with such signals are packaged and sorted away from other 
proteins sharing the same Golgi compartment (Klionsky et al., 1990; Raymond et al., 
1992). Membrane associated vacuolar proteins share the same physical compartments 
as soluble vacuolar proteins, but for proteins with transmembrane domains the default 
pathway appears to be transport to the vacuole (Raymond et al., 1992; T.H. Stevens, 
personal communication). 
To date the transport step from the distal Golgi compartment to the vacuole is 
poorly defined, partly because of a lack of conditional vesicle accumulating 
intermediates. The isolation and characterization of mutants missorting vacuolar 
proteins (Bankaitis et al., 1986; Robinson et al., 1988; Rothman et al., 1989a; Rothman 
and Stevens, 1986) intended to aid further analysis of the transport of soluble vacuolar 
enzymes from Golgi to vacuole, assumes that a block in this particular transport event 
leads to the secretion of vacuolar enzymes via the default secretory pathway. 
The overall half time for the migration and processing of CPY from its 
cytoplasmic site of biosynthesis to delivery to the vacuole has been shown to be 6 
minutes (Hasilik and Tanner, 1978a). Many soluble vacuolar hydrolases move through 
the common compartments of the secretory pathway as inactive precursors. Only upon 
delivery to the vacuole do these hydrolases undergo proteolytic processing and become 
active. This proteolytic activation process is mediated by the product of PEP4, 
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proteinase A (PrA) (Ammerer et al., 1986; Hemmings et al., 1981; Jones et al., 1982; 
Woolford et al., 1986; Zubenko et al., 1983). Mutants lacking active PrA often are 
unable to mature all other vacuolar hydrolases discovered to date (Jones et al., 1982; 
Rupp et al., 1991). Although these mutants are viable under laboratory conditions, the 
vacuolar proteolytic system seems to be required for survival under nutrient deprivation 
and the differentiation process of sporulation (Teichert et al., 1989). 
4.1.7. Sorting of Soluble Vacuolar Proteins 
Soluble vacuolar proteins traverse the secretory pathway from the ER to the Golgi 
apparatus together with secretory proteins. They are selectively sorted in the late Golgi 
where they are separated from secretory proteins (Novick et al., 1981; Klionsky et al., 
1990; Raymond et al., 1992; Stevens et al., 1982). The mechanism of this sorting 
process is not completely understood and differs from that of mammalian cells, because 
it is not dependent on protein glycosylation and phosphorylation (Schwaiger et al., 
1982). In certain mammalian cell lines mannose 6-phosphate serves as the secondary 
signal that targets certain lysosomal proteins to the lysosome (Komfeld and Mellman, 
1989). Different lines of evidence suggest that at least for CPY this is not the case, 
although yeast ppCPY expressed in Xenopus oocytes is correctly sorted to the lysosome 
indicative for a conserved pathway (Roitsch and Lehle, 1991). First, S. cerevisiae is 
able to efficiently sort and target CPY to the vacuole in the presence of tunicamycin. 
Such treatment completely blocks N-linked glycosyiation in the ER (Schwaiger et al., 
1982; Stevens et al., 1982). Second, site directed mutagenesis eliminating all four 
glycosylation acceptor sites present in PRCl, the structiu-al gene encoding ppCPY, did 
not lead to a missorting of the protein product. The engineered protein product is not 
glycosylated, and although its transport through the secretory pathway has slower 
kinetics, it is still sorted to the vacuole efficiently and enzymatically active (Winther et 
al., 1991). N-linked glycosylation may be required for the efficient sorting of PrA, or 
alternatively have a stabilizing function for overall stability of the normal conformation 
of the protein and not represent a sorting signal per se (Raymond et al., 1992). On the 
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other hand, PrA-invertase hybrid proteins lacking the glycosylation sites on PrA are 
efficiently located to the vacuole, arguing against a role of N-linked oligosaccarides in 
vacuolar protein sorting (Klionsky et al., 1988; Klionsky et al., 1990). This hypothesis 
is supported by the original findings that in presence of mnicamycin CPY, PrA and 
aminopeptidase I are efficiently located to the vacuole (Schwaiger et al., 1982). 
Progress has been made in identifying the protein sequence motifs which target 
some representative vacuolar enzymes to their correct location (Johnson et al., 1987; 
Klionsky et al., 1988; Roberts et al., 1989; Vails et al., 1990). Gene fusions between 
varying length of the N-terminus of the vacuolar ppCPY and the secretory invertase 
have established that the first 50 amino acids encoded by PRCl (i.e. the first 30 amino 
acids of proCPY after signal peptide cleavage) contains information that is necessary 
and sufficient for targeting of the fusion protein and to the vacuole (Bankaitis et al., 
1986; Johnson et al., 1987). Deletions and certain point mutations in the pro region of 
CPY led to the partial or complete secretion of CPY underlining the results obtained 
from the above gene fusion studies (Vails et al., 1987; Vails et al., 1990). The 
observation that the fusion of the prepropeptide of CPY to a truncated form of invertase 
leads to a targeting of the invertase to the vacuole confirms that the default route for 
soluble proteins upon entering the secretory pathway is secretion and that other 
targeting or retention information has to be present in proteins whose fate is not 
secretion (Vails et al., 1987). The presence of the four contiguous amino acids QRPL in 
position 24 to 27 of ppCPY is required for efficient sorting of CPY (Vails et al., 1990). 
The co-expression of CPY carrying sorting mutations within these four aminoacids and 
wild type CPY demonstrated that the wild type CPY was correctly sorted to the vacuole 
while the mutant protein was secreted (Vails et al., 1990). It has been argued that these 
findings provide evidence that CPY is sorted as a monomer. The vacuolar PrA is also 
synthesized as a prepro protein, and fusion studies were able to locate the information 
necessary for targeting to the pro sequence (Klionsky et al., 1988). However, this pro 
sequence has no significant identity to the CPY pro sequence, and also the complete pro 
sequence of PrA is required to confer targeting information. The probable location of 
the targeting information is within the C-terminal amino acids of the propeptide unlike 
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for CPY where the vacuolar targeting information is located two amino acids from the 
N-terminus of the propeptide (Klionsky et al., 1988; Klionsky et al., 1990). Little is 
known about the targeting information present in other soluble vacuolar proteins. It has 
been suggested that the propeptide of aminopeptidase I (API) contains a targeting signal 
(Chang and Smith, 1989; Klionsky et al., 1990). The apparent difference in vacuolar 
targeting signals lead to the question whether there is a common sorting apparatus for 
all soluble vacuolar proteins or whether different vacuolar proteins are sorted by 
different mechanisms. Overproduction of either CPY or PrA by increasing the gene 
copy number of their respective structural genes results in a partial secretion of the 
Golgi modified form of either protein (Rothman et al., 1986; Stevens et al., 1986), 
arguing for an active, saturable receptor for vacuolar proteins in the late Golgi 
compartment. Overexpression of ppCPY did not result in a secretion of PrA, neither did 
overexpression of ppPrA result in a secretion of p2CPY. This suggests that if sorting of 
soluble vacuolar proteins is an active process, there are several mono- or polyspecific 
receptors present in a late Golgi compartment that recognize and sort different vacuolar 
proteins (Rothman et al., 1986; Stevens et al., 1986; Raymond et al., 1992). An 
alternative explanation is that overexpressed ppCPY and ppPrA could form homo-
multimers or insoluble precipitates which are no longer recognized by the sorting 
machinery and as a result are secreted (Raymond et al., 1992). Studies in seel mutants 
blocking transport from Golgi to the plasmamembrane show that overexpression 
induced secretion of p2CPY depends on transit through the late secretory pathway 
(Stevens et al., 1986) and supports the receptor hypothesis considering that ppCPY-
invertase fusions when overexpressed take the same fate (Bankaitis et al., 1986). 
Further evidence for the presence of different sorting machineries for different soluble 
vacuolar proteins comes from characterization of mutants that are defective for vacuolar 
protein sorting {vps, ssv) and secrete a number of vacuolar proteins (Bankaitis et al., 
1986; Latterich and Watson, 1991; Rothman and Stevens, 1986; Robinson et al., 1988; 
Rothman et al., 1989). While most vps and ssv mutants mislocalize several vacuolar 
proteins, there are a few mutants which selectively secrete only one of several vacuolar 
enzymes tested for. A detailed analysis of one such mutant, vps35, provides additional 
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evidence that there are alternative pathways for the sorting of vacuolar proteins to the 
vacuole (Paravicini et al., 1992). A Avps35 deletion mutant only mislocalizes p2CPY to 
the cell surface but correctly sorts PrA, I*rB and API to the vacuole. It is intriguing to 
know that the putative gene product Vps35p lacks any signal peptide consensus and 
does not associate with any membraneous fraction (Paravicini et al., 1992). Though not 
being a likely candidate for the CPY sorting receptor, it could be a part of the sorting 
machinery for CPY specific protein sorting. 
One of the conditions required for efficient vacuolar protein sorting of soluble 
vacuolar proteins is vacuole acidification (Klionsky et al., 1990; Klionsky et al., 1992; 
Rothman et al., 1989). Although not required for maturation of vacuolar hydrolases as 
suggested before (Woolford et al., 1986), bafilomycin A l induced inhibition of the 
vacuolar membrane ATPase is associated with a secretion of newly synthesized 
vacuolar proteinases p2CPY, p2PrA and proPrB. This disputes previous findings that in 
a vat2 deletion mutant lacking the 60 kDa subunit of the vacuolar ATPase protein 
sorting is not significantly affected (Yamashiro et al., 1990). Subsequent analysis of 
vacuolar protein sorting defects associated with disrupted genes of the vacuolar ATPase 
complex led to the conclusion that vacuole or vacuolar network acidification is required 
for the efficient sorting of soluble and membrane associated vacuolar proteins. The 
same sorting defects can be induced in wild type yeast cells when grown on medium 
whose pH is 7.5, arguing for a role of acidification of the vacuolar network (Klionsky et 
al., 1992). The overall findings suggest that one step in the sorting machinery is 
sensitive to pH and requires an acidic environment to function. This could be analogous 
to the acidification dependent sorting receptor recycling (Mellman et al., 1986). 
The vacuole also derives part of its soluble constituents from the cell surface by 
endocytosis (Riezman, 1985), directly from the cytoplasm (Chiang and Schekman, 
1991), and from the cytoplasm via peroxysomes (H.L. Chiang, personal 
communication). The endocytotic pathway and glucose repression associated import of 
fructose-1,6-bisphosphatase into vacuoles is discussed in a subsequent section 
(Endocytosis and Protein Degradation Pathways). All these different routes are most 
likely to require independent sorting or import mechanisms. Little is known about how 
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endocytotic vesicles release their contents to the vacuole and whether an intermediate 
endosomal compartment is involved (Riezman, 1985). There is also no information 
available of whether vacuolar proteins in hypothetical late Golgi derived vesicles share 
a compartment or whether the two routes are independent from each other. With the 
exception of Rhylp which may be a ras homologue functioning in the targeting of 
vacuole destined vesicles to the vacuole (D. Gallwitz to M.D. Watson, personal 
communication) no other factors have been identified that are involved in the late 
transport stage. 
4.1.8. Sorting of Membrane Associated Proteins 
All membrane associated vacuolar enzymes appear to take the secretory pathway 
to transit to the vacuole (Klionsky and Emr, 1989; Klionsky et al., 1990; Nishikawa et 
al., 1990; Roberts et al., 1989; Schekman, 1985) with the possible exception of a-
mannosidase which enters the vacuole directly by some unknown mechanism 
(Yoshihisa and Anraku, 1990) and the the vacuolar ATPase subunits (except the 
transmembrane spanning 17 kDa subunit) which assemble in the cytosol and associate 
with the transmembrane subunit of the ATPase complex on the vacuolar membrane 
(Kane et al., 1989a, 1989b). Studies of the processing pathway of the vacuolar 
membrane proteins repressible alkaline phosphatase (Pho8p; ALP) and dipeptidyl 
aminopeptidase B (DPAP B) showed that both proteins co-migrate with secretory and 
soluble vacuolar proteins (Klionsky and Enu", 1989; Roberts et al., 1989). DPAP B is 
encoded by DAP2, a gene with a putative open reading frame of 841 amino acids. The 
deduced peptide has a predicted mass of 96 kDa (Roberts et al., 1989). Biochemical 
studies showed that it is a 120 kDa integral membrane glycoprotein (Roberts et al., 
1989). Using sec mutants it was shown that DPAP B precursor forms accumulate in 
secl8 and sec7 at the restrictive temperature but not in seel mutants that accumulate 
secretory vesicles. Immunolocalization of DPAP B in wUd type and sec mutants 
confirmed that the delivery of DPAP B is blocked in secl8 and sec? mutants. These 
observations show that DPAP B uses the same stages of the secretory pathway as 
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soluble vacuolar proteins. However, the co-vesicular transport of membrane bound 
vacuolar proteins together with soluble vacuolar proteins has not yet been investigated. 
Despite the fact that DPAP B and soluble proteins destined for delivery to the vacuole 
use the same stages, the sorting mechanism appears to be different as most vps mutant 
mislocalize soluble vacuolar proteins to the cell surface but not membrane-bound 
vacuolar proteins. 
The other well characterized membrane associated vacuolar protein is non-
specific alkaline phosphatase (ALP), a homo-dimer of 130 kDa (Onishi et al., 1979), 
which has been shown to be identical with fructose-2,6-bisphosphate 6-phosphatase 
(Plankert et al., 1991). A detailed biochemical analysis of the transport pathway of ALP 
showed that it is identical to that of DPAP B based on accumulation in sec 18 and sec7 
at the restrictive temperature (Klionsky and Emr, 1989). It also was shown that ALP, 
like DPAP B, is a type 11 integral membrane protein containing a short basic N-terminal 
cytoplasmic tail that is accessible to exogenous proteolytic degradation when associated 
both with ER and vacuole. Like DPAP B, ALP is sorted to the vacuole by a different 
mechanism than soluble vacuolar proteins since most vp^ mutants correctly localize 
ALP to the vacuole (Klionsky and Emr, 1989). ALP is the only vacuolar membrane 
protein known to undergo PEP4 dependent maturation by removal of its C-terminal end 
(Kaneko et al., 1985; Kaneko et al., 1987). 
Preliminary recent evidence suggests that the "default" pathway for membrane 
anchored proteins is delivery to the vacuole (reviewed in Raymond et al., 1992). An 
amino acid sequence comparison between ALP and DPAP B suggests that there is no 
significant sequence identity. However, this is also the case for ppCPY and ppPrA and 
it might only be an indication of two independent sorting pathways. More compelling 
evidence comes from fusion studies, where a cleavable signal peptide is fused to the N-
terminal lumenal domain of ALP (Klionsky and Emr, 1990). The signal peptide is 
cleaved, and the proteolytically processed protein which is identical to ALP is secreted, 
arguing that the lumenal domains do not contain sorting information. On the other hand, 
proteins containing the cytoplasmic domains and the transmembrane domains fused to 
invertase are located to the vacuole (Raymond et al., 1992). Deletion of the cytoplasmic 
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domain of DPAP B has no effect on its vacuolar targeting, nor does replacement of the 
transmembrane domain with the transmembrane domain of the Golgi retained DPAP A. 
Both fusions are faithfully located to the vacuole arguing against targeting information 
present in the transmembrane domain. Also the overexpression of Golgi proteins or the 
deletion of the Golgi retention information present in the cytoplasmic domain of two 
Golgi membrane proteins DPAP A and Kexlp results in the localization to the vacuole. 
The fact that the overproduction of DPAP B does not result in a localization of the 
protein to the plasmalemma is indicative that either the default pathway is localization 
to the vacuole, or that the sorting pathway is not satiu-able (Roberts et al., 1989). Up to 
date experimental approaches have not addressed the hypothesis that the default 
pathway for membrane bound proteins might still be the plasmalemma if no retention or 
targeting information is present, but that oversecreted or mislocalized proteins are 
retrieved from the plasmalemma by endocytosis. Membrane bound vacuolar proteins do 
not appear to proceed in this manner and normally travel from a Golgi compartment 
directiy to the vacuole (Klionsky et al., 1989; Roberts et al., 1989) unlike some 
mammalian membrane bound lysosomal proteins which migrate to the lysosome via the 
plasmalemma (Mellman et al., 1986). An interesting fact to remember is that 
overexpressed secretory transmembrane proteins are not localized to the vacuole 
directly from the Golgi arguing against a default pathway for membrane bound enzymes 
to the vacuole or saturable secretory sorting mechanism. Maybe there is no default 
pathway for membrane bound proteins, but their final localization depends on 
association with other proteins in distinct regions of the Golgi. This association could be 
mediated by the formation of multi-dimer lattices which rely on the interaction between 
certain transmembrane domains in a lipid environment as has been suggested to be 
involved in the Golgi retention of some proteins (G. R. Warren, open citation). It is 
interesting to note that all yeast transmembrane domains that result in vacuolar 
localization have a G(XQ.3)LLL motif 10 to 11 amino acid residues away from the N -
terminal start of the transmembrane domain (M. Latterich, unpublished findings). 
Studies of vacuolar acidification deficient mutants suggests that vacuole acidification is 
required for localization of ALP to the vacuole and a collapse of the vacuolar pH 
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gradient leads to an accumulation of vesicles containing unprocessed ALP (Klionsky et 
al., 1992). A similar situation is encountered when considering the differential 
subcellular localization of bovine |3l,4-galactosyltransferase. This enzyme is 
synthesized by two sets of mRNA transcripts that encode two forms of the protein with 
a complete and extended N-terminal domains (Russo et al., 1990). The truncated 
version is a resident type n Golgi protein while the 13 amino acid extended protein 
(also type II) is located to the plasma membrane (Lopez et al., 1991). The conclusions 
drawn are that either the N-terminal extension masks a cytoplasmically located Golgi 
retention signal, or that it represents a positive sorting signal for localization to the 
plasmalemma. The differential sorting mechanism awaits elucidation. 
a-mannosidase, a vacuolar inner membrane associated protein, is located to the 
vacuole independent to the secretory pathway (Yoshihisa and Anraku, 1989). The 
enzyme is a multimer consisting of 107, 73 and 31 kDa subunits the stoichiometry of 
which varies with the cell cycle (Yoshihisa et al., 1988). The smaller subunits result 
from PEP4 dependent cleavage of the 107 kDa peptide encoded by the a-mannosidase 
structural gene AMSl (Kuranda and Robbins, 1987; Yoshihisa et al., 1988; Yoshihisa 
and Anraku, 1989; Yoshihisa and Anraku, 1990). The protein product has no obvious 
N-terminal signal peptide, and althogh 7 potential N-terminal glycosylation sites are 
present, vacuolar a-mannosidase is not glycosylated. Newly synthesized a-
mannosidase is normally delivered to the vacuole and evenmally matured to the 73 kDa 
species even when the secretory pathway is blocked by a subset of sec mutations. 
Import into the vacuole is believed to occur via a protein channel present in the vacuolar 
membrane. Deletion and AMS1-SUC2 gene fusion smdies indicate that the targeting 
information is located between amino acids 747 and 927 of the protein. The fact that the 
putative signal is not terminally located together with the finding that an in frame fusion 
of 1067 N-terminal amino acids of AMSl with the 511 C-terminal amino acids of SUC2 
are indicative for an internal localization signal similar to the nuclear localization 
signal. Import into the vacuole is a saturable event with the excess a-mannosidase 
activity remaining in the cytoplasm. 
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There is as yet no data available on the targeting of other membrane bound 
vacuolar enzymes to the vacuole. Out of more than 100 vacuolar membrane associated 
proteins only ALP, DPAP B, a-mannosidase and to some extent a 78 kDa glycoprotein 
(Nishikawa et ah, 1990) and the 17 kDa subunit of the vacuolar ATPase representing 
the only transmembrane component of the ATPase (Kane et al., 1989a) have been 
characterized in terms of transport. Considering the fact that different sorting 
mechanisms exist for at least half of the vacuolar enzymes characterized so far it is too 
early to generalize on the transport phenomena. The whole picture is complicated in 
that different paths taken by different vacuolar constituents each of which require the 
presence of specific import mechanisms which also have to be localized to the vacuole. 
The disturbance of proper localization of any component may have secondary 
associated effects, as for example the missorting of proteins dependent on the vacuolar 
localization of the primary component. 
4.1.9. Endocytosis and Protein Degradation Pathways 
Most of the current research on the endocytotic pathway, representing the vesicle 
mediated fraffic routes that interconnect the trans Golgi network, the plasmalemma, 
endosomes and lysosomes, has been done on mammalian cell lines (Komfeld and 
Mellman, 1989) or protists (Fok and Allen, 1990). Due to the presence of a dense cell 
wall in 5. cerevisiae it appears unlikely that endocytosis plays a significant role in the 
uptake of high molecular weight or other compounds. Fluid phase endocytosis of lucifer 
yellow, a sulfonate dye, has been reported to occur (Riezman, 1985). The uptake is 
temperamre dependent and does not show saturation kinetics typical for receptor 
mediated endocytosis. Fluid phase endocytosis of FITC-dextran or Semliki Forest virus 
and vesicular stomatitis virus (Makarow and Nevalainen, 1987; Makarow, 1985a) by 
yeast sphaeroplasts have been elusive, since the reported uptake of FITC-dextran and 
accumulation of fluorescence in the vacuole was due to low molecular weight 
impurities present in commercial preparations of the FTTC-dextran conjugate (Preston et 
al., 1987). The use of yeast sphaeroplasts rather than intact yeast cells might not reflect 
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the wild type situation and caution has to be applied in interpreting endocytosis in 
sphaeroplasts. Although lucifer yellow shows kinetics of uptake characteristic for fluid 
phase endocytosis (Riezman, 1985), it has not yet been demonstrated that the dye does 
not enter the cell by an active process independent of endocytosis. 
Evidence that yeast possesses a receptor mediated endocytic pathway comes from 
studies into the mechanism of mating of haploid cells. Conjugation of haploid a and a 
cells requires the action of mating pheromones before successful mating can occur 
(Kurjan, 1985; Sprague et ah, 1983). Haploid cells respond to the reciprocal mating 
pheromone to their own mating type. The action of a-factor on a cells and of a-factor 
on a-cells initiates a cellular response that finally results in forming a diploid zygote. 
Preliminary studies demonstrated a binding of a-factor to an a-factor receptor located 
on the plasmamembrane (Jenness et al., 1983). The a-factor / a-factor receptor complex 
is internalized and delivered to the vacuole where proteolytic degradation occurs 
(Chvatchko et al., 1986; Dulic and Riezman, 1989; Konopka et al., 1988; Singer and 
Riezman, 1990). The same studies indicated that a-factor is internalized by a time, 
temperature and energy dependent process upon which it is rapidly degraded. The a-
factor receptor is expressed in a-cells and represents a 431 amino acid integral 
membrane protein encoded by STE2 (Jenness et al., 1983). It has seven transmembrane 
domains and a C-terminal hydrophilic cytoplasmic domain. The a-factor receptor on a-
cells shares the same structural homology with the a-factor receptor, but differs in 
length and seqence. The a-factor receptor is a 470 amino acid protein encoded by STE3. 
Both receptors are localized on the plasma membrane, and on binding of the reciprocal 
pheromone they are internalized and degraded in the vacuole in an PEP4 dependent 
manner (Jenness and Spatrick, 1986; Raymond et al., 1992). The C-terminal domains of 
both receptors are not involved in pheromone-induced signalling but necessary for 
receptor internalization (Konopka et al., 1988; Raymond et al., 1988; Reneke et al., 
1988). 
Evidence for the presence of an intermediate vesicular compartment comes from 
kinetic and inhibitor studies. At \5°C delivery of the a-factor is slowed significantly 
over uptake. PEP4 dependent degradation of the endocytosed a-factor is not rate 
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limiting at 15°C, and there is biochemical evidence of the accumulation of a transport 
intermediate. A protease protected transport intermediate can also be isolated after 
NaN3 or NaF treatment which is distinct from plasma membrane and vacuole as judged 
by differential and density gradient centrifugation. Whether this transport intermediate 
represents a vesicular intermediate in plasma membrane to Golgi transport, an 
endosome-like compartment or both is not yet clear. 
How the ligand-receptor complexes are internalized is not known. Clathrin, which 
is required for receptor mediated endocytosis in mammals (Goldstein et al., 1985), is 
not required for a-factor uptake in S. cerevisiae (Payne et al., 1988). Although clathrin 
heavy chain mutants display a reduced rate of a-factor uptake compared to wild type 
cells, this might simply be due to the reduced growth rate of the mutant. There is 
evidence that some of the SEC genes involved in transport in the secretory pathway 
(Novick et al., 1980; Novick et al., 1981) also are involved in endocytosis (Riezman, 
1985). However, these results were based on fluid phase endocytosis of lucifer yellow, 
whose uptake may not reflect true endocytosis (Raymond et al., 1992). It is not known 
how significant endocytosis is in vacuole biogenesis, and whether pinocytosis occurs. It 
would be interesting to see if S. cerevisiae endocytoses nutrients for degradation in the 
vacuole and how significant this hypothetical event is in survival under unfavourable 
conditions. It is also not known whether endocytotic membrane flow significanUy 
contributes to the vacuolar membrane. Is there a recycling pathway that will recycle 
endocytotic membrane vesicles back to the plasma membrane, maybe via an endosome? 
The answer is not clear, but there appears to be no need for mating factor receptor 
recycling. The directed budding, targeting and fusion of endocytic vesicles with the 
receptor compartment(s) will require factors specific for that particular transport step. 
The identification of such factors and the design of an in vitro system will help in an 
understanding of this pathway. An in vitro system that allows the cell-free 
reconstitution of transport from the late endosome to the lysososme in mammalian cells 
established fransport dependence on ATP and cytosol (Mullock et al., 1989). It should 
be interesting to see whether yeast cytosol can substitute the cytosolic factors involved 
in this pathway. 
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Protein degradation of cytoplasmic proteins in the vacuole has been suggested 
before (Klar and Halvorson, 1975), but it was not until much later that the selective 
import of a protein destined for vacuolar degradation has been described (Chiang and 
Schekman, 1991; Raymond et al., 1992). Indirect evidence points towards degradation 
of Golgi localized Kexlp, Kex2p and DPAP A in the vacuole (Raymond et al. 1992). In 
case of Kex2p the half life of the protein is extended in pep4 mutants compared to the 
isogenic wild type, but whether this phenomena is due to PEP4 dependent degradation 
in the vacuole is not known. 
Fructose 1,6-bisphosphatase (FBPase), a key regulatory enzyme in 
gluconeogenesis, is synthesized when yeasts are grown on a poor carbon source such as 
ethanol. Upon transfer to glucose containing growth medium, FBPase synthesis is 
repressed and the cytoplasmic enzyme is phosphorylated and degraded (Guerra et al. 
1988; Schafer et al., 1987). The degradation is dependent on the PEP4 gene product 
and comparatative immunoprecipitation studies led to the conclusion that the 
degradation of FBPase is a direct response to glucose (Chiang and Schekman, 1991). 
Subcellular fractionation and indirect immunofluorescence using an anti-FBPase 
antibody showed that the FBPase was taken up by the vacuole upon transfer of a pep4 
mutant from a poor carbon source to glucose. It appears likely that the FBPase destined 
for degradation enters the vacuole or a post-ER compartment beacause the three 
potential glycosylation sites on the protein are not glycosylated and the protein lacks an 
obvious signal peptide for translocation into the ER. It is not yet known how the protein 
is translocated across the vacuolar membrane or a prevacuolar compartment, but PEP4 
sec mutant strains blocking transport at different stages did retard the catabolite 
repression induced degradation of FBPase in PEP4 sec62, PEP4 seel8, PEP4 sec7 but 
not PEP4 seel at the restrictive temperature. This might be characteristic for the 
glucose induced expression of a protein that traverses the secretory pathway to the 
vacuole and is required for uptake of FBPase. The fact that in the presence of 
cycloheximide FBPase uptake into the vacuole does not occur corroborates these 
results. The translocation of FBPase into a membranous compartment occurs at a post 
ER stage since secl8 cells do not import FBPase into the ER during catabolite 
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repression. Together with the fact that a-mannosidase is targeted into the vacuole 
directly, bypassing the secretory pathway (Yoshihisa and Anraku, 1990), there appears 
to be a mechanism for regulated uptake and degradation of specific cytoplasmic 
compounds under certain metabolic conditions. Mammalian cells and yeast have 
different bulk degradation pathway for the rapid turn-over of proteins in the lysosome 
or vacuole, respectively (Chiang et al, 1989; Dice, 1990; Teichert et al, 1989; Zubenko 
and Jones, 1981). Hepatocytes deprived of amino acids will enclose random 
cytoplasmic material in ER derived autophagic vacuoles which will fuse with or 
"become" lysosomes (Dunn, 1990a; Dunn, 1990b). Little is known whether bulk 
degradation in 5. cerevisiae occurs analogously or whether different mechanisms 
operate to ensure bulk delivery to the vacuole. The engulfing of cytoplasmic material by 
vacuoles has been observed in yeast (Vorisek, 1989), but since the findings are solely 
based on observation of electron micrographs, caution has to be applied not to 
overinterpret potentially artefactual appearances. Selective import of proteins into the 
lysosome in serum deprived cells requires the presence of a peptide motif within the 
proteins to be degraded (Dice, 1990). The motif is KFERQ, or related sequences with 
the same chemical properties, which is recognized by a 73 kDa peptide recognition 
protein (73prp) which is identical to hspTO binding to and disassembling clathrin light 
chains. Interestingly, clathrin light chain has two overlapping peptides related to the 
KFERQ motif (Chappell et al., 1986; Dice, 1990). Similar motifs have been suggested 
to mediate the import of F6BPase into the yeast vacuole (Chiang and Schekman, 1991). 
The proteolytic activity of the vacuole is associated with general protein 
degradation as part of the sporulation response (Achstetter and Wolf, 1985; Heinemeyer 
et al., 1991). Inactivation of the PEP4 gene product leads to a drastic reduction in 
sporulation efficiency due to the pleiotropic inactivation of proteinases that depend on 
PrA activation. These proteinases function in the rapid turnover of unecessary cellular 
proteins during sporulation to provide amino acids for new sporulation specific gene 
products. The sporulation response can occur in the absence of an exogenous nitrogen 
source, and about 30% of vegetative proteins are turned over during sporulation (Klar 
and Halvorson, 1975). PrA and PrB are responsible for the majority of non-specific 
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protein degradation under nutritional stress conditions (Teichert et al, 1989). The 
import of proteins destined for degradation into the vacuole is at present subject to 
speculation. There is evidence that the yeast vacuole participates in the degradation of 
ubiquinated proteins also (Heinemeyer et ah, 1991). Considering the fact that proteinase 
yscE represents the yeast proteasome (Achstetter et al., 1984; Kleinschmidt et ai, 1988) 
required for the degradation of ubiquitin tagged proteins (Heinemeyer et al., 1991), and 
that mutants in subunits of the proteosome are lethal, it is interesting that there is a 
second pathway of degrading ubiquitin labelled proteins. Maybe there is a functional 
specialization between proteosome mediated degradation of regulatory proteins and 
(maybe) general turnover of ubiquinated proteins in the vacuole or mediated by a 
vacuolar process. 
4.1.10. Biosynthesis of Soluble Vacuolar Proteins 
Aminopeptidase Co. Aminopeptidase Co (APC) is a soluble metallo-
exopeptidase with a molecular mass of approximately 100 kDa. Its activity depends on 
the presence of Co2+ ions, and is inhibited in the presence of Zn2+ and EDTA 
(Achstetter et al., 1982). Its activity increases when cells reach stationary growth phase 
(Achstetter et al., 1984), similar to other vacuolar proteinases. There is currently no 
available information about its structural gene and its processing pathway. 
Aminopeptidase I . Aminopeptidase I (API) is a multimeric soluble metallo-
exopeptidase of a molecular mass of about 640 kDa (Frey and Rohm, 1978). It is 
activated in the presence of Zn^ "*" (Metz and Rohm, 1976), and is composed of 12 
identical glycoprotein subunits of approximately 50 to 53 kDa (Metz and Rohm, 1976; 
Klionsky et al., 1990). API activation is PEP4 dependent (Jones, 1991). Its strucmral 
gene, LAP4, was cloned and sequenced (Chang and Smith, 1989; Cueva et al., 1989). It 
encodes a 514 amino acid protein with a 45 amino acid prosequence at the N-terminus. 
API is synthesized as a 57 kDa precursor containing four potential glycosylation sites of 
which two seem to be utilized. The extreme N-terminus of the protein does not have a 
signal peptide conforming to von Heijne's rules (von Heijne, 1983). Part of the pro-
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sequence does have a hydrophobic/hydrophilic stretch that can be arranged into an 
ampiphilic a-helix and could represent a translocation signal peptide. The enzyme has a 
pH optimum in the neutral to basic range (Frey and Rohm, 1978). 
Carboxypeptidase S. Carboxypeptidase S (CPS) has been identified in mutants 
deficient in PrA, PrB and CPY activities (Wolf and Ehmann, 1978). It is encoded by 
CPSl, and little is known about its biosynthesis (Jones et al., 1982). CPS is 
constitutively active and thought to supply cells with amino acids when external amino 
acids or a nitrogen source is not available. Its activity is dependent on the presence of 
Zn2+ and is regulated by the available nitrogen source (Achstetter and Wolf, 1985). 
Carboxypeptidase Y. Carboxypeptidase Y (CPY) is a soluble serine peptidase 
representing a monomeric glycoprotein with a molecular mass of approximately 61 kDa 
(Achstetter and Wolf, 1985). CPY is the most extensively characterized vacuolar 
enzyme, and many of the pioneer studies that established the pathway of transit to the 
vacuole as well as vacuolar sorting relied upon the study of the biogenesis of CPY (see 
3.1; 4.1.6.). In the following only some general features of the enzyme will be 
discussed. ppCPY is encoded by PRCl (Wolf and Fink, 1975) which has been cloned 
by its overexpression induced secretory defect (Stevens et al., 1986). The gene encodes 
a 532 amino acid protein with no significant homology at the amino acid level with 
other vacuolar proteinases. The first 20 amino acids represent an ER specific signal 
peptide. Amino acids 19 to 111 represent the pro-peptide which is cleaved in a PEP4 
and PRBl dependent manner (Mechler et al., 1987). Removal of the signal peptide by 
deletion of amino acids 2 to 28 did not abolish CPY's ability to translocate into the ER 
but merely slowed its kinetics. The A2-28CPY that entered the ER was secreted into the 
medium (Blachly-Dyson and Stevens, 1987). This led to the idea that the first few 
amino acids of the pro-peptide contained vacuolar targeting information. Two 
approaches using deletions in the pro-sequence of ppCPY (Vails et al., 1987; Vails et 
al., 1990) and gene fusions of differing lengths of the N-terminus of CPY with invertase 
(Johnson et al., 1987) demonstrate that the first 30 amino acids of the propeptide are 
necessary and essential for vacuole delivery. Site directed mutagenesis identified that 
Gln-24 to Leu-27 form a vacuolar targeting signal. The cis-dominance of such 
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mutations are also indicative of interaction with a sorting apparatus conferring 
specificity rather than an unspecific sorting event. ppCPY undergoes N-linked 
glycosylation and is proteolytically processed in several events (Klionsky et al., 1990). 
The pro-peptide is important in maintaining CPY inactive until delivery to the vacuole 
(Achstetter and Wolf, 1985; Hasilik and Tanner, 1978a), a feature which has been 
observed with some other vacuolar enzyme precursors such as PrA, PrB, API (Jones, 
1991), trehalase (Har2ris and Cotter, 1987) and RNAse (Jones et al., 1982). Most of the 
activation is mediated by PrA and PrB (Jones, 1991). The pro-peptide of CPY has also 
been associated with the stabilising of the protein conformation and the correct self-
assembly during translocation and migration through the secretory pathway (Winther 
and S0rensen, 1991). Like other proteases, the activity of CPY is regulated and activity 
of CPY increases several-fold when cells enter diauxic growth, stationary phase or 
under starvation conditions (Distel et al., 1983; Hansen et at., 1977; Klar and 
Halvorson, 1975; Saheki and Holzer, 1975). The levels of CPY mRNA increase up to 
ten-fold at the end of the exponential growth period on glucose as a carbon source 
(Distel et al., 1983). A 6- to 8-fold increase in the gene copy number of PRCl leads to a 
50 to 55% secretion of the p2CPY synthesized during the exponential growth phase 
(Stevens et al., 1986). It has not been examined whether secretion of the p2CPY form 
naturally occurs during the life cycle and has a biological function in degradation of 
peptides present in the extracellular environment, especially since secreted p2CPY 
undergoes extracellular activation (Nielsen et al., 1990; Rothman and Stevens, 1986). 
This hypothetical phenomenon would be consistent with the observation that CPY 
expression is induced when cells grow on a peptide which is a substrate for the enzyme 
(Achstetter and Wolf, 1985). 
Phosphatases (Non-membrane Asscociated). There are two polyphophatases, 
endo-polyphosphatase and exo-phosphatase, highly enriched in vacuole preparations 
(Diirr et al., 1979; Wiemken et at., 1979). So far no data are available about their 
function and biogenesis. 
Proteinase A. Proteinase A (PrA) is a soluble, monomeric, carboxylic 
endopeptidase (Achstetter and Wolf, 1985). It is encoded by PEP4 which has been 
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cloned by overexpression induced secretion in an immunological screen (Rothman et 
al., 1986). PEP4 encodes a 405 amino acid precursor (ppPrA) with significant 
homology to the mammalian aspartyl proteases pepsin, renin and cathepsin D 
(Ammerer et al., 1986). The extreme N-terminus of ppPrA constitutes a signal peptide 
which is cleaved upon entry into the ER between amino acids 22 and 23 (Klionsky et 
al., 1988). The protein is core glycosylated on two sites corresponding to amino acid 
144 and amino acid 345 (piPrA) migrating on SDS-PAGE with a molecular mass of 48 
kDa (Ammerer et al., 1986). The protein has four cysteines which are believed to be 
engaged in the formation of disulphide bonds (Dreyer et al., 1986). During transit 
through the ER and Golgi p i PrA undergoes core oligosaccharide trimming and outer 
chain modification to yield p2PrA (52 kDa). The propeptide is cleaved between Glu-76 
and Gly-77 of the predicted protein sequence to form the mature active 42 kDa PrA 
upon delivery to the vacuole (Ammerer et al., 1986) in what is believed to be an 
autocatalytic process (Mechler et al., 1987). Site directed mutagenesis of the active 
catalytic site of PrA, exchanging Asp-294 with Ala-294, led to an inactivation of 
catalytic activity of the enzyme (Rupp et al., 1991). Cells expressing such a mutated 
PrA failed to proteolytically process the mutant PrA, supporting the view that p2PrA 
undergoes autocatalytic activation. The propeptide contains vacuolar targeting 
information (Klionsky et al., 1988), but a consensus sequence has not been established 
yet (see above). PrA has a preference for Phe, Leu and Glu in the -1 position and for 
Phe, lie. Leu and Ala in the 1 position of the cleavage site (Dreyer, 1989). Its substrate 
specificity is more limited than for example the related pepsin, and its cleavage pattern 
reflects that of cathepsin D, except that PrA is not restricted to cleavage between large 
hydrophobic amino acids. PrA dependent maturation of carboxypeptidase Y, proteinase 
B and autocatalysis is not solely accountable for the proteolytic action of PrA since its 
specificity does not account for cleavage at the cleavage points (see above). Rather the 
synergistic action of PrA and PrB is accountable for the observed processing of PrA, 
PrB and CPY (Jones, 1991). After autocatalytic removal of 47 N-terminal amino acids 
of p2PrA immediately before or upon delivery to the vacuole the remaining 7 amino 
acids of the propeptide are removed in a PrB catalyzed reaction. PrA activity is 
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regulated, and the PrA activity increases several-fold when cells enter stationary or 
diauxic growth phase (Hansen et ah, 1977) or as a sporulation specific response (Klar 
and Halvorson, 1975). PrA as well as PrB play an essential role in the maturation of 
proteinases and the starvation induced vegetative protein degradation (Jones, 1991; 
Teichert et ah, 1989). PrA migrates through the secretory pathway to the vacuole with a 
half-time of 6 minutes which is identical to that of CPY, suggesting that it reaches the 
vacuole via the same compartmental route or mechanism (Klionsky et al., 1990). 
Proteinase B. Proteinase B is a soluble serine-, sulphydryl endopeptidase with a 
pH optimum for proteolysis in the neutral range (Achstetter and Wolf, 1985). It is a 
monomeric enzyme with a molecular weight of 33 kDa, of which 10% represents 
carbohydrate insensitive to Endo H treatment. This is characteristic for an 0-linked 
carbohydrate moiety. Its structural gene, PRBl, has been cloned and sequenced (Moehle 
et al., 1987). It encodes an approximately 70 kDa protein, of which the fu-st 19 residues 
have the characteristics of a signal peptide supportmg the view that PrB enters the 
secretory pathway at the ER level. Using specific antisera combined with pulse chase 
and genetic experiments its maturation pathway has been established (Hirsch et al., 
1992; Moehle et al., 1989). Upon translocation of the ppPrB protein into the ER the 
signal peptide is cleaved by the signal peptidase and the protein receives one asparagine 
linked and an unknown number of 0-linked carbohydrate side chains. The glycosylated 
intermediate is proteolytically processed to a 39 kDa form while in the ER (plPrB), 
which becomes 40 kDa in the Golgi due to outer chain modification of the Asn-linked 
side chain (p2PrB). Upon arrival in the vacuole the p2PrB is converted to the mature 31 
kDa form via a 37 kDa intermediate. Site directed mutagenesis, substimting the 
catalytical Ser-519 of the active site with Ala-519 led to the formation of an inactive 
protein that enters the secretory pathway and reaches the vacuole as a 73 kDa protein 
but is not processed (Hirsch et al., 1992; Nebes and Jones, 1991). The active site 
mutation thus prevents clevage of the 41 kDa peptide called superpeptide and the 
subsequent cleavage of the C-terminal propeptide. Evidence suggests that in wild type 
cells the superpeptide remains associated with the pPrB until the vacuolar compartment 
is reached. In the vacuole PrA dependent cleavage of most of the propeptide takes place 
147 
resulting in the activation of PrB. The final trimming of the remaining amino acids of 
the propeptide, as well as the rapid degradation of the superpeptide is belived to occur 
as part of an autocatalytic event (Hirsch et al., 1992; Jones, 1991). At present unknown 
is the location of the vacuolar targeting signal, which might be located in the C-terminal 
propeptide or the superpeptide that remains associated with the pPrB (Klionsky et al., 
1990) . PrB levels, like PrA activity, are subject to environmental regulation (Klar and 
Halvorson, 1975; Moehle and Jones, 1990). PRBl transcription is repressed in the 
presence of glucose, and also subject to changes in the life cycle because PRBl 
transcription is induced as cells reach the stationary growth phase. Transcription is 
tightly regulated since an increase in copy number of the structural gene does not result 
in an overproduction of PrB under unfavourable glucose conditions. It has been 
suggested that SNF2 and 5A^F5, two of at least six genes required for the derepression of 
secreted invertase synthesis (Carlson et al., 1981) are transcriptional regulators of 
PRBl. PrB appears to be required for effective sporulation, proteolytic processes during 
nitrogen starvation and for the "trimming" of PrA cleaved vacuolar hydrolases (Jones, 
1991) . PrB is specifically expressed after irradiation with UV and enzyme activity is 
dose-dependent, althogh not much is known about the regulatory mechanism 
(Schwencke and Moustacchi, 1982), The transport and processing occurs with similar 
efficiency to that of CPY, suggesting that PrB as well as PrA and CPY share the same 
vesicular transport pathway (Moehle et al., 1989). 
Ribonucleases. Ribonuclease activity has been found in the vacuole (Wiemken et 
al., 1979) but nothing is known about its biosynthesis or biological function. The 
presence or import of RNA, its natural substrate, has not yet been shown. Ribonucleases 
in mammalian cells are selectively imported and degraded in lysosomes (Dice, 1990). 
This could also be the case in 5. cerevisiae, and the activity found in vacuoles might be 
residual activity of the RNAses before inactivation. 
Trehalase. Trehalase is the sole enzyme involved in the catabolism of trehalose, a 
storage carbohydrate (Thevelein, 1984) and stress protectant (Hottiger et al., 1987). 
There are two forms of trehalase in S. cerevisiae, a cAMP dependent cytosolic enzyme 
and a vacuolar enzyme (Keller et al., 1982; Thevelein, 1984). The cytosolic enzyme is 
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tightly regulated and only active when phosphorylated. The vacuolar enzyme is a 
glycoprotein of 215 kDa (Londesborough and Varimo, 1984) and transits through the 
early secretory pathway to the vacuole (Harris and Cotter, 1988). Its activation is PEP4 
dependent (Harris and Cotter, 1987). The biological function of the vacuolar enzyme is 
unknown and not essential under physiological conditions. 
4.1.11. Biogenesis of Vacuolar Membrane Associated Proteins 
a-mannosidase. a-mannosidase is an inner peripheral or ecto- vacuolar 
membrane protein that is associated with the membrane other than by a membrane 
spanning domain. The enzyme represents a 560 kDa multimer consisting of 107, 73 and 
31 kDa subunits (Yoshihisa et at., 1988). It appears likely that the 73 and 31 kDa 
subunits are due to specific proteolysis, since both are antigenically related to the 107 
kDa species and occur in an equimolar ratio. This proteolytic event occurs prevalently 
in the stationary phase. The structural gene for a-mannosidase, AMSl, has been cloned 
and sequenced (Kuranda and Robbins, 1987; Yoshihisa and Anraku, 1989). It encodes a 
107 kDa polypeptide with no obvious signal sequence and seven N-glycosylation 
consensus sites. A deletion mutant of the AMSl gene does not synthesize the 73 and 31 
kDa fragments, representing indirect evidence that they are derived from the 107 kDa 
fragment, a-mannosidase enters the vacuolar sytem directly bypassing the secretory 
pathway (Yoshihisa and Anraku, 1990), although the exact mechanism for translocation 
is unknown, a-mannosidase is subject to carbon catabolite repression and sporulation 
induced increase in activity, although its biological function is not known (Opheim, 
1978). It appears unlikely that a-mannosidase and fructose 1,6-bisphosphatase, both of 
which are selectively sequestered in the vacuole under certain conditions, take the same 
specific import pathway, because the uptake of FBPase depends on the expression of a, 
probably, vacuolar protein that transits the secretory pathway before uptake can occur 
(Chiang and Schekman, 1991). The uptake of a-mannosidase depends on the presence 
of a most likely constitutively expressed transporter (Yoshihisa and Anraku, 1990). The 
biological significance of this vacuolar import pathway has been disputed because of its 
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slow half-time of import, and it has been suggested that its uptake is part of a 
degradation process (Preston etai, 1991). On the other hand, unmasked a-mannosidase 
activity is found predominantly in the vacuole which has led to its use as vacuolar 
marker enzyme (Opheim, 1978) 
Alkaline Phosphatase. Among several phophatases located to the vacuole is one 
membrane associated alkaline phosphatase which is regulated in response to phosphate 
levels involving a regulatory system including Pho4p, PhoSOp, Pho81p and Pho85p 
(Oshima, 1982). It has a molecular mass of 130 kDa and is a glycosylated homodimer 
(Onishi et al., 1979). Its structural gene, PH08, has been cloned and sequenced 
(Kaneko et al., 1985; Kaneko et al., 1987). It encodes a 566 amino acid protein with 
one hydrophobic region near the N-terminus and two N-linked glycosylation sites in 
position 268 and 401. The protein is glycosylated and transits to the vacuole where 
PEP4 dependent proteolytic removal of a C-terminal peptide occurs. The half-time of 
transport is 6 minutes, suggesting that ALP shares the same transport pathway as 
soluble vacuolar enzymes. Protease protection studies confirmed that ALP is a type n 
membrane protein. The sorting signal of ALP is unknown, in fact it has been suggested 
that sorting of vacuolar membrane proteins occurs by default without any sorting 
information (Raymond et al., 1992). The role of this non-specific enzyme is unclear. An 
insight comes from the recent discovery that fructose 2,6-bisphosphate 6-phosphatase 
(Fru2,6P2-ase) is encoded by PH08, confirming the indentity of both enzymes. 
Fru2,6P2 plays an important role in the regulation of overall carbohydrate metabolism. 
Fru2,6P2 is rapidly formed as a response to high glucose levels which is believed to be a 
secondary effect resulting from an increase of cAMP levels (Hers et al., 1988). It 
represents a low molecular weight stimulator of 6-phosphofructo-l-kinase and 
simultaneously an inhibitor of fructose-1,6-bisphosphatase, and thus acts as a key 
regulatory metabolite in regulating glycolysis and gluconeogenesis. Upon shifting yeast 
cells to glucose containing growth medium the consequent increase of cAMP will 
activate protein kinase which subsequentiy phosphorylates at least three proteins: 
trehalase (activated), 6-phosphofructo-2-kinase (activated) and fructose-1,6-
bisphosphatase (inactivated). Fru2,6P2 is degraded by lructose-2,6-bisphosphate 6-
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phosphatase, presumably in the absence of glucose. The question remains why this 
enzyme is located to the vacuolar membrane and why it is activated upon delivery to the 
vacuole and not before. The vacuole might participate in regulating carbohydrate 
metabolism in yeast, maybe by importing fructose-2,6-bisphosphate for degradation. 
This would be analogous to import of fructose-1,6-bisphosphatase for degradation 
under glucose repression (Chiang and Schekman, 1991). 
AMPase. The presence of a vacuolar membrane bound AMPase has been 
suggested by a number of studies (Schwencke, 1977; Wiemken et al., 1979) although 
no further data are available yet. 
ATPase. The vacuoler membrane H^-ATPase is a complex consisting of at least 
three subunits (Aral et al., 1988; Bowman et al., 1986; Kane et al., 1989a; Kane et al., 
1989b; Mandala and Taiz, 1985; Uchida et al., 1985). It plays a crucial role in the 
acidification of the vacuole or the vacuolar network (Mellman et al., 1986) and thus is 
required for a number of vacuolar transport processes including the transport of ions 
and amino acids (Ohsumi and Anraku, 1983; Ohsumi et al., 1988; Okorokov et al., 
1985; Sato et al., 1984a) and the efficient sorting of soluble and membrane bound 
vacoular proteins (Klionsky et al., 1992). Its role in providing an acid environment for 
proteolysis has been suggested because the pH optimum of a number of vacuolar 
hydrolases is in the slightly acidic range (Woolford et al., 1986), but a recent 
investigation showed that it is not required for efficient proteolysis to occur (Klionsky 
et al., 1992). The vacuolar H+-ATPase is distinct from other F I F Q ATPases including E. 
coli, mitochondrial and chloroplastic ATPases and also from the plasma membrane 
E 1 E 2 ATPases in terms of immunological crossreactivity (Bowman and Bowman, 
1986) and inhibitor spectra (Bowman and Bowman, 1986; Bowman et al., 1988b). It is 
sensitive to bafilomycin A j , N-ethylmaleimide and cynanide, and insensitive to azide 
and vanadate. The H"*"-ATPase complex contains three major subunits of 69, 60 and 17 
kDa and other proteins of 100, 42, 36, 32 and 27 kDa in association (Kane et al., 
1989b). The same study was able to show that the 69 kDa subunit contains the catalytic 
site, mediating ATP binding alone or in conjunction with other subunits. These subunits 
bind radioactive ATP analogues such as 8-azido-ATP and are labeled by ATPase 
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inhibitos such as 7-chloro-4-nitrobenzo-2-oxa-l,3-diazole and N-ethylmaleimide 
(Uchida et al., 1988). It has been proposed that the 60 kDa subunit represents a 
regulatory ATP-binding subunit and the 17 kDa subunit the proton pore (Kane et al., 
1989a). Another proteolipid, the 16 kDa subunit, has been found which is distinct from 
the 17 kDa proteolipid (Umemoto et al., 1991). Littie is known about the assembly of 
the ATPase, but it has been suggested that the ATP binding subunits are located on the 
cytoplasmic face of the vacuolar membrane based on the fact that the putative catalytic 
subunit (69 kDa) can be stripped off from vacuolar vesicles (Ohsumi and Anraku, 
1981). Substrate accessibility is also restricted to the cytoplasmic site of the membrane 
(Kakinuma et al., 1981), which is inferred from the function of the ATPase in 
acidifying the interior (Klionsky et al., 1990). The other subunits have not been 
assigned a function yet, but it is believed that they either play a role in assembly or 
mediate attachment of the 69 and 60 kDa subunits to the 17 kDa pore complex (Kane et 
al., 1989a). They have subsequentiy been shown to be essential for vacuole 
acidification since disruptions of the structural genes encoding the 70, 60, 42, 27, 17 
and 16 kDa subunit lead to a complete inactivation of the ATPase in vitro and in vivo 
(Raymond et al., 1992). The same effect can be observed by cold K N O 3 inactivation, 
where the majority of subunits are released (Kane et ah, 1989b). It has been suggested 
that the 17 kDa subunit migrates through the secretory pathway as a transmembrane 
protein, and the actual assembly of the other cytoplasmic subunits take place on the 
vacuole or a prevacuolar compartment, but conclusive evidence is still missing. Several 
approaches have been taken to elaborate the mechanisms of its assembly and function. 
Kinetic studies revealed that the process of catalysis is similar to that of FQEJ ATPases 
in that it requires cooperativity between subunits and several ATP molecules per 
enzyme (Hirata et al., 1989; Kasho and Boyer, 1989; Uchida et al., 1988). Unlike FQFI 
ATPases where the disassembled F ] subunit complex can carry out ATP hydrolysis 
independentiy, none of the vacuolar ATPase subunits retaines the ability to hydrolyse 
ATP (Kane et al., 1989b). Several approaches have been taken to isolate mutations in 
the so^ictural genes of the subunits of the vacuolar ATPase. Based on the fact that 
acidification of the vacuole is dependent on the assembly of all subunits into a complex 
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and that vacuolar proteins are missorted, the examination of mutants defective in 
vacuolar protein localization yielded two mutants defective in vacuole acidification as 
judged by their failure to accumulate quinacrine (Preston et al., 1989; Rothman et al., 
1989c). Two direct approaches were taken to generate mutants in vacuole acidification 
and the ATPase. One method selected for mutants with reduced fluorescence after 
labeling with 6-carboxyfluorescein. One recessive mutant, vphl-l, was identified that 
maintains the vacuolar pH at 6.9 (Preston et al., 1989). The other approach concentrates 
on 2cloning the genes corresponding to the vacuolar ATPase subunits. The following 
genes corresponding to the ATPase subunits have been cloned, VMAl (70 kDa), VMA2, 
VAT2 (60 kDa), VMA3 (16 kDa), VMA4 (27 kDa), VMA5 (42 kDa) and VMA6 (36 kDa) 
(Anraku et al., 1989; Klionsky et al., 1990; Raymond et al., 1992; Rothman et al., 
1989). VMAl was cloned by hybridisation probing of a yeast genomic DNA library with 
a degenerate oligonucleotide probe whose sequence was deduced from the amino acid 
sequence of a protein fragment (Anraku et al., 1989; Hirata et al., 1989), VMAl encodes 
a 1071 amino acid protein, whose 285 N-terminal and 332 C-terminal amino acids are 
75% identical with the catalytic subunit of the Neurospora crassa H"*"-ATPase 
(Bowman et al., 1988). The 454 amino acid central domain is not essential to the 
ATPase and is believed to be removed by a protein processing mechanism or by 
autocatalysis to yield a 67 kDa protein (Anraku et al., 1989). It would be tempting to 
speculate that this processing event could be involved in activation or assembly of the 
ATPase. A disruption of VMAl results in low spore viability and a reduced growth rate 
but is not essential for vegetative growth. VAT2 was cloned by hybridisation probing of 
a yeast genomic library with a degenerate oligonucleotide whose sequence was deduced 
from the amino-terminal protein sequence (Yamashiro et al., 1990). It encodes a 517 
amino acid protein with a predicted molcular mass of 58 kDa without an obvious ER-
signal sequence. The protein was identical to the 57 kDa H^-ATPase isolated before 
(Nelson et al., 1989), except the C-terminus which was probably due to a sequencing 
artefact of the first sequence established. A deletion of VAT2 did not result in lethality 
but rather conferred an acidification defective phenotype, inability to grow on neutral 
growth medium and a weak vacuolar protein sorting defect (Yamashiro et al., 1990). 
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Zymogen activation was not impeded in the mutant. Other vacuole associated functions 
like amino acid storage were not examined in the deletion mutant. Its doubling time 
under normal growth conditions is significantly greater than the wild type. VMA3 was 
also cloned in a library screen with a degenerate oligonucleotide (Umemoto et al., 
1990). The gene has the potential to encode a 160 amino acid protein, which shares 
extensive sequence homology (65%) with the 16 kDa subunit of the chromaffin granule 
ATPase (Mandel et al., 1988). A disruption of the VMA3 gene has a similar growth 
defect as Avmal and Avar2. VMA4 is the structural gene for the 27 kDa subunit of the 
vacuolar ATPase. Its encodes a 233 amino acid hydrophilic polypeptide which exhibit 
34% sequence identity with the E subunit of the lysosomal ATPase from bovine 
microsomes (Foury, 1990). Judging from a deletion mutant the protein is not essential 
for vegetative growth, but it is defective in vacuolar ATPase activity and is cold- and 
temperature-sensitive. The structural genes for the 42 and 36 kDa subunits, VMA5 and 
VMA6 respectively, have been cloned and sequenced (Beltran et al., 1992; Raymond et 
al., 1992). They show homology to subunits of similar size from Neurospora crassa and 
bovine ATPase, and they are not essential under physiological conditions. The 42 kDa 
subunit (Vma5p; C-subunit) function can be rescued by the bovine equivalent of the 
subunit in a gene fusion between the yeast vcuolar ATPase and bovine V-ATPase, and 
it is essential for the assembly of the catalytic center of the enzyme (Beltr^ et ah, 
1992). Other genes have been identified which participate in vacuolar ATPase assembly 
or activation (Raymond et al., 1992). VMA12 and VMAIS mutants are deficient in the 
assembly of vacuolar ATPase, yet the genes do not encode abundant subunits of the 
ATPase complex (Ohya et al., 1991). Other vacuole acidification deficient mutants, 
vphl, vps3 and vps6, exhibit ATPase assembly defects although none of the gene 
products encode subunits of the ATPase (Raymond et al., 1992; Rothman et al., 1989b). 
Some 8 additional vps mutant sfrains fail to assemble the ATPase complex. It is difficult 
to judge at present whether the protein sorting defect results in a mislocalization of 
vacuolar proteins important for ATPase assembly, or whether the acidification defect 
leads to a missorting of vacuolar proteins, Lastiy disruptions in genes corresponding to 
subunits A (70 kDa), B (60 kDa) and c (16 kDa) of the ATPase confer a v/j^-phenotype 
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(Klionsky et al., 1992). It is difficult to judge at present which vacuolar and non-
vacuolar protein constituents are primary participants in assembly and function of the 
vacuole and which affect other vacuolar functions by disturbing the regulated 
equilibrium subject to control at many levels. 
Mutational analysis of a number of biochemical pathways has successfully been 
used to identify protein constituents participating in the biochemical event or involved 
in the regulation and gene expression of such constituents. Biochemical pathways 
sometimes are less complex than the biogenesis of a vacuole, and individual steps can 
be analysed in a cell free system. On the other hand, the secretory pathway has 
successfully been analysed by generating conditional mutants, but in case of a mutation 
inactivating an essential protein would be lethal. The vacuole is not an essential 
organelle, and a mutation in an essential protein constituent will not be lethal under 
physiological conditions. The reconstitution of the vacuole biogenesis pathway is 
difficult because of the sensitivity of the vacuole during isolation. The yeast plasma 
membrane H^-ATPase, which is localized via transit through the secretory pathway, is 
activated by progressive compartment dependent specific phosphorylation on multiple 
Ser and Thr residues during transit (Chang and Slayman, 1991). Upon arrival at the 
plasma membrane it undergoes specific phosphorylation of specific sites which regulate 
its activity in response to glucose. Whether the ATPase is active between assembly on 
the ER membrane and the exit of the Golgi is unknown, but a similar mechanism for the 
vacuolar ATPase could exist to regulate its activity by progressive phosphorylation. 
Dipeptidy aminopeptidase B. Dipeptidyl aminopeptidase B (Dipeptidyl 
aminopeptidase V; DPAP B) is a membrane associated exopeptidase (Bordallo et al., 
1984). Its structural gene, DAP2, has been cloned as a multicopy suppressor of a stel3 
mutant which lacks the Golgi dipeptidyl aminopeptidase A (DPAP A). Disruption of the 
locus led to an abolishment in DPAP B activity (Roberts et al., 1989) similar to mutants 
deficient in DPAP B activity (Suarez Rendueles and Wolf, 1987). DAP2 encodes a 841 
amino acid protein of a predicted molecular mass of 96 kDa and with a single 
hydrophobic domain near the N-terminus. The predicted sequence possesses 8 potential 
N-glycosylation sites of which at least 5 are used. DPAP B has a molecular mass of 110 
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to 113 kDa upon arrival in the vacuole and is not removed from the vacuole membrane 
by Na2C03 treatment. This plus presence of only one hydrophobic domain indicates 
that DPAP B has the characteristic of a type 11 transmembrane protein. The Golgi and 
vacuole species do not differ in size, indicating that proteolytic processing does not 
occur. This is consistent with the fmding that DPAP B is active in the ER (Roberts et 
al., 1989). The location of the hydrophilic domain suggests that DPAP B has a 
cytoplasmic domain of 29 amino acids. Previous reports indicated that DPAP B has a 
molecular mass of 40 kDa (Garcia-Alvarez et al., 1985) rather than the protein product 
described subsequentiy and shown to have DPAP B activity. This discepancy can be 
explained by assuming that the 40 kDa species results from proteolysis duing 
purification, or there is another dipeptidyl aminopeptidase activity present in 5. 
cervisiae. The sorting signal of DPAP B is unknown, in fact it has been suggested that 
sorting of vacuolar membrane proteins occurs by default without any sorting 
information (Raymond et al., 1992). 
Other Proteinaceous Constituents. Other proteins having reportedly been found 
associated with the vacuole are acetylesterase, acid phosphatase, exo-I3-l,3-gluconase, 
invertase, uricase, polyphosphate kinase and catalase A (Cooper, 1982; Schwencke, 
1991). The majority of enzymes have been characterized by their enzymatic activity, 
and in some cases (e.g. catalase A) their existence is doubtful (Wiemken et al., 1979). It 
is interesting to note the periplasmic proteins invertase and acid phosphatase 
(Schwencke et al., 1991), exo-P-l,3-glucanase (Cortat et al., 1972), p-nitrophenyl-
acetate esterase (Schwencke, 1991) and chitinase (Schwencke, 1991) present in the 
vacuole. Their presence in the vacuole might be due to accidential packaging into 
vacuole destined transport vesicles and/or by endocytosis of the secreted enzymes or 
considered doubtful. 
4.1.12. Mutants Defective for Vacuolar Biogenesis 
The diversity of vacuolar functions suggest the existence of a sophisticated 
mechanism of control at many stages, and a number of mutational approaches have 
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been taken to examine aspects of vacuole biogenesis. The number of approaches are 
almost as numerous as the vacuolar protein constituents. A surprising finding was that 
most genes involved in one aspect of vacuole biogenesis were also defective in other 
related or unrelated aspects of vacuole biogenesis which led to an extensive overlap of 
the genetic complementation groups identified (Raymond et al., 1992). This 
phenomenon is due to overlap of different aspects of vacuolar function, and thus 
prevents the unambiguous identification of whether a defect is primary or secondary. 
The following sections first describe the different approaches taken to isolate biogenesis 
mutants, and an effort is made in the last section to compile all available data on 
proteins that have been identified as participants in vacuolar biogenesis. 
4.1.13. Isolation and Characterization of Vacuolar Protein Sorting Mutants 
Since the majority of vacuolar proteins known so far enter the endoplasmic 
reticulum and transgress the secretory pathway in transit to the vacuole, this process of 
biogenesis has received most attention (Klionsky et al., 1990; Raymond et al., 1992). 
Based on the findings that secretion is the default pathway for soluble proteins that have 
entered the ER i f no other retention or targeting information is present, and that proteins 
with vacuolar sorting information are subject to a saturable, active sorting process, 
strategies have been devised to isolate mutants which mislocalize vacuolar proteins to 
the cell surface (Bankaitis et al., 1986; Rothman and Stevens, 1986; Robinson et al., 
1988; Rothman etal, 1989). 
To isolate mutants defective in the selective sorting of the vacuolar CPY two 
approaches have been designed to allow the selection for mutants mislocalizing CPY to 
the cell surface. One protocol selected for the secretion of a CPY-invertase fusion in 
AyMc2 strains of S. cerevisiae (Bankaitis et al., 1986; Robinson et al., 1988). This 
selection procedure took advantage of the fact that a gene fusion consisting of a 433-
residue amino-terminal domain of CPY and a 511-residue carboxy-terminal domain of 
the secretory invertase (pCYI433) is quantitatively located to the vacuole. I f the sorting 
process is affected by a mutation in a gene involved in sorting or vesicle budding in the 
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sorting compartment, or in the N-terminus of the pro-peptide of the gene fusion, the 
fusion peptide wil l be secreted. Asuc2 strains of 5. cerevisiae harbouring the pCYI433 
plasmid are unable to grow on media containing sucrose as sole carbon source because 
the only form of invertase is in the form of the fusion peptide located in the vacuole. 
Yeast is generally unable to transport sucrose into the vacuole efficiently. K the 
vacuolar sorting process is affected by a mutation, the fusion will be localized to the cell 
surface, and such mutants will be able to grow on sucrose medium. This procedure has 
been used to identify a total of 33 complementation groups termed vpt for vacuolar 
protein targeting mutants (Bankaitis et al, 1986; Robinson et a/., 1988). The second 
approach taken was based on the fact that the extracellular fraction of oversecreted 
p2CPY is proteolytically activated by an unknown periplasmic protease not identical to 
Barlp (Stevens et al., 1986). Since vacuolar CPY in a pep4-3 mutant is not matured to 
an active form, but secreted p2CPY is, this fact has been used to design a mutant 
isolation scheme (Rothman and Stevens, 1986; Rothman et al., 1989). Enzymatically 
active CPY is able to catalyze the peptide bond cleavage of the N-blocked dipeptide N-
CBZ-L-Phe-L-Leu (Kuhn et al., 1974; Wolf and Weiser, 1977). Leucine auxotrophs 
that have normal levels of active vacuolar CPY are able to maintain growth on medium 
containing N-CBZ-L-Phe-L-Leu as sole leucine source (Rothman and Stevens, 1986). 
Leucine auxotrophs carrying a pep4-3 mutation are unable to grow on medium 
containing the dipeptide as sole leucine source because intracellular CPY cannot be 
proteolytically activated (Jones et al., 1982). Overproduction induced secretion of 
p2CPY led to an activation of the extracellular CPY fraction, and the leu2 pep4-3 
auxotrophs were able to grow (Rothman and Stevens, 1986). These findings were used 
to isolate mutants that secrete significant amounts of p2CPY as a result of a vacuolar 
mislocalization defect. A total of 29 vpl recessive complementation groups (for vacuolar 
protein /ocalization) were identified by this procedure (Rothman and Stevens, 1986; 
Raymond et al., 1992; Rothman et al, 1989; C.K. Raymond, L Howald and T.H. 
Stevens, unpublished results). The VPL and VPT complementation groups have been 
given the common nomenclature ^ 5 (for vacuolar protein sorting) because 
complementation analysis between both sets of mutants established that a large number 
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are identical (Robinson et al, 1988; Rothman et al., 1989). Other mutants in different 
aspects of vacuolar function also show an extensive overlap with vps mutants, 
suggesting that many vacuolar functions overlap or are interdependent (see below). 
These vps mutants belong to 46 recessive complementation groups, indicating that a 
large number of gene products are directly or indirectly responsible for the correct and 
efficient sorting of vacuolar enzymes. A repeated complementation analysis of the vps 
phenotype demonstrated that VPS7 is identical to VPS34, and VPS40 to VPS15 
(Raymond et al., 1992). 
A comprehensive pheonotypic analysis of the vps mutants established that all 
mutants exhibited defects in the sorting and processing of several vacuolar hydrolases, 
namely CPY, PrA, PrB and a-mannosidase (Robinson et al., 1988). 19 of the 33 
original vpt alleles had extreme defects in that they secreted more than 50% of newly 
synthesized p2CPY and were unable to intracellularly mature the remaining p2CPY to 
its mature form. The fact that all so far examined vps mutants secrete the p2CPY 
precursor is indicative for a sorting defect at a stage immediately following the Golgi-
dependent processing of CPY and before the CPY precursor reaches the vacuole. The 
fact that the p2CPY precursor accumulates in secl-1 vps double mutants at 37 °C and is 
not secreted suggests that the sorting occurs at a stage in the Golgi apparatus where 
secretory vesicles are generated, and that the p2CPY is secreted via secretory vesicles or 
in other vesicles in a parallel pathway which also require the SECl gene product for 
secretion of its contents (Rothman and Stevens, 1986). Vacuolar membrane sorting was 
generally unaffected in most mutants except in alleles of four complementation groups 
where up to 50% a-mannosidase was mislocalized to the cell surface (Robinson et al., 
1988). This finding is interesting because subsequent studies demonstrated that a-
mannosidase does enter the vacuole directly from the cytoplasm (Yoshihisa and 
Anraku, 1990). Several complementation groups have ts alleles which co-segregated 
with the corresponding vps alleles, but the vp^ phenotype itself was not temperature 
sensitive (Robinson et al., 1988). Most mutants did secrete multiple soluble proteins but 
with four exceptions no membrane associated proteins, suggesting the existence of a 
common vacuolar protein sorting apparatus, at least for soluble vacuolar proteins 
159 
(Rothman et al., 1989). However, the extent of secretion of PrA and PrB precursors is 
not as obvious as that of CPY (Robinson et al., 1988), and it appears that instead the 
precursors accumulate in a compartment not identical to the vacuole (Klionsky et al., 
1992). Recent findings suggest that there are several independent sorting mechanisms 
even for soluble vacuolar hydrolases (Paravicini et al., 1992) because a vps35 mutant is 
only defective in the localization of CPY but not PrA or ALP. The Vps35 gene product 
is apparently not a sorting receptor and thus it is likely that different vacuolar proteins 
are sorted by a different mechanisms. It is believed that in some vps mutants the 
majority of CPY is secreted while PrA and PrB accumulate in an unknown 
compartment where they remain inactive. This compartment and the mechanism for 
selective retention has not yet been elucidated (Klionsky et al., 1990). Experimental 
data suggest that vacuolar membrane proteins are faithfully localized to the vacuole 
except in four vps alleles of mutants that do not have a morphologically distinct vacuole 
(Klionsky and Emr, 1989). This suggests that different sorting mechanisms for soluble 
and membrane associated vacuolar proteins exist but that both types at least initially 
migrate through the same compartment. 
Light and electron microscopic techniques have been used to assess the vacuolar 
morphology in vps mutants (Banta et al., 1988). Three distinct vacuolar morphology 
classes have been observed: Class A vps mutants in 26 complementation groups 
contained one to three vacuoles morphologically indistinguisable from vacuoles in the 
isogenic wild type strain, suggesting that only a fraction of vacuolar proteins, that are 
not required for maintenance of a vacuolar structiu-e, are mislocalized to the cell 
surface. Class B vacuolar mutants in three complementation groups have fragmented 
vacuoles, typically 20 to 40 individual small vacuole-like compartments in one cell. 
Lastly, class C vacuolar mutants in four complementation groups lack any organelle 
resembling a vacuole. Instead they accumulate structures with similarity to previously 
indentified Berkeley-bodies (Novick et al., 1981) resembling an aberrant Golgi 
oganelle. The nature of the vacuolar defects is not understood, and the interpretation of 
the results is merely the subject of speculation. It has been suggested before that class C 
mutants have a vps phenotype due to a lack of the target structure vacuole, or that the 
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lack of the vacuole is a consequence of an extreme sorting defect (Klionsky et al., 
1990). The vacuolar morphology of all vps complementation groups have recently been 
reassessed by using indirect immunofluorescence as a means to determine vacuolar 
morphology and the correct assembly of the vacuolar ATPase (Raymond et al., 1992). 
The authors assigned the vps mutant collection to six vacuolar morphology classes: 
Class A mutants exhibit wild type morphology in that anti-Pho8p and anti-60 kDa H+-
ATPase subunit localize to the vacuolar membrane. By indirect immunofluorescence 
the vacuole(s) are clustered in one region of the cell, segregtion patterns are observed 
that extend from mother cells into daughter cells. In addition, vital staining with 
CDCFDA are similar to the wild type, and vacuoles can positively been stained with 
quinacrine, suggesting a normal acidification of the vacuole. vps2, vps8, vpsll, vpsl3, 
vps30, vps32 and vps44 belong into this group, as do pepl, pep9 and pepl6. Class B 
mutants have multiple, dispersed vacuolar compartments as judged by inspection with 
Normarski contrast microscopy, which are often not recognized by immunofluorescence 
staining using either antibody because of their relative abundance. Vacuolar segregation 
structures were not observed but the presence of vacuolar material in newly emerging 
buds argues for segregation to occur. Multiple small vacuoles were observed by 
CDCFDA, and quinacrine is accumulated indicative for correct acidification. vps5, 
vpslO, vpsl7, vps41, vps42, vps43, vps46, pep2 and pepl3 belong to this group. Some 
genetic interaction has been observed between vps5, \ps39 and vps42, which suggests 
that in these three class B mutants the defect of vacuolar biogenesis is identical or that 
the three mutant gene products interact (L Howald-Stevenson and T.H. Stevens, 
unpublished results). Class C mutants have a diffuse anti-Pho8p and anti-60 kDa 
fluorescence pattern characteristic of the absence of a vacuolar membrane, and 
CDCFDA staining is evenly distributed throughout the cell, vpsll, vps 16, vps 18 and 
vps33 belong to this group. Class D morphology exhibiting mutants have a normal 
vacuole according to its anti-Pho8p fluorescence pattern, but show a vacuolar 
segregation defect in that segregation structures are hardly observed, and many buds 
and daughter cells have the appearance of class C vacuolar mutants. The absence of a 
spherical anti-60 kDa staining pattern, together with the finding that quinacrine in these 
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mutats does not cause any fluorescence is consistent with a defect in assembly and 
function of the vacuolar ATPase. vps3, vps6, vps9, vpsl5, vpsl9, vps21, vps26, vps29, 
vps34, vps35, vps38, vps45 and pepll belong into this group. Class E mutants are the 
largest group of vacuolar mutants and appear to have normal vacuoles as determined by 
anti-Pho8p fluorescence. The anti-60 kDa labelling localizes the vacuolar ATPase 
subunit to a smaller compartment in proximity to the vacuole, which is supported by the 
fact that most quinacrine labelling is localized next to the vacuole and only moderately 
to the vacuole. These data are consistent with the aberrant localization of functional 
vacuolar membrane ATPase to a non-vacuolar, membrane-enclosed compartment. vps4, 
vpsl4, vps20, vps22, vps23, vps24, vps25, vps27, vps28, vps31, vps36, vps37 and vps39 
belong into this class, vpsl has been placed into its own vacuolar morphology class, 
because it has one large central vacuole surrounded by a series of much smaller 
compartments as judged by its anti-Pho8p and anti-60 kDa fluorescence patterns. 
Apart from the severe morphological defects, and a vacuolar acidification defect 
in several vp^ alleles, members of seven complementation groups also were 
osmosensitive in that they are unable to grow on YPD medium supplemented with 1.5 
M NaCl, 2.5 M glycerol or 1 M KCl (Banta et al., 1988). Al l alleles of mutants 
belonging to class C complementation groups, alleles of one class B complementation 
group, and alleles of two class A complementation groups were osmosensitive, which 
has been interpreted that the vacuole plays an essential role in osmoregulation. Other 
pleiotropic effects, such as poor growth on non-fermentable carbon sources, poor 
growth in minimal medium containing proline as sole nitrogen source, poor sporulation 
of homozygous diploids, and low frequencies of DNA transformation have been 
observed. This indicates that the vacuole is involved in a number of interdependent 
functions, which are no longer maintained i f a mutation in vacuole biogenesis prevents 
the formation of a vacuole. Alternatively, a mutation in a gene required for one vacuolar 
function might disturb the equilibrium of vacuolar function and as a consequence lead 
to a pleiotropic defect resulting in the collapse of the vacuole as an organelle. Al l class 
C mutants isolated so far are viable at 30°C but are inhibited at a growth temperature of 
370C. The other associated defects of the mutants, including their vps phenotype, are 
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not conditional. This suggests that a function of the vacuole or of the mutated protein is 
required for maintaining cell growth at elevated temperature (Banta et al., 1988). 
4.1.14. Mutants Deflcient in the Maturation of Vacuolar Proteinases 
Mutants isolated on the basis of reduced levels of vacuolar hydrolases (Jones, 
1977) have subsequently been shown to be mostly identical to alleles of vps mutants 
(Klionsky et al., 1990; Raymond et al., 1992). The fact that N-acetyl-DL-phenylalanine 
P-naphthyl ester is a known substrate for CPY (Wolf and Fink, 1975) has led to the 
development of a chromographic assay to screen mutants for reduced CPY activity. 
These pep mutants (peptidase-deficient) fall into 17 complementation groups (Jones, 
1977; Jones et al., 1981). Althogh the mutagenic analysis was intended to assess the 
role of PrA, J>rB and CPY in protein degradation and turnover, subsequent analysis 
showed that with the exception of PEP4 which defines the genetic locus for PrA 
(Ammerer et al., 1986; Rothman et al., 1986; Woolford et al., 1986), all other pep 
mutants have a vps phenotype (Klionsky et al., 1990; Raymond et al., 1992). This 
suggests that the pep phenotype originally described is a secondary consequence 
resulting from mislocalization of several vacuolar proteinases, which do not activate 
intracellular CPY. 10 complementation groups are identical to subsequently identified 
vps complementation groups (Raymond et al., 1982). So far unaccounted for are pepl, 
pep2, pep9, pepll, pepl3 and pepl6, all of which have a vps mutant phenotype and 
complement the vps mutant collection (Raymond et al., 1992). Apart from a vps 
phenotype some pep-mutants are defective in other aspects of vacuolar biogenesis (see 
above). 
4.1.15. Endocytosis Mutants 
Two mutants, endl and end2, allegedly defective in endocytosis of lucifer yellow 
have been isolated (Chvatchko et al., 1986). An initial characterization demonstrated 
that endl was defective for the internalization of a-factor, suggesting a defect in 
receptor mediated endocytosis also, endl appeared to accumulate invaginations of the 
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plasma membrane and did not have any apparent visible vacuole, while end2 
accumulated an internal membrane bound organelle. Complementation analysis 
(Robinson et al., 1988) and the subsequent finding that the endl mutant is able to 
endocytose a-factor but is unable to degrade it, demonstrated that endl is not a 
endocytosis mutant but identical to vpsll (Dulic and Riezman, 1989). The lack of a-
factor degradation has been attributed to the lack of the vacuole which plays a 
prominent role in the degradation of a-factor in wild type cells (Riezman, 1985). The 
endl allele of VPSll has all other pleiotropic defects associated with the lack of an 
intact vacuole as described above (Dulic and Riezman, 1989; Dulic and Riezman, 
1990). It is defective in gluconeogenesis as well as in aspects of the pheromone 
response. end2 is also defective for a-factor degradation, but not endocytosis (Riezman 
et al., 1986). The defect is not a result of a vacuolar biogenesis defect as in endl, but 
rather a defect of fusion of intermediate vacuolar compartments (endosome) with the 
vacuole. The morphologically aberrant organelle accumulating in end2 cells could 
represent this organelle (Riezman et al., 1986). The subsequent isolation of novel 
endocytosis mutants has been undertaken but has not been published (Riezman et al., 
1986). 
4.1.16. Acidification Defective Mutants 
A mutant, vphl-l, deficient in the acidification of the vacuole was isolated using 
the fluorescent vacuole specific marker 6-carboxyfluorescein diacetate as an indicator 
of vacuolar pH (Preston et al., 1989). The vacuolar pH in the mutant is 6.91 as opposed 
to a pH of 6.17 in wild type cells when determined by pH/fluorescence flow cytometry. 
The mutant has no effect on vegetative growth. 
4.1.17. Calcium Sensitive Mutants 
Mutants in 18 complementation groups sensitive to 100 mM Ca2+ in the growth 
medium were isolated and characterized (Ohya et al., 1986). Five complementation 
groups, cls7 to clsll, have a Per phenotype additionally to their lesions in intracellular 
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calcium homeostasis (Ohya et al., 1991). Genetic and biochemical studies were able to 
demonstrate that their phenotype is related to defects in the vacuolar membrane H"*"-
ATPase, and these mutants are defective in their ATP-dependent Ca^^-uptake. 
Complementation analysis showed that CLS7 is identical to VMA3, the structural gene 
for subunit c (16 kDa) of the vacuolar ATPase, CLS8 to VMAl, the structural gene for 
subunit a (70 kDa), CLS9 to VMAll (17 kDa subunit), CLSIO to VMA12, and CLSll to 
VMA13. Other els mutants are identical with other vacuolar biogenesis mutants. clsl3 is 
allelic to vaml, vpsll, pep5 and endl. els 14 is allelic to slpl, vam5, vps33 and pepl4. 
clsl7 is allelic to mutations in vam9 and vpsl6, and clsl8 is allelic to vam8, vpsl8 and 
pep3. Apart from CLS4, allelic to CDC24, the other CLS gene products have not been 
assigned a function yet, and it is possible that they are also defective in a vacuolar 
function. The mutational analysis of sensitivity towards Ca^ "*" has proven the vacuolar 
participation in calcium homeostasis, and also demonstrated that several vacuolar 
functions are not separable. The fact that vacuolar ATPase mutants have a Pet"-
phenotype (Ohya et al., 1991) is interesting because the phenotype indicates that the 
mutants are unable to carry out gluconeogenesis. Judging from this finding acidification 
or another vacuolar membrane ATPase function might be required to carry out or 
regulate gluconeogenesis, possibly through an effect on Pho8p function (see above). 
4.1.18. Amino Acid Storage Mutants 
Of the 10 amino acids sequestered by the vacuole, lysine is taken up by only one 
specific transport system which is specific for it and arginine. This and the finding that 
the cytoplasmic lysine concentration is always maintained below 10 mM by uptake into 
the vacuole, led to the isolation of mutants which could not sequester lysine into the 
vacuole (Kitamoto et al., 1988b). One mutant, slpl, does not grow well in medium 
supplemented with 10 mM lysine and has other pleiotropic defects of vacuole function 
such as sensitivity to Ca2+ and histidine, small vacuolar pools for amino acids, a class C 
vacuolar phenotype and reduced enzymatic activities for PrA, PrB and CPY. 
Subsequent studies were able to demonstrate that SLPl and VPS33 are identical genetic 
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loci (Robinson et al., 1988; Wada et al., 1990). The fact that only one sip mutant was 
isolated does not indicate that it is the only mutant with a small lysine pool, because 
other class C vacuolar mutans share this phenotype (Klionsky et al., 1990). 
4.1.19. Vacuolar Morphology Mutants 
An initial report (Wada et al., 1988) describes the isolation of mutants with 
morphologically altered vacuoles in two principal approaches. The first approach relies 
on treating mutagenized cells with chloroquine, an acidophilic reagent, which is 
accumulated in the vacuole and causes cell death. Other candidates were selected on the 
basis that the red fluorophore in adel mutants is accumulated in an intact vacuole, but 
not in adel strains lacking a vacuole. The mutants fall into 9 complementation groups, 
vaml to vam9 (vacuolar /norphology). vaml, vam2, vam5, vam6, vam8 and vam9 are 
identical to vpsll, vps41, vps33, vps42, vps 18 and vpsl6, respectively (Raymond et al., 
1992). vam3, vam4 and vam7 are so far unaccounted for and may represent mutants in 
three novel vacuolar morphology genes. Their phenotypic analysis has not yet been 
reported. 
4.1.20. Vacuolar Segregation Mutants 
Initial studies addressing the inheritance of a vacuolar compartment from mother 
cell to daughter bud were rather controversial, because they suggested that die vacuole 
disintegrates before being inherited (Wiemken et al., 1970). Recent studies showed that 
the vacuole in the mother cells remains intact during budding and that each daughter 
bud receives some maternal material shortly after bud emergence (Weisman et al, 
1987). The vacuolar segregation structure has the shape of a tubule or stream of larger 
vesicles which derive from the large vacuole in the mother cell and are transported to 
the bud site (Gomes de Mesquita et al., 1991; T. Vida, personal communication; C.K. 
Raymond, unpublished results). Different strains of yeast have different segregation 
features (Gomes de Mesquita et al., 1991). Mutants defective in vacuolar segregation 
have been isolated by screening vp^-like mutants for mutants exhibiting temperature 
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sensitive growth and showing no vacuolar segregation (Weisman et al., 1990). The 
isolation of segregation mutants was based on the assumption that segregation deficient 
cells would secrete vacuolar precursors and also be temperature sensitive because the 
vacuole has been shown to be required for growth at elevated temperature (Banta et al., 
1988). Four mutants, vac7-l to vac4-l have beens characterized, vacl-l is identical to 
vpsl9 and pep7, vac3-l to vps36 and vac4-\ to vp^75 (L Howald-Stevenson and T.H. 
Stevens, unpublished results). Only the vflc2-l mutant appears to be unique, and 
although isolated on the basis of a vp^-like phenotype, it does not secrete vacuolar 
proteinases but matured all CPY intracellularly with wild type kinetics, suggesting that 
vacuolar segregation and missorting are two unrelated processes (Shaw and Wickner, 
1991). The vacuolar segregation defect is temperature sensitive, and the vacuole fails to 
segregate at 37°C. The VAC2 gene is thought to encode a component of the segregation 
apparatus (Raymond et al., 1992; Shaw and Wickner, 1991). The vac]-\ mutant is not 
deficient in nuclear division nor mitochondrial segregation, yet it is defective for 
vacuole segregation at both the permissive and restrictive temperature (Weisman et al., 
1990). Daughter buds eventually aquire a vacuole, presumably by de novo biogenesis 
from Golgi derived vesicles. The temperature sensitive phenotype has been attributed to 
the fact that a vacuolar structure but not the VACl gene product is necessary for growth 
at elevated temperature. Like most other vp^-mutants, the vacl-l mutant is deficient for 
growth on medium containing glycerol as a sole carbon source. 
4.1.21. Vacuole Biogenesis Genes 
To date a large number of mutantions defective in some aspect of vacuole 
biogenesis and defining some 60 to 70 complementation groups have been isolated (see 
above). Most of the mutants are defective in the localization of vacuolar proteins - the 
vp5 phenotype. This stresses the importance of correct protein sorting in vacuole 
biogenesis that is defined by 52 gene products. This, however, makes it difficult to look 
for mutants defctive in vacuolar function other than vacuolar protein sorting. The only 
exception so far has been vac2-l, which is a mutation in vacuole segregation and which 
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does not exhibit a vp5-phenotype (Shaw and Wickner, 1991). A defect in one gene in 
vacuole biogenesis often has a pleiotropic effect (Klionsky et al., 1990; Raymond et al., 
1992). This is due to the interdependence of a number of vacuolar functions. A good 
example is the vacuolar ATPase. A deletion mutant in VMA3, the 16 kDa subunit in the 
vacuolar ATPase, is primarily defective in the failure to assemble other ATPase 
subunits on the vacuolar membrane, which results in the lack of acidification of the 
vacuolar network (Anraku et al., 1989; Klionsky et al., 1990; Nelson and Nelson, 1990; 
Ohya et al., 1991; Raymond et al., 1992; Umemoto et al., 1990). The acidification 
deficiency has a number of physiological consequences, for example vacuolar Ca^ "*" 
homeostasis is affected which results in the mutant becoming sensitive to elevated 
concentrations of Ca^^ in the growth medium (Ohya et al., 1991). The same defect 
results in a perturbation of gluconeogenesis, which is probably regulated in the vacuole 
(Ohya et al., 1991; Plankert et al., 1991). A lack in vacuole acidification also results in 
the missorting of vacuolar proteins (Klionsky et al., 1992; Rothman et al., 1990). These 
considerations demonstrate the difficulty in unambiguously identifying the role certain 
genes play in vacuole biogenesis, and caution has to be applied when interpeting the 
following information regarding vacuole biogenesis and the hypothetical involvement 
of genes in its function. 
So far 13 VPS and related genes have been cloned and the sequence of 10 have 
been determined. With one exception, the genes encode gene products with unknown 
function and no homolygy to previously isolated gene products (Raymond et al., 1992). 
VPSl has been cloned based on complementation of its temperature sensitive phenotype 
and sequenced. It is identical SP015, an essential gene for meiotic cell division in 5. 
cerevisiae (Rothman et al., 1990; Yeh et al, 1991). It encodes a 704 amino acid 
hydrophilic protein with a predicted molecular weight of 79 kDa, which has been 
confirmed by immunoblot analysis. The protein has a GTP binding consensus and 
preliminary biochemical data suggest that it binds GTP (C.K. Raymond, unpublished 
data). It belongs to the Mx family of proteins and has significant homology (45% 
identity) to the microtubule bundling protein dynamin (Yeh et al., 1991). A deletion 
mutant is viable but unable to grow at an elevated temperature of 37°C. It almost 
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quantitatively secretes newly synthesized CPY and accumulates aberrant structures as 
detectable by electron microscopy. Vpslp has been localized to the Golgi and seems to 
perform an essential function in sorting of vacuolar proteins. Whether or not it 
participates in a microtubule based motor process remains unclear (Scaife and Margolis, 
1990). The Drosophila Shibire gene encodes the homologue of dynamin and functions 
in endocytosis (van der Bliek and Meyerowitz, 1991). So far unknown is whether the 
sporulation deficient phenotype of a vpsl-spolS mutant is a consequence of a disturbed 
nuclear division during meiosis (Yeh et al., 1991) or a consequence of the severe vps 
phenotype (Raymond et al., 1992). pep4 mutants as well as other vps mutants are 
sporulation deficient and one possible explanation is that the spo phenotype is a 
consequence of the lack of active vacuolar proteinases required for the sporulation 
response (Raymond et al., 1992; Zubenko et al., 1983). A structural dissection of Vpslp 
suggests that the N-terminal GTP-binding motif is required for biological function 
involving GTP-hydrolysis and the C-terminal domain functions in membrane 
attachment and is also required for biological function (Raymond et al., 1992). Its role 
in vacuole morphogenesis is not known. 
Mutations in VPS3 are deficient in the sorting of soluble vacuolar proteins and the 
acidification of the vacuole (Rothman and Stevens, 1986; Rothman et al., 1989). The 
VPS3 gene has been cloned from a yeast genomic library selecting for transformants 
that had a VPS phenotype, using N-CBZ-L-Phe-F3-Leu as growth inhibitor for the pep4 
vps3 strain (Raymond et al., 1990). It has been shown to encode a low abundance, 
hydrophilic protein of 117 kDa from an open reading frame of 1011 amino acids. It 
appears to be localized in the cytoplasm althogh its sedimentation behaviour suggests 
that part of it is associated with a sedimentable subcellular structure not identical to the 
yeast vacuole. Vps3p migrates as a 140 kDa protein on SDS PAGE suggesting 
posttranslational modifications. A loss of Vps3p function is accompanied by a 
missorting of CPY, a vacuolar acidification defect different fom that conferred by 
mutations in the vacuolar ATPase, and a vacuolar segregation defect. Studies with a ts 
conditional mutant strongly suggest that its primary defect is the sorting of vacuolar 
proteins. 100-fold overexpression of the protein in yeast resulted in a vps defect, and it 
169 
induced a class B-like vacuolar phenotype (Raymond et al., 1992). Its mode of action is 
not known. 
VPSll has been cloned by complementation of the ts phenotype of a conditional 
endl mutation (Dulic and Riezman, 1989) and a pep5 mutation (Woolford et al., 1990). 
Sequence analysis of the ENDl gene predicted an open reading frame capable of 
encoding a 1030 amino acid protein with a predicted molecular mass of 118 kDa which 
is in good agreement with the 120 kDa protein species detected by immunoprecipitation 
with anti-EndIp antibody. The protein product has no overall homology with other 
proteins but has a short consensus typical for ATP-binding proteins. A deletion mutant 
did not exhibit any other phenotypes not observed with endl alleles, was defective in 
protein sorting, gluconeogenesis, a-factor degradation and vacuole biogenesis in that it 
had a class C vacuolar morphology. Endlp seems to fractionate with vacuolar 
membranes in wild type cells, but its biological function is unknown. 
VPSl 5 has been cloned by complementation of its ts growth defect (Herman et 
al., 1991b). The complementing clone rescues all associated defects, including the class 
C vacuolar morphology of the mutant, and it encodes a protein of 1455 amino acids 
with a predicted molecular weight of 166 kDa. The protein's 300 N-terminal amino 
acids have a significant sequence similarity with the catalytic domain of 
serine/threonine protein kinases, it also has a consensus for attachment of myristic acid 
at its N-terminus. Subsequent experiments could demonstrate that it is cytoplasmic and 
myristoylated, verifying the assumption based on protein structure predictions. Vpsl5p 
fractionates together with Kex2p, a late Golgi enzyme, suggesting that it is located on 
the cytoplasmic site of the Golgi apparatus. Site directed mutagenesis of the kinase 
consensus resulted in an inactive gene product that was unable to function in protein 
sorting, osmoregulation or growth at high temperature. The same studies presented 
evidence that Vpsl5p is autophosphorylated. It also seems to partcipate in the 
phosphorylation reaction of Vps34p, another protein participating in vacuolar protein 
sorting (Herman and Emr, 1990; Herman et al., 1991a). Phosphorylation of Vpsl5p C-
terminus appears to be critical for function in sorting at elevated temperature. C-
terminal deletions of the protein result in a temperature dependent switch between 
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accumulation of soluble vacuolar precursors in a saturable intermediate compartment 
and delivery of the precursors to the vacuole. The point mutation, as well as the deletion 
mutation does not affect the sorting of vacuolar membrane proteins. The p2CPY 
accumulating compartment has not been identified, but it might represent an 
intermediate pre-vacuolar compartment. A morphological analysis of vpsl5 revealed 
that it is vacuolar class D, indicative for a defect in vacuolar ATPase assembly 
(Raymond et al., 1992). The acidification behaviour of the Vpsl5p C-terminal deletion 
mutant has not been examined. 
VPS18 has been cloned by complementation of the ts growth defect of a vpsl8 
mutant allele (Robinson et al., 1991) and its CPY deficiency in a pep3-l2 strain 
(Preston et al., 1991). The VPS18 gene encodes a 918 amino acid hydrophilic protein 
which is associated with the vacuolar membrane in wild type cells (Preston et al., 
1991). Unfortunately the subcellular fractionation methods does not exclude the 
possibility that another compartment of similar density cofractionated with the 
vacuoles. VpslSp has a cysteine-rich motif near the carboxy terminus which resembels 
the zinc-finger motif observed with Vpsl lp and that of a number of other proteins 
including the post-synaptic protein of rat, the adenovirus E l A protein and Gal4p 
(Robinson et al., 1991). A deletion of the VPS18 open reading frame results in the same 
pleiotropic vacuole related phenotypes observed in the vpsl 8 mutants. In vitro 
mutagenesis of the cysteine rich motif at the C-terminus led to a temperature-
conditional CPY sorting defect but not to a change in vacuolar morphology. The fact 
that the mutants have a defect in Kex2p dependent a-factor processing, but secrete a-
1,3 mannose modified pro-a-factor together with unglycosylated mature a-factor 
strongly suggests that in the vpsl8 mutant the most distal Kex2p containing Golgi 
compartment is affected by the mutation (Robinson etal., 1991). This compartment has 
previously been suggested to participate in protein sorting of vacuolar proteins away 
from secretory proteins. The fact that Vpsl8p is associated with vacuolar membranes 
does not exclude the possibility that the protein performs an important pre-vacuolar 
function. Vpsl lp and VpslSp have a conserved zinc-finger motif similar to that found 
in the 43 kDa protein of rat synaptic nerve termini and may be involved in maintaining 
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the integrity of the trans Golgi compartment (Raymond et al., 1992). The fact that both 
vpsll and vpsl8 strains have no vacuole might be a consequence of a block in Golgi to 
vacuole membrane flow. 
VPS 19 has been cloned as VACl by complementation of its temperature sensitive 
phenotype on medium containing glycerol as sole carbon source (Weisman and 
Wickner, 1992). The structural gene encodes a 515 amino acid protein with no known 
homologues but with three separate zink-finger motifs also found in Vpsllp and 
Vpsl8p. The protein is not essential, although a deletion mutation confers the same 
vacuolar segregation effect as was observed in the vacl-l allele (Weisman et al., 1990). 
The subcellular localization as well as the in vivo function of Vpsl9p are not known. 
Preliminary data suggest that Vpsl9p plays a direct role in vacuolar segregation since in 
vitro reconstitution of vacuolar segregation depends on functional Vpsl9p and Vac2p, 
possibly in concert with the cytoskeleton (T. Vida, open citation). 
VPS33 encodes a 691 amino acid protein. It has been cloned by complementation 
of its temperature sensitive phenotype in a vps33 mutant (Banta et al., 1990) and of the 
histidine hypersensitive phenotype in a slpl-\ strain (Wada et al., 1990). The gene 
encodes a 79 kDa hydrophilic protein with no significant homology to previously 
isolated proteins but with two ATP-binding consensus sequences typically found in 
ATPases. A disruption of the VPS33 (SLPl) locus was not lethal but resulted in the 
same aberrant phenotypes as the previously isolated slpl-l/vps33 mutants. Intracellular 
vacuolar proteins which are not secreted initially accumulate as Golgi modified 
precursors, although the majority are secreted. One vp,s-mutant had a missense mutation 
near the consensus for ATP binding which resulted in a temperature conditional 
phenotype that allowed a vacuole formation at the permissive temperature but lacked 
vacuoles at the restrictive temperature (Banta et al., 1990). The protein is a relatively 
rare protein and behaves as a freely soluble cytoplasmic protein in fractionation studies. 
It has been demonstrated that the ATP-binding of Vps33p is functionally significant, 
and suggests that the protein is involved in protein traffic from the Golgi to the vacuole. 
It is phosphorylated, but nothing is known about its function in vivo. 
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VPS34 has been cloned by complementation of a vp^ i i temperature sensitive 
growth defect, using a yeast genomic DNA library, and its sequence determined 
(Herman and Emr, 1990). It encodes a 875 amino acid protein with a predicted 
molecular mass of 95 kDa lacking any obvious signal sequence. A disruption of the 
VPS34 gene resulted in a temperature sensitive growth phenotype, a vacuole 
segregation and a severe sorting defect but morphologically normal vacuoles. The 
protein is a rare protein that in vivo associates with a particulate fraction, which can be 
solubilized with 2 M urea but not with Triton X-100, indicative that the interaction of 
Vps34p with the pelletable structure occurs by protein-protein interaction. Vps34p 
might act as a component of a large intracellular structure involved in specific steps of 
vacuolar protein delivery and vacuolar inheritance. The protein seems to be 
phosphorylated by Vpsl5p and in vitro experiments suggest that the two proteins 
associate with each other. The biological function of Vps34p and the role of its 
interaction with Vpsl5p is not known (Herman et al., 1991a). 
The product of VPS35 has been analysed in detail (Paravicini et al., 1992). The 
wild type VPS35 gene has been isolated by complementation of its vacuolar sorting 
defects. Its nucleotide sequence has been determined and shown to encode a 937 amino 
acid protein without any hydrophobic domains or homologies to other proteins. The 
majority of the protein is associated with a large multiprotein complex. Its association 
with the complex is saturable in that Vps35p remains cytoplasmic when overproduced. 
A gene disruption of the VPS35 locus is not lethal nor confers a temperature sensitive 
phenotype. The null mutant quantitatively secretes p2CPY but not PrA or PrB and ALP. 
The differential defect in protein sorting in the mutant is so extreme that all CPY is 
secreted while the other soluble and insoluble proteins are efficientiy located to the 
vacuole and proteolytically processed. This study provides the first concrete evidence 
that different pathways for vacuolar protein sorting exist in 5. cerevisiae. The Vps35p 
protein product is not a trans-membrane protein but remains associated with the 
cytoplasmic site of a multiprotein complex probably not associated with a 
membraneous compartment and thus is unlikely to be a specific sorting receptor for 
CPY. The precise nature of these findings cannot be explained, but there seem to be 
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several alternatives to account for this phenomenon. The most likely explanation 
suggests that different vacuolar proteins might utilize the same transport system to 
mediate their Golgi to vacuole delivery but utilize different sorting receptors for their 
selective packaging into a common carrier. Vps35p might function in the specific 
packaging or modification of the CPY-specific receptor complex (Paravicini et al, 
1992). 
The nature of other VPS genes is as yet unknown, and it seems to be too 
premature to speculate about the mechanism of vacuole biogenesis fi"om the available 
information. Some general trends have become obvious: the Golgi apparatus plays a 
major role in proper vacuole biogenesis, and most if not all mutants not developing a 
vacuole (class C) seem to have a Golgi associated defect. Several intriguing possibilities 
seem likely: the class C vacuolar morphology mutants isolated so far do not have a 
vacuole, and an analysis of a temperature conditional vacuole mutation in VPS33 
showed that the gene product is not required for the maintenance of the vacuole but 
rather in the formation of a new vacuolar compartment. In addition other class C 
phenotype conferring mutations are in gene products located in the cytoplasm or 
between the Golgi aparatus and the vacuole. Thus it is likely that the four class C genes 
identified so far function in sorting or vesicle budding from the trans Golgi 
compartment. Other VPS gene products are either cytoplasmic or associated in 
multiprotein complexes. This argues that the most important steps of vacuolar protein 
sorting involves a sophisticated machinery located in the cytoplasm or on the 
cytoplasmic site of membranes. There is sufficient evidence to suggest that there are 
differential sorting pathways. One intriguing question remains: in vpsl8 the trans-Golgi 
is impeded in its normal function and yet vacuolar membrane proteins are faithfully 
retained in the cell although in an inactive form. There are two possibilities: vacuolar 
membrane proteins are sorted to the vacuole by a default mechanism independent of 
vesicular transport of soluble proteins to the vacuole, or the proteins are located to the 
plasma membrane and endocytosed immediately in the mutant and accumulated in 
endocytotic vesicles. 
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The nature of the gene products corresponding to the most severe vacuolar 
biogenesis mutants has revealed that the primary defect of the mutants is in the almost 
quantitative mislocalization of vacuolar proteins and thus the defects associated with 
some mutants are of a secondary nature. For example in case of Slplp which initially 
was thought to function in regulating lysine uptake or metabolism (Kitamoto et a/., 
1988a, 1988b) it now seems unlikely that this is the proteins primary defect (Banta et 
al, 1990). The question arises whether the hypothesized lack of a particular vacuolar 
function will result in pleiotropic defects, or whether a failure to sort many gene 
products will also result in a pleiotropic defect. The latter seems to be the more likely 
hypothesis. This suggests that for future studies in isolating particular vacuolar mutants 
a double selection procedure has to be developed excluding vps-\\ke. mutants in the 
collection, although caution has to be applied because some acidification related 
mechanisms might have mislocalization as a consequence. 
4.1.22. The Isolation and Characterization of Salt-Sensitive Vacuolar Mutants 
Several approaches have concentrated on the elucidation of vacuolar structure and 
function, including the generation of mutants in different aspects of vacuolar function. 
Some advancement has so far been reported in understanding the pathway soluble 
vacuolar proteins take. The proposed sorting mechanism for these proteins led to the 
isolation and characterization of vacuolar protein sorting mutants. Approximately sixty 
genes participating in the sorting of soluble vacuolar proteins have been identified, and 
gene products corresponding to eight VPS genes have been analysed. It appears that all 
the genes identified so far act in the cytoplasm or associated with some subcellular 
compartments. Approaches to identify other vacuolar functions by a reverse genetic 
approach have been described (Klionsky et ah, 1990; Raymond et ai, 1992). However, 
most other genes hypothesized to function in vacuole biogenesis are identical to VPS 
genes, or the mutants have a severe VPS phenotype. Considering the fact that vacuolar 
protein sorting plays a prominent role in supplying the vacuole with its proteinaceous 
constituents it is not surprizing that mutants that mislocalize vacuolar proteins have 
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other associated phenotypes. One possible explanation is that other vacuolar mutants 
which have been isolated on the basis of other phenotypes, as for example their 
sensitivity to lysine due to the lacking storage function, are identical to vps mutants 
because their primary defect is in sorting which has other consequences. Due to the 
large number of genes involved in enabling protein sorting to the vacuole it is more 
likely to identify genes participating in sorting rather than isolating a gene involved in 
one particular aspect of vacuole biogenesis, because the sorting defect induced similar 
secondary defects. These considerations led to the experimental approach described in 
this study to identify novel mutants in one particular aspect of vacuole biogenesis: the 
proposed role of the vacuole in osmoregulation. 
Some of the vps mutants isolated do not have a vacuole, or have a large number of 
small, disrupted vacuoles (Banta et al., 1988). Alleles in four complementation groups 
(vpsll, vpsl6, vps 18 and vps33) lack any recognizable vacuolar structure, secrete 
soluble vacuolar proteins and are sensitive to a high osmotic strength in the growth 
medium (e.g. 1.5 M NaCl) and elevated temperature. Four other osmosensitive vps 
mutants have either disrupted vacuoles (vpsl), or possess aberrant organelles (ypslS, 
vps34, vps40). All other vp -^mutants in a PEP4 background are tolerant to high 
concentration of osmotically active compounds. These observations indicate that normal 
vacuolar function might be required for osmoregulation in S. cerevisiae, and further that 
most mutants deficint in sorting maintain osmoregulation, except for those that have 
severe vacuolar morphology defects. 
To study the process of vacuole formation and to collect further evidence for the 
involvement of the vacuole in osmohomeostasis, an approach was designed to isolate 
and identify further genes involved in osmoregulation as well as in vacuolar function 
and biogenesis. All vps mutants were selected on the basis of mislocalization of 
carboxypeptidase Y (Rothman and Stevens, 1986) or a CPY-Invertase fusion system 
(Bankaitis et al., 1986). Only eight out of 47 complementation groups had alleles with 
aberrant vacuoles, five of these also had osmosensitive alleles. It was expected that 
among mutants selected directiy for osmosensitivity would be novel mutations with 
aberrant vacuolar function and structure, but not necessarily witii a vps phenotype. It 
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appears to be a general feature of the vacuole to carry out many overlapping functions 
(Klionsky et al., 1990), and a mutant allele of a gene directly or indirectly connected 
with one aspect of vacuole sorting or biosynthesis might lead to the expression of other, 
related mutant phenotypes. Alternatively, osmosensitivity has been reported in 
cytoskeletal mutants (Novick and Botstein, 1985), plasma membrane ATPase mutants 
(McCuscer et al., 1987), and perhaps associated with nonsense-suppressors (Singh, 
1977), or they might be unable to grow under osmotic stress because they fail to 
accumulate intracellular glycerol (Blomberg and Adler, 1989). However, most 
osmosensitive mutants isolated so far in S. cerevisiae have not been examined for 
vacuolar morphology and the secretion of vacuolar proteins, and may have some 
defective vacuolar function. In addition, initial studies addressing the phenomenon of 
aquired osmoresistance in yeast suggest that the accumulation of glycerol is one of 
many mechanisms that control osmohomeostasis in S. cerevisiae, and efficient 
osmoregulation depends on protein synthesis and not solely to synthesis of glycerol 
(Blomberg and Adler, 1989). Considering the fact that not every osmosensitive 
mutation will have a vacuolar defect, it was decided to isolate osmosensitive mutants 
and screen the mutants for vacuole associated defects, such as vacuolar morphology. 
Mutants that were strictly osmosensitive and also had one or several vacuolar 
biogenesis defects associated with it were termed salt-sensitive vacuolar (ssv) mutants, 
whose isolation and characterization is described in the following part. 
5. cerevisiae was mutagenized and 97 mutants were obtained which were unable 
to tolerate high osmotic stress. They were tested for complementation against each other 
and previously isolated vacuolar mutants to determine the number of putative genes 
associated with this phenotype. Subsequent examination of vacuolar morphology and 
vacuolar protein sorting established that most osmosensitive mutants defined new 
complementation groups and were defective in several aspects of vacuole biogenesis, 
including vacuolar morphology and the sorting of vacuolar proteins. 
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4.2. Results 
4.2.1. Mutagenesis of SEY6210 and SEY6211 
The wild type strains SEY6210 and SEY6211 were mutagenized by either E.M.S. 
induced mutagenesis at a predicted rate of 50% survival (Fink, 1970) or U.V. 
mutagenesis at 20% survival. Since the efficiency of U.V. mutagenesis depends very 
much on the type and age of the light source and the conditions under which the 
mutagenesis is performed, a dose response curve was constructed as described in 
Materials and Methods (Figure 4.1). From the dose-response curve it was found that an 
exposure time of 210 seconds yielded 20% survivors, a value estimated to give an 
optimal ratio between single and double mutations. Mutagenesis was carried out by 
placing a 10 mL agitated yeast cell suspension in a 9 cm petri-dish underneath a UV 
source (254 nm) at a distance of 10 cm from the light source and samples were taken at 
set intervals (see Materials and Methods). The survival rate was calculated by dividing 
viable cell counts of the mutagenized culture by the original viable cell count before 
mutagenesis times 100%. 
Analysis of each mutagenized culture showed that the average percentage of 
survivors after mutagenesis was 13.0% for E.M.S., and 13.4% for U.V. mutagenesis 
(Table 4.2). The variation between different subcultures of the wild type subjected to 
the same mutagenesis conditions was quite large. Since different numbers of cells were 
screened for osmosensitive mutants, a direct comparison of the rate of killmg and the 
number of osmosensitive mutants was not possible. A rough estimate of the number of 
mutants obtained for each 100 isolated colonies after mutagenesis varied drastically and 
any obvious relationship describing the mutagenesis efficiency related to dose or 
mutagen was not detectable. 
A total of 339 putative salt sensitive mutants from 13 independent mutagenised 
cultures were isolated by negative selection of replicas on 1.5 M NaCl-containing YPD 
medium. Mutagenized colonies grown on YPD agar plates at 30°C for 48 hours were 
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replica-plated onto YPD medium supplemented with 1.5 M NaCl. The selective plates 
were incubated at 30°C for 7 days, and the original master plates were kept at 4°C. Out 
of 4002 colonies (1503 EMS; 2499 UV), 339 (154 EMS; 185 UV) colonies did not 
grow under the selective conditions as compared to the original master plate. All 339 
colonies on the master plate, which were unable to grow on the replica were picked and 
purified on YPD. After 48 hours incubation at 30oC, single colonies were taken and 
streaked onto YPD and YPD supplemented with 1.5 M NaCl. Among 339 mutant 
clones, a total of 97 mutants (54 EMS; 43 UV) were truly salt sensitive, i.e. they were 
unable to grow on YPDA + 1.5 M NaCl after 7 days incubation at 30°C and did not 
show any colony growth under surface microscopic examination. Overall, 3.25% 
(;tf5„=2.7) of all clones recovered after mutagenesis had a truely salt-sensitive 
phenotype, with no significant differences between the two mutagens used. It was 
observed that the growth of an even larger proportion of the mutants was affected by the 
salt concentration used. About 7% of all mutagenized colonies did not show growth on 
YPD + 1.5 M NaCl until 5 days compared to 3 to 4 days of tiie wild type, and showed 
some growth after 6 to 7 days, or they were able to grow more slowly than the wild type 
as judged by colony size. Any mutant that was able to grow to some degree was not 
chosen for further study. Although this selection might introduce some bias into the 
mutational analysis of vacuole biogenesis, it is expected to simplify the cloning of the 
corresponding genes by complementation, since selection for complementation is less 
troublesome with strains that are totally sensitive to selective conditions, than those that 
are able to grow to some degree, even under stringent selective conditions. 
Additionally, all seven osmosensitive vps mutants isolated to date were absolutely 
inhibited by concentrations above 1.2 M NaCl (Banta et ah, 1988; M. Latterich, results 
not shown). All 97 mutants were assigned sti-ain numbers, reflecting the mutagenesis 
event and the allele number of the original isolate. Derivatives from culture 1 were 
MLYOlOl, MLY0103, MLY0104, MLY0106, MLY0107, MLY0108, MLY0109, 
MLYOll l , MLY0113, MLY0115, MLY0116, MLY0117, MLY0120, MLY0121, 
MLY0124, MLY0125, MLY0126, MLY0127, MLY0134, MLY0139, MLY0144, from 
culture 2 MLY0202, MLY0209, from culture 3 MLY0304, MLY0307, MLY0309, 
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MLY0310, from culture 4 MLY0402, MLY0416, MLY0419, MLY0420, from culture 5 
MLY0506, MLY0508, MLY0512, MLY0513, MLY0522, MLY0524, MLY0526, 
MLY0527, from culture 6 MLY0601, from culture 7 MLY0701, MLY0702. MLY0704, 
MLY0705, MLY0706, MLY0709, MLY0712, MLY0713, MLY0716, MLY0725, 
MLY0728, MLY0729, MLY0731, MLY0732, culture 8 MLY0803, MLY0805, 
MLY0806, MLY0808, MLY0810, MLY0811, MLY0812, MLY0813, MLY0815, 
MLY0816, culture 9 MLY0902, MLY0905, MLY0908, MLY0911, MLY0913, culture 
10 MLYlOOl, MLY1002, MLY1005, MLY1006, culture 11 MLY1105, MLY1124, 
MLY1129, MLY1138, MLY1141, MLY1143, MLY1153, MLY1156, MLY1161, 
MLY1162, MLY1164, MLY1172, MLY1176, culture 12 MLY1203, MLY1214, 
MLY1218, MLY1219, MLY1232, MLY1233, and culhire 13 were MLY1309, 
MLY1311, MLY1315, MLY1330 amd MLY1332. Strains MLY0527, MLY0304 and 
MLY0309 were not pure clones as judged by different colony appearence. Subclones 
derived from the mixed cultures were designated MLY0527A, MLY0527B, 
MLY0304A, MLY0304B, MLY0309A and MLY0309B. All subclones were 
osmosensitive. 
4.2.2. Complementation Analysis 
A genetic complementation test was employed to evaluate the number of genes 
involved in conferring osmoresistance to the wild type yeast cell that were identified 
before. Generally, if two recessive mutations in a diploid cell complement by restoring 
the wild type phenotype they affect different genes. A failure to complement indicates 
that two mutations are in the same gene or, one of the mutation is in a regulatory 
element of the other gene, or lastly one of the mutations yields an inhibitory gene 
product. Two major complementation tests were carried out sequentially, the first being 
intended to obtain an estimate of how many complemementation groups were defmed 
by the mutants, and also to select out mutants with aberrant complementation 
behaviour, especially those mutants apparently members of several complementation 
groups. K any aberrant complementation pattern is genuine and caused by a single gene 
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mutation, it is potentially interesting in that it is possible to derive information about 
genetic interaction of gene products involved in osmoregulation. 
Selection for diploids between mutants of different mating type was carried out 
via complementing auxotrophic markers on yeast minimal medium only supplemented 
with common nutritional requirements. Diploid colonies were replica-plated onto YPD 
+ 1.5 M NaCl. Growth was recorded after 7 days incubation at 30°C, where 
complementing mutations showed growth under these conditions. The complementation 
test was carried out three times, and overall the complementation data were in good 
agreement with each other (Table 4.3). The second complementation tests were 
performed to examine complementation of mutants of the same mating type. All mutant 
stiains which were thought to be genuine single mutations as judged by tiieir 
complementation pattern were first crossed against the appropriate wild type, then salt 
sensitive spores of the opposite mating type were identified after screening random 
spore isolates for the desired phenotypes. After mating type analysis of at least 5 
randomly chosen adel salt-sensitive spore isolates members of opposite mating type 
were then subjected to complementation analysis (Table 4.4). Every salt sensitive allele 
of both mating types was crossed against all others in a drop-overlay complementation 
test. Since the method employed could not rely on the isolation of auxotrophy 
complementing diploids, log phase cultures of the salt sentive alleles were harvested, 
and each mutant was crossed against all other mutants in microtiter plates which were 
incubated at 30"^ C for 48 hours to allow mating to occur. 5 |xL aliquots of each mating 
mixture were plated out onto YPD medium supplemented with 1.5 M NaCl, and growth 
was recorded after 14 days. Diploids that failed to grow on the medium were said to 
either belong to the same complementation group or to be unable to form diploids. All 
mating mixtures that failed to grow were assessed for their ability to form ascospores 
under limiting nuttient conditions, and if no ascospores were observable under phase 
contrast microscopy the result was recorded as ND (no diploids). 
The complementation analysis allowed the assignment of the salt sensitive 
mutants to at least 23 different complementation groups (Table 4.5), which were 
assigned the complementation allele designation ssvl to ssv20 (for salt sensitive 
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vacuolar mutants, since each group had alleles deficient in at least one vacuolar 
function; see following sections), osm3 and osm4 (o^mosensitive growth). Members of 
osm3 and osm4 were only osmosensitive but had no other obvious vacuolar defects. The 
results of the initial complementation test (Table 4.3) were generally unambiguous, but 
a number of mutants were unclassifiable. Assuming that they were double mutants, they 
were not characterized further. 23 mutants showed only weak complementation with a 
large proportion of the other ssv mutants (semi-dominant phenotype). They were 
assigned an allele number j'^ v-lOO to 55'v-122. As these mutants are all phenotypically 
very similar and completely fail to complement each other, they might constitute 
different members of one further complementation group, ssvl7. Two mutants, both of 
the a-mating type, did not form diploids under any conditions. They were thought to be 
truly sterile and were designated wv-123 and wv-124. All remaining ssv mutants 
exhibited osmosensitive phenotypes which were recessive in heterozygous diploids. An 
auxotrophy marker analysis of all once back-crossed strains was carried out, and in 
general only back-crossed strains were used in future analysis to reduce the risk of their 
phenotype being the result of several mutations. Where the phenotypic marker differed 
from the original isolate a new strain designation was given (Table 4.6). Genetic tests 
on the validity of the first 17 complementation groups carried out by others (I. Howald-
Stevenson and T.H. Stevens, unpublished results) suggest that with the exception of 
ssvl-1, which is identical to vps33, and ssv9-\, which does not belong in the ssv9 
complementation group, the assignment into groups was largely correct, although 
allelism tests yet have to show the number of genes involved in conferring a ssv 
phenotype. 
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Culture % Survivors of Mutagenesis Total Colonies 1.5MNaCls Mutants 
E.M.S. U.V. Screened 1 St Screen 2nd Screen 
1 26.0% 651 45 21 
2 9.1% 99 11 2 
3 9.9% 165 16 4 
4 8.8% 158 20 4 
5 6.5% 104 27 8 
6 4.9% 88 2 1 
7 26.4% 238 33 14 
8 22.0% 100 16 10 
9 16.0% 311 13 5 
10 20.0% 270 6 4 
11 6.2% 501 76 13 
12 9.1% 732 38 6 
13 7.2% 585 36 5 
Average 13.0% 13.4% 
Table 4.2: Mutagenesis outcome of EMS and UV mutagenesis of parental strains 
SEY6210 and SEY6211. The mutagenized cultures 1, 8, 9 and 10 were derived 
from SEY6210, cultures 2, 3,4, 5, 6, 7,11,12 and 13 from SEY6211. A total of 
339 1.5 M NaCl sensitive mutants were obtained from 13 independent 
mutagenesis events (see text). 
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Figure 4.1: Dose-response curve of SEY6210 exposed to UV light as measure of time. 
A 10 mL suspension of 9.0 x 10^  cells/mL was irradiated under conditions as 
described in the text. 100 |J,L samples were removed at 15 second intervals, and 
the viable cell number was determined. 
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Table 4.3 
a-mutant SEY6211 MLY0202 MLY0209 MLY0304 MLY0307 MLY0309 MLY0310 MLY04 
a-mutant 
SEY6210 + ND + + + + + + 
MLYOlOl + ND + + + + + + 
MLY0103 + ND + ND + + + + 
MLY0104 + ND + /- + /- - + + + 
MLY0106 + ND - - - + + + 
MLY0107 + ND + + + + + + 
MLY0108 + ND + + /- - + + + 
MLY0109 + ND + + /- + /- + + + 
M L Y O l l l + ND + + + + + + 
MLY0113 + ND + + /- + /- + + + 
MLY0115 + ND + + /- + /- + + + 
MLY0116 + ND - + /- + + - + 
MLY0117 + ND + + + ND + + 
MLY0120 + ND + + /- + /- + + + 
MLY0121 + ND ND + + + + + 
MLY0124 + ND ND + + + + ND 
MLy0125 + ND + + /- - + /- + + 
MLY0126 + ND + + + + + + 
MLY0127 + ND + /- - + /- + + + 
MLY0134 + ND - + + + + + /-
MLY0139 + ND + + + + + + 
MLY0144 + ND + + /- - + + + 
MLY0145 ND ND ND - - ND + ND 
MLY0803 + ND + + + + + + 
MLY0805 + ND + + /- + + + + 
MLY0806 + ND + + + + + + 
MLY0808 + ND + + + + + + 
MLY0810 + ND • + + + + + + 
MLY0811 + ND + + + - - +/-
MLY0812 + ND + + + + + /- + 
MLY0813 + ND + + + + + +/-
MLY0815 + ND + + /- + + + + 
MLY0816 + ND + + + + + + 
MLY0902 + ND + + + + + + 
MLY0905 + ND + + + + + + 
MLY0908 + ND + + + + + + 
MLY0911 + ND + + + + /- + + 
MLY0913 + ND + + + + + + 
MLYlOOl + ND + + + + - + 
MLY1002 + ND + + + + - + 
MLY1005 + ND + + + + /- - + 
MLY1006 + ND + + + + + + 
vps 5 + ND ND + ND - + ND 
vpsll + ND ND + + + + + 
vpsl 6 + ND ND + ND ND ND + 
vpsl 7 + ND + + ND + + ND 
vps 18 + ND ND + ND + + + 
vps 3 3 + ND ND + ND + ND + 
B-4164 + ND ND + + + ND + 
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Table 4.3 - continued 
a-mutant MLY0416 MLY0419 MLY0420 MLY0508 MLY0512 MLY0513 MLY0522 MLY0524 
a-mutant 
SEY6210 + + + + + + + + 
MLYOlOl + + + + + + + + 
MLY0103 + + + + + + + + 
MLY0104 + + + + + + + + 
MLY0106 + + + + + + +/- + 
MLY0107 + + + + + + + +/-
MLY0108 + + + + /- + + + /- + 
MLY0109 + + + + + + - + 
M L Y O l l l + + - ND + + + + 
MLY0113 + + + + + + +/- + /-
MLY0115 + + + + + + +/- + 
MLY0116 - + + - + + +/- + 
MLY0117 ND ND ND ND ND ND + ND 
MLY0120 + + + + ND + /- + + 
MLY0121 + + + ND + + + + 
MLY0124 + + - ND + + + + 
MLY0125 + + + + + + + + 
MLY0126 + + + + + + + + 
MLY0127 + + + + + + +/- + 
MLY0134 + + + ND + + + + 
MLY0139 + + + + + + + + 
MLY0144 + + + + /- + + +/- + 
MLY0145 + - - ND + + - + 
MLY0803 + + /- + - + + + + 
MLY0805 + + /- + - + + + + 
MLY0806 + + /- + - + + + + 
MLY0808 + + + - + + + + 
MLY0810 + + /- + - + + + + 
MLY0811 - + /- - - + + + -
MLY0812 + /- + /- + - + + + +/-
MLY0813 + +/- + - + + + +/-
MLY0815 + /- + /- + - + + + +/-
MLY0816 + + /- + - + + + + 
MLY0902 + + /- + - + + + +/-
MLY0905 + + /- + - + + + + 
MLY0908 + + /- + - + + + + 
MLY0911 + + /- + - + + + + 
MLY0913 + + /- + - + + + + 
MLYlOOl + + /- + - + + + + 
MLY1002 +/- + /- + /- - + + + -
MLY1005 + + /- + /- - + + + + 
MLY1006 + + + + + + + + 
vps5 + + + + + + + + /-
vpsll + + + + + + + + 
vpsl 6 + ND + ND + + + + 
vpsl 7 + ND ND + + + + + 
vpsl 8 + ND + + + + + + 
vps33 + ND + + + + + + /-
B-4164 + ND + + + + + + 
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T a b l e 4.3 - continued 
a-mutant MLY0526 MLY0527A MLY0527B MLY0601 MLY0701 MLY0702 MLY0704 MLY0705 
a-mutant 
SEY6210 + + + + + + + + 
MLYOlOl + + + + + + + + 
MLY0103 + + + + + + + + 
MLy0104 + + + + /- + + + + 
MLY0106 + ND + + /- + + + + 
MLY0107 + + + + + + + + 
MLY0108 + + + + /- + + + + 
MLYOlOg + ND + + /- + + + + 
M L Y O l l l + ND ND + + + + + 
MLY0113 + + + /- + /- + + + + 
MLY0115 + + + + /- + + + + 
MLY0116 + + /- + + /- + + + + 
MLY0117 ND ND + + + - ND ND 
MLY0120 + ND ND + + + + + 
MLY0121 + ND ND + + + - + 
MLY0124 + ND ND + + + ND + 
MLY0125 + ND + /- + /- + + + + 
MLY0126 + ND + + + + + + 
MLY0127 + + + /- + /- + + + + 
MLY0134 + ND + + + + + + 
MLY0139 + + + + + + + + 
MLY0144 + + + + /- + + + + 
MLY0145 + ND ND + /- + + + + 
MLY0803 + + + - + + + + 
MLY0805 + + + - + + + + 
MLY0806 + + + - + + + + 
MLY0808 + + + - + + + + 
MLY0810 + + + - + + + + 
MLY0811 + + + - + - +/- + 
MLY0812 + + + - + + + + 
MLY0813 + + /- + + /- + + + + 
MLY0815 + + + - + + + + 
MLY0816 + + + - + + + + 
MLY0902 + + + - + + + + 
MLY0905 + + + - + + + + 
MLY0908 + + + - + + + + 
MLY0911 + + + - + + + + 
MLY0913 + + + - + + + + 
MLYlOOl + + + - + + + + 
MLY1002 + + + - + + + /- -
MLY1005 + + + - + + + + 
MLY1006 + + + + + + + + 
vps 5 + + + ND + + + + 
v p s i l + ND + + + + ND + 
v p s l 6 ND ND - ND + ND + + 
vpsl 7 + + ND ND + + + + 
v p s l 8 + ND + ND + + + + 
vps 33 + ND ND ND + ND + + 
B-4164 + ND ND ND + + + + 
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T a b l e 4.3 - continued 
a-mutant MLY0706 MLY0709 MLY0712 MLY0713 MLY0716 MLY0725 MLY0728 MLY0729 
a-mutant 
SEY6210 + + ND + + + + + 
MLYOlOl + + ND + + + + + 
MLY0103 + + ND + + + + + 
MLY0104 + + ND + /- + /- + - + 
MLY0106 + + ND + /- + /- + - + 
MLY0107 + + ND + + + + + 
MLY0108 + + ND + /- - + - + 
MLY0109 + + ND + /- + /- + - + /-
M L Y O l l l + + ND + + + + + 
MLY0113 - + ND + /- + /- + - + /-
MLY0115 + + ND + /- + /- + - + 
MLY0116 + /- + ND + /- + /- + /- - + /-
MLY0117 + ND ND + + + + + 
MLY0120 + + ND + + + + + 
MLY0121 + + ND + ND + + + 
MLY0124 ND + ND + ND + + + 
MLY0125 - + ND + /- + /- + - +/-
MLY0126 + + ND - + + + + 
MLY0127 - + ND + /- + /- + - + /-
MLY0134 + + ND + + /- + + + 
MLY0139 + + ND + + + + + 
MLY0144 + + ND + /- + /- + - +/-
MLY0145 + + ND + + + - + 
MLY0803 + + ND - - + - + 
MLY0805 + + ND - - + - + 
MLY0806 + + ND - - + - + 
MLY0808 + + ND - - + - + 
MLY0810 + + ND - - + - + 
MLY0811 + /- + /- ND - - - - -
MLY0812 + + /- ND - - + - + 
MLY0813 + + /- ND - - + ND +/-
MLY0815 + + ND - - + - + 
MLY0816 + + ND - - + - + 
MLY0902 + + ND - - + - + 
MLY0905 + + ND - - + - + 
MLY0908 + + ND - - + - + 
MLY0911 + + ND - - + - + 
MLY0913 + + ND - - + - + 
MLYlOOl + + ND - - + - + 
MLY1002 + /- + /- ND - - - - + /-
MLY1005 + + ND - - + - + 
MLY1006 + + ND + + + + + 
vps5 + + ND + + + + + 
v p s l l + + ND + + + + + 
v p s l 6 + + ND + + + + + 
vpsl 7 + + ND + + + + + 
vpsl 8 + + + + + + + + 
vps33 + + ND + + + + + 
B-4164 + + ND + ND + + + 
188 
Table 4.3 - continued 
a-mutant MLy0731 MLY0732 MLY1105 MLY1124 MLY1129 MLY1138 MLY1141 MLY1143 
a-mutant 
SEY6210 + + + + + + + + 
MLYOlOl + + + + + + + + 
MLy0103 + ND + + + + + + 
MLY0104 + + + + /- + /- + /- + /- -
MLY0106 + + + + /- + /- + /- + /- -
MLY0107 + + + + + + + + 
MLY0108 + + + + /- + /- + /- + /- + 
MLY0109 + +/- + + /- + /- + /- + /- -
MLYOlll + ND + + + + + + 
MLY0113 + /- + + + + /- + /- + /- -
MLY0115 + + + + /- + /- + /- + /- -
MLY0116 + /- + + /- + /- + /- + /- + /- -
MLY0117 + ND + ND + + + + 
MLY0120 + + + + + + + + /-
MLY0121 + ND + + + + + + 
MLY0124 ND ND ND + + + + + 
MLY0125 + /- ND + /- + /- + /- + /- + /- + /-
MLY012 6 + + + + + /- + /- + + 
MLY0127 + + + + /- + /- + /- + /- -
MLY0134 + ND + + + + + + 
MLYOlSg + ND + + + + + + 
MLY0144 + /- + + + /- + /- + /- + /- -
MLY0145 + ND + + /- + /- + /- + /- -
MLY0803 + + + + /- + /- + /- + /- + 
MLY0805 + + + + /- + /- + /- + /- + 
MLY0806 + + + + /- + /- + /- + /- + 
MLY0808 + + + + /- + /- + /- + /- + 
MLY0810 + + + + /- + /- + /- + /- + 
MLY0811 + /- + + /- + /- + /- + /- + /- + 
MLY0812 + + + + /- + /- + /- + /- + 
MLY0813 + ND ND + /- + /- + /- + /- + 
MLY0815 + + + + /- + /- + /- + /- + 
MLY0816 + + + + /- + /- + /- +/- + 
MLY0902 + + + + /- + /- + /- +/- + 
MLYOgOS + + + + /- + /- + /- •+/- + 
MLY0908 + + + + /- + /- + /- +/- + 
MLY0911 + + + + /- + /- + /- +/- + 
MLY0913 + + + + /- + /- + /- +/- + 
MLYlOOl + + + + /- + /- + /- + /- + 
MLY1002 - + - + /- + /- + /- + /- + 
MLY1005 + + + + /- + /- + /- + /- + 
MLY1006 + + + + + + + + 
vps5 + + + + + + + + 
v p s l l + + + + + + + + 
v p s l 6 + ND + + + + + + 
vpsl 7 + + + + + + + + 
vpsl 9 + + + + + + + + 
vps33 + + + + + + + + 
B-4164 + ND + + + + + + 
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Table 4.3 - continued 
a-mutant MLY1153 MLY1156 MLY1161 MLY1162 MLY1164 MLY1176 MLY1203 MLY12] 
a-mutant 
SEY6210 + + + + + + + + 
MLYOlOl + + + + + + + + 
MLYOIOS + + + + + + + + 
MLY0104 + /- + + + /- + /- + /- +/- + 
MLY0106 + /- + + + /- + /- + /- + /- + 
MLY0107 + + + /- + + + + + 
MLY0108 + + + + /- + /- + /- +/- + 
MLY0109 + /- + /- + + /- + /- + /- + /- + 
MLYOlll + ND + + + + + + 
MLY0113 + /- + /- + + /- + /- + /- + /- + 
MLY0115 - + + + /- + /- + /- + /- + 
MLY0116 - - + /- + /- + /- + /- +/- + 
MLY0117 + ND ND + ND + + ND 
MLY0120 + + + + + + + + 
MLY0121 + + ND + + + + + 
MLY0124 + ND ND + + + + + 
MLY0125 +/- ND + + /- + /- + /- +/- + 
MLY0126 + ND + + + + + + 
MLY0127 + /- + + + /- + /- + /- + /- + 
MLY0134 + ND ND + + + + + 
MLY0139 + + + + + + + + 
MLY0144 + /- + + + /- + /- + /- + /- + 
MLY0145 + /- ND + + /- + /- + /- + /- + 
MLY0803 + + + + /- + /- + /- +/- + 
MLY0805 + + + + /- + /- + /- +/- + 
MLY0806 + + + + /- + /- + /- +/- + 
MLY0808 + + + + /- + /- + /- + /- + 
MLY0810 + + + + /- + /- + /- + /- + 
MLY0811 + + /- + /- + /- + /- + /- + /- +/-
MLY0812 + + + + /- + /- + /- + /- +/-
MLY0813 + + + + /- + /- + /- + /- + 
MLY0815 + + + + /- + /- + /- + /- + 
MLY0816 + + + + /- + /- + /- +/- + 
MLY0902 + + + + /- + /- + /- +/- + 
MLY0905 + + + + /- + /- + /- + /- + 
MLY0908 + + + + /- + /- + /- + /- + 
MLY0911 + + + + /- + /- + /- + /- + 
MLY0913 + + + + /- + /- + /- + /- + 
MLYlOOl + + + + /- + /- + /- + /- + 
MLY1002 + + - + /- + /- + /- + /- + /-
MLY1005 + + + + /- + /- + /- + /- + 
MLY1006 + + + + + + + + 
vps5 + + + + + + + + 
vpsll + + + + + + + + 
vpsl 6 + ND ND + + + + + 
vpsl 7 + + + + + + /- + + 
v p s l S + + + + + + + + 
vps33 + ND + + + + + + 
B-4164 + + + + + + + + 
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T a b l e 4.3 - continued 
a-mutant MLY1218 MLY1219 MLY1232 MLY1233 MLY1309 MLY1311 MLY1315 MLY1330 
a-mutant 
SEY6210 + + + + + ND + + 
MLYOlOl + + + + + + + + 
MLY0103 + + + + + + + + 
MLY0104 + /- + /- + /- + + /- + + /- + 
MLY0106 + /- + /- + /- + + /- + + /- + 
MLY0107 + + + + /- + + + + 
MLY0108 + + /- + + + + + + 
MLY0109 + /- + /- + /- + + /- + + /- -
MLYOlll + + + + + ND + + 
MLY0113 + /- + /- + /- + + /- + + /- -
MLY0115 + /- + /- + /- + + /- + + /- + 
MLY0116 + /- + /- + /- + /- + /- + + /- +/-
MLY0117 + ND + + + ND + + 
MLY0120 + /- + + + + + + + 
MLY0121 + + + + + ND + + 
MLY0124 + + + ND + ND + + 
MLY0125 + /- + /- + /- + + /- + +/- + /-
MLY0126 + + + + + + + + 
MLY0127 + /- + /- + /- + + /- + +/- + 
MLY0134 + + + + + + + + 
MLY0139 + + + + + + + + 
MLY0144 + /- + /- + /- + + /- + + /- +/-
MLY0145 + /- + /- + /- + + /- ND + /- + 
MLY0803 +/- + /- + + + + + + 
MLY0805 + /- + /- + + + + + + 
MLY0806 + /- + /- + + + + + + 
MLY0808 + /- + /- + + + + + + 
MLY0810 + /- + /- + + + + + + 
MLY0811 + /- +/- + + + - + + 
MLY0812 + /- + /- + + + + + + 
MLY0813 + /- + /- + /- + + /- + +/- + 
MLY0815 + /- +/- + + + + + + 
MLY0816 + /- + /- + + + + + + 
MLY0902 + /- + /- + + + + + + 
MLY0905 + /- + /- + + + + + + 
MLY0908 + /- + /- + + + + + + 
MLY0911 + /- + /- + + + + + + 
MLY0913 + /- + /- + + + + + + 
MLYlOOl + /- + /- + + + + + + 
MLY1002 + /- + /- + + + - + + 
MLY1005 + /- + /- + + + + + + 
MLY1006 + + + + + + + + 
vps5 + + + + + + + + 
vpsll + + + + + + + + 
vpsl 6 + + + + + + + + 
vpsl 7 + + + + + + + + 
vpsl 8 ND + + + + + + + 
vps33 + + + + + ND + + 
B-4164 + + + + + + + + 
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T a b l e 4.3 - continued 
a-mutant MLY1332 vpsi vps8 D597 
a-mutant 
SEY6210 + + + 
MLYOlOl + + + 
MLY0103 + + + 
MLY0104 + +/- + 
MLY0106 + - + 
MLY0107 + + + 
MLY0108 + +/- + 
MLY0109 + +/- + 
MLYOlll + + + 
MLY0113 + +/- + 
MLY0115 + +/- + 
MLY0116 + - + 
MLY0117 ND + ND 
MLY0120 + +/- + 
MLY0121 + + ND 
MLY0124 + + ND 
MLY0125 + +/- + /-
MLY0126 + + + 
MLY0127 + - + 
MLY0134 + + + 
MLY0139 + + + 
MLY0144 + +/- + 
MLY0145 + - ND 
MLY0803 + + + 
MLY0805 + + + 
MLY0806 + + + 
MLY0808 + + + 
MLY0810 + + + 
MLY0811 + + + 
MLY0812 + + + 
MLY0813 + + + 
MLY0815 + + + 
MLY0816 + + + 
MLY0902 + +/- + 
MLY0905 + + + 
MLY0908 + + + 
MLY0911 + + + 
MLY0913 + + + 
MLYlOOl + + + 
MLY1002 + + + 
MLY1005 + + + 
MLY1006 + + + 
vps5 + /- + ND + 
vpsll + + + + 
vpsl 6 + ND + + 
vpsl 7 + + + + 
vpsl 8 + + + + 
vps33 + + ND + 
B-4164 + + + 
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Table 4.3: Complementation of the osmosensitive growth phenotype of the original 
mutant isolates and previously isolated salt sensitive strains. Every mutant of a-
mating type was crossed against every mutant of a-mating type and auxotrophy 
complementing diploids were isolated. Diploids were replica-plated onto YPD 
supplemented with 1.5 M NaCl, and growth or non-growth under selective 
conditions was scored after 7 days incubation at 30''C. Two mutant strains were 
said to complement if the diploid was able to maintain growth under selective 
conditions (+). Two mutants were said to not complement if diploids failed to 
grow at all under the selective conditions (-). Some diploid strains showed an 
intermediate phenotype in that they grew slowly but not as well as a 
homozygous wild type diploid strain (+/-). Certain other mutants failed to form 
diploids in the drop overlay complementation test and their complementation 
pattern could not be tested (ND = no diploids). The scores recorded in the table 
are the results of three independent complementation tests, and generally were in 
good agreement in that they were identical in most cases. Strains that failed to 
complement the NaCl sensitive phenotype of other strains were placed in one 
complementation group. A number of strains had an aberrant complementation 
pattern in that they showed weak complementation against other osmosensitive 
mutants but were fully complemented by the wild type. Since their 
complementation patterns were similar they were placed into one 
complementation group (see text). Mutants that occurred in several 
complementation groups were thought to be double mutants and were eliminated 
from the groups in which they occurred. 
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Table 4.4 
a-mutant SEY6210 MLYOlOl MLY0103 MLY0104 MLY0106 MLY0108 MLYOlll MLYOl 
a-mutant 
SEY6211 + + + + + + + + 
MLYOlOl + - + + + + - • -
MLY0103 + + - + + + + + 
MLY0104 + + + - - - + + 
MLY0106 + + + + /- - - + + 
MLY0108 + - + + /- - - + ND 
MLYOlll + - + - + + - -MLY0117 + - + + + + - -
MLY0120 + + + + + + + + 
MLY0124 + + + + + + + + 
MLY0126 + + + + + + + + 
MLY0134 + - + + + ND ND ND 
MLY0139 + + + + + + + + 
MLY0145 + ND + ND ND - + ND 
MLY0209 + + + + - ND + + 
MLY0304A + - + + - - + + 
MLY0307 + + + - - - + + MLY0309A + + + + + + ND ND 
MLY0309B + + + + + + + + 
MLY0310 + + + + + + + + 
MLY0402 + + + + + + + + 
MLY0416 + + + + + + + -
MLY0512 + + + + + + + ND 
MLY0513 + + + + + + + ND 
MLY0522 + + + + + + + + 
MLY0524 + + + + + + + ND 
MLY0526 + + • + + + + + ND 
MLY0527A + + + + + + ND ND 
MLY0701 + + + + + + + + 
MLY0704 + + + + + + + ND 
MLY0705 + ND + + + + ND ND 
MLY0706 + + + + + + + + 
MLY0709 + + + + + + + + 
MLY0716 + + + + + - + + 
MLY0725 + + + + + + + + 
MLY0729 + + + + + + + + 
MLY0731 + + + + + + + + 
MLY0732 + + + + + + + + 
MLY1105 + + + + + + + + 
MLY114 3 + + + - - ND + + 
MLY1153 + + + + + + + + 
MLY1156 + + + + + + ND ND 
MLY1161 + + + + + + + + 
MLY1214 + + + + + + + + 
MLY1232 + + + + /- + /- + /- + + 
MLY1233 + + + + + + + + 
MLyi311 + + + + + + ND ND 
v p s l + + + + /- - +/- + + 
vps5 + + + + + + + + 
v p s l l + + + + + + + + 
v p s l 6 + + + + + + ND ND 
vpsl 7 + + + + + + + + 
vpsl 8 + + + + + + + + 
vps33 + + + + + + + + 
vps34 + ND + + + + + ND 
D597-6D + ND + ND ND ND ND ND 
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Table 4.4 - continued 
a-mutant MLY0120 MLY0124 MLY0126 MLY0134 MLY0139 MLY0145 MLY0209 MLY03 
a-mutant 
SEY6211 + + + + + + + + 
MLYOlOl + + + + + + + + 
MLY0103 + + + + + + + + 
MLY0104 +/- + + +/- + +/- + /- + /-
MLY0106 + + + + + - - -
MLY0108 + + + + + +/- + + /-
MLYOlll + + + + + + + + 
MLY0117 + + + + + + + + 
MLY0120 - + + + + + + + /-
MLY0124 + - + + + + ND + 
MLY0126 + + - + + + + + 
MLY0134 + + + - + + - + 
MLY0139 + + + + - + + + 
MLY0145 + + + + + + /- + -
MLY0209 + + + - + + - + /-
MLY0304A + /- + + + + - + -
MLY0307 + /- + + + + - + -
MLY0309A + + + + + + + + 
MLY0309B + + + + + + + + 
MLY0310 + + + + + + + + 
MLY0402 + + + - + + + /- + 
MLY0416 + + + + + + + + 
MLY0512 + + + + + + + + 
MLY0513 + /- + + + + + + + 
MLY0522 + + + + + - + + /-
MLY0524 + + + + + + + + 
MLY052 6 + + + + + + + + 
MLY0527A + + + + + + + + 
MLY0701 + + + + + + + + 
MLY0704 + + + + + + + + 
MLY0705 + + + + + + + + 
MLY0706 + + /- + + + + + + 
MLY0709 + + + + + + + + 
MLY0716 + + + + + + + + 
MLY0725 + + + + + + + + 
MLY0729 + + + + + + + + 
MLY0731 + + + + + + + + 
MLY0732 + + + + + + + + 
MLY1105 + + + + + + + + 
MLY1143 + /- + + + + - + /- -
MLY1153 + + + + + - + -
MLY1156 + + + + + + + + 
MLY1161 + + + + + + + + 
MLY1214 + + + + + + + + 
MLY1232 + + + + + - + 
MLY1233 + + + + + + + • 
MLY1311 + + + + + + + + 
v p s l + + + + + + /- + -
vps5 + + + + + + + + 
v p s l l + + + + + + + + 
v p s l 6 + + + + + + + + 
vpsl 7 + + + + + + + + 
vpsl 8 + + + + + + + + 
vps33 + + + + + + + + 
vps34 + + + + + + + + 
D597-6D ND ND ND + + ND ND ND 
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Table 4.4 - continued 
a-mutant MLY0307 MLY0309A MLY0309B MLY0310 MLY0402 MLY0416 MLY0512 MLY05 
a-mutant 
SEY6211 + + + + + + + + 
MLYOlOl + + + + + + + + 
MLY0103 + + + + + + + + 
MLY0104 - + + + + + + + 
MLY0106 - + + + + + + + 
MLY0108 - + + + + + + + 
MLYOlll + + + + + + + + 
MLY0117 + + ND + + + + + 
MLY0120 + /- + + + + + + + /-
MLY0124 + + + + + + + + 
MLY0126 + + + + + + + + 
MLY0134 + + + + - + + + 
MLY0139 + + + + + + + + 
MLY0145 - ND + + + + + + 
MLY0209 + /- + + + - + + + 
MLY0304A + /- + + + + + + + 
MLY0307 - + + + + + + + 
MLY0309A + - + + + + + + 
MLY0309B + + + + + + + + 
MLY0310 + + + - + + + + 
MLY0402 + + + + - + + + 
MLY0416 + + + + + - + + 
MLY0512 + + + + + + + + 
MLY0513 + + + + + + + -
MLY0522 + /- + + + + + + + 
MLY0524 + + + + + + + + 
MLY0526 + + + + + + + + 
MLY0527A + + + + + + + + 
MLY0701 + + + + + + + + 
MLY0704 + + + + /- + + + + 
MLY0705 + + + + + + + + 
MLY0706 + + + + + + + + 
MLY0709 + + + + + + + + 
MLY0716 + /- + + + + + + + 
MLY0725 + + + - + + + + 
MLY0729 + + + + + + + + 
MLY0731 + + + + + + + + 
MLY0732 + + + + + + + + 
MLY1105 + + + - + + + + 
MLY1143 - + + + + + + + 
MLY1153 - + + + + + + + 
MLY1156 + + + + + + + + 
MLY1161 + + + + + + + + 
MLY1214 + + + + + + + + 
MLY1232 - + + + + + + + 
MLY1233 + + + + + + + + 
MLY1311 + + + - + + + + 
v p s l - + + + + + + + 
vps5 + + + + + + + + 
v p s l l + + + + + + + + 
v p s l 6 + + + + + + + + 
vpsl 7 + + + + + + + + 
vpsl 8 + + + + + + + + 
vps33 ND + + + + + + + 
vps34 + + + + + + + + 
D597-6D ND + ND ND + + + + 
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Table 4.4 - continued 
a-mutant MLY0522 MLY0524 MLY0526 MLY0527A MLY0701 MLY0704 MLY0705 MLY07 
a-mutant 
SEY6211 + + + + + + + + 
MLYOlOl + + + + + + + + 
MLY0103 + + + + + + + ND 
MLY0104 + + + + + + + + 
MLY0106 - + + + + + + + 
MLY0108 + /- + + + + + + + 
MLYOlll + + + + + + + + 
MLY0117 + ND + ND + + + + 
MLY0120 + + + + + + + + 
MLY0124 + + + + + + + + 
MLY0126 + + + + + + + + 
MLY0134 + + + + + + + + 
MLY0139 + + + + + + + + 
MLY0145 - + + + + + + + 
MLY0209 + + + + + + + + 
MLY0304A - + + + + + + + 
MLY0307 - + + + + + + + 
MLY0309A + + + + + + + + 
MLY0309B + + + + + + + + 
MLY0310 + + + + + - + -
MLY0402 + + + + + + + + 
MLY0416 + + + + + + + + 
MLY0512 + + + + + + + + 
MLY0513 + + + + + + + + 
MLY0522 + + + + + + + + 
MLY0524 - - + + + - + -
MLY052 6 + + - + + + + + 
MLY0527A + + + - + + + + MLY0701 + + + + - + + + 
MLY0704 - + + + + - + -
MLY0705 + + + + + + - + 
MLY0706 + + + + + - + -
MLY0709 + + + + + + + + 
MLY0716 + + + + + + + + 
MLY0725 + + + + + - + -
MLY0729 + - + + + + + + 
MLY0731 + - + + + + + + 
MLY0732 + + + + + + + + 
MLY1105 +/- + + + + - + -
MLY1143 - + + + + + + + 
MLY1153 - + + + + + + +/-
MLY1156 + + + + + + + + 
MLY1161 + + + + + + - + 
MLY1214 + + + + + - + -
MLY1232 - + + + + + + + 
MLY1233 + + + + + + + + 
MLY1311 + + + + + - + + 
v p s l + /- + + + + + + + 
vps5 + + + + + + + + 
v p s l l + + + + + + + + 
v p s l 6 + + + + + + + + 
vpsl 7 + + + + + + + + 
vpsl 8 + + + + + + + + 
vps33 + + + + + ND + ND 
vps34 + + + + + + + ND 
D597-6D ND ND + + + ND + ND 
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Table 4.4 - continued 
a-mutant MLY0709 MLY0716 MLY0725 MLY0729 MLY0731 MLY0732 MLY1105 MLYll 
a-mutant 
SEY6211 + + + + + + + + 
MLYOlOl + + + + + + + + 
MLY0103 + + + + + + + + 
MLY0104 + + + + + + + -
MLY0106 + + + + + + + -
MLY0108 + + + + + + + + /-
MLYOlll + + + + + ND + + 
MLY0117 ND + + + + ND + + 
MLY0120 + + + + + + + + 
MLY0124 + ND ND ND ND + + + 
MLY0126 + + + + + + + + 
MLY0134 + ND + + + ND + + 
MLY0139 + + + + + + + + 
MLY0145 + + + + + + + -
MLY0209 + + + + + + + + 
MLY0304A + + + + + + + + 
MLY0307 + + + + + + + -
MLY0309A + + + + + + + + 
MLY0309B + + + + + + + + 
MLY0310 + + - + + + - + 
MLY0402 + + + + + + + + 
MLY0416 + + + + + + + + 
MLY0512 + + + + + + + + 
MLY0513 + + + + + + + + 
MLY0522 + + + + + + + + 
MLY0524 + + + - - + + + 
MLY052 6 + + + + + + + + 
MLY0527A + + + + + + + + 
MLY0701 + + + + + + + + 
MLY0704 + + - + + + - + 
MLY0705 + + + + + + + + 
MLY0706 + + - + + + - + 
MLY0709 - + + + + + + + 
MLY0716 + - + + + + + + 
MLY0725 + + - + + + - + 
MLY0729 + + + - - + + + 
MLY0731 + + + - - + + + 
MLY0732 + + + + + - + + 
MLY1105 + + - + + + - + 
MLY1143 + + + + + + + /- -
MLY1153 + + + + + + + -
MLY1156 + + + + + + + + 
MLY1161 + + + + + + + + 
MLY1214 + + - + + + - + 
MLY1232 + + + + + + + -
MLY1233 + + + + + + + + 
MLY1311 + + - + + + - + 
v p s l + + + + + + + -
vps5 + + + + + + + + 
v p s l l + + + + + + + + 
v p s l 6 + + + + + + + + 
vpsl 7 + + + + + + + + 
v p s l S + + + + + + + + 
vps33 + + ND + + + ND + 
vps34 + + + + + + + + 
D597-6D ND ND ND + + + + ND 
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Table 4.4 - continued 
a-mutant MLY1153 MLY1156 MLY1161 MLY1214 MLY1232 MLY1233 MLY1311 vp s l 
a-mutant 
SEY6211 + + + + + + + + 
MLYOlOl + + + + + + + + 
MLY0103 + + + + + + + + 
MLY0104 - + + + - + + + /-
MLY0106 - + + + - + + -
MLY0108 + + + + + + + + /-
MLYOlll + ND + + + + ND + 
MLY0117 + ND + ND + + ND + 
MLY0120 + + + + + + + + /-
MLY0124 + ND ND + + ND ND + 
MLY0126 + + + + + + + + 
MLY0134 + ND ND + + + + + 
MLY0139 + + + + + + + + 
MLY0145 - ND + + - + ND -
MLY0209 + + + + + + + + 
MLY0304A - + + + - + + -
MLY0307 - + + + - + + -
MLY0309A + + + + + + + + 
MLY0309B + + + + + + + + 
MLY0310 + + + - + + - + 
MLY0402 + + + + + + + + 
MLY0416 + + + + + + + + 
MLY0512 + + + + + + + + 
MLY0513 + + + + + + + + 
MLY0522 + + + + + + + + 
MLY0524 + + + + + + + + 
MLY052 6 + + + + + + + + 
MLY0527A + + + + + + + + 
MLY0701 + + + + + + + + 
MLY0704 +/- + + - + + - + 
MLY0705 + + - + + + + + 
MLY0706 + + + - + + - + 
MLY0709 + + + + + + + + 
MLY0716 + + + + + + + + 
MLY0725 + + + - + + - + 
MLY072 9 + + + + + + + + 
MLY0731 + + + + + + + + 
MLY0732 + + + + + + + + 
MLY1105 + + + - + + - + 
MLY1143 - + + + - + + + 
MLY1153 - + + + - + + + 
MLY1156 + - + + + + + + 
MLY1161 + + - + + + + + 
MLY1214 + + + - + + - + 
MLY1232 - + + + - + + + 
MLY1233 + + + + + - + + 
MLY1311 + + + - + + - + 
v p s l - + + + + - + + 
vps5 + + + + + + + + 
v p s l l + + + + + + + + 
v p s l 6 + + + + + + + + 
vpsl 7 + + + + + + + + 
vpsl 8 + + + + + + + + 
vps33 ND + + ND ND + ND ND 
vps34 + + + + + + + + 
D597-6D ND + + ND + + ND + 
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Table 4.4 - continued 
a-mutant vps5 v p s l l v p s l 6 v p s l 7 v p s l 8 vps33 vps34 B-41 
a-mutant 
SEY6211 + + + + + + + + 
MLYOlOl + + + + + + + + 
MLY0103 + + + + + ND + + 
MLY0104 + + + + + + + + 
MLY0106 + + + + + ND + + 
MLY0108 + + + + + + + + 
MLYOlll + + + + + ND + + 
MLY0117 + ND ND + + ND + + 
MLY0120 + + + + + + + + 
MLY0124 + + + + + + + + 
MLY0126 + + + + + + + + 
MLY0134 + + + + + + + + 
MLY0139 + + + + + + + + 
MLY0145 + + + + + ND + + 
MLY0209 + + + + + + + + 
MLY0304A + + + + + + + + 
MLY0307 + + + + + ND + + 
MLY0309A + + + + + + + + 
MLY0309B + + + + + + + + 
MLY0310 + + + + + + + + 
MLY0402 + + + + + + + + 
MLY0416 + + + + + + + + 
MLY0512 + + + + + + + + 
MLY0513 + + + + + + + + 
MLY0522 + + + + + + + + 
MLY0524 + + + + + + + + 
MLY0526 + + + + + + + + 
MLY0527A + + + + + + + + 
MLY0701 + + + + + ND + + 
MLY0704 + + + + + ND + + 
MLY0705 + + + + + + + + 
MLY0706 + + + + + ND + + 
MLY0709 + + + + + ND + + 
MLY0716 + + + + + + + -
MLY0725 + + + + + + + + 
MLY0729 + + + + + + + + 
MLY0731 + + + + + + + + 
MLY0732 + + + + + + + + 
MLY1105 + + + + + ND + + 
MLY1143 + + + + + + + + 
MLY1153 + + + + + + + + 
MLY1156 + + + + + + + + 
MLYll61 + + + + + + + + 
MLY1214 + + + + + ND + + 
MLY1232 + + + + + ND + + 
MLY1233 + + + + + + + + 
MLY1311 + + + + + ND + + 
v p s l + + + + + ND + + 
vps5 + + + + + + + + 
v p s l l + ND ND + + ND + + 
v p s l 6 + + - + + + + + 
vpsl 7 + + + + + + + + 
vpsl 8 + + + + - + + + 
vps33 + + + + ND ND + + 
vps34 + + + + + + - + 
D597-6D + + ND + ND ND + -
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Table 4.4: Complementation of the osmosensitive growth phenotype of random spore 
mutant isolates. Every mutant of a-mating type was crossed against every 
mutant of a-mating type in rich liquid medium (YPD), and putative diploids 
were dotted onto YPD supplemented with 1.5 M NaCl, and growth or non-
growth under selective conditions was scored after 14 days incubation at 30°C. 
Two mutant strains were said to complement i f the putative diploid was able to 
form colonies and maintain growth under selective conditions (+). Two mutants 
were said not to complement i f diploids (judged by their ability to sporulate) 
failed to grow at all under the selective conditions (-). Some diploid strains 
showed an intermediate phenotype in that they grew slowly but not as well as a 
homozygous wild type diploid strain (+/-). Certain other mutants failed to form 
diploids in the drop overlay complementation test and their complementation 
pattern could not be tested (ND = no diploids). The scores recorded in the table 
are the results of a single complementation test, and generally in good agreement 
with the previous complementation test (Table 4.3). Strains that failed to 
complement the NaCl sensitive phenotype of other strains were placed in one 
complementation group. Whenever possible, once back-cossed mutant strains 
with the same auxotrophy markers as the original mutant strain were used in 
subsequent experiments to reduce the risk of a synergistic phenotype due to 
several unrelated mutations 
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Complementation Allele 
Group 
ssv\ -1 (MLY0104), -2 (MLY0106), -3 (MLY0108), 
-4 (MLY0120), -5 (MLY0145). -6(MLY0304A), 
-7 (MLY0307), -8 (MLY1143), -9 (MLY1153), 
-10 (MLY1232), -11 (MLY1309), -12 (MLY1315) 
ssv2 -1 (MLYOl 17), -2 (MLYOl 11) 
ssv3 -1 (MLY0732) 
ssv4 -1 (MLY0126) 
ssv5 -1 (MLY0524), -2 (MLY0729), -3 (MLY0731) 
ssv6 -1 (MLY0527A) 
ssvl -1 (MLY309A), -2 (MLY1005) 
ssvS -1 (MLY0134), -2 (MLY0209), -3 (MLY0402) 
ssv9 -1 (MLY0310), -2 (MLY0704), -3 (MLY0706), 
-4 (MLY0725), -5 (MLYl 105), -6 (MLY1214), 
-7 (MLY1311) 
ssvlO -1 (MLY0103) 
ssvll -1 (MLY0124) 
ssvl2 -1 (MLY0139) 
ssv\3 -1 (MLY0526) 
ssvlA -1 (MLY0701) 
ssv\5 -1 ( M L Y l 502) 
ssvl6 -1 ( M L Y l 156) 
ssv -100 (MLY0419), -101 (MLY0508), -102 (MLY0601), 
{ssvll) -103 (MLY0728), -104 (MLY0803), -105 (MLY0805), 
-106 (MLY0806), -107 (MLY0808), -108 (MLY0810), 
-109 (MLY0812), -110 (MLY0816), -111 (MLY0902), 
-112 (MLY0905), -113 (MLY0908), -114 (MLY0913), 
-115 ( M L Y l 124), -116 ( M L Y l 141), -117 (MLYl 162), 
-118 ( M L Y l 164), -119 ( M L Y l 176), -120 (MLY1203), 
-121 (MLY1218), -122 (MLY1219) 
ssvlS -1 (MLY0416) 
ssv\9 -1 (MLY0709) 
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Complementation Allele 
Group 
ssv20 -1 ( M L Y l 161) 
ssv -123 (MLY0202), -124 (MLY0712) 
osm3 -1 (MLY0513) 
osmA -1 (MLY0705) 
Table 4.5: ssv and osm complementation groups. Two mutations were said to 
complement each other, i f heterozygous diploids were able to grow on YPD + 
1.5 M NaCl after 7 days (see text). The validity of this complementation group 
was confirmed by others with the in the text mentioned three exceptions. The 
assignment of mutants into complementaion groups was based solely by 
complementation of the osmosensitive phenotype. The assignment of mutants in 
^5'v77 is preliminary and based on their similar semi-dominant phenotype rather 
than true complementation of alleles in this group. They are fully complemented 
by the wild type. osm3 and osm4 are complementation groups of two mutants 
that have no other defects except in maintainig growth on YPD + 1.5 M NaCl. 
The two ssv-M'i and ssv-\2A alleles are sterile, and their normal 
complementation pattern could not be assessed. They may or may not be 
identical. One mutant of each complementation group having more than one 
member was chosen to represent the complementation group in subsequent 
experiments. These "type alleles", namely ssvl-%, ssv5-2, ssv7-\, ssv8-2, ssv9-l 
and i'^v-lOO, were chosen because their vps phenotype as well as vacuolar 
morphology defect was clearly distinctive from the wild type (see below). 
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Strain Parent Genotype 
MLY1501 MLY0103 MATa leu2-3,\ 12 ura3-A52 his3-A200 trpl-A90\ lys2-m 
ade2-m suc2-A9 GAL ssvlO-1 
MLY1502 MLY0716 MATa leu2-3,l 12 ura3-A52 his3-A200 trpl-A90l lys2-m 
ade2-l0l suc2-A9 GAL ssv-aro7 
MLY1503 MLY0310 MATa leu2-3,l 12 ura3-A52 his3-A200 trpl-A90l lys2-m 
ade2-l0l suc2-A9 GAL ts ssv9-l 
MLY1505 MLY0526 MATa leu2-3,\ 12 ura3-A52 his3-A20O trpl-A90l lys2-m 
ade2-m suc2-A9 GAL ssvl3-l 
MLY1506 MLY0304 MATa leu2-3,\ 12 ura3-A52 his3-A2Q0 trpl-A90l Iys2-S0l 
ade2-101 suc2-A9 GAL ssvl-6 
MLY1507 MLYOl 11 MATa leu2-3,\ 12 ura3-A52 his3-A200 trpJ-A90\ ade2-m 
SUC2-A9 GAL ssv2-2 
MLY1508 MLY0304 MATa leu2-3,\ 12 ura3-A52 his3-A200 trpl-A90l Iys2-S0\ 
ade2-\0\ suc2-A9 GAL ssvl-1 
MLY1509 M L Y l 143 MATa leu2-3,\\2 ura3-A52 his3-A200 trpl-A90l lys2-m 
SUC2-A9 GAL ssvl-% 
MLY1510 MLY0527A MATa Ieu2-3,n2 ura3-A52 /iw5-A200 trpl-A90l suc2-A9 
GAL ssv6-l 
MLY1511 MLY0309 MATa leu2-3,\\2 ura3-A52 his3-A200 trpl-A90l ade2-\0l 
SUC2-A9 GAL ssv7-l 
MLY1512 MLY0527A MATa Ieu2-3,U2 ura3-A52 his3-A200 trpl-A90\ suc2-A9 
GAL ssv6-\ 
MLY1513 MLY0732 MATa Ieu2-3,U2 ura3-A52 his3-A200 trpl-A90\ Iys2-%Q\ 
ade2-m suc2-A9 GAL ts ssv3-\ 
MLY1514 MLY0732 MATa Ieu2-3M2 ura3-A52 his3-A200 trpl-A90\ ade2-m 
SUC2-A9 GAL ts ss\3-\ 
MLY1515 MLY0729 MATa Ieu2-3M2 ura3-A52 his3-A200 trpl-A90l ade2-m 
SUC2-A9 GAL ssv5-2 
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Strain Parent Genotype 
MLY1516 MLY0729 MATa Ieu2-3,n2 ura3-A52 his3-A200 trpl-A90\ ade2-m 
SUC2-A9 GAL ssv5-2 
MLY1517 MLY0309 MATa leu2-3,m ura3-A52 his3-A200 trpl-A90l ade2-\0\ 
suc2-A9 GAL ssv7-\ 
MLY1518 MLY1311 MATa Ieu2-3,U2 ura3-A52 his3-A200 trpl-A90l lys2-m 
ade2-l0\ suc2-A9 GAL ssv9-l 
Table 4.6: Strain designation and phenotype of random spore isolates from heteozygous 
diploids between osmosensitive mutant strains and their isogenic wild type. The 
auxotrophy phenotypes and mating type of each strain were tested. Unless 
indicated otherwise, these strains rather than the originally isolated mutant 
alleles were used in subsequent experiments. 
4.2.2. Vacuolar Morphological Analysis 
4.2.2.1. Light and Fluorescence Microscopy 
Light microscopic analysis, using Nomarski contrast optics, of all 97 originally 
isolated mutants showed that a large proportion had an altered vacuolar morphology 
(Table 4.7). One group had many small vacuole like structures, whereas another group 
did not show any vacuoles at all. These findings are consistent with previous findings 
(Banta et al, 1988), which led to the classification of vps mutants into three discrete 
vacuolar morphology classes: Class A with large, normal appearing vacuoles, Class B 
with many small vacuoles, and Class C with no detectable vacuoles. Vital staining, 
using FTTC, quinacrine or CDCFDA were initially attempted in this study, but it yielded 
somewhat ambiguous results, because an adequate fluorescence microscope was not 
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available at the time. Thus only the vacuolar appearance under Normarski contrast 
microscopy was recorded. 
4.2.2.2. Indirect Immunofluorescence Microscopy 
Alhough the morphological characterization of the ssv mutants isolated in this 
study was facilitated by electron microscopy, a rapid method that relatively 
unambiguously could identify vacuolar morphology in a short time period was sought. 
The immunolocalization of two vacuolar membrane markers, Pho8p and the 60 kDa 
subunit of the vacuolar ATPase could give a valid estimate of the morphology of the 
vacuole (Raymond et ai, 1991). This method was used to assess the vacuolar 
morphology of mutants that escaped classification by electron microscopy (Table 4.7). 
4.2.23. Electron Microscopy 
The results obtained by light microscopy and fluorescence microscopy were 
verified by electron microscopy, using a preparation method specifically staining 
double-membranes and carbohydrate structures that accentuates vacuoles (Table 4.7). 
Class A mutants had one to three large, dark staining vacuoles. Class B mutants had 
between 4 to 15 small, disrupted vacuole-like structures per thin-section and cell. All 
other mutants, which had no normal staining or no vacuoles at all, were said to be class 
C (Figure 4.2). One striking feature was that not all alleles of one complementation 
group had an identical vacuolar morphology. These findings are consistent with 
previous observations (Klionsky et al., 1990; S. Emr, personal communication), where 
different vps alleles of the same complementation group have different vacuolar 
morphologies. Thus for a gene to be placed in class A, all mutant alleles must be of this 
phenotype. Individual mutants in a class B gene may exhibit either A or B morphology, 
while mutants in class C may exhibit all three morphologies. Taken together with the 
complementation data previously obtained, these considerations allowed the 
classification of the complementation groups in terms of vacuolar morphology (Table 
4.8). Eight groups contain alleles all of which show class A morphology (^^v^, ssvlO, 
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ssvll, ssvl2, ssvl4, ssv20, osm3 and osm4). Twelve groups contain alleles, which are 
either of class B or class A morphology {ss\>2, ssv5, ssv6, ssv7, ssv8, ssvI3, ssvl6, 
ssvl8, ssvl9, ssv-123 and i'.yv-124). Five groups had alleles which were only class C 
(ssvl, ssv3, ssv9, ssvl5 and ssvlT). Of the above classes, only class C is a final 
classification, because complementation groups of A or B morphology may reflect the 
failure to isolate alleles of C morphology. 
A common feature of members of ssvl7 complementation group alleles was that 
some mutant alleles conferred a mixed vacuolar phenotype in that about 50% of all cells 
had vacuoles present while the remaining cells had a class C phenotype, indicative of a 
vacuolar segregation defect. A vacuolar segregation defect was detectable in alleles of 
several complementation groups (wv2, ssv5, ssv8, ssv9 and ssvlJ). Its characteristic 
morphological appearance was that some cells were class A while others were class C. 
In all cases large mother cells had a clearly visible vacuole, while daughter cells of the 
first generation were devoid of any detectable vacuolar compartment. This phenotype 
was scored as A/C in Table 4,7. 
Table 4.7; Vacuolar morphology 
Strain Vacuolar Morphology by 
Normarski Qinacrine Pho8pIIF 60kI IF EM 
SEY6210 A + A A A 
SEY6211 A + ND ND ND 
15113-8 A + ND ND A 
14121-26 B +/- ND ND B 
0552-11 C +/- ND ND C 
MLYOlOl C - A/C A/C C 
MLY0103 B/C - A A A 
MLY0104 A/B +/- B B B 
MLY0106 A/B +/- ND ND B 
MLY0107 A + ND ND ND 
MLY0108 B +/- ND ND ND 
MLY0109 A/B +/- ND ND B 
M L Y O l l l B + B B B 
MLY0113 Blv +/- ND ND B 
MLY0115 A + ND ND A 
MLY0116 B + ND ND ND 
MLY0117 A7C + A A B 
MLY0120 B/C +/- ND ND B 
MLY0121 C +/- ND ND A 
MLY0124 A/C + A/C A/C A/C 
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Strain Vacuolar Morphology by 
Normarski Qinacrine PhoSpIIF 60kI IF EM 
MLY0125 A/B -1 - ND ND ND 
MLY0126 A/B + ND ND A/B 
MLY0127 A/B +/- ND ND A/B 
MLY0134 B +/- ND ND B 
MLY0139 A +/- ND ND ND 
MLY0144 A - ND ND A/B 
MLY0145 C ND ND ND A/B 
MLY0202 A/B ND ND ND B 
MLY0209 B ND ND ND B 
MLY0304 B/C ND ND ND A 
MLY0307 B ND B B ND 
MLY0309 A/B ND ND ND ND 
MLY0310 Ar/lc ND C C Abnormal 
MLY0402 A/B ND A A ND 
MLY0416 B/C ND ND ND B 
MLY0419 B/C ND C B/C B/C 
MLY0420 A/C ND ND ND ND 
MLY0508 A/C ND A/C A/C C 
MLY0512 B/C ND ND ND B 
MLY0513 C ND ND ND A 
MLY0522 B/C ND ND ND B 
MLY0524 A/B/C ND ND ND A 
MLY0526 Al ND A A B 
MLY0527 A ND ND ND A 
MLY0601 B/C ND B/C B/C ND 
MLY0701 A/B ND ND ND A 
MLY0702 A/C ND ND ND A 
MLY0704 C ND A/C A/C C 
MLY0705 c ND ND ND A 
MLY0706 B/C ND ND ND A/C 
MLY0709 C ND ND ND B 
MLY0712 A/B ND ND ND ND 
MLY0713 B ND ND ND A 
MLY0716 C ND ND ND B 
MLY0725 C ND A A A 
MLY0728 B/C ND ND ND B 
MLY0729 C ND ND ND B 
MLY0731 A/C ND ND ND ND 
MLY0732 C ND ND ND ND 
MLY0803 B ND ND ND A/B 
MLY0805 C ND B B B 
MLY0806 A ND A A ND 
MLY0808 A ND ND ND A 
MLY0810 A ND ND ND A/B 
MLY0811 A ND ND ND ND 
MLY0812 B ND B B B 
MLY0813 A/B ND ND ND B/C 
MLY0815 C ND ND ND ND 
MLY0816 A ND A A ND 
MLY0902 A ND A A B 
MLY0905 A ND A A B 
MLY0908 A ND A A ND 
MLY0911 A ND ND ND B 
MLY0913 B ND ND ND B 
MLYlOOl A/B ND ND ND ND 
MLY1002 C/B ND ND ND A 
MLY1005 A ND ND ND B 
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Strain Vacuolar Morphology by 
Normarski Qinacrine Pho8p IIF 60 k UF EM 
MLY1006 C ND ND ND A 
MLY1105 B ND ND ND C 
MLY1124 B ND ND ND ND 
MLY1129 C ND ND ND A 
MLY1138 C ND ND ND A/B 
MLY1141 B/C ND ND ND ND 
MLY1143 C ND B B B 
MLY1153 A/B ND A/C A/C C 
M L Y n 5 6 B ND ND ND B 
MLY1161 C ND ND ND A/B 
MLY1162 C ND ND ND B 
MLY1164 A ND ND ND ND 
MLY1176 C ND ND ND A 
MLY1203 B/C ND ND ND A 
MLY1214 B ND A A AR 
MLY1218 B/C ND ND ND B 
MLY1219 C ND ND ND ND 
MLY1232 C ND ND ND A/B 
MLY1233 C ND ND ND A 
MLY1309 A ND ND ND A/B 
MLY1311 B/C ND C C C 
MLY1315 C ND A A A/B 
MLY1330 A ND ND ND A 
MLY1332 B ND ND ND ND 
MLY1511 ND ND ND A/B 
Table 4.7: Vacuole morphology of mutant alleles. The data compiled in this table were 
obtained from examining at least two independent cultures of the mutant strains 
for each method. The criteria for assignment of vacuolar classes are described in 
the text. A: class A vacuolar morphology; B: class B vacuolar morphology; C: 
class C vacuolar morphology; A/C: vacuolar segregation defect; B/C: mixed 
poulation of class B and class C vacuolar phenotype; 1: large vacuoles; Iv: large 
vacuoles surrounded by vesicles; r: rough vacuolar membrane; ND: not 
determined. 
Among a small selection of mutants screened for a vacuolar acidification defect 
using quinacrine as a vacuole specific fluorophore, two mutants, MLY0103 {ssvlO-l) 
and MLY0144, with apparently normal morphological vacuoles failed to show 
quinacrine fluorescence indicative for a vacuolar acidification defect. The ssvIO-l allele 
did not have defects associated with vacuolar membrane ATPase mutants such as 
sensitivity to Ca^ "*" or a Pet' phenotype (see later sections). MLY0144 could not be 
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assigned to any complementation group. Several mutants screened for the proper 
assembly of the vacuolar ATPase by determining the localization of the 60 kDa 
vacuolar ATPase subunit to the vacuolar membrane did not have any aberrant assembly 
compared to Pho8p as a vacuolar membrane marker. There was an obvious discrepancy 
between the results obtained by light microscopy and electron microscopy. Assuming 
that not all vacuolar structures could be seen by light microscopy or that some vacuoles 
might have an altered refractive index making them invisible to Normarski contrast 
microscopy, only results obtained by electron microscopy were used for classification 
purposes. 
SSV Total Alleles 5^ Alleles Vacuolar Morphology Vacuolar Class 
Class A Class B Class C 
1 12 0 5 6 1 c 
2 2 0 1 1 0 B 
3 1 1 0 0 1 C 
4 1 0 1 0 0 A 
5 3 0 1 2 0 B 
6 1 0 0 1 0 B 
7 2 0 1 1 0 B 
8 3 0 0 3 0 B 
9 8 1 3 0 5 C 
10 1 0 1 0 0 A 
11 1 0 1 0 0 A 
12 1 0 1 0 0 A 
13 1 0 0 1 0 B 
14 1 0 1 0 0 A 
15 2 0 0 0 2 C 
16 1 0 0 1 0 B 
17 23 0 5 16 2 C 
18 1 0 0 1 0 B 
19 1 0 0 1 0 B 
20 1 0 0 1 0 B 
Sterile 2 0 0 2 0 B 
Table 4.8: Classification of ssv complementation groups according to vacuolar 
morphology. A: normal intact vacuoles; B: small disrupted vacuoles; C: no 
vacuoles (see text). 
4.2.3. Morphological Features 
Apart from differences in vacuolar morphology, some mutants had aberrant 
morphological phenotypes compared to the wild type (Figure 4.3). Excessively large 
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vacuoles were observed in strains MLY0127, MLY0310 (^.yv9-l) and MLY0526 {ssvl3-
1) (Figure 4.3 B-D). A similar phenotype has been described before, observable in two 
vps mutant strains (Banta et al., 1988). It has been suggested that these giant vacuoles 
could have a osmoregulatory defect. Complementation analysis (Tables 4.3 and 4.5) 
provides evidence that these mutant alleles are not identical to prevoiously isolated vps 
mutants exhibiting a similar phenotype where viable diploids could be generated. 
MLY0127 cells are not spherical but "flattened", suggesting another defect in cell wall 
morphogenesis. MLY0127 could not unambiguously be assigned to any 
complementation group. Budding defects were associated with two mutant strains, 
MLY0124 (ssvll-l) and MLY0704 («v9-2). Other observable defects included 
vacuoles surrounded by larger vesicles in MLY0113, an increase in overall cell size in 
MLY0116, large, "shmoo"-like cells in MLY0120 (ssvl-A), small cells of variable 
shape in MLY0144 and the formation of large cell aggregates in culture that led to the 
formation of pellets in MLY0134 (wv5-l). Various aberrant subcellular structures were 
also detectable in some alleles of ssvl, ssv2, ssv5, ssv7, ssv8, ssv9, ssvJO, ssv-121 and 
osm3 (Figure 4.4), which showed either similarity to previously identified Berkeley-
bodies and Golgi-like organelles (Novick et al., 1981) or organelles which stained like 
vacuoles in their periphery but whose center was electron transparent. These organelles 
appear to be taken up by vacuoles by a process sunilar to endocytosis and accumulate in 
some vacuolar class C mutants. The organelles were also found in the vacuole of mutant 
strains with an electron transparent vacuole probably due to leakage of the contents 
before or during fixation (Figure 4.4 H and M). In one strain these organelles underwent 
fusion or fission (Figure 4.4 P). These organelles are also present in some but not all 
class B cells and could represent intermediates in class B vacuole formation, especially 
since their density varied from completely transparent to completely dense (Figure 4.4 
I) . Some 5sv9-7 class C mutant cells (10% of total) accumulate electron transparent 
membrane enclosed structures (Figure 4.4 L). These structures could represent lipid 
bodies or intermediates in vacuole formation, although they could not be found in wUd 
type cells. Other alleles, as for example 5sv7-10 accumulated structures with similarity 
to autophagic vacuoles (Figure 4.4 4), which in plants were identified to be involved in 
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cellular degradation processes (Dunn, 1990). Also, several cells of the j^v5- l , ssvlO-\, 
osm3-l alleles and strain MLY1138 did have cytoplasmic inclusions and organelles 
inside the vacuole, suggesting a role for the yeast vacuole in organelle degradation. Two 
alleles of ssvl7, namely wv-119 and ssv-\2l, had a mixed vacuolar phenotype in that 
cells had class A, class B and class C vacuoles, although they were repeatedly purified 
to ensure that the phenotype is not due to contamination by other strains with different 
vacuolar morphology. Other abnormalities found were tubular structures ("y"-bodies) in 
ssv8-2, an extreme class B phenotype in that the whole cytoplasm contained fragmented 
vacuoles in MLY0109, electron dense, crystal like inclusions ("x"-bodies) in ssvll-l 
and extremely large vacuoles in MLY1006. The osm3-l allele did have normal size 
vacuoles and did not secrete vacuolar proteins (see later sections). However, most 
vacuoles in the strain had larger transparent inclusions inside the vacuole. Similar 
inclusions have been suggested to represent polyphosphate deposits (Banta et al., 1988). 
Since these inclusions are much smaller in wild type cells, the polyphosphate is 
probably deposited in this mutant but fails to be degraded. Since polyphosphates 
represent a charge balancing agent in a non-osmotically active form (see above), the 
putative accumulation of polyphosphates might be accompanied by an increase of 
cations in the vacuole which might have an adverse effect on osmoregulation of the cell. 
Thus osm3-l might after all represent a ssv mutant in that its osmosensitivity is caused 
by a vacuolar defect. This mutant was not further analyzed. The nature of all organelles 
found to accumulate in some ^^v mutants is not known. They might reflect aberrant 
strucmres resulting from a defect in vacuole formation and are not normally found in 
wild type yeast, except the "e"-bodies perhaps. Alternatively they might represent 
intermediates in vacuole formation whose biosynthesis pathway is delayed by some ssv 
mutations. Also, whether the engulfing of cytoplasmic material occurs in the wild type 
is not known. This process might play a role in the general starvation induced turn-over 
of cytoplasmic material, and some ssv mutants might simulate starvation conditions 
because of a defect in a biosynthetic pathway or signalling mechanism. 
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Figure 4.2: Electron microscopical classification of ssv mutants. Mutants that had one 
to three large vacuoles were of vacuolar class A (A; ssv9-6), mutants that had 
between 4 and 30 small vacuoles were of class B (B; 5^v7-10), while mutats that 
did not have any vacuoles were of vacuolar class C (C; ssv9-l). The comparison 
between two alleles of the same complementation group (A and C) demonstrates 
that different alleles from one ssv complementation group can develop a 
different vacuolar morphology (see text). AV, autophagic vacuole; ER, 
endoplasmic reticulum; N , nucleus; M , mitochondrium; V, vacuole. 
Magnification: A, 19,500x; B, 19,500x; C, 19,500x. 
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Figure 4.3: Aberrant morphological featurs of ssv mutants as determined by Normarski 
contrast microscopy. Compared to the wild type SEY6210 (A), three strains, 
MLY0127 (B), MLY0310 (C) and to some degree MLY0526 (D) have enlarged 
vacuoles that take up a large proportion of the cytoplasm. MLY0126 (E) and 
MLY0704 (F) have a budding defect in that several buds form simultaneously. 
MLY0113 (G) has normal size vacuoles which are surrounded by samaller 
vesicles (see also Figure 4.4 J). MLYOl 16 (H) has large flattened cells. 
MLY0120 (I) has a shmoo-like appearance typical for cells that undergo zygote 
formation. However, fusion of these cells with each other could not be observed. 
MLY0144 (J) forms tube like structures possibly consisting of unseparated buds, 
while MLYOl34 (K) forms large cell aggregates and flocculates in culture. 0.75 
cm = 1 |J,m. 
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Figure 4.4: Ultrastructural examination of selected ^^v mutants with atypical 
subcellular features. Strains MLY1214 ssv9-6 (A; 19,500x), MLY1005 ssv7-2 
(B; 22,000x), MLYOlOl (C, D; 19,500x), MLY0120 (E; 15,200x), MLY0117 
ssv2-l (F; 15,200x), MLY0121 (G; 7,000x), MLY0121 (H; 15,200x), MLY0716 
(I; 19,500x), MLY0113 (J; 33,000x), MLY1311 ssv9-l (K; 19,500x), MLY1311 
SSV9-7 (L; 1 l,700x), MLYOl 11 ssv2-2 (M; 19,500x), MLY0103 ssvlO-1 (N; 
15,200x), MLY1233 (O; 15,200x), MLY1218 wv-121 (P; ll ,700x), MLY0524 
ssv5-\ (Q; 15,200x), MLY1138 (R; 25,000x), MLY0103 ssvlO-l (S; 25,000x), 
MLY0134 ssv8-l (T; ll,700x), MLYOlOl (U; 19,500x), MLY0522 (V; 7,000x), 
MLY1218 ssv-121 (W; ll,700x), MLY1176 ssv-n9 (Y; 7,000x), MLY0120 (Z; 
15,200x), MLY0713 (1; 15,200x), MLY1002 ssv7-2 (2; 19,500x), MLYOl 17 
ssv2-l (3; 19,500x), MLY1232 ssvl-lO (4; 19,500x), MLY0513 osm3-l (5; 
15,200x), MLY1311 ssv9-l (6; 117,000x), MLY0109 (7; 19,500x), MLY0209 
ssv8-2 (8; 22,000x), MLY0109 (9; 14,000x), MLY0124 ^ ^ v i i - l (10; 29,500x) 
and MLY1006 (11; 22,000x) were prepared for electron microscopy as 
described in Materials and Methods. Some mutants accumulate organelles which 
probably represent prevacuolar compartments (e) (A-H, O, R, S). These 
organelles appear to be engulfed by the vacuole (F, arrow) and can be found in 
vacuoles that have lost part of its contents (M) or that are naturally electron 
transparent (d) (G, H). Some mutants are probably unable to take up these 
organelles which as a result accumulate around the vacuole (J). A small 
proportion of class C mutants accumulate membrane enclosed structures that 
have been previously suggested to be lipid bodies (1) (K, L) altough they also 
may represent aberrant vacuoles that do not accumulate glycoproteins. One 
strain (ssvlO-1) has smaller "e" structures (p) (N), while others accumulate "e" 
structures that have a aberrant shape (O) or appear to fuse or divide (P). 
Vacuoles also are able to take up cytoplasmic material (Q-S), or to locate 
adjacent to the plasma membrane (T). Vacuoles in a normally class C strain (C, 
D) form in 5% of all buds and are sometimes surrounded by little vesicles (U). 
Mixed population phenotype was observed in some ssvl 7 alleles (V-Y). 
Berkeley bodies (z) (Z-3), autophagic vacuoles (a) (4), Golgi structures (g) (6,7) 
and tubules (y) (8) were also observable. Some mutants had disrupted (9) or 
intact (11) vacuoles that occupied an overproportional volume of the cell. 
Crystal-like structures (x) were detectable in ssvll-l (10). 
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4.2.4. Sensitivity to other high osmotic strength compounds 
Since the mutants were selected on the basis of sensitivity to 1.5 M NaCl, they 
were subjected to plate assays to assess their ability to grow if other osmotically active 
components besides NaCl were added as a supplement to the medium. Al l mutants 
failed to grow on YPD medium containing 2.0 M sorbitol or 2.0 M glycerol, showing 
that they are truly osmosensitive and not selectively sensitive to Na"*" or CI' ions (Table 
4.9). Only ssvl5-l showed weak growth i f sorbitol or glycerol was the osmotically 
active substance. The fact that among the type alleles screened none had a selectively 
sensitive growth phenotype to NaCl or to other osmotically active components is 
potentially useful to interpret the nature of the mutants isolated in this study. 
Type allele Growth after 7 days on 
1.5 M NaCl 2.0 M sorbitol 2.0 M glycerol 
_ _ _ _ 
ssvl-S 
s^v2-l - - . 
ssv3-l 
ssv4-\ . _ -
ssv5-2 
ssv6-l 
ssv7-l . . . 
SSV8-2 
ssv9-l - - . 
ssvlO-l 
ssvll-\ . . . 
ssvl2-\ 
ssvJ3-l 
ssvl4-l - . . 
^^vi5-l - (-) (-) 
ssvl6-l 
ssv-\0O 
ssv-n3 
ssv-124 -
Table 4.9: Osmosensitive phenotype of representative type alleles of all ssv 
complementation groups. The mutants were tested for their ability to grow on 
YPD supplemented with different osmotically active compounds. Except ^ 5v75-
1 which showed some growth on YPD supplemented with 2.0 M sorbitol or 2.0 
M glycerol, all other ssv mutant alleles failed to grow on medium supplemented 
with different osmotically active compounds, unlike their isogeneic wild type. 
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4.2.5. Differential Growth Inhibition by NaCl and Sorbitol 
The effect of two different osmosensitive growth inhibitors, NaCl and sorbitol, 
was tested on the wild type and a representative ssv mutant, ssvl-2. This study was 
initiated by the observation that the osmosensitive phenotype of all ssv mutants was 
absolute in that no growth was observed after 21 days on YPD + 1.5 M NaCl, while 
some growth could be detected on YPD agar supplemented with 2.5 M sorbitol after the 
same time and thus were still viable and able to grow. Two log-phase cultures of 
SEY6210 (wt) and MLY0106 {ssvl-2) were dUuted to 2 x 10^ cells/mL into YPD, YPD 
+ 1.2 M sorbitol, YPD + 2.5 M sorbitol and YPD + 1.5 M NaCl. Growth was recorded 
at the start of the experiment immediately after inoculation (t=0) and after 24 hours 
(t=24) incubation at 30°C and 140 rpm by determining viable cell counts and total cell 
counts (Figure 4.5). While there is no obvious discrepancy in cell numbers between the 
wild type and the mutant grown in YPD after 24 hours, some growth inhibition occurs 
for both mutants in YPD + 1.2 M sorbitol. The growth of the ssvl-2 mutant is impeded 
at 2.5 M sorbitol, although growth itself is not completely inhibited. The use of 1.5 M 
NaCl as a supplement inhibits active growth of the mutant and severely impedes wild 
type growth. While the wild type total cell counts and the viable cell counts are in good 
agreement, no viable mutant cells could be recovered even at t=0 hours, strongly 
suggesting that 1.5 M NaCl is lethal to the mutant almost instantly (within 
approximately 10 seconds after inoculation after which a sample was taken), while 
sorbitol does not have such a drastic effect. These findings are indicative for a 
differential effect of osmotically active components on cell growth or survival. While in 
case of sorbitol the presence of the osmotically active compound alone is not sufficient 
for lethality, other osmotically active components are lethal i f the strain carries a 
mutation in a gene confering osmosensitivity. This suggests the presence of an 
osmoregulatory mechanism in wild type yeast that facilitates the instant adaptation of 
the cells to an otherwise lethal environment. The adaptation to other osmotic stress as 
for example in the presence of sorbitol or glycerol appears to be mediated by the same 
mechanism, although this osmotic stress does not result in the killing of all cells and 
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allows growth to continue. Since all mutants showed growth on 2.5 M sorbitol 
supplement to YPD agar but not to 1.5 M NaCl supplement this suggests that all 
mutants examined (4.2.4.) are defective in the instantaneous osmoadaptation response. 
This was tested by diluting a middle log phase culture to 2 x 10^ cells/mL in YPD + 1.5 
M NaCl medium, and taking a sample for viable ceU counts after 30 seconds. Except for 
the wild type, all ssv type alleles, namely ssvl-2, ssv2-\, ssv3-\, ssv4-\, ssv5-2, ^^v6-l, 
w v 7 - l , ssv8-2, ssv9-7, ssvlO-\, ssvll-\, ssvl2-\, ssvl3-\, ssvl4-\, ssvl5-\, ssvl6-l, 
55V-100, 55V-123 and 55V-124 were not viable when plated out onto YPD agar plates. 
Also interesting is the fact that equiosmolar amounts of sorbitol have a differential 
growth inhibitory effect on the wild type. 
4.2.6. Ca2+-Sensitive Alleles Among ssv Mutants 
Ca2+ uptake and homeostasis is facilitated by the vacuole, and a number of 
mutants deficient in this function have been isolated, most of which had vacuolar 
morphology or vacuolar ATPase defects (Kitamoto et ai, 1988; Ohya et al., 1991). To 
test i f the ssv-mutants exhibited similar defects, representative type alleles were 
streaked out onto freshly prepared YPD agar supplemented with 100 mM CaCl2. 
Growth was recorded after 48 hours (Table 4.10). Only 3 alleles of the alleles tested 
exhibited a calcium sensitive phenotype (c/5), of which the 55v2 - l mutant allele was 
only slowed in growth, but not completely defective. Growth of the mutant alleles 5 5 v i -
1 and ssv4-\ was inhibited completely by the concentration of calcium used. The three 
mutant alleles tested did have aberrant vacuolar morphologies, of which ssv3-\ did not 
have any vacuoles, and 55v2 - l had class B vacuoles. It is not known if the calcium 
sensitive growth defect was caused by a primary vacuolar defect. In the case of 5 5 v i - l it 
seems likely that the absence of a vacuolar compartment diminishes the cell's potential 
to regulate its cytoplasmic Ca^ "*" concentration. The partial growth defect of the vacuolar 
class B allele 55v2 - l might be a consequence of the disturbed assembly of the vacuolar 
compartment. Other definite class C alleles, e.g. ssv9-l, were not calcium sensitive. A 
possible explanation is that in this allele the homeostatic function of the vacuole is 
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taken over by another compartment, or residual vacuolar or prevacuolar compartments 
function analogously. Previously isolated mutants defective in the vacuolar ATPase had 
a calcium sensitive phenotype and also were Pet" (Ohya et ah, 1991). Only one of the 
calcium sensitive ssv alleles, ssv5-l, is also defective for growth on non-fermentable 
carbon sources (4.2.7.), Considering its class C vacuolar phenotype it is unlikely its 
primary defect is in the vacuolar ATPase. The ssvi-l allele is very slow in growth, and 
all other vacuolar sorting defects are the most severe observed, and it is likely that this 
mutant is a genuine vacuolar mislocalization mutant. 
Type allele Growth on YPD Growth on YPD + 100 mM CaCl2 
wt + -1-
55v7-8 + + 
5SV2-1 + (+) 
55V5-1 + -
55V4-1 + -
s5v5-2 + + 
55V6-1 -1- + 
S5V7-1 -1- + 
S5VS-2 + + 
s5v9-7 + + 
55ViC»-l + + 
s s v i i - l + + 
5SVi2-l + + 
5 S V i i - l + + 
ssvl4-\ + + 
ssvl5'\ + + 
ssvl6-\ + 
ssv-lOO + + 
SSV-123 + + 
ssv-124 + + 
Table 4.10: els phenotype of ssv mutants. Strains were judged for their ability to grow 
on YPD supplemented with CaCl2 to 100 mM after 48 hours. Three alleles, 
ssv2-l, ssv5-l and ssv-^-l were sensitive to 100 mM CaCl2, where ssv2-l 
displayed an intermediate phenotype in that it displayed partial growth under the 
above conditions. Al l other ssv-mutants displayed wild type growth behaviour. 
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Figure 4.5: Differential growth inhibition by equiosmolar concentrations of sorbitol 
and NaCl. Log phase SEY6210 (wt) and MLY0106 issvl-2) cells were dUuted 
into YPD, YPD + 1.2 M sorbitol, YPD + 2.5 M sorbitol and YPD + 1.5 M NaCl. 
Growth was recorded immediately after dilution of the starter cultures and after 
24 hours incubation at SO C^ (A). To emphasize the lethal effect of NaCl on ssvl-
2 the results described above are drawn to a different scale (B). Data of this 
analysis are the average from three independent measurements. 
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4.2.7. Growth on Non-fermentable Carbon Sources 
A number of previously isolated vps mutants failed to grow on non-fermentable 
carbon sources such as glycerol (Raymond et al, 1992) giving them an identical 
phenotype to mitochondrial Pet' mutants (Sherman, 1963). Since the vacuole might 
participate in some aspects of glycolysis (see Introduction), representative j^v-type 
alleles were tested for their Pet' phenotype on YPG medium (Table 4.11). A number of 
mutants, usually alleles with more severe ssv defects, also had a PET' phenotype. 
Except ssv6-\ and ssvlO-\, which have a class A vacuolar morphology, all other alleles 
were either class B or class C. Some vps mutant alleles, usually with more severe 
morphological defects (Dulic and Riezman, 1989), were also defective for growth on 
glycerol. Their defect was not associated with a mitochondrial defect. Al l ssv mutants 
unable to grow on on glycerol as carbon source were not tested whether the defect was a 
result of a mitochondrial mutation. 
Type allele Growth on 
YPD YPG 
wt + -1-
ssvl-2 -1- -
ssv2-\ -1- + 
ssv3-\ + -
ssv4-\ + + 
ssv5-2 + + 
ssv6-\ + -
ssv7-\ + -
SSV8-2 -1- + 
ssv9-l -1- -
ssvlO-\ -1- -
ssvl 1-I -1- + 
ssvl2-l -1- 4-
ssvl 3-1 + ++ 
ssvl4-l -1- + 
ssv 15-I + + 
ssvl 6-1 + -1-
.y^v-lOO + -
55V-123 + -
55 V-124 + -
Table 4.11: Growth of 55v mutant alleles on YPG. 55v type alleles were streaked out 
onto YPD (control) and YPG. Plates were incubated at 30°C for 48 hours. 
Generally Pet" mutants did not grow on the medium at all, unlike mitochondrial 
petite mutations which grow to small size colonies. 
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4.2.8. Temperature sensitive alleles 
Since the osmosensitive phenotype and sensitivity to elevated temperamre 
cosegregate in mutants lacking vacuoles (Banta et ah, 1988), and vacuolar function may 
also be required for growth at 37°C (Klionsky et al., 1990), all osmosensitive mutants 
isolated in this study were tested for their ability to grow on YPD agar at putatively 
restrictive temperatures of 31°C and 390C (Table 4.12). 
Type allele Growth after 48 hours at 
240C 370c 390c 
wt + + + 
SSV7-8 + + 
ssv2-l + + + 
ssvJ-1 + - -
ssv4-l + + + 
ssv5-2 + + + 
ssv6-l + + -
ssv7-l + + -
ssv8-2 + + -
ssv9-l + - -
ssv9-7 + 4- + 
ssviO-1 -1- -
ssvi i - l + + + 
ssvi2-l + + + 
ssv i i - l + + -
ssvi4-l + + + 
ssvi5-l + + + 
ssvi6-l + + -
ssv-lOO + + + 
ssv-123 + + + 
ssv-124 + + -
Table 4.12: Temperature sensitive growth of ssv mutants. Type alleles of all 55^-
complementation groups were streaked onto YPD agar and incubated at the 
indicated temperatures. The growth phenotype was scored after 48 hours 
incubation. Growth or temperature sensitive growth were unambiguous in that ts 
mutant alleles did not grow at all while temperature resistant alleles grew to 
large colonies. 
It was found that most osmosensitive alleles did not confer temperature sensitivity 
to growth at 37°C. Only two complementation groups had a ts allele each which 
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cosegregated with the osmosensitive phenotype (ssv3-l and ssv9-l), suggesting that the 
vacuole itself is not necessarily required for survival under elevated temperature stress. 
Also, light microscopic examination of ssv5-l and ssv9-l grown at both 24°C and 24°C 
which then were shifted to 37°C for 2 hours revealed that the mutants do not have 
vacuoles at either temperature. A number of mutants showed temperature sensitive 
growth at 39^0 (Table 4.12). These mutants had generally severer vacuolar morphology 
defects than those that sustained growth at 39°C, although there is no direct correlation 
detectable between temperature sensitivity and vacuolar morphology. For example, 
ssv9-7, a vacuolar class C allele, did grow at 39°C. The cosegregation of the 39°C 
sensitive growth phenotype with the ssv phenotype was not assessed. The experimental 
findings dispute the previously suggested role of the vacuole in adaptation to elevated 
temperature (Banta et al., 1988), since all severe class C alleles described in this study 
with one exception are not temperature sensitive. On the other hand, not all alleles of 
class C vacuolar mutants isolated so far are temperature sensitive, suggesting that 
temperature sensitive growth is a property of the aberrant gene product rather than a 
defect resulting from the absence of a vacuole. 
4.2.9. Secretion of Vacuolar Proteinases 
Mutants in each complementation group were tested for the secretion of one of 
several vacuolar proteinases in a non-lysing colony immunoblot. It was found that some 
alleles of each complementation group secreted several soluble vacuolar enzymes, 
namely CPY, proteinase A (PrA) and proteinase B (PrB), to different degrees (Table 
4.13; Figure 4.6). 
Table 4.13: Qualitative secretion of soluble vacuolar proteins. 
Strain Secretion of 
PrA PrB CPY 
SEY6210 - = -
SEY6211 ND 
15113-8 ND ND ++ 
14121-26 ND ND ++ 
0552-11 ++ + ++ 
MLYOlOl + ND 
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Table 4.13 - continued 
Strain 
PrA 
Secretion of 
PrB CPY 
MLY0103 + - + 
MLY0104 + - + 
MLY0107 ND ND + 
MLY0108 ND ND + 
M L Y O l l l -f-+ ++ 
MLY0116 ++ ++ 
MLY0117 + + + 
MLY0120 -t-+ ++ ++ 
MLY0121 -1- -1- -
MLY0124 - + + 
MLY0126 ND ND + 
MLY0134 + -
MLY0139 + + + 
MLY0202 ++ ++ 
MLY0304 ++ ++ 
MLY0307 ND ND ++ 
MLY0309 ++ - - H -
MLY0310 ++ + ++ 
MLY0402 ND ND + 
MLY0416 + + -
MLY0419 + + ++ 
MLY0508 ++ 
MLY0512 - - -
MLY0513 - -
MLY0522 + ND ND 
MLY0524 ND ND + 
MLY0526 -i-i- + 
MLY0527A + ++ + 
MLY0527B + + + 
MLY0601 ND ND + 
MLY0701 ++ ++ 
MLY0702 - - -
MLY0704 ND ND - H -
MLY0705 (+) - -
MLY0709 (+) - -
MLY0712 + -1- -H-
MLY0713 + + -
MLY0716 + ND ND 
MLY0725 - - + 
MLY0729 ++ ++ 
MLY0731 - -1- + 
MLY0732 -1- + + 
MLYlOOl ND - -
MLY1002 -t- - -
MLY1005 ND - -
MLY1006 + - -
MLY1105 -1- -1- ND 
MLY1143 -1- ND ND 
MLY1153 + ND ND 
MLY1156 ++ + ++ 
MLY1161 i+) - ++ 
MLY1214 + + 
MLY1233 - - -
MLY1309 ND ND + 
MLY1311 + -1- + 
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Strain 
PrA 
Secretion of 
PrB CPY 
MLY1315 ND ND + 
MLY1330 - - -
MLY1332 - - -
MLY1511 + + + 
Table 4.13: Qualitative secretion of soluble vacuolar proteins in ssv mutants. Secretion 
of vacuolar proteinases was detected in a non-lysing colony hybridization blot. 
The secretory phenotype was assessed by comparison to the isogenic wUd type 
strain SEY6210 as a negative control (-) and strain 0552-11 (ypsii) as a positive 
control (+) which were included in every filter examined. ND = not determined. 
Although the colony blot allows detection of secretion of vacuolar proteinases, a 
quantification was hardly possible because different vacuolar precursors have different 
stability (Rothman and Stevens, 1986) and the different antisera used appeared to have 
different specific binding. The results of the immunoblot were quantified by 
immunoprecipitation of vacuolar proteinases from yeast sphaeroplasts and culture 
supernatant. It has been demonstrated before that sphaeroplasts behave identically to 
intact yeast cells in terms of protein secretion and protein sorting (Robinson et al., 
1988). This method has the advantage over using intact cells for pulse-chase 
experiments with subsequent sphaeroplasting in that accidentally lysed sphaeroplasts or 
cells do not distort the secretion pattern. The immunoprecipitations showed that 
vacuolar enzymes are mislocalized into the medium, although not necessarily to a high 
degree (Table 4.14). Alleles of complementation groups ssv5, ssv9, ssvi6 and ssv-lOO 
secreted more than 50% of CPY, ssvi, ssv8, ssvlO, and ssv]5 mislocalized between 20 
and 50% of CPY (Figure 4.7). A l l other complementation groups secreted CPY between 
7 and 20%. The results show that only the 68 kDa CPY precursor is secreted, never the 
61 kDa mature form. Therefore, the mislocalization occurs before vacuolar localization 
where the PrA mediated proteolytic processing of CPY takes place. Alleles of ssvi and 
ssv9 (ssvi-1, ssv9-l and ssv9-7) were unable to process intracellular CPY to its mature 
form, although PrA was present in both mutants. PrA (Figure 4.8) and PrB (Figure 4.9), 
the two other soluble vacuolar hydrolases tested for, are significantly secreted in only a 
225 
few mutants mutants. PrA is secreted in 55v i , 55v i2 and 55v75 to any significat degree, 
although it accumulates as 48 kDa precursor in 55^^, 55v5, 55v6, 55V7, 55v5, 55v9, 5 5 v i 6 
and 55V-100. Similarly, PrB is secreted only in 55v7 and S5v-100 and accumulates as 42 
kDa precursor in 55v9 only (Table 4.14). The precursor form(s) of the respective 
proteinases are accumulated in some mutants (Figures 4.8 and 4.9). The 55v5 - l and 
55v72 - l alleles examined for secretion of CPY by immunoprecipitation and 
autoradiography were unable to produce any significant amount of CPY during the 
pulse-chase period, although PrA and PrB were synthesized to a normal degree. 
Immunoprecipitated CPY from supernatant and intact spheroplasts was washed and 
SDS eluted as were the other strains, except that the radioactivity was determined by 
scintillation counting of both fractions. Pulse-chased vacuolar precursors of a wild type 
control retained over 95% of immunoprecipitable radioactivity intracellularly. The 
pattern of mislocalization in representative 55v mutants suggest that apart from s5v / , 
55v5, 55v9, ssvlO, ssvl 6 and 55V-IOO the other mutants do not mislocalize CPY to a 
significant degree. Among the significant secretors two are identical with known vps 
mutants (see above). PrA is secreted in 55vi and 55v i2 only, while PrB is secreted in 
55v7 and 55V-IOO only. Thus only 55v7 secretes all three vacuolar proteins tested for. 
PrA and PrB accumulate in a number of mutants suggesting that their mislocalization 
does not lead to secretion. Instead, PrA appears to be accumulated in a compartment 
different from the vacuole, while PrB appears to be matured in all mutants excepting 
55v9. Since PrB maturation depends on PrA, this maturation must be catalyzed by 
residual vacuolar PrA (most mutants accumulating PrA have a small mature pool). 
Together these findings suggest the following: the vps defect in ssvl affects a 
compartment common to all three vacuolar enzymes. Other mutations secreting CPY 
except 5 5 v i 2 selectively affect the CPY sorting compartment (in 55V-100 also the PrB 
sorting compartment) and/or lead to an accumulation of PrA. This is indicative for 
differential sorting of all three enzymes, and also suggests that PrA and CPY are 
shuttled to the vacuole by a different mechanism. The 55v mutations in 55v5, 55vS, and 
S5V-100 might primarily affect the PrA trafficking machinery, resulting in some 
marginal effect on CPY sorting. 
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Figure 4.6: Non-lysing colony hybridization immunoblot of ssv mutants. Type alleles 
of each complementation group were tested for the secretion of PrA, PrB and 
CPY after blotting whole growing patches onto nitrocellulose over a period of 
10 hours. The nitrocellulose blot was developed as described in Materials and 
Methods. 
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Colony blot assay testing for 
secreted vacuolar enzymes 
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Figure 4.8: Secretion of PrA in 55v mutants. Lanes P and S of each mutant show the 
immunoprecipitation of PrA from sphaeroplasts and culture supernatant 
respectively. Bands of approx. 48 kDa represent the PrA precursor, and at 42 
kDa the proteolytically processed mature form is seen. 
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Figure 4.9: Secretion of PrB in ssv mutants. Lanes P and S of each mutant show the 
immunoprecipitation of PrB from sphaeroplasts and culture supernatant 
respectively. Bands of approx. 42 kDa represent the CPY precursor, and at 33 
kDa the proteolytically processed mature form is seen. The extra band around 40 
kDa is probably an intermediate in PrB processing 
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Relative secretion of 
s sv a-gls CPY PrA PrB a-ms 
WT 0% 0% 0% 0% 0% 
ssv1-2 2% 51% 51% 32% 38% 
ssv2-\ 2% 10% 5% 3% 13% 
ssv3-\^ 2% 71% 3% 5% 42% 
ssv4-\ 5% 5% 5% 5% 46% 
ssv5-2 3% 10% 4% 4% 25% 
ssv6-\ 1% 5% 1% 4% 17% 
ssv7-\ 4% 10% 1% 6% 21% 
ssv8-2 3% 35% 8% 3% 102% 
ssv9-l 1% 71% 8% 7% 47% 
ssvlO-l 7% 25% 2% 5% 44% 
ssvll-l 1% 5% 5% 1% 54% 
SSV12-P 3% 33% 56% 5% 28% 
ssvl3-l 1% 4% 2% 4% 114% 
ssvl4-l 2% 7% 10% 6% 119% 
ssvl5-l 1% 22% 20% 10% 14% 
ssvl6-l 4% 80% 10% 1% 77% 
ssv-lOO 5% 64% 5% 45% 75% 
ssv-\23 2% ND ND ND 12% 
ssv-124 1% ND ND ND 41.6% 
Table 4.14: Relative secretion of vacuolar hydrolases proteinase A, B, carboypeptidase 
Y, a-mannosidase and of a-glucosidase, a cytoplasmic marker. The relative 
secretion of a-mannosidase (a-ma) and a-glucosidase (a-gls) of periplasmic 
and cellular fractions of the ^^v mutants was determined enzymatically, whereas 
the values for relative secretion of CPY, PrA and PrB were obtained by 
quantifying intracellular and secreted fractions on fluorographs using an LKB 
laser densitometer. ND = Not determined, % secretion was determined by 
immunoprecipitating vacuolar enzymes with subsequent scintillation counting 
(see text). 
Mutant strains were transformed with the preproCPY-invertase fusion plasmid 
pCYI433 (Bankaitis et al., 1986), encoding an in-frame fusion of prepro-CPY and 
invertase. This hybrid protein retains vacuolar targeting information. Transformants 
were subsequently assayed for the presence of the invertase activity in the total cell 
fraction and in the periplasm. The results show that in all ssv mutants some of the fusion 
peptide is mislocalized to the periplasm compared to the wild type where it is correctiy 
delivered to the vacuole (Figure 4,10). Overall, the levels of secreted invertase are 
similar to those determined by immunoprecipitation of CPY, except in ssv3 and ssvl3 
where significantiy less of the CPY-Inv fusion is mislocalized than CPY, and in ssv4 
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and ssv7, where the mislocalization effect of the fusion peptide is more severe than that 
of CPY. Al l heterozygous diploids of representatives of each complementation group, 
which harboured pCYI433, were recessive for the mislocalization of the CPY-Inv 
fusion (Figure 4.10). However, some representative alleles were not fully 
complemented by the wild-type allele. ssvlO, ssvll, ssvll and ssvl5 were fully 
complemented whereas ssvl6-\ still showed 20% secretion of CPY-Invertase in the 
heterozygous diploid. These particular mutants are truly recessive for the osmosensitive 
phenotype (Table 4.3 and 4.4). 
Mutants were also tested for mislocalization of a-mannosidase into the periplasm 
or the cell surface (Table 4.14). Although recent evidence suggests that this membrane 
associated vacuolar enzyme does not transit through the secretory pathway to the 
vacuole (Yoshihisa et ah, 1990), all ssv mutants mislocalize a-mannosidase at 
significantly higher levels than the wild-type. ssv8, ssvl3 and ssvM mislocalize 100% 
of the total a-mannosidase activity. In the other complementation groups the levels of 
mislocalization are similar to that of the soluble vacuolar enzymes. 
Al l mutants retained a-glucosidase, a cytoplasmic marker enzyme, strongly 
suggesting that the vacuolar protein sorting defect is genuine and not due to leakage of 
cytoplasmic content (Table 4.14). This result is supported by the fact that all ^^v 
mutants examined for secretion of vacuolar proteinases only secrete the p2-forms of 
vacuolar proteins but not the unglycosylated pp-forms, suggesting that the presence of 
the vacuolar proteinases in the external fraction is due to a missorting defect at a post-
Golgi stage rather than a leakage of freshly synthesized precursor. 
4.2.10. Cosegregation of Mutant Phenotypes 
Random spores isolates of each back-crossed mutant strain were examined for 
cosegregation of the different mutant phenotypes. In only two cases (55vi-l and ssv9-\), 
temperature sensitivity, vacuolar morphology, osmosensitivity and secretion of one or 
more vacuolar enzymes cosegregated and probably are allelic. A cosegregation of 
osmosensitivity, vacuolar morphology and the secretion of vacuolar hydrolases in all 
232 
other non-temperatiu-e sensitive alleles of all complementation groups where examined 
could be demonstrated (Table 4.15). 
Strain OSM osm ts vam 
MLYOlOl 38 38 0 38 A 
42 0 0 42 A 
MLY0103 13 13 0 13 A 
(ssvlO-l) 67 0 67 A 
M L Y O l l l 13 13 0 ND 
{ssv2-2) 35 0 0 ND 
MLY0117 7 7 0 ND 
{ssv2-l) 1 0 0 ND 
MLY0121 6 6 0 ND 
10 0 0 ND 
MLY0124 0 0 0 ND 
(ssvll-\) 24 ND 0 ND 
MLY0134 11 11 0 ND 
issv8-l) 13 0 0 ND 
MLY0139 9 9 0 9 A 
issvl2-l) 71 0 0 71 A 
MLY0304 5 5 0 ND 
(ssvl-6) 11 0 0 ND 
MLY0309A 16 16 0 ND 
{ssv7-l) 32 0 0 ND 
MLY0310 5 5 5 5Ar 
issv9-l) 19 0 0 ND 
MLY0416 10 5 0 ND 
14 0 0 ND 
MLY0512 34 34 0 34 A 
46 0 0 46 A 
MLY0513 5 0 0 ND 
{osm3-l) 24 0 0 ND 
MLY0522 6 6 0 ND 
2 0 0 ND 
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Strain OSM osm vps ts vam 
MLY0526 5 5 0 5 A 
(ssvlS-l) 75 0 0 75 A 
MLY0527A 24 24 24 ND ND 
(ssv6-l) 0 ND ND ND ND 
MLY0527B 12 12 12 ND 
9 0 0 ND 
MLY0701 30 30 0 30 A 
(ssvM-l) 60 0 0 30 A 
MLY0705 11 0 0 ND 
iosm4-l) 12 0 0 ND 
MLY0709 5 0 0 ND 
(ssvl9-l) 3 0 0 ND 
MLY0713 6 6 0 ND 
9 0 0 ND 
MLY0716 4 4 0 ND 
20 0 0 ND 
MLY0729 12 12 0 ND 
{ssv5-2) 12 0 0 ND 
MLY0731 0 ND ND ND 
issv5-3) 16 ND 0 ND 
MLY0732 11 11 11 ND 
issv3-\) 13 0 0 ND 
MLY1002 3 3 0 ND 
21 0 0 ND 
MLY1105 15 15 0 ND 
{ssv7-2) 9 0 0 ND 
MLY1143 5 5 0 ND 
(ssvl-S) 3 0 0 ND 
MLY1153 2 2 0 ND 
(ssv]-9) 22 0 0 ND 
MLY1156 0 ND ND ND 
issvM-l) 8 0 0 0 ND 
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Strain OSM osm vps ts vam 
MLY1161 1 0 0 ND 
issv20-l) 17 0 0 ND 
MLY1214 3 3 0 ND 
{ssv9-6) 5 0 0 ND 
MLY1233 18 18 0 ND 
6 0 0 ND 
MLY1311 6 6 0 ND 
(ssv9-7) 10 0 0 ND 
Table 4.15: Cosegregation of pleiotropic phenotypes in ^ 5v-mutants. Random spore 
isolates were tested for osmosenstive growth {osm), vacuolar protein sorting 
defects (yps), temperature sensitive growth (jts) and aberrant vacuolar 
morphology (vam). The vps phenotype was determined in a non-lysing colony 
dot-blot, the vacuolar morphology was assessed under Normarski-optics. 
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Figure 4.10: Cosegregation of osmosensitive and vacuolar protein sorting defective 
phenotype in ssv mutants. Random spore isolates of heterozygous diploids 
between ssv mutants and their isogenic parent strain were tested for their 
phenotypes by subjecting each isolate to a series of tests (see text). The photo 
depicts a non-lysing colony dot-blot on several random spore isolates. The 
isolates were also tested for their sensitivity to 1.5 M NaCl and their growth at 
elevated temperature. Phenotypic traits were said to cosegregate if all spore 
isolates were either wild type for all phenotypic characters or all had all mutant 
phenotypes. 
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4.2.11. Dominance/Recessiveness of Phenotypes 
All pieiotropic phenotypes of the ssv mutants isolated and characterized so far are 
recessive with one exception: the vps phenotype of the ssvl6-l allele is semi-dominant 
(Figure 4.11). Especially no dominant osmosensitive phenotype was observable as is 
the case for a actl-l mutant allele (Tables 4.3 and 4.4). The dominance/recessiveness of 
the vacuolar defect in heterozygous diploids was not examined by subjecting the strains 
to a detailed electron microscopic examination. However, under Normarski interference 
microscopy all heterozygous diploids of ssv mutants and their isogenic wild type 
appeared to have vacuoles. Other studies (Banta et al, 1988) also suggest that vacuolar 
morphology defects are recessive in nature. 
4.2.12. Comparison With Other Osmosensitive Alleles 
A number of mutants with defective vacuolar function other than the ones 
described here have been isolated, such as vacuole inheritance (Weisman et al., 1990), 
vacuolar morphology (Wada et al., 1988), amino acid storage (Kitamoto et al., 1988), 
ion transport (Ohya et al., 1986), and acidification of the vacuole (Preston et al., 1989; 
Yamashiro et al., 1990). A partial genetic overlap of mutants deficient in different 
vacuolar functions with mutants defective in correct vacuolar protein targeting has been 
observed, stressing the complexity of vacuolar functions (Klionsky et al., 1990). 
Osmosensitivity has been reported in a number of different mutants, as for example 
actl-l (Novick and Botstein, 1985), osml, osml (Singh and Sherman, 1978) and some 
vps mutants (Klionsky et al., 1990). Al l alleles of each ssv complementation group were 
tested for complementation of the osmosensitive phenotype against all available 
previously identified osmosensitive mutants, namely vpsl, vpsll, vpsl5, vpsl6, vpsl8, 
vps33, vps34, actl-l, and osm2 (Tables 4.3 and 4.4). Except ssvl, which is allelic to 
vpsl, and ssvl5, which is identical to osm2, none of the other previously identified 
osmosensitive alleles overlap with the ones isolated in this study based on 
complementation of the associated osmosensitive growth phenotype. Representative ssv 
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mutants of each complementation group were tested for complementation of the Vps 
phenotype against representatives of all 47 yp^ complementation groups (Rothman et 
al., 1989) using a non-lysing colony dot-blot of purified diploids (M. Latterich and 
M.D. Watson, unpublished results; I . Howald-Stevenson and T.H. Stevens, unpublished 
results). Except ^^v7-2, which is allelic to vpsl, ssv9-l which is identical to vps33 none 
of the other ssv alleles are identical to any of the remaining vps genes (Table 4.16). It 
appears that the ssvl-1 allele is identical to vps33, also judged by its non-
complementation of the vps phenotype ( I . Howald-Stevenson and T. Stevens, personal 
communication). The allelism of the three mutant alleles could for the before mentioned 
reason not be confirmed. Complementation analysis of the ssv collection against the vps 
mutants screening for complementation of the vps phenotype confirmed that with the 
afore mentioned exceptions the ssv mutants are not identical to all known vps mutants 
( I . Howald-Stevenson and T. Stevens, personal communication). 
Also, none of the ssv mutants appears to be allelic to the actl-\ gene, since the ts 
phenotype is complemented by all ^^v mutants (the osmosensitive phenotype is 
dominant in actl-l). Mutants in three complementation groups defective in plasma 
membrane ATPase function are also osmosensitive (McCusker et al., 1987). Although 
no vacuolar defects have been reported in these mutants there remains the possibility 
that some of the ssv mutants are defective in a similar function and their vacuolar 
defects are of a secondary nature. 
Other vacuolar mutants, of which none were sensitive to osmotic stress, were 
selectively sensitive to cations such as Ca^ "*" at elevated concentrations (Ohya et al., 
1986). Although Ca^ "*" sensitivity has been associated with some vacuolar morphology 
mutants before (Wada et al., 1988), only three of the ssv alleles are moderately sensitive 
to the divalent cation {ssv2, ssv3, and ssv4) of which only ssv3 lacks a vacuole (Table 
4.10). Other vacuolar mutants were not available for complementation tests, and any 
statement/comparison is not possible at this stage. 
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Figure 4.11: Complementation of vacuolar protein mislocalization in ssv mutants in 
heterozygous diploids, using the CPY-Invertase fusion plasmid to quantify the 
vacuolar mislocalization defect. The values of relative secretion were obtained 
by division of the periplasmic fraction by the total invertase activity and 
corrected against the residual wild type activity. ssv-\23 and ssv-\24 (sterile) 
were not tested for complementation of the vacuolar protein mislocalization 
effect since they could not be crossed against the wild type. Each value represent 
the average of two independent estimations. 
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ssv Mutant Allele Genetic Overlap 
ssvl-2 vpsl 
^^v7-8 vpsl 
ssv1-1 vps33 
ssv9-2 to -71 vps33 
ssvl5-\ aro7-osm2 
Table 4.16: Genetic overlap between ssv mutants with previously isolated mutants. :^ 
The ssv9-\ allele complements the vps33 mutant and is thus not allelic. 
4.2.13. Other Associated Phenotypes 
There are other phenotypes associated with some mutants isolated in this study. 
So far most strains have only been analysed for vacuole biogenesis associated defects, 
but during routine procedures other pleiotropic defects were found. Two mutant strains, 
MLY0202 (wv-124) and MLY0712 (55V-125), were sterile judged by their inability to 
form diploids with any sfi-ain of opposite mating type (Table 4.3). 
Most ade2 strains lacking intact vacuoles did not accumulate the pink ade2 
fluorophore giving the strains an ADE2 appearance. This observation has been exploited 
to isolate some of the vam mutants (Wada et al., 1988). The ade2 ssv7-\ leads to an 
excessive accumulation of the ade2 fluorophore giving the strain a reddish appearance. 
The strain also has other associated defects, such as aberrant nuclear morphology and a 
cell cycle defect. The gene corresponding to the mutation has been cloned and 
sequenced (Chapter 6). 
4.2.14. Mutants in Metabolic Pathways With ^^v-like Phenotypes 
The fact that osm2-aro7, a mutant defective in chorismate mutase activity, is 
allelic to a ssv mutant is intriguing, and the ssv phenotype of the mutant has been 
examined in more detail (Chapter 7). A primary defect in chorismate mutase, an 
enzyme involved in aromatic amino acid biogenesis, results in a number of secondary 
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vacuole associated defects such as vacuole morphology and the secretion of vacuolar 
enzymes. This represents evidence for the vacuolar biogenesis being subject to 
metabolic control. One characteristic of previously isolated vps mutants is their defect 
in gluconeogenesis, and the question arises whether their primary defct is in vacuolar 
protein sorting or in gluconeogenesis. Also, the adaptive osmoregulatory response in S. 
cerevisiae is mediated by glycerol accumulation (Blomberg and Adler, 1989). Two 
mutants with defects in glycerol catabolism, gutl and gutl, have been isolated and 
found to be defective in glycerol kinase and glycerol phosphate dehydrogenase activity, 
respectively (Sprague and Cronan, 1977). The mutants were examined for their vacuole 
associated phenotypes to examme whether mutations in GVTl and GUT2 were 
osmosensitive for growth or had vacuolar defects as a secondary response. While both 
mutant alleles had normal vacuoles judged by immunofluorescence (data not shown), 
they were moderately osmosensitive for growth on YPD supplemented with 1.5 M NaCl 
compared to the wild type, but not as much as the other ssv mutants isolated in this 
study (data not shown). Both gutl-I and gutl-I had a strong vp^-phenotype in that they 
secreted up to 40% p2CPY and were unable to mature a large proportion to the vacuolar 
form (Figure 4.12). The question arises whether two different vps defects cause the gutl 
and gutl phenotype, or whether defects in glycerol catabolism provoke a vps phenotype. 
The nature of the primary defect in the two mutants makes it appear unlikely that the 
latter is true. 
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Figure 4.12: Secretion of CPY in SEY6210 (wild type), S5 (gutl) and S22 (gutl). 
Lanes P and S of each strain show the immunoprecipitation of CPY from 
sphaeroplasts and culture supernatant respectively. Compared to the wild type 
which has only 61 kDa matured CPY present intracellularly, both gutl and gut2 
secrete a large proportion of the 68 kDa precursor form of CPY (S) and also fail 
to mature part of their intracellular CPY (P). 
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4.3. Discussion 
A number of osmosensitive mutants in S. cerevisiae were isolated in an effort to 
identify and isolate genes involved in vacuole biogenesis and osmoregulation. Standard 
complementation analysis could assign the mutants to at least 23 complementation 
groups. A significant number of mutants showed weak complementation to alleles of 
most of the 22 groups and thus appear to have a semi-dominant phenotype. As most of 
these mutations fail to complement each other, they may all be members of a 
complementation group, ssvl7. Their novel complementation properties make this 
group a potentially interesting one for further investigation. Although the genetic tests 
employed in this study deserve caution when interpreting their results, it was observed 
that a large number of mutants did not complement mutant alleles of several distinct 
complementation groups. This non-complementation was allele specific, and is 
characteristic for proteins forming a multimeric complex. Two sterile osmosensitive 
mutants were also isolated {ssv-123 and ssv-124), but they have not been characterized 
further. Subsequent electron microscopic analysis of all mutants showed that alleles of 
17 complementation groups had an altered vacuolar morphology similar to that 
observed by Banta et ah, 1988, with five groups having alleles completely lacking a 
vacuole. A number of aberrant subcellular structures were detectable in some mutant 
strains such as autophagic vacuoles, aberrant membraneous structures with similarity to 
Berkeley bodies representing accentuated Golgi structures, and small vacuole-like 
compartments. These are similar to "organelles" that also accumulate in end! mutants 
which have been suggested to represent an intermediate in endocytosis (Chvatchko et 
al., 1986). The nature of this compartment has not yet been examined, although it 
should be fruitful to attempt an isolation and characterization. Its appearance using the 
reduced osmium-thiocarbohydrazide-reduced osmium procedure differs from that of 
vacuoles in that it has a center of low electron density, unlike vacuoles which have an 
uniform electron-dense appearence except with a confined region of electron 
transparancy representing polyphosphate crystals. Some mutant alleles contained a large 
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number of these compartments giving them the appearance of class B mutants. It would 
be tempting to speculate that these compartments represent a pre-vacuolar endosome. 
Some vacuolar class B mutants do not possess this compartment. In these mutant strains 
the putative prevacuolar compartment cauld fail to fuse with the vacuole, thus class B 
vacuoles representing "mature" prevacuolar compartments. The fusion of these 
compartments with the vacuole has been observed in some mutants, though not yet in 
wild type cells. If this fusion process occurs as part of normal vacuole biogenesis the 
fusion might be delayed in these mutants allowing the intermediates to be detected by 
electron microscopy. A less likely alternative explanation is that these compartments 
represent peroxysomes because the fusion of peroxysomes with the vacuole has been 
reported before (H.-L. Chiang, personal communication). However, peroxisomes should 
not be abundant or present at all in yeast grown on high glucose concentrations. A 135 
kDa glycoprotein (vgpl35) has been located to a probably prevacuolar compartment 
(Nishikawa et al., 1990). Immunolocalization of this protein to the putative prevacuolar 
compartment described here could test this hypothesis. 
Although a new vacuolar morphology classification scheme has been presented 
elsewhere taking account of the vacuolar membrane ATPase assembly based on 
immunofluorescence methods (Raymond et al., 1992), the morphological criteria in this 
study are largely based on electron microscopic data, partly because an assessment of 
other subcellular features was thought to be important and to be sufficient to adhere to 
the one proposed by Banta et al., 1988. The knowledge of detailed phenotypes, such as 
different vacuolar morphology, permits the application of epistasis analysis (Botstein 
and Maurer, 1982). However epistasis analysis is only feasible if the mutations to be 
analysed affect a linear pathway, such as genes in the secretory pathway. Vacuolar 
morphology could be subject to a number of independent pathways or bypass pathways 
and thus complicating the othewise informative analysis. Also, epistasis analysis 
requires the construction of double mutants by genetic means involving tetrad 
dissection, which was not possible to carry out during the time of this study. 
Some alleles of the identified complementation groups secreted several soluble 
vacuolar hydrolases and also a-mannosidase, a membrane associated vacuolar enzyme, 
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was mislocalized to the cell surface. The vacuolar protein missorting defect in all but 4 
cases (ssvl-2, ssv8-l, ssv9-l and 5^ v-100) was not as severe as in most other vps 
mutants previously isolated (Robinson et al., 1988; Rothman et al., 1989). Excepting 
one complementation group (ssvl5), mutants of a class C phenotype had more severe 
vacuolar protein mislocalization defects than alleles with a class A or class B 
phenotype. ssvl6-l (class B) secretes CPY and a-mannosidase at a comparable level to 
class C alleles. Mutants of vacuolar morphology class A and B still have an intracellular 
pool of mature CPY but secrete the precursor of CPY. Since the PrA dependent 
processing of CPY occurs in the vacuole, these mutants still have biochemically intact 
vacuoles, or functionally similar compartments. Thus the alleles which secrete only a 
fraction of the total vacuolar hydrolases, may have mutations that cause inefficient 
delivery of vesicles destined for the vacuole or change the fidelity of the sorting process 
as a result of another mutation in a different vacuolar function. Alleles of two 
complementation groups {ssvS and ssv9), which have no vacuoles, are unable to process 
the CPY precursor to the mature form and secrete a large proportion of it. This is most 
easily explained by the lack of mature PrA found in these strains. In this context it 
appears to be remarkable that ssvl5 lacks any detectable vacuole as judged by electron 
microscopy and still is able to mature a large proportion of the CPY synthesized (see 
Chapter 7). All other ssv mutants examined for their mislocalization and intracellular 
accumulation of PrA, PrB and CPY were able to mature all of the intracellularly 
localized vacuolar proteins, and only traces of vacuolar proteinase precursors were 
localized to the cell surface. Only ssvl-2, ssvl6-l, ssv-lOO, gull and to some extent 
gut2 accumulated both precursor and mature proteinases intracellulaly. Most vacuolar 
class B ssv alleles examined for their quantitative secretion of vacuolar proteinases 
secrete very little precursor, unlike previously isolated class B vps mutants which 
secrete vacuolar proteins almost quantitatively (Robinson et al., 1988). This difference 
is probably due to the mutant isolation strategies developed. Vacuolar class B alleles 
identified previously were isolated on the basis of a vacuolar protein missorting defect 
(Bankaitis et al, 1986; Banta et al., 1988). It is likely that the sorting defect results in an 
aberrant vacuolar morphology because putative proteins needed for vacuolar integrity of 
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fusion are not localized correctly. Class B ssv mutants were isolated on the basis of an 
osmoregulatory defect. While vps mutants are probably defective in sorting at the Golgi 
level or the putative receptor recycling and thus secrete vacuolar proteins, the ssv 
mutants isolated in this study could be defective in any hypothetical vacuolar function. 
While sorting in these mutants still can occur, subsequent requirements for vesicle 
transport and fusion might be disturbed in the mutation. Assuming unidirectionality of 
vesicular transport from Golgi to the vacuole and that it represents the main route by 
which the vacuole derives its constituents, the mutants will fail to form vacuoles but 
still may be able to perform part of their function in a prevacuolar compartment. 
Though no evidence for this hypothesis can be provided here, the accumulation of 
vacuole like compartments in some mutant alleles that failed to assemble a vacuole 
could represent such intermediates in vacuole biogenesis. 
Members of complementation groups ssv3 and ssv9 mislocalize not more than 
fifty percent of a-mannosidase although they lack a structurally recognizable vacuole. 
Mutants in other complementation groups, ssv8 (class B), ssvl3 (class B) and ssvl4 
(class A), mislocalize up to 100% of a-mannosidase, whereas less than 40% of soluble 
vacuolar enzymes are secreted. These findings are similar to previous studies of vps 
mutants which showed that only up to 50% of the total vacuolar hydrolase is secreted in 
four class C complementation groups (Robinson et al., 1988). The intracellular location 
of a-mannosidase and the soluble vacuolar enzymes was not further investigated, a-
mannosidase is not delivered to the vacuole via the secretory pathway, but it might be 
able to insert into the vacuole directly (Yoshihisa and Anraku, 1990). The simplest 
explanation for the mislocalization of a-mannosidase is that a hypothetical vacuolar 
transmembrane protein associated with the import of a-mannosidase is mislocalized to 
the cell surface causing a-mannosidase to subsequentiy insert into the plasma 
membrane. This explanation raises the question of how a vacuolar membrane protein 
can be sorted to the cell surface. Among several possibilities three appear plausible: 
vacuolar membrane proteins are actively sorted to the vacuole, and a mutation affecting 
part of the sorting process will result in a secretion of the proteins through the default 
pathway. Since membrane bound and even different soluble vacuolar proteins are sorted 
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independently (Klionsky et al., 1990; Paravicini et al., 1992) this interpretation of the 
results obtained in this study seems plausible. The mislocalization of other vacuolar 
membrane proteins has not been assessed. The active sorting process of membrane 
associated vacuolar proteins has recently been questioned (Raymond et al., 1992). 
Secondly, a cytoplasmic protein could mediate import of a-mannosidase by associating 
with the vacuolar membrane and directing the protein into the vacuole without having 
itself to take the secretory pathway. In ssv8, ssvlS and ssvl4 this protein could associate 
with the plasma membrane and direct translocation of a-mannosidase through the 
membrane. This model is supported by the fact that in early sec mutants translocation of 
a-mannosidase still occurs efficiently and there seems not to be a requirement for the 
import machinery to be translocated through the secretory pathway although they could 
be present on the vacuolar membrane before the blocking the secretory pathway is 
imposed (Yoshihisa and Anraku, 1990). Thirdly, the substrate for the a-mannosidase 
assay, p-nitrophenyl-a-D-mannopyranoside, could be transported into intact cells and 
hydrolysed in the cytoplasm or in the vacuole more efficiently than in the wild type. 
This explanation does not account for the fact that a-glucosidase, a cytoplasmic marker 
in yeast, is retained in the cell, arguing against a leaky plasma membrane. Several 
mutants such as vacl to vac4 (Shaw and Wickner, 1991; Weisman et al., 1990), vps3 
(Raymond et al., 1990) and vps34 (Herman and Emr, 1990) have been identified which 
appear to have delayed segregation of vacuoles to the growing bud. A few ssv isolates, 
as judged by light and electron microscopy, also show this defect. With the exception of 
vacl, which has a segregation defect but not a sorting defect, the other segregation 
mutants have also a vps phenotype. One possible explanation that is consistent with all 
available experimental data is that the sorting defect is responsible for the 
mislocalization of a component that serves the attachment onto the segregation 
apparatus to the cell surface. As an immediate result the vacuole is unable to segregate, 
and at a later stage will form de novo from Golgi derived material. The distribution of 
organelles seems to be mediated either by cytoskeletal elements, cytoplasmic movement 
or by attachment to the plasma membrane (Yaffe, 1991). Assuming that one of the 
cytoskeletal features attached to the vacuole is mutated in ssv mutants exhibiting a 
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segregation defect but not a sorting defect the osmosensitive phenotype can be 
explained by that either the vacuole will be destabilized under low water stress or that 
cytoskeletal mutants, like actin, are intrinsically osmosensitive irrespective of 
osmoregulatory function. There is evidence that both vacuoles and the mammalian 
lysosomes are associated with cytoskeletal proteins. Dynein has been localized to 
lysosomes (Lin and Collins, 1992) as has actin (Mehrabian et al., 1984) and 
microtubules (Matteoni and Kreis, 1987), of which the attachment of the latter is 
mediated by a 50 kDa protein in an ATP dependent process (Mithieux and Rousset, 
1989). Also, there is evidence that the organelle shape is dependent on movement along 
microtubules (Kachar et al., 1987). Thus, cytoskeletal elements are known to be 
associated with lysosomes and also to mediate movement of cytoskeletal elements. The 
unambiguous association of microtubules with vacuoles has not yet been demonstrated, 
and thus the formal possibility remains that vacuolar morphology as well as vacuolar 
segregation depends on some cytoskeletal element, possibly different from 
microtubules. 
By selecting for mutants involved in osmoregulation, mutants deficient almost 
exclusively in several vacuolar functions were isolated. This seems to suggest that in 
most cases osmohomeostasis and other vacuolar functions, such as protein sorting, 
vacuole biogenesis, or correct vacuolar assembly are inextricably linked, or that a large 
number of genes participate in vacuole mediated osmoregulation. Whether the 
osmoregulatory defect is primary and results in a number of secondary defects such as 
aberrant vacuole biogenesis or is a secondary defect as a consequence of vacuolar 
defects is difficult to judge at present, but evidence suggest that the latter is more likely. 
For example the absence of the vacuole (class C) always confers an osmosensitive 
phenotype as a result (Banta et al., 1988). However, three vps complementation groups 
and at least 18 ssv groups, which do not have a class C phenotype, also have 
osmosensitive alleles. This suggests that in cases where a vacuolar structure exists, only 
certain functions within these vacuoles are required for osmoregulation. Any defect in 
delivery of these osmotically active components to the vacuole, rather than vacuole 
biogenesis in toto, will cause an osmosensitive phenotype. Alternatively one gene 
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product could be required for different independent functions such as osmohomeostasis 
and vacuole biogenesis. The concept of bi- or multifunctional proteins is not new, and a 
recent study has assigned several roles to the endoplasmic reticulum protein disulphide 
isomerase (PDI) catalysing disulphide bridge formation and also representing the 
glycosylation site binding protein (LaMantia et ah, 1991; Noiva and Lennarz, 1992). 
The PDVGBP protein represents one protein with at least two separate, independent 
functional domains one of which is a catalytic site. It is known to catalyze the 
rearrangement of disulfide bonds of secretory proteins as well as being part of the 
prolyl-4-hydroxylase and it also represents the glycosylation site binding protein 
(LaMantia etal, 1991). 
A possible explanation for why some vps mutants are osmosensitive comes from 
the observation that most vps mutants in a pep4-3 background are osmosensitive, while 
pep4-3 mutants as well as all but seven vps mutants in a PEP4 background are not 
osmosensitive. An examination of the data of vacuolar protein mislocalization and 
maturation of PrA, PrB and CPY taken from Robinson et al., 1988, seems to suggest 
that in all osmosensitive vps alleles hardly any CPY, PrA and PrB are matured or 
enzymaticaUy active. Together with their extreme vps phenotype it seems possible that 
a component required for vacuole associated osmoregulation is partially mislocalized 
and the other fraction that is localized to the vacuole cannot be activated by PrA or a 
PrA activated secondary proteinase. Some ssv mutants accumulate the p2PrA, 
supporting this hypothesis. The osmosensitive phenotype of other ssv mutants isolated 
in this study which are not exhibiting extreme vps phenotypes or are maturation 
deficient, can be explained by that the selection for osmosensitive mutants specifically 
seclected for mutants which mislocalizes or inactivates the unknown osmoregulatory 
component but not other vacuolar proteins to the same extent. Another speculative 
alternative is that the vacuole has components that allow the immediate release of water 
from the vacuole into the cytoplasm to prevent precipitation of cytoplasmic proteins 
under altered osmotic conditions or water stress in the wild type before secondary 
measures such as regulation of water permeability by the plasma membrane can be 
taken. This is supported by the experimental evidence obtained in this study that salt-
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stress is not immediately lethal in the wUd type but is in all ssv mutants examined. 
These mutants could be defective in this pathway. Osmosensitive vps mutants could 
mislocalize these components to the cell surface and thus make this mechanism of 
immediate osmoregulation ineffective. 
Alternatively, some mutants could have aquired an osmosensitive phenotype 
because of a mutation in the osmoadaptive glycerol regulatory pathway, or a mutation 
which inactivates an essential gene product under osmotic stress. So far unknown is the 
nature of osmoregulation and how the vacuole participates in it. The results obtained 
from the isolation of salt-sensitive mutants suggests that the vacuole actively 
participates in at least some osmoregulatory response. Other studies have addressed the 
adaptive osmoregulatory response, which enables S. cerevisiae to adapt to osmotically 
active medium facilitated by the accumulation of glycerol to compensate for the 
osmotically active surroundings (Blomberg and Adler, 1989). The same studies show 
that in an exponential culture only 0.02% of yeast cells are viable when exposed to 1.4 
M NaCl, while stationary phase cultures are more osmotolerant as are cells that have 
been conditioned to low water stress. The results contradict the experimental results 
obtained in this study, because wild type yeasts cells remained viable after shift to YPD 
liquid medium supplemented with 1.5 M NaCl, and are able to grow albeit more slowly. 
It appears possible, though unlikely, that the low water potential will inhibit the growth 
of the majority of cells present in liquid culture and allows the small proportion of 
osmoresistant cells to actively grow, while the rest of the cells remains viable. The 
studies addressing the phenomenon of aquired osmotolerance (Blomberg and Adler, 
1989) plated samples of different cultures directiy onto YPD pour-plates supplemented 
with 1.4 M NaCl to test cells for osmotolerance, and only 0.02% of a exponential phase 
culture were able to form colonies. The difference in the experimental approach 
suggests that YPD -i-1.4 M NaCl pour-agar plates impose a different osmotic stress onto 
individual yeast cells and cells might not be able to exert enough force to the 
surrounding to grow to colony size. Also the brief heating to 42°C before pouring might 
have influenced the experimental outcome. Alternatively, sti-ain differences might 
account for the different findings. 
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Though glycerol plays an important part in a later response to osmotic changes in 
the surrounding (Blomberg and Adler, 1989), the same studies indicate that de novo 
protein synthesis is also required for the osmoadaptive response. This response is 
different from the heat shock induced trehalose accumulation in Schizosaccharomyces 
pombe which does not depend on de novo protein synthesis or hspl04 (De Virgilio et 
ah, 1990; De Virgilio et ah, 1991). The fact that unfavourable osmotic conditions such 
as 1.5 M NaCl present in the medium can terminally inactivate ssv mutants within 
seconds argues for the involvement of the vacuole in an immediate osmoregulatory 
mechanism that protects cells from cell death. The mutants isolated in this smdy are 
terminally inactivated by 1.5 M NaCl within 10 to 30 seconds. Other mutants were 
identified in the initial screening process which were inhibited in growth by the NaCl 
present in the medium but not killed, since they grew to small size colonies after 7 days. 
They were hot characterized further to avoid unambiguities in cloning the 
corresponding genes by complementation of the salt-sensitive phenotype. These 
mutants are probably involved in a defect in secondary osmoregulatory responses since 
they remain viable. The fact that after prolonged periods of incubation (21 days) ssv 
mutants grown on equiosmolar concentrations of sorbitol will grow to normal colony 
size is indicative for their ability to adapt to osmotic conditions, and the initial lag 
observed may be characteristic for a defect in an immediate osmoregulatory response 
but since sorbitol has a membrane protecting function it might not kill the cells. Another 
reason for the differential effect is that the presence of either sodium or chloride ions 
can trigger the release or exchange of other ions directiy or by changing the membrane 
potential. If the vacuole does not maintain its homeostatic function this process could 
lead to a depletion or intoxification of the cytoplasm followed by cell death. An 
osmosensitive mutant in A^ . crassa that is defficient in the accumulation of intracellular 
polyols is still able to increase its biomass although only by 10% when compared with 
the wild type (Ellis et al., 1991). Although these data were obtained from a filamentous 
fungus it strongly suggests that mutants defective in the accumulation of glycerol will 
be viable to some degree under low water pressure conditions. Unfortunately, the nature 
of the ssv mutants does not permit to test for the accumulation of glycerol as adaptive 
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osmotic response since the mutations confer lethality under low water pressure if NaCl 
is used as an osmolyte. Evidence corroborating the above considerations that .^yv 
mutants are not primarily defective in the adaptive osmoregulatory response come from 
a study in which a number of salt-sensitive mutants were isolated in 
Zygosaccharomyces rouxii {Debaryomyces hansenii) (Yagi and Toda, 1988). The 
mutants are deficient in their ability to synthesize glycerol under low water stress, 
maintain intracellular glycerol levels, take up glycerol from the medium or that had 
other defects. None of the mutants was salt-intolerant, unlike the ssv mutants which 
were isolated on the basis of salt-intolerance. Some bacteria accumulate K"*", amino 
acids and carbohydrates in their cytoplasm to prevent osmotic dehydration and to 
maintain turgor pressure (Elsheikh and Wood, 1990). The vacuole acts as store for K"*" 
and amino acids, and an immediate osmotic response also might involve the release of 
K"*" and amino acids to balance the osmotic gradient between cytoplasm and 
environment. A compromized vacuolar function can thus affect the immediate osmotic 
response of S. cerevisiae. Alternatively, the missorting of channels mediating an 
osmotic response to the plasma membrane might function properly under osmotic stress 
and drain the cytoplasm of osmoprotective components. 
When interpreting the results presented in this study, there remains the possibility 
that genes other than in vacuolar function have been identified. Mutations in other genes 
unrelated to osmoregulation can have an osmosensitive phenotype, such as the actl-\ 
mutant, osmosensitive suppressor mutants, mutants in members of the translation 
machinery, and so forth. It has been argued that osmosensitivity in these mutations is 
related to temperature sensitivity in that a different environment (osmotic stress or 
temperature stress) can inactivate an essential gene product or that a change in osmotic 
conditions can promote misreading during translation in osmosensitive suppressor 
mutants (Singh, 1977). This model still does not account for the irreversibility of the 
salt-induced inactivation and the fact that mutants in 21 out of 23 complementation 
groups had vacuolar defects. Alternatively, defects in the above mentioned pathways 
could have secondary defects associated with vacuole biogenesis. The allelism or 
identity of the ^^ v alleles with known osmosensitive suppressors could not be tested. 
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Some vacuolar class A ssv mutants could be defective in the assembly or specificity of 
ion transport channels located in the plasma membrane. By analogy, the HOLl-l,-lOl 
strain is hypersensitive to several ions due to a mutation altering the specificity of the 
HOLl encoded transporter protein (Gaber et al., 1990). Finally, single mutations can 
alter the characteristics of voltage gated ion channels by changing ion specificity 
(Heinemann et al., 1992), supporting the assumption that a point mutation could change 
specificities of ion channels. 
Since four ssv mutants mislocalize vacuolar enzymes to a greater extent, the 
question arises whether new osmosensitive alleles of previously identified vps mutants 
were isolated. A genetic overlap based on the complementation of the osmosensitive 
phenotype was observable only between ssvl-2 and vpsl. All other vps alleles which 
confer a salt-sensitive phenotype complement all ssv mutations. This has been 
confirmed by showing that in crosses between the 21 ssv complementation groups and 
the 47 vps complementation groups, only ssvl-2 and vpsl, and ssv9-7 and vps33 are 
identical based on the non-complementation of their vps phenotype. Other mutants 
isolated on the basis of different vacuolar defects, such as sensitivity to Ca^ "*", showed 
extensive overlap with vps alleles (Klionsky et al., 1990). Ca^"*" sensitive els mutants do 
not have an osmosensitive phenotype (Ohya et al., 1986), which suggests that ssv2, ssv3 
and ssv4 with Ca2+ sensitive alleles are not identical to els genes. Several properties of 
some of the mutants isolated in this study suggest interesting new aspects of vacuole 
biogenesis. For example, gluconeogenic growth relies on some vacuolar function, and 
many mutants in aspects of vacuolar biogenesis are unable to grow on non-fermentable 
carbon sources. A possible explanation is that in some vacuolar mutants the vacuolar 
membrane protein Pho8p, which corresponds to fructose-2,6-bisphosphate 6-
phosphatase, is not activated or its substrate fructose-2,6-bisphosphate (F2,6BP) cannot 
reach the vacuolar compartment. F2,6BP is produced in response to growth on glucose 
and disables gluconeogenesis by inhibiting fructose-1,6-bisphosphate 1-phosphatase 
and stimulating phosphofructokinase 1 to initiate glycolysis (Hers et al., 1988). If tiie 
regulatory F2,6BP cannot be degraded it will arrest gluconeogenesis. Thus a 
hypothetical vacuolar defect not allowing the degradation of F2,6BP would prevent 
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gluconeogenesis and lastiy growth on non-fermentable carbon sources. Another 
interesting though not desirable phenotype of exclusively all ssv mutants was their 
extremely low transformation efficiency. While electroporation was the only method 
these mutants could be transformed with, their efficiency was very low. One extreme 
was ssvl3-l which had a transformation efficiency of one transformant per 10 [Lg 
plasmid DNA. The nature of this defect is not known but could be associated with a 
vacuolar function since most class C vps mutants also transform badly (Banta et al., 
1988). 
So far the only SSV gene products which have been identified are those for SSVl, 
SSV9 and SSW5 by virtue of their identity with VPSl, VPS33 and 0SM2, respectively, 
and SSV7 which has been cloned and sequenced (Chapter 6). VPSl encodes a 80 kDa 
GTP binding protein related to mammalian Mx proteins (Rothman et al., 1990), which 
recentiy has been shown to be of significant homology to the microtubule bundling-
protein, dynamin (Yeh et al., 1991). It appears to play an essential role in vacuolar 
protein sorting, membrane organization, growth at elevated temperature and spindle 
formation during mitosis. Evidence suggests that Vpslp is associated with some 
intermediate structure in the protein transport pathway, possibly the Golgi-apparatus, 
although its function and mechanism of action are still obscure. It appears likely that in 
the mutant the osmosensitive phenotype and fragmented vacuoles are secondary defects 
since the protein is not directiy associated with the vacuole. Other small 21 kDa GTP 
binding proteins such as Yptlp, Sec4p and the rab homologues, all closely related 
members of the ras super-family, are involved in directed vesicle traffic (Balch, 1990). 
However, the role of an 80 kDa GTP-binding protein in organelle biogenesis is 
unknown. Generally proteins binding and hydrolysing GTP are participants in 
molecular switch actions (Bourne, 1988). This can serve the purpose of signal 
amplification as is the case in trimeric GTPases or function in irreversibility or 
directionality of biochemical processes such as protein biosynthesis and vesicle 
mediated transport reactions (Bourne, 1988; Bollag and McCormick, 1991; Rodbell, 
1992; Rothman and Orci, 1992). Vpslp binds and hydrolyzes GTP and associates with a 
membrane compartment which is probably identical with the Golgi apparatus (Rothman 
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et al., 1990; Raymond et al., 1992). Both its membrane association and GTPase 
function are required for its sorting function and deletions in either domain results in 
quantitative secretion of vacuolar hydrolases (C.K. Raymond and T.H. Stevens, 
unpublished results). Since it is localized on the Golgi compartment there remains the 
possibility that it acts in mediating transport from the Golgi to the vacuole. A few 
possibilities appear likely: Vpslp could associate with the Golgi and allow budding of 
hypothetical transport intermediates to occur, similar to Sarlp on the ER membrane 
(d'Enfert et al., 1991b). The fact that Vpslp remains associated with the Golgi is 
different to the situation from vesicle budding from the ER where Sarlp associates with 
Secl2p to enable budding but after this process is released following GTP hydrolysis. 
Vpslp could be a stationary molecular switch that signals the presence of receptor 
bound proteinases in the sorting compartment of the Golgi apparatus, and initiate the 
retrieval or budding mediated by other proteins. Since Vpslp is a dynamin homologue 
(Yeh et al., 1991) the possibility remains that it performs a function in a cytoskeletal 
motor process (Vallee and Shpetner, 1990). Maybe it mediates the hypothetical budding 
or scission process from the Golgi sorting compartment for which GTP hydrolysis is 
required. The N-terminal domain is reminiscent of similar domains in myosin and 
kinesin representing a "force-producing" head (Obar et al., 1991), which might function 
in the budding or scission of Golgi sorting vesicles, expecially since the bulk flow 
pathway is secrtion, and other budding processes might not rely on the force generated 
by lipid flow alone. The coexistence of constimtive Mx related proteins involved in 
intracellular transport and the mammalian Mx proteins induced in virally infected cells 
might suggest that the virally induced Mx proteins divert transport of viral particles to 
the lysosome rather than the cell surface (Amheiter and Meier, 1990). 
VPS33 encodes a hydrophilic protein of 691 amino acids with an ATP nucleotide 
binding site (Banta et al., 1990; Wada et al., 1990). Subcellular fractionation studies 
suggest that it is a cytoplasmic protein. The cellular function of this protein is currentiy 
not known, although certain alleles have an interesting phenotype in that they have a 
differential vacuolar segregation defect at 37°C. Most previously isolated vps33 alleles 
are temperature sensitive for growth, independent of whether they have vacuoles or not 
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(Banta et al., 1990). The vps33 alleles isolated in this study are not temperature 
sensitive, although some do not have a vacuole (e.g. ssv9-l). This shows that the 
vacuole itself is not necessary to grow at elevated temperature contrary to evidence 
presented before (Banta et al., 1988). 
0SM2 appears to be identical to AR07, which encodes chorismate mutase (Ball et 
al., 1986). The mechanism of how an enzyme involved in aromatic amino acid 
biosynthesis can influence protein targeting and vacuole biogenesis remains obscure 
(Chapter 7). The nature of the other ssv mutants is subject to speculation. A number of 
genes, including some coding for vacuole associated proteins, cytoskeletal elements and 
proteins mediating vesicle budding and fusion are likely candidates. 
In the following chapter an effort is made to elucidate the mechanism of 
osmoregulation in connection with vacuolar morphology or protein sorting in yeast by 
identifying and analysing the ssv genes and gene products. The present study already 
provides some preliminary evidence that the understanding of vacuole biogenesis is 
complicated by the fact that both vacuolar morphology and the sorting of vacuolar 
proteins is directiy or indirectiy under metabolic control. This phenomenon might also 
explain the large number of complementation groups involved in vacuolar protein 
sorting (Klionsky et al., 1990; Raymond et al., 1992), because they probably encode 
gene products required for the actual sorting process as well as mutations in the 
regulation of vacuole biogenesis or regulating the metabolic state of the cell. Evidence 
obtained from Dictyostelium discoideum indicates that lysosomal enzymes are secreted 
under starvation conditions (Dimond et al., 1981). Maybe this is the case also in S. 
cerevisiae, and mutants affecting metabolic pathways could simulate starvation 
associated conditions and thus induce the secretion of vacuolar enzymes. Other 
enzymes in intermediate metabolism are associated with the cytoskeleton (Barnes et al., 
1992). One enzyme, glyceraldehyde 3-phosphate dehydrogenase in all three isoforms 
(GAPDH), is associated with microtubules. Furthermore, GAPDH bundles 
microtubules, suggesting a second role for the enzyme other than in catalyzing the 
metabolic step between glyceraldehyde 3-phosphate and 1,3-bisphosphoglycerate. 
Among several explanations, two seem plausible: 1. the enzyme is a true bifunctional 
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enzyme, and the fiinctions present in the protein are independent from each other. 2. 
The enzyme attaches to the cytoskeleton to ensure distribution, or it is prevented from 
being degraded if disassociated. If the latter process is regulated by the metabolic state 
of the yeast cell the attachment could be part of a mechanism to regulate enzyme 
activity in response to metabolic changes analogous to glucose repession. Other 
metabolic enzymes, such as Arolp and Citlp also associate with microtubules (Barnes 
et al., 1992). Lastiy, the hydrolysis of GTP is associated with the molecular switch 
action of a number of cellular processes such as signal transmission, vesicle budding 
and fusion and protein biosynthesis (Bourne, 1988). The conformational change 
connected with this reaction often functions in affecting other proteins to change 
conformation or to make reactions irreversible. The GTPases might not be unique in 
performing a cellular function by GTP hydrolysis mediated conformational changes. 
Other enzymes change their conformation during catalysis also, and this change could 
be exploited by the cell to govern other processes, maybe subject to regulation by the 
metabolic state of the cell. A dissection of different functional domains could provide 
further knowledge about the nature and purpose of the interaction. The dual role of 
metabolic enzymes in metabolism as well as structural components is not new. Lens 
crystallin, the major protein in the optical lens, is a lactate dehydrogenase with 
metabolic function (Graeme and Piatigorsky, 1987; Hendiks et al., 1988). Similarly, 
Gutlp and Gut2p, could directly or indirectiy involve in vacuolar protein sorting either 
by associating or functionally participating with components of the vacuolar sorting 
pathway which is affected by the mutation and leads to missorting. Alternatively, the 
two enzymes when mutated disturb the metabolic equilibrium of the cell which directiy 
or indirectiy results in secretion of vacuolar enzymes which may or may not have a 
function in vivo. The two possibilities are difficult to distinguish at present. Directed 
studies addressing the function of Gutlp and Gut2p may provide an answer. 
Mammalian cells can localize otherwise lysosomal enzymes to the cell surface as a 
response to platelet derived growth factor (Prence et al., 1990). This response involves 
the redistribution of the mannose 6-phosphate receptors such that the Golgi 
concentration of the receptor becomes limiting and thus causes the selective secretion of 
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a lysosomal protein. This protein has been identified as the major secreted protein 
(MEP) in transformed mouse fibroblasts strongly suggesting that carcinogenic 
transformation can result in missorting of proteins as a result of disturbances in signal 
transduction pathways. Golgi function in mammalian cells is affected by an oxysterol 
binding protein on ligand binding (Ridgway et al, 1992). The hormonal response might 
alter the equilibrium of sorting or protein export from the Golgi. By analogy, vacuolar 
protein sorting might be subject to environmental stimuli in yeast. Whether or not 
similar mechanisms exists in yeast that allow the selective secretion of vacuolar proteins 
in response to environmental conditions is not known. Judging from the presence of 
different sorting paths for different vacuolar enzymes (Ammerer et al., 1986; Paravicini 
et al., 1992; Stevens et al., 1986) this might be a likely possibility. 
An actl-l mutant has pleiotropic phenotypes including osmosensitivity and 
disrupted vacuoles (Novick and Botstein, 1985). The osmosensitive phenotype has been 
explained that osmotic stress destablized the mutant actin so that actin function cannot 
be carried out, similar to its temperature sensitivity. Three other possibilities 
theoretically exist. First, actin stabilizes vacuoles, and i f destabilized, vacuoles fragment 
and perturb osmoregulatory functions. Second, mutations in actin result in a 
destabilized plasma membrane, which cannot adapt to changes in turgor and result in a 
collapse of the plasma membrane enclosed cell. Mammalian cells rely on the 
organization of F-actin to counteract osmotic changes in the surrounding (Kajstura and 
Reiss, 1989). Lastly, the mutant actin might be defective in the transmission of 
osmotically induced electrical signals and thus not initiate a perhaps linked 
osmoregulatory response. The last consideration is based on the finding that actin cables 
upon exposure to osmotic changes induce an electrical signal by changing its electrical 
potential and charge (Cantiello etal., 1991). This change could affect the net membrane 
potential and thus open or close electrically regulated transmembrane channels. It has 
been suggested that the electrical properties of actin, which are also subject to changes 
following an elecfrical field change, might also change the structural status of actin 
polymerization and thus permitting structural remodelling of the plasma membrane or 
similar processes (Cantiello etal.,199\). 
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It is believed that many proteins required for the Golgi to vacuole pathway have 
not been identified yet and the majority of proteins involved in this pathway are 
associated with the regulation of vacuolar protein sorting. Since there appear to be a 
large number of true vps mutants, other vacuolar mutants might be more difficult to 
isolate because the majority will affect sorting rather than the vacuolar function. 
Although this study provided a new approach to isolate vacuolar mutants, it is rather 
limited because up to date there is no possibility to discriminate between true vacuolar 
defects or associated defects due to alterations in the biochemical regulation of the 
organelle. Although successful in the isolation of sorting mutants, all present 
approaches to elucidate vacuolar function other than sorting and dissection of the 
vacuolar ATPase by reverse genetics have failed, and only isolated more sorting 
mutants. The vac2 mutant so far seems to be an exception in that it is a true vacuolar 
segregation mutant which has no vacuolar sorting defect (Shaw and Wickner, 1991). 
The characterization of the ssv gene products will show whether they are directly 
involved in vacuole biogenesis and related pathways. There are numerous possibilities 
to extend the analysis of the ssv mutants and to examine the nature of their defect. For 
instance, their sensitivity or resistance to hygromycin B would show whether their 
defect involves the plasma membrane ATPase since vacuolar ATPase mutants are also 
osmosensitive (McCusker et al., 1987). Also the monitoring of substances involved in 
osmoregulation, such as glycerol (Blomberg and Adler, 1989; Reed et al., 1987), in 
response to osmotic stress would identify mutants that are defective in an osmoadaptive 
response rather than osmohomeostasis. The proposed role of in mediating 
osmoregulation was also not tested, because evidence obtained in other studies suggests 
that the K"*" status of the cell does not affect the osmoadaptive response in S. cerevisiae 
(Meikle et al., 1991). The exchange of ions could be measured, or the influx of Na"*" or 
CI" monitored. It was decided against an extensive analysis of the ssv mutants because 
lastly it will always be difficult to jugdge whether any of the described defects is a 
primary defect or a consequence of another defect. The isolation and characterization of 
the corresponding gene products appeared more profitable, lastly because the 
identification and analysis of gene products participating in osmoregulation and/or 
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vacuole biogenesis allows a more detailed study of their cellular function. This was 
attempted by isolating a gene which complements the 5.yv7-l mutation (Chapter 6). 
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CHAPTER 5 
CONSTRUCTION OF A PLASMID BASED YEAST GENOMIC 
DNA LIBRARY 
5.1. Introduction 
The amenability of 5. cerevisiae to genetic as well as molecular biological 
methodology permits the isolation of genes corresponding to mutant alleles by 
complementation of the mutant phenotype. Analogous to complementation of a 
mutation by a wild type copy of the same gene in heterozygous diploids, a recessive 
mutation in a yeast gene can functionally be complemented by a wild type copy of the 
gene present on a plasmid i f the mutation confers a selectable phenotype. The cloning 
by complementation approach is feasible because the size of the yeast genome of only 
15,(X)0 kb permits the construction of a genomic plasmid library, and also S. cerevisiae 
can easily be transformed with plasmid DNA by diverse means. Thus, a relatively small 
number of clones has to be screened. This reasoning has led to the construction of 
several genomic DNA libraries in yeast shuttle vectors that simultaneously allow the 
maintenance of the plasmid library in E. coli, as well as the introduction and stable 
maintenance of library clones in S. cerevisiae (Nasmyth and Reed, 1980; Carlson and 
Bostein, 1982; Rose et al., 1987). The earlier yeast genomic DNA libraries were 
constructed by ligation of random genomic DNA fragments into yeast shuttle vectors 
based on the ARSl element for autonomous replication (Nasmyth and Reed, 1980), or 
into vectors derived from the 2|J, plasmid (Carlson and Botstein, 1982). However, the 
shuttle vectors are maintained in high copy number in yeast, which can lead to problems 
if the gene product is toxic when overexpressed (Rose and Fink, 1987). Also, 
overexpression of genes other than the mutated gene can lead to a suppression of the 
defect used for selection (Kuo and Campbell, 1983; MacKay, 1983; Pringle et al., 1984; 
Bender and Pringle, 1989), especially i f the gene products interact with each other 
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(Adams and Botstein, 1989; Novick et at., 1989). Although useful for the identification 
of genes whose gene products directly interact or are involved in signal transduction 
pathways, the isolation of a clone by complementation as well as multicopy 
suppression can infroduce ambiguity into the identification of the gene. Another 
limitation of the use of ARSl and 2jj. based shuttle vectors is their instability, which will 
introduce complications when analysing a particular phenotype, because individual 
yeast cells will have different concentrations of the complementing gene product - i f 
any - present. These considerations have led to the construction of a YCp50 based 
genomic DNA plasmid library (Rose, 1987; Rose et al., 1987), where random fragments 
of yeast DNA were inserted into the centromeric shuttle vector YCp50, which is present 
in low copy number (1 to 2 per cell) and mitotically stable (less than 1% loss per 
generation per cell). However, genes toxic to E. coli, as well as genes proximal to 
centromeres will be underepresented, because of the high copy number of the pBR322 
derived shuttle vector in the bacterial host, and the frequent breakage of dicentric 
plasmids, respectively. 
A common finding in 5. cerevisiae is that different sfrains of the same species can 
differ widely in the restriction map of identical genes (Rose, 1987), and thus genetic 
studies as for instance restriction map verification of single step gene disruptions with 
the same gene from a different host strain can lead to ambiguities. It was therefore 
desirable in this study to construct a yeast genomic DNA library from the same strain 
from which the ssv mutants were isolated. Another advantage of constructing a new 
library rather than amplification of an existing library is that the loss of rare clones 
which have a selection disadvantage during bacterial growth can be minimized (Vogeli 
and Kaytes, 1987). 
The above considerations led to the construction of a S. cerevisiae SEY6210 
genomic DNA library in YCp50, principally as described in Rose et al., 1987, which 
was subsequently used in attempts to clone the genes corresponding to the ssv mutant 
alleles isolated in this work. 
The isolation of yeast genes by complementation from a plasmid based library 
requires an efficient method of transformation. Several such methods have been 
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published, which are either based on the transformation of yeast sphaeroplasts (Beggs, 
1978), the use of Li"*" ions (Ito et al., 1983), or electroporation of DNA into the cell 
(Meilhoc et al., 1990). Although a very efficient method, the transformation of 
sphaeroplasts brings about some problems which make it undesirable for transforming a 
library into yeast. For example, co-transformation of several plasmids into the same cell 
is a common phenomenon that can make the identification of positively complementing 
clones by curing the transformant of the plasmid difficult (Rose, 1987; Rose et al., 
1987). Secondly, some properties of the ssv mutants indicated potential difficulties in 
the choice of the optimal transformation method. The .y^ v mutants described in this 
study were isolated on the basis of sensitivity to high osmolarity of the growth medium. 
This also decides against using the sphaeroplast transformation method and also some 
electroporation protocols, because both require the addition of an osmotic stabilizer (1.2 
M sorbitol) immediately before or after transformation (BioRad Electroporator manual). 
Another property of most ssv and also some vp^ mutants is the grossly reduced 
transformation efficiency, which might make the Li+ based methods unsuitable because 
of their lower transformation efficiency compared to the sphaeroplast method (Ito et al., 
1983). These considerations led to a trial of all available methods on one of the ssv 
mutants and the SEY6210 wild type to find the most efficient transformation protocol. 
5.2. Results 
5.2.1. Isolation of SEY6210 Genomic DNA 
SEY6210 derived genomic DNA was isolated as described in Materials and 
Methods according to the method desribed in Rose et al., 1987, except that the 
preparative sucrose gradient step to separate genomic DNA from mitochondrial DNA 
was omitted to avoid unnecessary shearing of the DNA during the experimental 
procedure. A total of 1260 ^g DNA was recovered from a 1 L culture, of which the 
majority migrated to a size of approximately 50 to 60 kb on a 0.4% agarose gel (Figure 
5.1). 
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5.2.2. Plasmid Bank Construction 
The SEY6210 genomic DNA was partially digested with Sau 3A using different 
concentrations of the enzyme to establish ideal conditions for preparative digests to 
yield genomic DNA fractions over a range of 10 to 30 kb in size. It was digested with 2 
U/|ig DNA to 0.015 U/)ig DNA at 37°C for 60 minutes and the digests separated on a 
0.4% agarose gel. As the highest fluorescence of the 10 to 30 kb region of the gel was 
reached at a Sau 3A concentration of 0.015 U/|ig SEY6210 DNA (Figure 5.1), half the 
enzyme concentration of the same batch (0.008 U/|j,g DNA) was used for a preparative 
digest to yield the maximum number of molecules in that size range, because the 
intensity of fluorescence is related to the mass disfribution of DNA, not the size 
distribution (Maniatis et al., 1982). 
500 ^ig SEY6210 genomic DNA was digested with 0.008 U/^ig DNA for 60 minutes, 
and after phenol:chloroform extraction and subsequent ethanol precipitation, the 
partially digested DNA was separated according to size on a preparative 10 to 40% 
sucrose gradient. 0.5 mL fractions were collected from the top and every third fraction 
was screened for the size of the separated DNA (Figure 5.2). The size of DNA was 
related to the fraction number (Figure 5.3), and fractions 36 to 41 were pooled to yield 
size fragments between 10 to 15 kb, 42 to 47 to yield fragments of 15 to 20 kb, and 
fractions 48 to 51 for 20 to 30 kb fragments. The pooled fractions were dialyzed against 
TE buffer and concentrated by ethanol precipitation. 
Bam HI cut and dephosphorylated YCp50 DNA (see Figure 5.4 for the plasmid 
map) was combined with size-fractionated SEY6210 DNA in a 2:1 mass ratio of vector 
to insert, and ligation of the 10 to 15 kb DNA was carried out at 30 fi.g/mL, the 15 to 20 
kb DNA at 22.5 |ig/mL, and of the 20 to 30 kb DNA at 15 |xg/mL total DNA 
concentration. The ligations were transformed into E. coli for amplification of the 
library. 
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5.2.3. Optimal Conditions for Tranformation of the Gene Bank into E. coli 
To avoid loss of rare clones underepresented in the SEY6210 genomic DNA 
plasmid bank, it was sought to employ the most efficient method of transformation with 
the recommended host strain HB101 at an ideal plasmid DNA concentration. 
The most efficient method of transformation of E. coli with plasmid DNA is that 
described by Kushner et al., 1978, which routinely transforms at a plasmid probability 
of 3.0 X 10"^ for strain HBlOl , the plasmid probability being defined as the number of 
transformants at 2.0 x 10^ cells divided by the number of plasmids present (Hanahan, 
1983). Although JM83 transforms at a more efficient ratio than the recA' HBlOl, it was 
not used for maintaining the plasmid bank, because recombination of highly repetitive 
yeast genomic DNA sequences was a common occurrence (results not shown). Using 
different concentrations of YCp50 vector DNA, ranging from 1 ng to 500 ng per 
transformation, it was established that 10 ng DNA per transformation gave the best 
plasmid probabUity (3 x lO""*) of YCp50 with HBlOl as host (Figure 5.5). 
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Figure 5.1: Partial digestion of SEY6210 genomic DNA (9) with Sau 3A to establish 
the restriction enzyme concentration needed to create a maximum number of 
fragments between 10 and 30 kb. 10 |J,g DNA was digested with varying 
concentrations of Sau 3 A for 60 minutes and electrophoresed in a 0.4% agarose 
gel. The enzyme concenttations were 2 U/|Xg DNA (1), 1 U/^ig DNA (2), 0.5 
U/|Xg DNA (3), 0.25 U/|ig DNA (4), 0.12 U/^ig DNA (5), 0.06 U/|Xg DNA (6), 
0.03 U/[Lg DNA (7) and 0.015 U/[ig DNA (8). Molecular size markers were X 
{Eco RI) (10), X (Pst I) (11) and X DNA (12). The largest restriction fragment of 
each marker correspond to 21.2 kb (10), 14.1 kb (11) and 48 kb (12). 
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Figure 5.2: Fractions recovered from the sucrose gradient. Fractions 33 (1), 36 (2), 39 
(3), 42 (4), 45 (5), 48 (6) and 51 (7) were electrophoresed in a 0.4% agarose gel. 
Molecular size markers were X (Eco RI) (10), X (Pst I) (11) and X DNA (12). 
The largest restriction fragment of each marker correspond to 21.2 kb (9), 14.1 
kb (10) and 48 kb (11). The region of brightest fluorescence was extrapolated to 
determine the average molecular size of the fraction. Data were presented in 
graphic form (Figure 5.3). 
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Figure 5.3: Average fragment size (kb) of Sau 3A partially digested SEY6210 DNA 
after fractionation on a 10 to 40% sucrose gradient. The average fragment size 
was determined by relating the region of greatest fluorescence in Figure 5.2 to 
the relative distance migrated on the agarose gel against standards of known 
size. 
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Figure 5.4: Restriction map of YCp50. 
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Figure 5.5: The probability of transformation (Pp) of HBlOl with YCp50 is drawn as a 
function of the absolute amount of YCp50 DNA present per tranformation of 2 
xlO^ competent cells. The Pp ratio is defined as the ratio of transformants at a 
total cell concentration of 2 x 10^ cells/mL divided by the number of plasmids 
present, assuming that 1 ng of an 8 kb plasmid is equivalent to 1 x 10^ plasmid 
molecules (Hanahan, 1983). The curve shows that an optimal Pp ratio of 
approximately 3 x 10"^  is reached at a plasmid concentration of about 10 
ng/transformation. 
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5.2.4. Maintenance of the Gene Bank in HBlOl 
The plasmid bank was transformed into ultra-competent HBlOl at the ideal DNA 
concentration of 10 ng DNA/transformation, and transformants were selected on Luria 
broth supplemented with ampicillin. All transformants from each ligation were 
harvested by washing off the transformants on each plate with 1 mL sterile Luria broth, 
which were then pooled and centrifuged. Pellets were resuspended in 1 mL sterile 50% 
(v/v) glycerol and stored at -84°C for long term storage. Aliquots of each bank were 
diluted, and the number of insert containing YCp50 plasmids was determined. Overall 
70% of all clones in the library did contain inserts significantly larger than the YCp50 
host vector as judged by electrophoresis of plasmid mini-preps isolated from 20 clones 
for each library pool (results not shown). A total of four library pools for each size class 
was produced (table 5.1), where the estimated size class was based on the 
electrophoretic mobility of SEY6210 genomic DNA fragments after fractionation on a 
preparative sucrose gradient. The overall number of independent clones was about 
35,500 in 12 separate libraries. Large scale plasmid preparations were made from 
pooled cells after diluting the cells to 2 x 10^ cells/mL in Luria broth supplemented 
with ampicillin and growing the culture to saturation. 
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Library Estimated Size Class No. of Independent Clones Volume equivalent 
to 2 X 10^ clones 
A l 10 -15 kb 7119 15 ^iL 
A2 10 -15 kb 3701 5^L 
A3 10 -15 kb 3066 5^L 
A4 10- 15kb 2629 5^iL 
B l 15-20kb 2199 3\iL 
B2 15 - 20 kb 2233 2\LL 
B3 15-20kb 2479 2[LL 
B4 15 - 20 kb 4815 13 ^iL 
CI 20 - 30 kb 1400 3nL 
C2 20 - 30 kb 1470 3\LL 
C3 20 - 30 kb 2480 S\iL 
C4 20 - 30 kb 1570 25\iL 
Table 5.1: SEY6210 genomic DNA plasmid bank structure. The total number of 
independent clones represented the number of independent HB101 transformants 
which harbour insert containing plasmids. The estimated size class was based on 
the electrophoretic mobility of SEY6210 DNA fragments after fractionation on a 
preparative sucrose gradient. The absolute insert size as determined by 
restriction mapping of some average size clones represented the lower range of 
the corresponding size class (data not shown). 
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5.2.5. Efficiency of Transformation Protocols for S. cerevisiae 
Sfrains SEY6210 and MLY0106 {ssvl-2) were processed in accordance with the 
three lithium acetate protocols, the sphaeroplast transformation protocol and the 
electtoporation protocol as described in Materials and Methods. YCp50 DNA was used 
to transform the strains at concentrations that were thought to be optimal by the 
developers of each transformation protocol. Transformants were selected on suitable 
medium lacking uracil but supplemented with all other required amino acids. 
A comparison of the five different, commonly used methods shows that 
electroporation of dithiothreitol treated intact yeast cells (Meilhoc et al., 1990) yields a 
higher transformation efficiency for 1 \ig YCp50 DNA for both the wild type as well as 
the ssvl-2 allele (Figure 5.6). In fact, this method appears to be the only method to 
transform the ssvl-2 allele with YCp50 DNA with high efficiency. Elecroporation 
yields about 1.5 times more transformants/|i.g DNA in the wild type than the 
sphaeroplast transformation (Beggs, 1978), and 22.6 times as many transformants/|ig 
DNA than the lithium acetate based protocols. For the ssvl-2 allele, the electroporation 
is 40% less efficient than for the parental wild type strain, but still 14.3 times more 
efficient than the most efficient lithium acetate protocol after U. Certa. The ssvl-2 
mutant strain MLY0106 could not be transformed with the sphaeroplast transformation 
method, probably because the sorbitol required in the regeneration medium inhibits 
growth of the osmosensitive mutant strain. 
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Figure 5.6: Efficiency of transformation of the wild type SEY6210 and a representative 
ssv mutant, MLY0106 issvl-2), with different transformation protocols. 1: 
Lithium acetate method (Ito et al., 1983); 2: Improved lithium acetate protocol 
(M.D. Watson, personal communication); 3: Improved lithium acetate method 
(U. Certa, personal communication); 4: Sphaeroplast transformation protocol 
(Beggs, 1978); 5: Electroporation of dithiothreitol treated intact yeast cells 
(Meilhoc et al., 1990). The transformation efficiency is expressed in absolute 
numbers of transformants obtained for each |ig YCp50 transformed in oder to 
choose the most efficient method in terms of use of plasmid DNA. 
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5.3. Discussion 
High molecular weight SEY6210 DNA was partially digested with Sau 3A and 
fractionated by size on a preparative sucrose gradient. Different size classes of 
SEY6210 yeast DNA were collected and ligated into the Bam HI site of YCp50 to yield 
12 independent libraries (Table 5.1). Assuming an average size of the S. cerevisiae 
genome of 15,000 kb (Lauer et al., 1977), each individual library represents between 
1.7 and 4.7 times the yeast genome, although the absolute number of genomic clones 
will be smaller because of the presence of mitochondrial DNA sequences. It was 
decided to maintain separate libraries according to genomic insert size classes rather 
than pooling all plasmid clones into a larger library to reduce bias during amplification 
in E. coli due to different growth properties of cells harbouring plasmids of different 
size (Rose et al., 1987). Additionally, a library containing plasmids of widely different 
size are expected to select for the smaller plasmids in a population, since larger 
plasmids are transformed less efficiently into both E. coli and S. cerevisiae. The 
screening of several independent libraries will also ensure that plasmid isolates are of 
independent origin, rather than identical clones of the same plasmid (Rose et al., 1987). 
Although a centromere based plasmid library will avoid the isolation of multicopy 
suppressor alleles of a given mutant allele, the SEC4 gene was able to suppress certain 
seclS, sec8 and sec2 alleles if inserted in YCp50 (Salminen and Novick, 1987). The 
identity of the library copy with the originally isolated mutant allele has to be confirmed 
in each case by integration mapping. This can be achieved by cloning the library isolate 
into YIp5 which will integrate next to the chromosomal copy, and subsequent Southern 
analysis to screen for correct integration of the wild type copy next to the chromosomal 
allele. If both mutant allele and library allele are identical, the mutant phenotype will 
cosegregate with the auxotrophy marker of the YIp5 vector (Salminen and Novick, 
1987). Gene disruption analysis ("null alleles") and subsequent analysis of the 
associated phenotype can provide further evidence of identity of the complementing 
gene as the one which contains the mutation (Rose, 1987). 
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The YCp50 based library constructed in this work is comparable to the one 
described by Rose et al., 1987, except that SEY6210 DNA rather than GRF88 DNA 
was used for the construction. Three genes, SSV7 (see Chapter 6), SSV9 and a ts 
suppressor of the ssv9-l allele (M. Latterich, unpublished results), were isolated from 
the library up to date. All isolates were present at an approximate frequency of 0.3%, 
which lies within the estimated frequency of 0 to 0.4% of acquiring complementing 
plasmids from any single library pool (Rose et al., 1987). So far no complementing 
clones were isolated from this library for j ^ v i - l , ssv5-2, ssvlO-], and ssvl3-l (M. 
Latterich, unpublished results). The failure to isolate complementing clones is most 
probably due to the very low transformation efficiency of the ssv mutant alleles 
mentioned above, rather than the absence of the corresponding genes from the library. 
The library described here has also been successftiUy screened by hybridization to 
isolate the OSMl gene (Ma, 1991). 
The above findings suggest that electroporation is the method of choice when 
transforming the YCp50 based library into ^^ v mutant strains. Although far more 
efficient than other transformation methods, some ^^ v alleles still failed to be 
transformed efficiently. For the ssvl3-\ allele, for example, only two transformants 
were obtained after transforming a total of 20 |Xg library DNA into the strain. For some 
obscure reason most ssv alleles and also most vacuolar class C vps alleles transform 
magnitudes less efficiently than the corresponding wild type strains, even after 
backcrossing (S.D. Emr, personal communication; M. Latterich, unpublished data). The 
reason for this phenomenon is yet unknown, but it appears that some of the SSV gene 
products are required for recovery of the transformed strains rather than for the 
efficiency of transformation. In case of strains carrying the ssv7-\ mutant allele, the 
mutant sfrain has a strongly reduced apparent transformation efficiency with eqimolar 
amounts of YCp50, than with the SSV7 conferring plasmid pMLY36, which reaches 
almost the transformation efficiency of the wild type with YCp50 (M. Latterich, results 
not shown). 
A way to circumvent the problem of direct gene bank transformation into low 
frequency transformable ssv alleles would be to employ the strategy used by Novick et 
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al., 1989, which was devised by J. Rhine, University of California, Berkeley, USA 
(unpublished data). In brief, a karl strain with high transformation efficiency is 
transformed with the gene bank. The library transformants then are replica plated onto 
lawns of the ssv strain to be complemented with the libray on YPD plates. The strain to 
be transformed has to be of opposite mating type as the karl mutant strain and has to 
have at least one drug resistance marker (e.g. CANl or CYHl). Cytoductants can be 
selected on medium lacking uracil (YCp50 based library) but supplemented with 
canavanine and/or cycloheximide (both resistance markers are recessive in 
heterozygous diploids). Colonies growing under these conditions are probably 
cytoductants of the recipient strain, since the karl strain is more likely to transfer the 
plasmid than the nucleus during mating. The library cytoductants can then be screened 
for complementation of the mutant phenotype analogous to library transformants. One 
possible dawback this method has is that most ssv strains that transform poorly also 
show a reduced ability to mate with strains of the opposite mating type. 
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CHAPTER 6 
CHARACTERIZATION OF THE SSV7 GENE 
6.1. Introduction 
The feasability of cloning yeast genes by complementation has led to progress in 
understanding the molecular basis of many cellular processess, the most prominent 
being the cell cycle (Forsberg and Nurse, 1991) and the secretory pathway (Schekman, 
1985). The analysis of enzymes in biochemical pathways was greatly facilitated by 
identifying the structural and regulatory genes involved and allowed a manipulation of 
genes and their products. The same reverse genetic approach has been employed by a 
number of researchers to dissect vacuole function (reviewed in Klionsky et al., 1990; 
Raymond et al., 1992; see also Chapter 4). Lastly the isolation and characterization of 
salt-sensitive vacuolar mutants (ssv) was intended to facilitate the cloning and 
molecular characterization of genes and their products participating in vacuole 
biogenesis and to examine the validity of the previously voiced hypothesis of vacuole 
mediated osmoregulation (Banta et al., 1988; Klionsky et al., 1990). While the isolation 
of osmosensitive vacuolar mutants was successful (Latterich and Watson, 1991; 
Chapter 4), a preliminary phenotypic analysis did not provide any evidence in favour or 
against vacuole mediated osmoregulation. Considering previous studies which stressed 
the overlapping function of vacuolar processes (reviewed in Klionsky et al., 1990) and 
the fact that many differing isolation protocols resulted in the isolation of identical 
vacuolar sorting mutants, it appears to be necessary to examine the role of gene 
products functioning in vacuole biogenesis at the molecular level. Complementation 
analysis of the ssv mutations showed that excepting three complementation groups none 
were identical to other vacuolar protein sorting mutants (Chapter 4). 
ssv mutants of different complementation groups were transformed with a plasmid 
based yeast genomic DNA library (Chapter 5), and genes complementing three different 
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mutants were identified (M. Latterich, unpublished results). In the following the 
molecular cloning and preliminary characterization of the 55^7 gene and the 
corresponding ssv7-l mutant are described. 
Although a strain carrying the ssv7-\ mutant allele only has a moderate sorting 
defect in that about 20% of the vacuolar protein carboxypeptidase Y is mislocalized to 
the cell surface and it had a class B vacuolar phenotype, it was the first mutant gene that 
was cloned by complementation. Subsequent analysis of the complementing gene and a 
more detailed phenotypic characterization of the original ssv7-l mutant strain provided 
many promising observations that may lead to an understanding of the nature of key 
cellular processes such as nuclear assembly and the regulation of the cell cycle. 
6.2. Results 
6.2.1. Morphological Features Conferred by the ssv7-l Allele 
A routine analysis of the .y^v7-l mutant strain by fluorescence microscopy 
indicated that apart from a class B vacuolar morphology it had a nuclear defect judged 
by DAPI staining of fixed cells (Figure 6.1). While wild type cells have a very distinct 
and confined DAPI fluorescence pattern representing the nucleus, and a punctate 
fluorescence pattern in the periphery of the cell near to the plasma membrane 
representing mitochondrial DNA, ssv7-l mutants had slightly larger confined loci of 
fluorescence near the plasma membrane probably representing exaggerated 
mitochondria. The distinct nuclear fluorescence was absent in these mutants and the 
DAPI fluorescence was more diffuse and evenly distributed throughout the cytoplasm. 
ssv7-\ cells were approximately twice to three times as large as wild type cells, which 
could also explain the fact that the mitochondria in these cells appeared larger. 
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Figure 6.1: Light and fluorescence microscopical analysis of fixed MLY1511 (ssv7-l) 
(A-C) compared to fixed SEY6210 (wild type) (D-F). Normarski contrast 
microscopy (A and D) revealed that MLY1511 had approximately two to four 
times larger cells (A) than the isogenic wild type (D) and also a highly disrupted 
vacuole typical for vacuolar class B mutants. The latter was confirmed by 
indirect-immunofluorescence labelling of fixed sphaeroplasts with anti-Pho8p 
antiserum, which localizes the vacuolar membrane protein (C and F). MLY1511 
showed fluorescence localization of several small vacuoles (C), which in the 
wild type was located around a large vacuole (F). DAPI staining revealed that 
MLY1511 has a diffuse cytoplasmic staining pattern and a punctate pattern near 
the plasma membrane probably representing exaggerated mitochondria (B), 
unlike the wild type which has a defined highly fluorescing nuclear staining 
patterns and a small punctate mitochondrial fluorescence (E). 0.5 cm equivalent 
to 1 \im. 
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Figure 6.2: Electron microscopic examination of SEY6210 (wild type) (A) and 
MLY1511 (s^v7-l) (B and C) of ferrocyanide-reduced osmium -
thiocarbohydrazide - ferrocyanide-reduced osmium fixation method. While this 
fixation method stains double membrane structures including the nucleus in the 
wild type (A), MLY1511 did not have such a nuclear membrane detectable in 45 
sections examined (B). Instead, they have a number of Golgi like structures 
present in the cytoplasm (C). ER, endoplasmic reticulum; G, Golgi-like 
organelle; M, mitochondrion; N; nucleus; V, vacuole. Magnification: A, 
19,500x; B, 17,000x; C, 60,000x. 
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To confirm that the putative anuclear phenotype of the 5^ v7-l mutant was not a 
result of the fixation method used in preparing cells for immunofluorescence, wild type 
and mutant cells were examined by electron microscopy (Figure 6.2). In SEY6210 
96.5% of 50 ultra-thinsections examined had a nucleus, and cells not exhibiting a 
nuclear structure were cut near the plasma membrane. MLY1511 cells did not have a 
single visible nucleus in 45 thin-sections examined, indicative of the absence of a 
nuclear membrane. Some Golgi-like organelles accumulated in some cells examined. 
Similar structures were also present in some other ^^ v mutants, such as ssv9-l (Chapter 
4). Alternatively, these structures could represent degenerate nuclear features. 
Mitochondria in ssv7-l were proportional in size to the wild type, making it appear 
unlikely that the mutant affects mitochondrial morphogenesis to a visible extent. 
6.2.2. VPS phenotype of ssv7-l 
ssv7-l secreted a small proportion of its p2CPY and properly localizes the 
remaining intracellular fraction to its 61 kDa mature form (Figure 6.3). This phenotype 
is indicative for a mutation in a gene not directly involved in protein sorting but other 
aspects, like vacuole biogenesis or nuclear morphogenesis. A number of other ssv 
mutants and also acidification defective mutants secrete a similar proportion of CPY. 
Alternatively, the mutation could affect a gene acting in both vacuole and nuclear 
morphogenesis. 
6.23. Growth Behaviour of ssv7-l 
It was expected that a mutant lacking a nuclear envelope would have a grossly 
altered growth pattern, because a number of regulatory processes rely on the selective 
import or exclusion of nuclear proteins in a cell cycle regulated fashion. 
A comparison of the growth curves between ssv7-l and its isogenic wUd type 
shows an interesting correlation (Figure 6.4). Defining growth as the increase in cell 
number, the ssv7-l mutant has a mean generation time of 3.5 hours compared to 1.75 
hours for the wild type. By extrapolation from Figure 6.4., the mutant takes exactly 
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twice the time to bud and divide. Despite the differene in generation time, both cultures 
reach the stationary phase simultaneously after approximately 16 hours. Two 
explanations appear plausible. Firstly, ssv7-l might be an unknown auxotrophy mutant 
whose auxotrophy requirement is depleted in the culture. The wild type not having this 
requirement would divide until some or all nutrients are depleted. Secondly, ssv7-\ 
could continue to grow as efficiently as the wild type in terms of increase of biomass, 
but division occurs half as frequently, leading to an increase in cell size. The latter 
possibility would also explain the increase in cell size observed with the ssv7-\ 
mutation. To test this hypothesis, the cell volume of log phase cultures of SEY6210 and 
MLY1511 in YPD was determined in a Coulter Counter (Figure 6.5). A comparison 
between the volume distribution of the wild type with the ssv7-l mutant revealed that 
the ssv7-\ mutant is unable to control its cell volume (or cell size) resulting in cells of 
widely different volume. While the average unbuded wild type cell has a volume of 40 
to 75 jxm ,^ the ssv7-l cells have a volume from 20 to 500 jim^. Light microscopic 
examination revealed that the budding was not affected in this mutant. Overall the rate 
of increase in volume of both mutant and wild type appear to be the same, and only the 
actual budding process or mitosis occurs more slowly. 
6.2.4. Molecular Cloning and Characterization of the SSV7 Locus 
S. cerevisiae carrying ssv mutations are unable to grow on YPD medium 
supplemented with 1.5 M NaCl. This was exploited to develop a cloning strategy to 
clone the gene corresponding to the ^^v7-l mutation. MLY1511 (,ssv7-\, ura3-52) cells 
were transformed with a YCp50 based yeast genomic DNA library (Chapter 5), and 
URA3 transformants on yeast minimal medium selected for. A total of 3847 URA"*" 
transformants were obtained, of whih three conferred salt resistant growth. 3-
Fluoroorotic acid curing of the plasmids was not successful, suggesting that the 
plasmids confer a selective advantage to the 5^ v7-l mutants that make accidental loss or 
curing an unfavourable event. 
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Figure 6.3: Secretion of CPY in SEY6210 (wild type) and MLY1511 (^^v7-l). The 
immunoprecipitation of CPY from cells (P) and culture supernatant (S) are 
shown. The 68 kDa p2CPY precursor is secreted by the ssv7-\ mutant while the 
61 kDa mature form is retained intracellularly. The wild type does not 
mislocalize any CPY extracellularly. 
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Figure 6.4: Growth curves of SEY6210 (wild type) and MLY1511 issv7-l) in YPD at 
30°C and 140 rpm. 200 |a,L samples were taken in regular intervals, the total cell 
mumber was determined using a Coulter Counter and plotted against time. Each 
time point represents the average of three independent measurements. The mean 
generation time was determined by extrapolation from the graph during the 
cultures log phase. 
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Plasmid DNA was isolated from each of the three yeast transformants, amplified 
in E. coli HBlOl, and reintroduced into MLY1511. All three plasmids, pMLY36, 
pMLY37 and pMLY38 complemented the salt sensitive phenotype associated with the 
ssv mutation. pMLY38 not only restored growth under osmotic stress but also enhanced 
growth in an allele specific manner in that the wv7-l mutant strain harbouring pMLY38 
grew faster and to larger colonies on YPD + 1.5 M NaCl than the wild type on YPD 
only. This plasmid when transformed into SEY6210 did not lead to the same growth 
behaviour suggesting that pMLY38 is an allele specific low copy enhancer/suppressor. 
Preliminary restriction enzyme mapping demonstrated that pMLY36 and pMLY37 
contained overlapping genomic DNA inserts, while pMLY38 had an unrelated 
restriction pattern (results not shown). Since both pMLY36 and pMLY37 restored wild 
type growth in the mutant and rescued the mutant phenotypes, it was assumed that both 
clones represent the genuine SSV7 locus. Plasmid pMLY38 was not further analysd in 
this study. Because the 4.9 kb genomic DNA insert of pMLY36 was entirely contained 
within that of the 14 kb fragment of pMLY37, only pMLY36 was analysed further. 
pMLY36 was transformed into representative alleles of all other ssv complementation 
groups, but except for ssv7-\ it failed to restore osmoresistant growth in all other alleles 
tested. It also did not restore a wild type phenotype in a mutant carrying the ssv7-l 
allele, indicating that either the mutant has a second osmosensitivity confering mutation 
whose defect is not rescued by pMLY36, or that its previous complementation pattern 
was caused by intergenic non-complementation associated with genetically interacting 
genes (the latter appears to be the case; M.D. Watson, personal communication). A 
detailed restriction analysis was carried out, digesting pMLY36 with all available 
enzymes alone or in combination (Figure 6.6 A). Smaller fragments of the genomic 
DNA fragment contained within pMLY36 were subcloned into pRS316, an URA3 amp'' 
centromeric shuttle vector, and transformed into MLY1511. None of the smaller 
subclones was able to complement the ssv7-\ mutation, and it was concluded that most 
of the genomic DNA insert in pMLY36 represents the coding region of SSV7 (Figure 
6.6 B) and is necessary to restore gene function, unlike in some cases where partial 
subclones are able to complment a mutation (Erdmann et ai, 1991). 
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Figure 6.6: Restriction map and subcloning strategy to find the smallest possible 
complementing subclone. pMLY36 was restriction digested in single and double 
digests, and a restriction map was constructed (A). The assignment of restriction 
sites was unambiguous except for some EcoRl sites downstream of the Sail site, 
because fragments were very similar in size. Fragments of the genomic clone 
were subcloned into pRS316 (B). SphI cut fragments were blunt ended and 
ligated into the Smal site. Constructs were transformed into MLY1511 {ssv7-l), 
and URA3 transformants were tested for their osmosensitive phenotype. 
Subclones complemented the ssv7-l mutation if they were able to sustain growth 
on YPD + 1.5 M NaCl. Restriction enzymes: C, Clal; E, EcoRI; H, Hpal; I , 
Hindm; P, Sphl; S, Sail; X, Xbal. 
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Figure 6.7: Typical sequencing gel autoradiograph. The sequencing gel represents the 
genomic DNA sequence of SSV7 upstream of the Hpal site. The autoradiograph 
was read twice manually and was assembled using the UWGCG package. 
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Figure 6.8: Sequencing strategy of SSV7. Subclones in pKS" of the genomic clone 
containing the SSV7 gene were sequenced using standard reverse and T7 
sequencing primers. Some sequences were established using custom synthesized 
oligonucleotides as primers based on regions of known sequence. Custom made 
oligonucleotides are represented as black circles. Restriction enzymes: C, Clal; 
E, EcoRL; H, Hpal; I, HindOl; P, Sphl; S, Sail; X, Xbal. 
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Figure 6.9: Restriction map derived from the SSV7 sequence analysis and open reading 
frame map. A good correlation between the established and the deduced 
restriction map of SSV7 was observed (A), the only discrepancy being in the 
position of the Sphl site which is explainable by experimental error in 
determining the precise size of the restriction fragments. The subclone 
sequenced has one large open reading frame in the forward direction (B) and no 
significant other open reading frames. Short vertical lines in the open reading 
frame (ORE) map represent initiator codons (ATG), long vertical lines stop 
codons (TAA, TGA, TAG). Restriction enzymes: C, Clal; E, EcoRl; H, Hpal; I, 
HindRl; P, Sphl; S, Sail; X, Xbal. 
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Figure 6.10: Genomic nucleotide sequence of SSV7 and the predicted amino acid 
sequence. Putative TATA boxes upstream of the initiator codon are underlined 
in blue. Stop codons immediately adjacent to the open reading frame are 
underlined in red. A putative transcriptional terminator region is underlined in 
black. 
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N 
TCC 
S 
GTA 
V 
ATG 
M 
ATT 
I 
5 0 9 
8 9 
5 1 0 
9 0 
ATT 
I 
CAA 
0 
TTA 
L 
AAT 
N 
TAT 
Y 
GTT 
V 
TAC 
Y 
TAC 
Y 
AAG 
K 
GTA 
V 
ATT 
I 
CAC 
H 
ATT 
I 
ATT 
I 
GTA 
V 
551 
101 
5 5 5 
105 
ACA 
T 
ACC 
T 
AAT 
N 
ATT 
I 
CCT 
P 
CAT 
H 
TTA 
L 
AGT 
S 
GAA 
E 
TTC 
F 
GCC 
A 
AAG 
K 
ATT 
I 
AAA 
K 
TTA 
L 
5 9 9 
119 
6 0 0 
120 
CAT 
H 
AAG 
K 
AGC 
S 
ACG 
T 
AGT 
S 
GAT 
D 
GAG 
E 
GGC 
G 
AAC 
N 
GGT 
G 
AAT 
N 
AAC 
N 
AAC 
N 
AAT 
N 
AAT 
N 
6 1 1 
131 
6 1 5 
135 
GAA 
E 
TTT 
F 
CAA 
0 
CTC 
L 
ATG 
M 
AAC 
N 
ATT 
I 
TAC 
Y 
AAC 
N 
ACT 
T 
TTG 
L 
CTG 
L 
GAA 
E 
ACC 
T 
TTA 
L 
6 8 9 
119 
6 9 0 
150 
TTA 
L 
AAA 
K 
GAT 
D . 
GAA 
E 
AAC 
N 
ATT 
I 
GCA 
A 
AAA 
K 
ATA 
I 
AAA 
K 
AGT 
S 
TTC 
F 
ATT 
I 
AAG 
K 
TCT 
S 
731 
161 
7 3 5 
165 
TCC 
S 
ATA 
I 
AAA 
K 
CAA 
Q 
ACA 
T 
AAA 
K 
TTG 
L 
AAC 
N 
CAT 
H 
GAG 
E 
CAA 
Q 
GAA 
E 
GAA 
E 
TGT 
C 
AAC 
N 
7 7 9 
179 
7 8 0 
180 
CTG 
L 
ATG 
M 
AGA 
R 
ACG 
T 
GGT 
G 
TCC 
S 
TAT 
Y 
ATC 
I 
ACT 
T 
TCC 
S 
AAT 
N 
CAA 
Q 
TTA 
L 
AAC 
N 
TCC 
S 
821 
191 
8 2 5 
195 
CTA 
L 
ATA 
I 
AGT 
S 
TCA 
S 
TCA 
S 
GCA 
A 
AAT 
N 
TCT 
S 
GCT 
A 
TCC 
S 
TCC 
S 
CAA 
0 
ATG 
M 
GAG 
E 
ATA 
I 
8 6 9 
2 0 9 
8 7 0 
2 1 0 
CTA 
L 
CTG 
L 
ATA 
I 
GAT 
D 
ATA 
I 
CGA 
R 
TCA 
S 
AGG 
R 
TTG 
L 
GAA 
E 
TTC 
F 
AAC 
N 
AAG 
K 
TCA 
S 
CAT 
H 
911 
221 
9 1 5 
2 2 5 
ATT 
I 
GAT 
D 
ACA 
T 
AAA 
K 
AAT 
N 
ATT 
I 
ATA 
I 
TGC 
C 
CTG 
L 
GAG 
E 
CCT 
P 
ATT 
I 
TCT 
S 
TTT 
F 
AAA 
K 
9 5 9 
2 3 9 
9 6 0 
2 1 0 
ATG 
M 
TCA 
S 
TAT 
Y 
TCA 
S 
GAT 
D 
CAT 
H 
GAT 
D 
TTG 
L 
GAG 
E 
AAA 
K 
AAA 
K 
TCA 
S 
TTA 
L 
ATT 
I 
ACT 
T 
1001 
251 
1005 
2 5 5 
TCT 
S 
CCT 
P 
AAT 
N 
AGT 
S 
GAG 
E 
ATT 
I 
AAA 
K 
ATG 
M 
TTT 
F 
CAA 
Q 
AGT 
S 
AGA 
R 
AAT 
N 
CTT 
L 
TTC 
F 
1019 
2 6 9 
1050 
2 7 0 
AAG 
K 
TTT 
F 
ATC 
I 
ATT 
I 
CTC 
L 
TAT 
Y 
ACA 
T 
GAC 
D 
GCA 
A 
AAC 
N 
GAA 
E 
TAC 
Y 
AAT 
N 
GTT 
V 
AAA 
K 
1091 
2 8 1 
1095 
2 8 5 
CAG 
Q 
CAG 
Q 
TCT 
S 
GTC 
V 
CTG 
L 
TTG 
L 
GAC 
D 
ATT 
I 
CTG 
L 
GTG 
V 
AAT 
N 
CAT 
H 
TCC 
S 
TTT 
F 
GAA 
E 
1139 
2 9 9 
1110 
3 0 0 
AAA 
K 
CCA 
P 
ATA 
I 
TCC 
S 
GAT 
D 
GAC 
D 
TTT 
F 
ACC 
T 
AAA 
K 
ATT 
I 
TTC 
F 
ATT 
I 
CTG 
L 
GAA 
E 
TCT 
S 
1181 
311 
1185 
3 1 5 
GGT 
G 
TTT 
F 
CCA 
P 
GGT 
G 
TGG 
W 
CTT 
L 
AAG 
K 
TCA 
S 
AAT 
N 
TAT 
Y 
GGG 
G 
AGG 
R 
AAA 
K 
GTA 
V 
TCA 
S 
1229 
3 2 9 
1230 
3 3 0 
TCA 
S 
TCT 
S 
TTT 
F 
CCA 
P 
TCA 
S 
AAT 
N 
AAC 
N 
AAT 
N 
ATT 
I 
AAG 
K 
GAT 
D 
GAT 
D 
AGT 
S 
GTT 
V 
TAT 
Y 
1271 
311 
1275 
3 4 5 
TTT 
F 
AAT 
N 
GGT 
G 
AAC 
N 
ACT 
T 
TCT 
S 
GGC 
G 
CTA 
L 
AGT 
S 
TTA 
L 
CAA 
Q 
CAT 
H 
TTA 
L 
CCT 
P 
AAG 
K 
1319 
3 5 9 
1320 
3 6 0 
ATG 
M 
TCT 
S 
CCC 
P 
AGT 
S 
ATA 
I 
AGA 
R 
CAT 
H 
TCA 
S 
ATG 
M 
GAC 
D 
GAC 
D 
TCT 
S 
ATG 
M 
AAA 
K 
GAA 
E 
1364 
374 
1365 
3 7 5 
ACT 
T 
GCT 
A 
AGT 
S 
TGG 
W 
CCT 
P 
ACT 
T 
CCA 
P 
TTA 
L 
ATT 
I 
CAT 
H 
CTT 
L 
CAA 
Q 
CAA 
0 
CAG 
0 
CAA 
0 
1409 
3 8 9 
1410 
3 9 0 
CAA 
Q 
CAG 
0 
CAA 
0 
TCA 
S 
GAC 
D 
AAT 
N 
GAT 
D 
CAT 
H 
GTG 
V 
CTA 
L 
AAA 
K 
AGA 
R 
TCT 
S 
TCA 
S 
AGT 
S 
1454 
404 
1455 
4 0 5 
TTC 
F 
AAA 
K 
ACA 
T 
TTA 
L 
TTC 
F 
TCA 
S 
AAT 
N 
TAT 
Y 
ACG 
T 
TCT 
S 
CCT 
P 
AAT 
N 
CCG 
P 
AAG 
K 
AAT 
N 
1499 
4 1 9 
1500 
4 2 0 
TCA 
S 
AAT 
N 
TCA 
S 
AAC 
N 
TTA 
L 
TAT 
Y 
TCT 
S 
ATA 
I 
TCT 
S 
TCG 
S 
TTG 
L 
TCC 
S 
ATA 
I 
TCT 
S 
AGT 
S 
1544 
434 
1545 
4 3 5 
TCA 
S 
CCA 
P 
TCG 
S 
CCT 
P 
TTA 
L 
CCT 
P 
CTA 
L 
CAT 
H 
TCG 
S 
CCT 
P 
GAC 
D 
CCA 
P 
GTT 
V 
AAG 
K 
GGC 
G 
1589 
4 4 9 
1590 
4 5 0 
AAT 
N 
TCA 
S 
TTG 
L 
CCA 
P 
ATC 
I 
AAT 
N 
TAT 
Y 
CCG 
P 
GAA 
E 
ACG 
T 
CCA 
P 
CAT 
H 
CTT 
L 
TGG 
W 
AAA 
K 
1634 
464 
1635 
4 6 5 
AAC 
N 
AGT 
S 
GAG 
E 
ACA 
T 
GAT 
D 
TTT 
F 
ATG 
M 
ACA 
T 
AAT 
N 
CAA 
Q 
AGA 
R 
GAA 
E 
CAG 
Q 
TTG 
L 
AAT 
N 
1679 
4 7 9 
1680 
4 8 0 
CAC 
H 
AAC 
N 
TCT 
S 
TTT 
F 
GCT 
A 
CAC 
H 
ATA 
I 
GCT 
A 
CCT 
P 
ATC 
I 
AAC 
N 
ACG 
T 
AAG 
K 
GCC 
A 
ATC 
I 
1724 
494 
1725 
4 9 5 
ACT 
T 
TCT 
S 
CCA 
P 
TCA 
S 
AGA 
R 
ACT 
T 
GCC 
A 
ACA 
T 
CCG 
P 
AAG 
K 
TTA 
L 
CAA 
Q 
CGC 
R 
TTC 
F 
CCG 
P 
1769 
5 0 9 
1770 
5 1 0 
CAA 
Q 
ACA 
T 
ATT 
I 
AGT 
S 
ATG 
M 
AAC 
N 
CTT 
L 
AAT 
N 
ATG 
M 
AAC 
N 
TCC 
S 
AAT 
N 
GGA 
G 
CAC 
H 
AGT 
S 
1814 
524 
1815 
5 2 5 
TCT 
S 
GCC 
A 
ACC 
T 
TCT 
S 
ACC 
T 
ATT 
I 
CAA 
0 
CCT 
P 
TCG 
S 
TGT 
C 
CTA 
L 
TCC 
S 
TTG 
L 
TCT 
S 
AAT 
N 
1859 
5 3 9 
1860 
5 4 0 
AAT 
N 
GAC 
D 
TCT 
S 
T T C 
F 
AGA 
R 
TCA 
S 
TAC 
Y 
GAG 
E 
ATG 
M 
TTA 
L 
CAC 
H 
CAA 
0 
CTT 
L 
CTT 
L 
CTC 
L 
1904 
554 
1905 
5 5 5 
ATA 
I 
ATT 
I 
ATG 
M 
ACC 
T 
TTG 
L 
ATT 
I 
TCG 
S 
CGG 
R 
TTG 
L 
GTT 
V 
TGG 
W 
GAA 
E 
AAC 
N 
CTA 
L 
GAA 
E 
1949 
5 6 9 
1950 
5 7 0 
ATC 
I 
CCG 
P 
TGT 
C 
TAC 
Y 
ATG 
M 
AAC 
N 
TGT 
C 
ATC 
I 
ATT 
I 
CAG 
0 
TGT 
C 
ACC 
T 
TTA 
L 
GGT 
G 
ACA 
T 
1994 
584 
1995 
5 8 5 
CAC 
H 
GAA 
E 
TTA 
L 
ACC 
T 
CAA 
Q 
ATC 
I 
TTT 
F 
TTG 
L 
GAC 
D 
GAT 
D 
TCA 
S 
TAT 
Y 
GCT 
A 
AAA 
K 
CAC 
H 
2 0 3 9 
5 9 9 
2 0 4 0 
6 0 0 
ATC 
I 
AAT 
N 
ATT 
I 
AAT 
N 
AGT 
S 
AAG 
K 
TTG 
L 
GGA 
G 
TCG 
S 
AAA 
K 
GGT 
G 
ATT 
I 
CTG 
L 
GCA 
A 
AAA 
K 
2 0 8 4 
614 
2 0 8 5 
6 1 5 
TAT 
Y 
T T T 
F 
GCA 
A 
AGG 
R 
TTG 
L 
GTT 
V 
CAT 
H 
ATG 
M 
ATG 
M 
TAT 
Y 
AAG 
K 
GAA 
E 
CAG 
Q 
GTT 
V 
GAT 
D • 
2 1 2 9 
6 2 9 
2 1 3 0 
6 3 0 
GGT 
G 
TCA 
S 
AAG 
K 
AAA 
K 
ATT 
I 
TCC 
S 
ATA 
I 
TCA 
S 
CCG 
P 
ATA 
I 
AAA 
K 
TTT 
F 
AAA 
K 
TTG 
L 
GCA 
A 
2 1 7 4 
644 
2 1 7 5 
6 4 5 
TGT 
C 
GGA 
G 
TCT 
S 
GTT 
V 
AAC 
N 
TCA 
S 
TTA 
L 
TTT 
F 
AAG 
K 
ACT 
T 
GCA 
A 
TCC 
S 
CAA 
Q 
CAG 
Q 
GAC 
D 
2 2 1 9 
6 5 9 
2 2 2 0 
6 6 0 
TGC 
C 
CAA 
Q 
GAG 
E 
TTT 
F 
TGC 
C 
CAA 
Q 
TTC 
F 
CTT 
L 
CTA 
L 
GAT 
D 
GGT 
G 
CTT 
L 
CAT 
H 
GAA 
E 
GAC 
D 
2 2 6 4 
6 7 4 
2 2 6 5 
6 7 5 
TTG 
L 
AAC 
N 
CAA 
Q 
TGC 
C 
GGT 
G 
TCA 
S 
AAC 
N 
CCA 
P 
CCT 
P 
TTG 
L 
AAG 
K 
GAG 
E 
CTT 
L 
TCT 
S 
CAA 
Q 
2 3 0 9 
6 8 9 
2 3 1 0 
6 9 0 
GAA 
E 
GCT 
A 
GAG 
E 
GCG 
A 
AGA 
R 
AGA 
R 
GAA 
E 
AAA 
K 
CTG 
L 
TCT 
S 
TTG 
L 
CGA 
R 
ATT 
I 
GCC 
A 
TCG 
S 
2 3 5 4 
704 
2 3 5 5 
7 0 5 
TCA 
S 
ATT 
I 
GAG 
E 
TGG 
W 
GAA 
E 
CGA 
R 
TTC 
F 
TTG 
L 
ACT 
T 
ACT 
T 
GAT 
D 
TTC 
F 
AGT 
S 
GTT 
V 
ATT 
I 
2 3 9 9 
7 1 9 
2 1 0 0 
7 2 0 
GTC 
V 
GAC 
0 
TTA 
L 
T T T 
F 
CAG 
Q 
GGA 
G 
CAA 
Q 
TAC 
Y 
GCC 
A 
TCA 
S 
CGA 
R 
CTA 
L 
AAA 
K 
TGT 
C 
AAA 
K 
2 1 1 1 
731 
2 1 1 5 
7 3 5 
GTC 
V 
TGT 
C 
AGT 
S 
CAT 
H 
ACC 
T 
TCG 
S 
ACA 
T 
ACA 
T 
TAC 
Y 
CAA 
Q 
CCT 
P 
TTT 
F 
ACG 
T 
GTG 
V 
CTG 
L 
2 1 8 9 
7 1 9 
2 1 9 0 
7 5 0 
TCA 
S 
ATC 
I 
CCT 
P 
ATT 
I 
CCT 
P 
AAA 
K 
AAA 
K 
AAT 
N 
TCC 
S 
CGA 
R 
AAT 
N 
AAT 
N 
ATT 
I 
ACC 
T 
ATT 
I 
2 5 3 1 
761 
2 5 3 5 
7 6 5 
GAA 
E 
GAT 
D 
TGT 
C 
TTC 
F 
AGA 
R 
GAG 
E 
TTC 
F 
ACC 
T 
AAA 
K 
TGT 
C 
GAG 
E 
AAC 
N 
TTG 
L 
GAA 
E 
GTG 
V 
2 5 7 9 
7 7 9 
2 5 8 0 
7 8 0 
GAT 
D 
GAG 
E 
CAA 
Q 
TGG 
W 
TTG 
L 
TGC 
C 
CCA 
P 
CAT 
H 
TGT 
C 
GAA 
E 
AAA 
K 
AGG 
R 
CAG 
Q 
CCC 
P 
TCC 
S 
2 6 2 1 
791 
2 6 2 5 
7 9 5 
ACG 
T 
AAA 
K 
CAA 
0 
TTG 
L 
ACA 
T 
ATA 
I 
ACG 
T 
AGA 
R 
TTA 
L 
CCG 
P 
AGG 
R 
AAT 
N 
CTG 
L 
ATA 
I 
GTC 
V 
2 6 6 9 
8 0 9 
2 6 7 0 
8 1 0 
CAT 
H 
TTA 
L 
AAG 
K 
AGA 
R 
TTT 
F 
GAT 
D 
AAT 
N 
TTA 
L 
TTA 
L 
AAC 
N 
AAA 
K 
AAT 
N 
AAT 
N 
GAC 
D 
TTC 
F 
2 7 1 1 
821 
2 7 1 5 
8 2 5 
GTC 
V 
ATA 
I 
TAC 
Y 
CCT 
P 
TTT 
F 
TTG 
L 
TTG 
L 
GAC 
D 
TTG 
L 
ACT 
T 
CCA 
P 
TTT 
F 
GGG 
G 
GCC 
A 
AAT 
N 
2 7 5 9 
8 3 9 
2 7 6 0 
8 1 0 
GAT 
D 
TTT 
F 
GAC 
D 
GGG 
G 
GTT 
V 
TTT 
F 
CCT 
P 
CCA 
P 
GGT 
G 
GTT 
V 
AAT 
N 
GAC 
D 
GAT 
D 
GAA 
E 
CTA 
L 
2 8 0 1 
851 
2 8 0 5 
8 5 5 
CCA 
P 
ATA 
I 
AGG 
R 
GGA 
G 
CAA 
Q 
ATA 
I 
CCA 
P 
CCT 
P 
TTT 
F 
AAG 
K 
TAT 
Y 
GAA 
E 
TTA 
L 
TAT 
Y 
GGT 
G 
2 8 1 9 
8 6 9 
2 8 5 0 
8 7 0 
GTA 
V 
GCA 
A 
TGC 
C 
CAC 
H 
TTT 
F 
GGT 
G 
ACT 
T 
TTG 
L 
TAT 
Y 
GGT 
G 
GGT 
G 
CAT 
H 
TAT 
Y 
ACA 
T 
GCC 
A 
2 8 9 1 
8 8 1 
2 8 9 5 
8 8 5 
TAT 
Y 
GTG 
V 
AAA 
K 
AAG 
K 
GGA 
G 
TTA 
L 
AAG 
K 
AAG 
K 
GGA 
G 
TGG 
W 
CTA 
L 
TAT 
Y 
TTT 
F 
AAT 
N 
GAT 
D 
2 9 3 9 
8 9 9 
2 9 1 0 
9 0 0 
ACC 
T 
AAA 
K 
TAT 
Y 
AAA 
K 
CCT 
P 
GTC 
V 
AAA 
K 
AAC 
N 
AAA 
K 
GCC 
A 
GAT 
D 
GCA 
A 
ATT 
I 
AAC 
N 
TCT 
S 
2 9 8 1 
9 1 1 
2 9 8 5 
9 1 5 
AAT 
N 
GCA 
A 
TAC 
Y 
GTT 
V 
TTG 
L 
TTT 
F 
TAT 
Y 
CAC 
H 
CGC 
R 
GTC 
V 
TAC 
Y 
GGT 
G 
GTT 
V 
TGA 
« 
TTCA 3 0 3 0 
9 2 8 
3031 T T I G A A . I M A 1 M C I G A A A A C C G T T G T C T A T A C A C T T T T T T T C C C G T T C A A C A T G G C A T A 3 0 9 0 
3 0 9 1 TCATTATTTCCATCTAAGGTCAAAGTAAAAAACCCTAAATACAAATGATTTATTTTAACG 3 1 5 0 
3151 GTAACAAACGAACTTTTTTTTAGAAGGTGTAAAGATGAGATCACGCCCAGATTTTGTCTT 3 2 1 0 
3211 CCTCCTGTGCATCTCTTGGGTTGATGATTTTCCTTTCTACCATAATACGTCATGAAAAGT 3 2 7 0 
3271 ATGTAAATATTTATGGGCTTACATATTATCTTTTATTTGGAGAAAATTCCCTCATTCCCA 3 3 3 0 
3 3 3 1 GTCATCATCGTCGGTCGGTCGTCCTTGCTCTCACCCTTGTTGGGGGGGGCCACCTGGGGC 3 3 9 0 
3391 A C T A A C C T T T T T C C A A T C C C C C C 3 1 1 3 
Further downstream the nucleotide sequence 
3270XATG 3282XATG 3301xTTTA conformed the consensus of a transcriptional 
terminator (Zaret and Sherman, 1982). The immediate nucleotides preceding the ATG 
start codon are GTT which is similar to that found in a number of regulatory genes in 
the same position. Complete consensus sequences required for intron splicing in 5. 
cerevisiae (Langford et al., 1984) were not detected. Thus, 55V^ 7 appears not to contain 
introns. A hydrophobicity analysis of the deduced protein sequence (Kyte and Doolittle, 
1982) indicates that Ssv7p is relatively hydrophilic and seems to have no N-terminal 
signal sequence and no outstanding uninterrupted stretches of a helix of P sheet (Figure 
6.11 and 6.12). Therefore, this protein would not be expected to enter the secretory 
pathway by translocation into the ER lumen, or represent an intermediate filament-like 
protein characterized by a long uninterrupted a helical stretch. Some residues of the 
protein are acidic (Figure 6.11) which results in the protein having a predicted 
isoelectric point of 8.50 (Figure 6.13). 
A protein sequence comparison of the deduced amino acid sequence with a 
consensus sequence library available on the UWGCG package revealed that the protein 
has seven putative N-linked glycosylation sites and a link-patch consensus from amino 
acid 792 to 807 (QPSTKQLTITRLPRNL) often found associated with proteins having 
separate functional domains. A number of other secondary consensus sequences were 
detected, the most prominent that for phosphorylation (Table 6.1). It has not yet been 
examined whether the protein is phosphorylated in vivo. 
A comparison of the predicted amino acid sequence to other known protein 
sequences contained in all available protein sequence databases including a daily 
updated EMBL data base showed that the gene and protein have not been sequenced 
before and do not have any overall homology to other genes and proteins. Using the 
FASTA and TFASTA algorithms (Pearson and Lipman, 1988) it was found that the C-
terminal 300 amino acids of Ssv7p were 20% identical and 42% homologous to the 
catalytic domains of nucleotide exchange factors such as the S. cerevisiae Cdc25p 
(Camonis et al., 1986) and 16% identical and 41% homologous to Bud5p (Chant et al., 
1991; Powers et al., 1991), another nucleotide exchange factor. 
294 
Figure 6.11: Secondary protein structure analysis of Ssv7p. The protein has no 
significant hydrophobic signal peptide required for translocation into the ER, nor 
does it have any distinct secondary structure defined by a helices or (3 sheets. A 
map representing acidic and basic residues reveals that the protein has a 
significant number of acidic and basic residues, of which the acidic residues are 
located near the C-terminus. The length of the vertical bars are proportional to 
the dissociation potential of acidic and basic residues. The Cys and His map 
suggests that the protein possibly has some tertiary structure not only defined by 
its primary amino acid sequence because some cysteines have a high potential to 
form cystines (long vertical bars) and the protein has a number of histidine 
residues (intermediate vertical bars) and other cysteines unlikely to undergo 
disulphide bridge formation (short vertical bars). 
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Figure 6.12: Chou-Fasman prediction of the secondary structure of Ssv7p. The protein 
lacks any significant long a-helical structures and probably is not a cytoskeletal 
or structural element. Most short a-helical stretches coincide with charged 
residues which could function in recognition. 
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Figure 6.13: Isoelectric point map of Ssv7p. The isoelectric point of Ssv7p was 
calculated with the help of the UWGCG package. An isoelectric point of 8.5 
indicates that the protein's net charge is 0 at a pH 8.5, typical for basic proteins. 
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Conensus s i t e s Sequence 
A m i d a t i o n xG(R,K) (R,K) 
xG(R) (K) 
324: WLKSN YGRK VSSSF 
A s n - G l y c o s y l a t i o n N~(P) (S,T)~(P) 
N~P(S)~P 
2 2 1 : SRLEF NKSH IDTKN 
295: LDILV NHSF EKPIS 
34 8: VYFNG NTSG LSLQH 
4 1 1 : KTLFS NYTS PNPKN 
540: LSLSN NDSF RSYEM 
7 6 1 : KNSRN NITI EDCFR 
898: GWLYF NDTK YKPVK 
cAMP-phosphorylation s i t e (R,K)2x(S,T) 
(K) { 2}x(S) 
63: ILSIY KKNS KDIKN 
326: KSNYG RKVS SSFPS 
400: NDHVL KRSS SFKTL 
632: QVDGS KKIS ISPIK 
755: SIPIP KKNS RNNIT 
C K 2 - p h o s p h o r y l a t i o n s i t e (S,T)x2(D,E) 
(T ) x { 2 } ( D ) 
8: QNIIS TIRD ECIRH 
50: DQDLS SLLD KCIDI 
122: IKLHK STSD EGNGN 
123: KLHKS TSDE GNGNN 
144: MNIYN TLLE TLLKD 
205: ANSAS SQME ILLID 
216: LIDIR SRLE FNKSH 
223: LEFNK SHID TKNII 
2 4 1 : ISFKM SYSD HDLEK 
243: FKMSY SDHD LEKKS 
367: PSIRH SMDD SMKET 
3 7 1 : HSMDD SMKE TASWP 
393: QQQQQ SDND HVLKR 
466: HLWKN SETD FMTNQ 
538: SCLSL SNND SFRSY 
656: LFKTA SQQD CQEFC 
704: SLRIA SSIE WERFL 
763: SRNNI TIED CFREF 
772: CFREF TKCE NLEVD 
M y r i s t y l G~ (E, D,K,R,H ,P, Y,F,W)x2 (S,T,A, G,C,N)~(P) 
G~ (E,D, K,R,H,P,Y,F,W)x{2} (S)~P 
79: SCKNK GAMISS NSVMI 
127: STSDE GNGNMN NNEFQ 
129: SDEGN GNNNNN EFQLM 
184: NLMRT GSYITS NQLNS 
347: SVYFN GNTSGL SLQHL 
646: FKLAC GSVNSL FKTAS 
725: VDLFQ GQYASR LKCKV 
875: VACHF GTLYGG HYTAY 
879: FGTLY GGHYTA YVKKG 
889: AYVKK GLKKGW LYFND 
Table 6.1 - continued on next page. 
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Conensus s i t e s Sequence 
(S,T)x(R,K) 
(T)x(R) 
8: QNIIS TIR DECIR 
40: NEFII TGK AKDQD 
74 : I K N I I SCK NKGAM 
165: SFIKS SIK QTKLN 
237: CLEPI SFK MSYSD 
363: PKMSP SIR HSMDD 
3 7 1 : HSMDD SMK ETASW 
404 : LKRSS SFK TLFSN 
502: PSRTA TPK LQRFP 
542: LSNND SFR SYEML 
6 3 1 : EQVDG SKK ISISP 
699: RREKL SLR IAS SI 
794 : EKRQP STK QLTIT 
(R, K ) x { 2 , 3 } (D,E)x { 2 , 3}Y 
PKC-phosphorylation s i t e 
T y r - p h o s p h o r y l a t i o n s i t e 
820: DNLLN 
(K)x { 2 } (D)x { 3}Y 
KNNDFVIY PFLLD 
Table 6.1: Consensus sites of the predicted SSV7 protein. The deduced protein 
sequence of Ssv7p was searched with a consensus library using the MOTIF 
search on the UWGCG package. Amino acids of Ssv7p perfectly matching with 
the putative consensus sequences (displayed above alignment) are highlighted in 
boldface, and their location in the Ssv7 protein is indicated. 
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Since the homology was conserved over a region which has been associated with 
nucleotide exchange function, and the conservation between different exchange factors 
usually never exceeded 20% identity and 45% similarity within one species (Chant et 
al., 1991), there is good reason to propose that based on sequence analysis Ssv7p has a 
consensus for mediating a nucleotide exchange process (Figure 6.15). The N-terminal 
400 amino acids has homology to Gramicidin S synthetase I (GrsA) fi-om Bacillus 
brevis (Kratzschmar et al., 1989). The N-terminal domain of GrsA was homologous to 
the N-terminus of tyrocidine synthetase, both of which are involved in thioester linkage 
formation between phenylalanine and subsequent amino acids of the peptide antibiotic. 
The reaction is characterized by the initial binding of phenylalanine to a conserved 
cysteine. However, the particular conserved cysteine residues in GrsA (in position 331, 
377, 474 and 1065; Kratzschmar et al., 1989) are not conserved in Ssv7p (Figure 6.14), 
making it unlikely that the N-terminus of Ssv7p performs an analogous function. A 
short peptide sequence at the extreme C-terminus of Ssv7p is homologous (48.6%) to 
Ira2p and to a lesser degree to Iralp (Figure 6.14). The region of homology is adjacent, 
but not identical to the catalytic domain of GTPase activating proteins (GAPs) (Tanaka 
et al., 1990), making it appear unlikely that Ssv7p represents a GAP protein. Secondary 
structure predictions of the region of homology between Ssv7p and Ira2p strongly 
suggests that the domains appear very similar (Figure 6.16). 
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Gap Weight: 3.000 Average Match: 0.54 0 
Length Weight: 0.100 Average Mismatch: -0.396 
Q u a l i t y : 120.5 Length: 375 
R a t i o : 0.353 Gaps: 13 
Percent S i m i l a r i t y : 42.249 Percent I d e n t i t y : 20.365 
Ssv7p (565-927) x Cdc25p (1190-1530) 
565 WENLEIPCYMNCIIQCTLGTHELTQIFLDDS YAKHININSKLGS 608 
. I . I : 1 : . I : I : : I . : . : . : : M : : . I • 
1190 . . .NPIKCRWNIMR.TFLTQYWTRNYYEPGIPLILNFAKMWSEKIPGA 1235 
60 9 KGILAKYFARLVHMMYKEQVDGSKKISISPIKFKLACGSVNSLFKTASQQ 658 
. : : I . I . . : I : : M • M h i : : . | 
1236 EDLLQKINEKLINENEKEPVDPKQQDSVSAWQTTKRDNKSPIHMSSSSL 1285 
659 DCQEFCQFL.LDGLH.EDLNQCGSNPPLKELSQEAEARREKLSLRIASSI 706 
. : . : . I : I . I . I : : . : . . . . I . | . : : M M . 
1286 PSSASSAFFRLKKLKLLDIDPYTYATQLTVLEHD LYLRITMFE 1328 
707 EWERFLTTDFSVIVDLFQGQYASRLKCKVCSHTSTTYQPFTVLSIPIPKK 756 
: : I : . I . : : : | . : . I . . : | | • : . I : : • : . I • 
1329 CLDRAWGTKYCNM GGSPNITKFIANANTLTNFVSHTIVKQADVKT 1373 
757 NSRNN...ITIEDCFREFTKCENLEVDEQWLCPHCEKRQPSTKQLTITRL 803 
. I : . : I : . : : | . | : . . I . . I . : 1 . | 
1374 RSKLTQYFVTVAQHCKELNNFSSMTAIVSALYSSPIYRLKKTWDLVSTE. 1422 
804 PRNLIVHLKRFDNLLNKNNDFVIYPFLL.DLTPFGANDFDGVFPPGVNDD 852 
. : : I M . : : I I : : . . . : M I • 11 . : I . . : . . I I I : : . I 
1423 SKDL...LKNLNNLMDSKRNFVKYRELLRSVTDVACVPFFGVY...LSDL 1466 
853 ELPIRGQIPPFKYELYGVACHFGTLYGGHYTAYVKKGLKKGWLYFNDTKY 902 
. : . : I . I . I I . . . : I . . : . 
1467 TFTFVGN.PDF...LHNSTNIINFSKRTKIANIVEEIISFKRFHYKLKRL 1512 
903 KPVKNKADAINSNAYVLFYHRVYGV 927 
. . : . . : I . I . : 
1513 DDIQTVIEASLENVPHIE 1530 
Figure 6.14 A: Alignment (Devereux et al, 1984) of Ssv7p and Cdc25p. Vertical bars 
represent amino acid identities, colons represent conserved regions and dots 
represent similarities. 
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Gap Weight: 3.000 Average Match: 0.54 0 
Length Weight: 0.100 Average Mismatch: -0.396 
Q u a l i t y : 115.6 Length: 450 
R a t i o : 0.318 Gaps: 11 
Percent S i m i l a r i t y : 41.477 Percent I d e n t i t y : 15.625 
Ssv7p (565-927) x Bud5p (100-538) 
565 WENLEIPCYMNCIIQC 580 
I : : I . I : I : : . 
100 LIQLVMGQDDLLFSMDDVLQEDFRIQLYLNKMLPHNSHKWQKPSPFDSAN 14 9 
581 TLGTHELTQIFL DDSYAKHINI NS 604 
I : . I : : : I : . I : : | . | : I 
150 LLLNFRDWTTDNALLQELLLSYPTINKNKHKNHSVPRLIQIWVESYWQDS 199 
605 KLGSKGILAKYFARLV HMMYKEQVDG.SKKISISPIKFKLACGSV 648 
. . I : I I . : : . : I . : : : : | : . | : | : . . . . 
200 ETTLKDILNFWYSHLAEYYEYQELFADIVQLFINKKRTRQLKIHYIGLTD 249 
649 NSLFKTASQQDCQEFC.QFLLDGLHEDLNQCGS...NPPLKELSQEAEAR 694 
| : : | : . : : | | . . . | : : . | : . 
250 KEIEENKPPLDYENLFLQYEIDKTNANDELCGATDLSDLLFQWKQGELLE 2 99 
695 REKLSLRIASSIEWERFLTTDFSVIVDLFQGQYASRLKCKVCSHTS 740 
I : . I . : . . . . : : I : . : I : | . . . . | 
300 VEAFALNVSPWSLAKTLTLLESSLYLDIETIEFTRHFKHNDTTIDSVFTL 34 9 
741 TTYQPFTVLSIPIPKKNSRNNITIEDCFREFTKC.ENLEV 779 
I I . I . . : I . : . I : : : : . : . . : : | . : 
350 SNQLSSYVLETTLQQTHTISYWLQVALSCLYLRNLNSLASIITSLQNHSI 399 
780 DEQWLCPHCEKRQPSTKQLTITRLPRNLIVHLKRFDNLLNKNNDFVIYPF 829 
: .1 : : • : • : . I . I I : . 
4 00 ERLSLPIDVKSDHLFQRLKWVHPNNNYNVYRRTIKHIFHSQLPCVPFTS 449 
830 LLDLTPFGANDFDGVFPPGVNDDELPIRGQIPPF.KYELYGVACHFGTLY 878 
I I . . I : : . I . . : . I : : : . . I I . . : : . I . : : : . : . 
450 LLIRDITFIRDGNDTFTKDGNNVNMQKFNQITKIVAFAQYLQQKQYEDIH 4 99 
879 GGHYTA.YVKKGLKKGWLYFNDTKYKPVKNKADAINSNAYVLFYHRVYGV 927 
. : : i I : : : I . . : M . I . 
500 CSNTTARSLLGAMIKVHTLYNDNKDRAYQVSIAKVPRLT 538 
Figure 6.14 B: Alignment between Ssv7p and Bud5p. Vertical bars represent amino 
acid identities, colons represent conserved regions and dots represent 
similarities. 
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Gap Weight: 3.000 Average Match: 0.54 0 
Length Weight: 0.100 Average Mismatch: -0.396 
Q u a l i t y : 145.7 Length: 463 
R a t i o : 0.427 Gaps: 14 
Percent S i m i l a r i t y : 47.319 Percent I d e n t i t y : 26.814 
Cdc25p (1190-1518) x Bud5p (150-538) 
1190 NPIKCRWNIMRTFLTQYWTRNYY. 1213 
I . I : . : I I . I . I . . I : 
150 LLLNFRDWTTDNALLQELLLSYPTINKNKHKNHSVPR..LIQIWVESYWQ 197 
1214 . .EPGIPLILNFAKMWSEKIPGAEDLLQKINEKLINENEKEPVDPKQQD 1261 
I . . : . I I I I : . I . : : : I : . . I : : I I • • . . : . . 
198 DSETTLKDILNFWYSHLAEYY.EYQELFADIVQLFINKKRTRQLKIH... 243 
1262 SVSAWQTTKRDNKSPIHMSSSSL PSSASSAFFRL 1296 
: | | . | : . . . | : . . I . : I . : 
244 .YIGLTDKEIEENKPPLDYENLFLQYEIDKTNANDELCGATDLSDLLFQW 292 
1297 KKLKLLDID PYTYATQLTVLEHDLYLRITMFECLDRAWGTKYC 1339 
I . .11::: I : . . I . I I : M . I I I I . : I : • I : 
293 KQGELLEVEAFALNVSPWSLAKTLTLLESSLYLDIETIE.FTRHF 336 
1340 NMGGSPNITKFIANANTLTNFVSHTIVKQADVKTRSKLTQYFVTVAQHCK 1389 
I . . . : . . I I . . : I . I . : . I . . . . I : : I I | 
337 .KHNDTTIDSVFTLSNQLSSYVLETTLQQTHTIS ..YWLQVALSCL 379 
1390 ELNNFSSMTAIVSALYSSPIYRLKKTWDLVSTESKDLLKNLNNLMDSKRN 1439 
| . | : . I : . . I : . . I . . I I I . . I : . I . . I : . . I . : : I 
380 YLRNLNSLASIITSLQNHSIERLSLPIDV...KSDHLFQRLKWVHPNNN 426 
1440 FVKYRELLRSV..TDVACVPFFGVYLSDLTFTFVGNPDFLHNSTNIINFS 1487 
: I I : : : . : : : I I I I : : . : . I : I I . | | . . | . : : . I : | : 
427 YNVYRRTIKHIFHSQLPCVPFTSLLIRDITFIRDGNDTFTKDGNNV.NMQ 475 
1488 KRTKIANIVEEIISFKRFHYK LKRLDDIQTV 1518 
I . . I . . I I . : . . : I . I : . : : I : 
476 KFNQITKIVAFAQYLQQKQYEDIHCSNTTARSLLGAMIKVHTLYNDNKDR 525 
1519 .lEASLENVPHIE 1530 
. : . I : . . M : : . 
52 6 AYQVSIAKVPRLT 538 
Figure 6.14 C : Alignment of Cdc25p x Bud5p. Vertical bars represent amino acid 
identities, colons represent conserved regions and dots represent similarities. 
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Gap Weight: 3.000 Average Match: 0,54 0 
Length Weight: 0.100 Average Mismatch: -0.396 
Qu a l i t y : 134.3 Length: 408 
Ra t i o : 0.357 Gaps: 13 
Percent S i m i l a r i t y : 41.341 Percent I d e n t i t y : 20.670 
Ssv7p (1-390) X Grs A (45-420) 
1 MEQNIISTIRDECIRHRSKYLTIAQLTAIAEAKINEFIITGKAKDQDLSS 50 
: I : . : . . : . I . . | I . : | . . | : . . I I . I : I I : : 
45 FEEQVSKRPNNVAIVCENEQLTYHELNVKANQLARIFIEKGIGKDTLVGI 94 
51 LLDKCID....ILSIYKKNSKDIKNIISC.KNKGAMISSNS...VMIIQL 92 
: : : I : I I | | . : . | . : : . | . : | : : . | . : | : : : . | 
95 MMEKSIDLFIGILAVLKAGGAYVPIDIEYPKERIQYILDDSQARMLLTQK 144 
93 NYVYYKVIHIIVTTNIPHLSEFAKIKLHKSTSDEGNGNNNNNEFQLMNIY 142 
: . I . : I I I . . . . : | . . | | : : . : | . . . : . . . : . : : . 
145 HLVH..LIHNIQFNGQVEIFEEDTIKIREGTNLHVPSKSTDLAYVIYTSG 192 
143 NT..LLETLLKDENIAKIKSFIKSSIKQTKLNHEQEECNLMRTGSYITSN 190 
. 1 : I : I I . . : I I : . . | : . | I . : . . : . | : . | 
193 TTGNPKGTMLEHKGISNLKVFFENSLNVT EKDRIGQFASISFDAS. 237 
191 QLNSLISSSANSASSQMEILLIDIRSRLEFNKSHIDTKNI..ICLEPISF 238 
: . : : . . : I I : | : I | . . : . . | : | : | | . | . | . . 
238 .VWEMFMALLTGAS..LYIILKDTINDFVKFEQYINQKEITVITLPPTYV 284 
239 KMSYSDHDLEKKSLIT..SPNSEIKMFQSRNLFKFIILYTDANEYNVKQQ 286 
. : : I . . . I I I I : . I . | | . . . : . . 
285 VHLDPERILSIQTLITAGSATSPSLVNKWKEKVTYINAYGPTETTICATT 334 
287 SVLLDILVNHSFEKPISDDFTKIFILESGFPGWLKSNYGRKVSSSFPSNN 336 
: I . : . I I . . . . : I . I : I : : . . : . Ill 
335 CVATKETIGHSVPIGAPIQNTQIYIVDENLQ. .LKS 368 
337 NIKDDSVYFNGNTSGLSLQHLPKMSPSIRHSMDDSMKETASWPTPLIHLQ 386 
: : . . : . . . I I I : . : I . . . 
369 ..VGEAGELCIGGEGLARGYWKRPELTSQKFVDNPFVPGEK....LYKTG 412 
387 QQQQ.... 390 
: I . . 
413 DQARWLSD 420 
Figure 6.14 D: Alignment of Ssv7p x Grs A. Vertical bars represent amino acid 
identities, colons represent conserved regions and dots represent similarities. 
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Gap Weight; 3.000 Average Match: 0.54 0 
Length Weight: 0.100 Average Mismatch: -0.396 
Q u a l i t y : 30.7 Length: 95 
Rat i o : 0.370 Gaps: 2 
Percent S i m i l a r i t y : 48.649 Percent I d e n t i t y : 20.270 
Ssv7p (845-927) x Ira2p (2160-2245) 
845 FPPGVNDDELPIRGQIPPFKYELYGVACHFGTLYGGHYTAYVKK 888 
. . I : . : : : I . : . : I . . . : : I I I : : . . : . . 
2160 SDEGLMKSVGITGQGLKVLQDIRVSLHDI TLYDEKRNRFTPV 2201 
889 GLKKGWLYFNDTKYKPVKNKADAINSNAYVLFYHRVYGV 927 
: M I : I I . . . I . I . : : . : : : : I I : : 
2202 SLKIGDIYFQVLHETPRQYKIRDM.GTLFDVKFNDVYEISRIFEV 2245 
Figure 6.14 E: Alignment of Ssv7p x Ira2p. Vertical bars represent amino acid 
identities, colons represent conserved regions and dots represent similarities. 
Gap Weight: 3.000 Average Match: 0.540 
Length Weight: 0.100 Average Mismatch: -0.396 
Q u a l i t y : 34.4 Length: 2938 
Ra t i o : 0.414 Gaps: 4 
Percent S i m i l a r i t y : 48.193 Percent I d e n t i t y : 18.072 
Ssv7p (845-927) x I r a l p (1701-1850) 
845 FPPGVNDDELPI 856 
: . . . I : I : 
1701 SFVFLRFIGPALVSPDSENIIIVTHAHDRKPFITLAKVIQSLANGRENIF 1750 
857 RGQIPPFKYEL YGVACHFGTLYGGHYTAYVKKG 889 
: : I . I i : : . . : . : . . : . . : : I . I : . : 
1751 KKDILVSKEEFLKTCSDKIFNFLSELCKIPTNNFTVNVREDPTPISFDYS 1800 
8 90 LKKGWLYFND . TKYKPVKNKADAINSNAY VLFYHRVYGV 927 
: . : : I : I : I I . : I : i : : . : : . I I 
1801 FLHKFFYLNEFTIRKEIINESKLPGEFSFLKNTVMLNDKILGVLGQPS^4E 1850 
Figure 6.14 F: Alignment of Ssv7p x Iralp. Vertical bars represent amino acid 
identities, colons represent conserved regions and dots represent similarities. 
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Figure 6.15: Chou-Fasman predictions of the regions of conserved homology between 
Ssv7p (A) and Ira2p (B). Both proteins have a helix - pleated sheet - helix motif, 
of which the sheet consits of a marginally hydrophobic region followed by two 
charged regions. 
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PLOTSTRUCTURE o f : ssv7p.gcg ck: 5267 
P I ; S s v l p - S i C c h j r o w v c t s c e r c v i 3 . « f -
MH2 
8 5 0 
Cto-j-rAsaar. . ' r e d : c : : 3 r 
J u n f 7). '.99,- KD B r d r o p b a l i c i t y > " 1 . 3 
E ) H y d i o p b o b i c i t y > - I . 3 
9 0 0 
PLOTSTROCTURE of:.ira2_Yeast.sw ck:" 919 
P I ; i * l A 2 i f r ^ S r - :N--:i5:T0.= : R f : ^ ' ^ ? © ! ! P R O T E I K !S-».2 ( G I C < P R O T E I S ) . 
C^o•J-^35"•d^. P r e s i c t U r 
KD B y d r c p L i l i c i t y > = ; . 3 
KD flydrophocicitj > * i . 3 
KH2 
COOH 
Ssv7p (668) GLHEDLNQCGSNPPLKELSQEAEARREKLSLRIASSI 
Cdc25p (1298) LKLLDIDPYTYATQLTVLEHD LYLRITMFE 
Scd25p (944) ESILAVDPVLFATQLTILEHE lYCEITTFD 
Bud5p (302) AFALNVSPWSLAKTLTLLESS LYLDIETIE 
Ste6p (657) ELVLLLPPREIAKQLCILEFQ SFSHISRIQ 
L t e l p (62) PFILMYDSLSVAQQMTLIEKE ILGEIDWQD 
Ssv7p (832) DLTPFGANDFDGVFPPGVNDDELPIRGQ 
Cdc25p (1448) SVTDVACVPFFGVYLSDLTFTFVGNPDF 
Scd25p (1096) SLHSAPCVPFFGVYLSDLTFTDSGNPDY 
Bud5p (438) FHSQLPCVPFTSLLIRDITFIRDGNDTF 
Ste6p (805) ENCVLPCVPFLGVYFTDLTFLKTGNKDN 
L t e l p (222) VNPLVGCVPFIWYLSDLSANAEKKDWI 
***** ********* ** * 
Figure 6.16: Nucleotide exchange factor consensus of Ssv7p, Cdc25p (Camonis et al, 
1986), Scd25p (Boy-Marcotte et ai, 1989), Bud5p (Chant et ai, 1991), Ste6p 
(Hughes et al., 1990) and Ltelp (Wickner et al., 1987). Identical and similar 
amino acids are indicated by an asterix or dot, respectively, using the following 
stringent similarity criteria: (K,R), (D,E), (N,Q), (S,T), (L,I,V), if more tiian 
three amino acids of the aligned sequences form a consensus. 
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6.3. Discussion 
A mutation in ssv7-l causes a pleitropic phenotype affecting a number of cellular 
processes such as nuclear and vacuolar morphogenesis, cell cycle and osmoregulation. 
The fact that the mutation causes an anuclear phenotype while the strain remains viable 
is a unique feature. Most mutants deficient in nuclear segregation (Yaffe, 1991) or in 
profilin (Haarer et al, 1990) are conditionally lethal in that they exhibit a nuclear 
morphology defect at the restrictive temperature at which normal cell growth ceased. 
Also, these strains had a different DAPI staining pattern to the one observed in ss\7-\. 
Judged by electron microscopy, the mutant fails to assemble a nuclear envelope which 
is supported by the fact that the otherwise nuclear confined DAPI staining pattern is 
diffuse in the mutant. Compared to the nuclear morphology defect observed, the 
vacuolar defects like the secretion of CPY and the disrupted vacuoles are minor and 
probably of secondary nature. The anuclear phenotype raises the question of how the 
cell can compensate for the loss of the nuclear membrane. A number of cellular 
processes rely on temporal differential nuclear import (Nasmyth et al., 1990). Also, if 
no nuclear membrane exists, how does correct and efficient splicing of mRNA occur? 
Splicing occurs in the nucleus and it has been suggested that the nuclear envelope 
prevents unspliced RNA from escaping into the cytoplasm (Michaud and Goldfarb, 
1991). On the other hand, nuclei of nearly all eukaryotic cells vesicularize during 
mitosis (Fry et al, 1976; Lucocq et al., 1987; Zeligs and Wolhnan, 1979) and the 
presence of chromosomes in the cytoplasm alone seems not to affect viability. 
Consequently, the phenotype of the 5.yv7-l mutant argues that yeast cells are viable 
without a nucleus under laboratory conditions. This is even more bizarre when one 
considers that the yeast nucleus does not vesicularize before division (Yaffe, 1991). 
Alternatively, the nucleus in ssv7-\ could be fragmented into micronuclei, where each 
chromosome is surrounded by a miniature nuclear envelope. This would raise the 
problem of how partitioning of the chromosomes takes place during mitosis and 
requires spindle pole bodies for each micronucleus. Lastly one possibility accounting 
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for the anuclear phenotype remains. ssv7-\ strains could have morphologically intact 
nuclei, but the mutation affects the nuclear stability during both formaldehyde and 
glutaraldehyde fixation procedure. This later possibility seems unlikely as DAPI 
staining of live cells shows the same effect (C.A. Hartley and M.D. Watson, 
unpublished results). 
Judged from the growth rate of the ssv7-\ mutant it appears that the mutant is 
viable and not too significantly affected by the mutation. However several regulatory 
processes are severely affected, including the cell cycle. While in wild type the cell 
growth and budding are coupled, the ssv7-\ strain uncouples cell growth from budding, 
typical for a limitation in the division cycle (Cross et al., 1989). Although the exact 
defect in the cell cycle was not further analysed, an explanation consistent with all 
available evidence is that cell size is unlinked to START thus allowing uncontrolled 
growth. From the data obtained it it is impossible to judge which is the primary defect 
in the mutation, although the aberrant nuclear phenotype is a good candidate, because 
all other phenotypes can be explained as a consequence of a regulatory defect resulting 
from the dilution of transcriptional regulators by the cytoplasm. Other regulatory 
pathways were not studied in detail but it appears that at least adenine biosynthesis is 
also affected by the mutation because the adel ssv7-\ strain MLY1511 accumulates an 
excess of the red adenine fluorochrome giving it a bright red appearence. 
It was decided to study the mutation at the molecular level by cloning and 
sequencing its corresponding gene. While the cloning was successful, some standard 
genetic tests could not be performed because the necessary plasmid constructs for single 
step gene disruption and integrative mapping were not available at this time. Therefore 
no further data are available whether the gene 55^7 is the wild type copy of ssv7-\ or a 
single copy suppressor (see Chapter 5), and whether the cloned gene is essential for cell 
growth. Sequence analysis established that the gene has a single open reading frame 
encoding a 927 amino acid protein with a predicted molecular mass of 105,000 Da. It 
has no extensive secondary structure in the form of a long a helix, making it unlikely 
that it represents an intermediate filament type protein. Sequence comparison revealed 
that the N-terminal domain of Ssv7p has homology to gramicidin S I synthetase, a 
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protein involved in a racemisation reaction (Kratzschmar et al., 1989). The significance 
of this homology is not understood, but may be indicative for either similar substrate 
binding (phenylalanine) or the catalysis of a similar reaction. The region of limited 
homology is separated from another functional region by approximately 200 amino 
acids with no known homology to other proteins. The C-terminal domain of the protein 
has significant homology to the consensus sequence of GDP-GTP exchange factors 
(Boy-Marcotte et al., 1989; Broek et al., 1987; Camonis et al., 1986; Chant et al., 1991; 
Hughes et al., 1990; Powers et al., 1991; Wickner et al., 1987). It has previously been 
suggested that the structural similarities between the putative nucleotide exchange 
factors could reflect general features of the mechanism of nucleotide exchange (Powers 
et al., 1991). As yet, their mechanism of nucleotide exchange is not known. Cdc25p, 
Scd25p and Ste6p are true nucleotide exchange factors for RAS proteins (Broek et al., 
1987; Camonis et al., 1986; Chant et al., 1991; Hughes et al., 1990; Powers et al., 1991) 
and actually mediate nucleotide exchange. Other similar factors, such as BudSp or 
Ltelp, bind to ^ 5 proteins but are thought not to directly mediate exchange (Powers et 
al., 1991). Since Ssv7p is closer related to Cdc25p than to Bud5p it appears plausible 
that Ssv7p is a true nucleotide exchange factor. The limited homology and structural 
similarity to a short region of the GAPs Iralp and Ira2p, not identical to their catalytic 
domain (Tanaka et al., 1990), suggests that they share a common function to both GAPs 
and nucleotide exchange factors. 
What is the intracellular target of Ssv7p? The answer is unknown, but speculation 
suggests that it might function in the organization of the nucleus or cytoskeletal 
features. Nucleotide exchange factors activate corresponding GTPases by exchanging a 
GDP with an GTP (Engelberg et al., 1990). The GTPase activated by Ssv7p has to be 
identified as has its exchange activity. Judging from the appearance of the ssv7-l 
mutation, it might control a nuclear envelope function. Postmitotic nuclear assembly in 
mammals occurs by GTP dependent vesicle fusion on chromatin condensation points 
(Boman et al., 1992; Newport and Dunphy, 1992). The GTPase involved in this 
assembly might be regulated by an exchange factor similar to Ssv7p. On the other hand, 
the yeast nucleus does not vesicularize during mitosis, and thus Ssv7p might function in 
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its maintenance. Alternatively, Ssv7p could stimulate the polymerization status of 
cytoskeletal elements, which when disrupted leads to fragmentation of nuclei as well as 
vacuoles. 
The findings described in this chapter provide starting material for future 
investigations into the nature of the nuclear defect observed in the ssv7-l mutant as well 
for the analysis of the Ssv7 protein at the molecular level. Site directed mutagenesis 
might help to define regions involved in GTPase binding, nucleotide exchange and 
putative upstream or downstream effector regions. At the same time it can be addressed 
what effect a complete or partial deletion of the coding sequence has on nuclear 
morphology. PCR mediated cloning of the ssv7-l mutant allele will help to indentify the 
location of the mutation and thus further domains. The isolation of suppressors and their 
analysis as well as biochemical cross-linking experiments will enable the identification 
of upstream and downstrem elements. Immunolocalization of the Ssv7 protein will 
locate its action to a compartment. Assuming that nuclear assembly will occur in the 
presence of wild type Ssv7p, an in vitro system can be developed that allows the 
dissection of nuclear assembly as well as the analysis of Ssv7p action. Epistasis analysis 
of a ssv7 mutant could determine the location of the cell cycle defect. Of interest is also 
the nature of osmosensitive growth in the ssv7-l mutant. Lastly the mutant was isolated 
on the basis of osmosensitivity and aberrant vacuolar morphology, although at present it 
appears that the osmoregulatory defect is a consequence of the nuclear defect. 
Although part of the genetic analysis of 55^7 could not be performed because the 
necessary recombinant plasmids were not available, its outcome would not have 
furthered the knowledge about SSV7 and its direct and indirect role in nuclear 
morphogenesis. Whether Ssv7p is defective in the formation of a nuclear envelope or 
can suppress a defect of another mutation, cannot be decided at present. What is 
unambiguous is the fact that a putative nucleotide exchange factor participates in the 
assembly/maintenance of nuclear integrity. 
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CHAPTER 7 
CHARACTERIZATION 0¥ AR07-OSM2 
7.1. Introduction 
0SM2, a gene required for osmohomeostasis in yeast, has been mapped near to 
the AR07 locus (Singh and Sherman, 1978). Subsequent genetic analysis showed that 
0SM2 and AR07 are identical (Ball et al., 1986). 5SW5, a gene involved in 
osmohomeostasis and vacuole biogenesis in yeast, is allelic to the AR07 locus by virtue 
of its complementation pattern. A mutation in the SSV15 locus leads to the partial 
secretion of the vacuolar enzymes such as carboxypeptidase Y (CPY) and a-
mannosidase, and the absence of any visible vacuole (Latterich and Watson, 1991; see 
Chapter 4). 
AR07 is located on chromosome XVI (Mortimer et al., 1989) and encodes 
chorismate mutase (B.C. 5.4.99.5) (Kradolfer et al., 1977; Schmidheini et al., 1989). 
The enzyme is required to catalyze the reaction from chorismate to prephenate in the 
aromatic aminoacid biosynthesis pathway in the yeast Saccharomyces cerevisiae 
(Braus, 1991; see Figure 7.1). Its structural gene AR07 has been cloned, and its 
nucleotide sequence determined (Ball et al., 1986; Schmidtheini et al., 1989). It encodes 
a protein of 256 amino acids, which has no recognizable signal peptide and which 
shows no significant homology to the corresponding domains of the two bifunctional E. 
coli enzymes required for the same biosynthetic step (Braus, 1991). 
Aro7p has been extensively characterized in terms of its biosynthetic properties 
and its regulation (Braus, 1991). The enzyme, a dimer consiting of two identical 30 kDa 
subunits, is feedback inhibited by tyrosine representing one of its end products of the 
biosynthetic branch and also activated by tryptophan, the other end product of the 
branch (Kradolfer et al., 1977). Gene expression of the AR07 gene (Schmidheini et al., 
1989; Schmidheini et al., 1990b) as well as mRNA stability of the AR07 transcript 
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(Braus, 1991) are not subject to feedback regulation by metabolic precursors or end-
products. The precise mechanism of stimulation or inhibition of the enzyme is 
unknown, except that tryptophan can allosterically activate chorismate mutase 10 fold 
while tyrosine can inhibit the enzyme 10 fold (Braus, 1991). Constitutively activated 
choismate mutase mutants are irresponsive to inhibition or activation by its two 
effectors (Schmidheini et ah, 1990a). Cloning of the chorismate mutase gene and the 
constitutively activated gene revealed that a point mutation resulting in an amino acid 
substitution from threonine to isoleucine in position 226 of the peptide sequence is 
responsible for the constitutive active enzyme (Schmidheini et al., 1989). The 
constitutively active enzyme will result in a depletion of the chorismate pool. The active 
enzyme converts chorismate directly and irreversibly to prephenate without any 
detectable intermediates (Schmidheini et al., 1990a). Kinetic data have shown that the 
dimerized enzyme is in equilibrium with the monomeric form, where the monomers 
have a lower affinity for the ligands (revied in Braus, 1991). The role of chorismate 
mutase in osmotic stability is not known. 
Since the gene corresponding to the AR07-OSM2 locus has been cloned twice and 
sequenced before, the cloning and sequencing of the SSV15 gene by complementation 
of the ssvl5-\ allele was omitted, but the phenotype of the original osm2 mutation (here 
after referred to as aro7) was closer examined to understand its function in the wild type 
yeast cell. An aro7-\ mutant like the previously isolated ^^v7J-l mutant (MLY0716; 
MLY1502) was found to confer multiple mutant phenotypes, namely osmosensitivity, 
inability to grow on medium lacking tryptophan and phenylalanine, secretion of 
vacuolar proteinases and a severe defect in vacuole biogenesis. It was decided to use the 
aro7-\ allele rather than the ssvl5-\ allele for a phenotypic analysis because the latter 
allele tended to revert to the wild type at a higher frequency than did the aro7-\ allele. 
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Figure 7.1: Biosynthesis of aromatic amino acids and feedback regulation of the 
enzymes in S. cerevisiae. CA: chorismate; AA: anthranilate; PPA: prephenic 
acid; AR03/AR04: 3-deoxy-D-arabinoheptulosonate 7-phosphate synthase (EC 
4.1.2.15); AROIC: 5-dehydroquinate synthase (EC 4.6.1.3); AROIE: 3-
dehydroquinate dehydratase (EC 4.2.1.10); AROID: dehydroshikimate 
dehydrogenase (EC 1.1.1.25); AROIB: shikimate kinase (EC 2.7.1.71); AROIA: 
5-enolpyruvylshikimate 3-phosphate synthase (EC 2.5.1.19); AR02: chorismate 
synthase (EC 4.6.1.4); AR07'. chorismate mutase (EC 5.4.99.5); PHA2: 
prephenate dehydratase (EC 4.2.1.51); TYRl : prephenate dehydrogenase (EC 
1.3.1.13); TRP2: anthranilate synthase (EC 4.1.3.27); TRP3C: glutamine 
amidotransferase; TRP4: anthranilate phosphoribosyltransferase (EC2.4.2.18); 
TRPl: PRA isomerase; TRP3B: InGP synthase (EC 4.1.1.48); TRP5: tryptophan 
synthase (EC 4.2.1.20). The AROl gene product is a pentafunctional enzyme 
catalyzing five individual enzymatic reactions. The TRP3 gene product is a 
bifunctional enzyme encoding two enzyme activities. 
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7.2 Results 
7.2.1. Electron Microscopic Examination of the aro7-l Mutant 
Electron microscopic examination of the aro7-\ mutant using two different 
fixation protocols shows that the mutant has no visible intact or disrupted vacuoles 
(Figure 7.2). Whereas the wild type strain SEY6210 always has one to three large, dark 
staining vacuoles present (Figure 7.2 A and C), the aro7-l mutant strain has no 
detectable vacuoles present in more than 100 individual cells examined under the 
electron microscope (Figure 7.2 B and D). The results are consistent with different 
staining procedures, making the artefactual absence of vacuoles in the aro7-\ mutant 
unlikely. While other previously isolated vacuolar class C mutants did not have distinct 
vacuoles, they did accumulate some small membrane enclosed vesicles whose periphery 
stained like vacuoles but whose center was electron opaque (Chapter 4). No similar 
structurs could be observed in the aro7-\ mutant indicative of a different defect than in 
other class C mutants. No other abnormal subcellular structures were observable in this 
strain. 
7.2.2. Indirect Immunofluorescence 
Since a small fraction of an aro7-l culture has normal vacuoles as determined by 
Normarski contrast microscopy, its vacuolar morphology was examined by indirect 
immunofluorescence microscopy with antibodies against two vacuolar membrane 
proteins, namely alkaline phosphatase (Pho8p) and the 60 kDa subunit of the vacuolar 
ATPase (60 K) (Roberts et al., 1991). Pho8p is not localized in a large vacuolar 
compartment, as is the case for the wild type, but seems to accumulate in numerous 
small vesicles in the cytoplasm, as is characteristic for ssv or vp^ class C mutants 
lacking normal or disrupted vacuoles (Figure 7.3). Using an antibody against 60 K, the 
immunofluorescence pattern reveales the presence of the vacuolar ATPase subunit as is 
typical for normal cells with a mature vacuole, but only in cells which appear to have a 
mature vacuole under Normarski contrast microscopy also. A total of approximately 
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20% of all cells do have a visible vacuole by this method, the rest having a class C 
morphology only. It was not tested whether the cells with morphologically mature 
vacuoles were revertants or part of a mixed vacuolar phenotype population. The 
osmosensitive phenotype in this mutant reverts quite readily to the wild type, and stock 
cultures had to be purified and tested for osmosensitivity before each use. 
7.2.3. Missorting of Carboxypeptidase Y 
Immunoprecipitation of the soluble vacuolar enzyme CPY in both intracellular 
and extracellular fractions provides evidence that a significant amount (approximately 
20%) of the 68 kDa CPY precursor is secreted in the aro7-l mutant rather than 
correctly targeted to the vacuole as in the wild type, whereas the remaining intracellular 
CPY fraction is processed to the 61 kD mature form of the vacuolar enzyme (Figure 
7.4). The maturation pattern suggests that aro7-l mutants must have an intracellular 
compartment where PEP4 dependent maturation of p2CPY to mature CPY can occur. 
7.2.4. Examination of Other Mutants in the Aromatic Amino Acid Pathway 
Two mutants in the aromatic amino acid biosynthesis pathway, aro3-2, aro4-\ 
defective in both isoenzyme activities of 3-deoxy-D-arabinoheptulosonate 7-phosphate 
synthase (EC 4.1.2.15) and in aro2 defective in chorismate synthase (EC 4.6.1.4) 
activity were tested for their vacuole biogenesis related phenotypes. Both mutants affect 
steps prior to chorismate mutase and thus do not synthesize chorismate. Compared to 
aro7-\ and the wild type both strains were able to maintain growth on YPD 
supplemented with 1.5 M NaCl. Vacuolar morphological analysis by localizing Pho8p 
and the 60 kDa subunit of the vacuolar ATPase did not reveal any aberrant vacuolar 
morphology in both mutants. Also immunoprecipitation of intracellular and 
extracellular CPY did not detect any extracellular CPY (results all not shown). All 
intracellular CPY was matured to the 61 kDa CPY. Thus mutants defective in other 
enzymes of the same biosynthetic pathway did not have the same phenotype as the 
aro7-\ mutant. 
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Figure 7.2: Electron micrographs of SEY6210 (wild type) and B-4164 {aro7-l), using 
two different fixation protocols. The wUd type strain has a clearly visible 
electron dense vacuole (A) and (C), which cannot be found in the aro7 mutant 
strain (B) and (D). Cells in (A) and (B) were fixed using the ferricyanide 
reduced osmiumtetroxide - thiocarbohydrazide - reduced osmiumtetroxide 
protocol to specifically stain double membranes and carbohydrate structures. 
Cells in (C) and (D) were fixed and stained according to the method by Byers 
and Goetsch. ER, endoplasmic reticulum; N, nucleus; M, mitochondrium; V, 
vacuole. Bar = 0.5 |xm. 
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Figure 7.3: Indirect immunofluorescence of SEY6210 (wild type), and B-4164 {aro7-
1), using primary antibodies against Pho8p and 60 K. In the wild type (A-F) 
vacuoles are visible under Normarski contrast (A and D), and vacuolar 
membrane proteins Pho8p and the 60K subunit of the vacuolar ATPase are 
highlighting a compartment that corresponds to the yeast vacuole (C and F, 
respectively) which differ from the nucleus (B and E). In the aro7 mutant strain 
B-4164, vacuoles are detectable by Normarski contrast microscopy only in some 
cells (G and J) and are recognized by the anti-60K antiserum (L), but not by the 
anti-Pho8p antiserum (I). The DAPI staining of nucleus and mitochondria (H 
and K) served as a control. Bar = 1 fim. 
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Figure 7.4: Secretion of CPY in SEY6210 (wild type) and B-4164 {aro7-l). Lanes P 
and S of each strain show the immunoprecipitation of CPY from sphaeroplasts 
and culture supernatant respectively. After 0 minutes chase, equal amounts of 
the 68 kDa carboxypeptidase Y (CPY) precursor and 61kD mature CPY are 
present in the sphaeroplasts. After a chase of 30 minutes with cold methionine, 
all of the precursor has been converted into the 61kD mature form. In the wild 
type none of the CPY is secreted, whereas in the aro7 mutant strain part of the 
CPY precursor is secreted (lane S) and the remaining intracellular form is 
matured (lane P). 
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7.3. Discussion 
The aro7 mutant has a vacuolar morphology phenotype characteristic of class C 
yps mutants described before (Banta et al., 1988), and also a significant vps mutant 
phenotype in that it secretes a considerable amount of the precursor of the vacuolar 
proteinase CPY. Based on indirect immunofluorescence microscopy studies of two 
vacuolar membrane markers, alkaline phosphatase and the 60 kDa subunit of the 
vacuolar ATPase, a sub-population of cells present in a aro7-l culture has a vacuolar 
compartment as defined by localization of the 60 kDa subunit of the vacuolar 
membrane ATPase to a large spherical compartment representing a vacuole. Alkaline 
phosphatase/fructose-2,6-bisphosphate 6-phosphatase (Pho8p) appears to accumulate in 
vesicles in all cells examined, which is typical for a class C phenotype. aro7-\ differs 
from other ssv and vps mutants in that it is able to mature the intracellular fraction of 
CPY, which has not been observed with other vacuolar class C mutant strains Robinson 
et al., 1988; Chapter 4). These results cannot be explained with the current concept of 
proteinase A dependent maturation of CPY, since this process requires a fully 
functional vacuolar compartment (Klionsky et al., 1990), and all previously identified 
mutants lacking an electron microscopically visible vacuole are unable to mature 
intracellular CPY (Latterich and Watson, 1991; Robinson et al., 1988). One plausible 
explanation is that the aro7 mutation affects directly or indirectly the assembly of a 
structurally intact vacuole but not its biochemical function. The vacuole may be 
vesicularized in the mutant as is the Golgi apparatus in wild type yeast (Fransuzoff et 
al., 1991a). The vacuolar biochemical functions could be maintained within the 
vesicles. Alternatively, the mixed vacuole phenotype might cause the missorting 
phenomenon of the vacuolar proteinase CPY in the mutant. In a mixed population some 
cells have intact vacuoles and are able to correctly sort and mature the CPY. Cells in the 
same population that do not have vacuoles will secrete all of the CPY due to the 
absence of the receptor compartment. Taken together, the culture will have the secreted 
precursor CPY present, as well as matured CPY in a vacuole expressing sub-population. 
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However the proportion of cells secreting CPY does not correspond to the relatively 
small proportion of cells with vacuole like compartments as seen by 60 kDa 
immunofluorescence. 
Considering the results obtained by immunolocalization of 60 K, it appears that in 
the arol mutant the structural organelle "vacuole" exists in a sub-population, but it 
seems to selectively accumulate certain vacuolar proteins, and not others. Considering 
also the results obtained by electron microscopy, and the maturation of the intracellular 
fraction of CPY, some mutant cells appear to have a partially functioning organelle that 
is competent for some proteolytic processing, but not for other functions such as 
osmoregulation, delivery of Pho8p and some factors that cause elctron dense vacuoles 
with the staining methods employed. The fact that the majority of aro7-\ cells do not 
have any visible vacuole by any criterion is interesting because the gene product of 
AR07 is a biosynthetic enzyme in aromatic amino acid biosynthesis. 
It is startiing that a mutation in a gene encoding a biosynthetic enzyme has such 
severe pleiotropic effects on protein targeting and especially organelle biogenesis even 
in presence of the end metabolites of the pathway affected. The question is whether the 
reaction product(s) or the enzyme per se are required to maintain vacuole structure and 
function. The lack of available tyrosine and/or phenylalanine, or an excess of 
tryptophan could lead to a stall in the synthesis of a protein required for organelle 
biogenesis. The wild type phenotypes are not restored when the mutant is grown in 
mediiun supplemented with an excess of aromatic amino acids (data not shown). This 
makes it appear less likely that a lack of aromatic amino acids alone is responsible for 
the multiple phenotypes associated with the mutant. Also, mutants in aro3, aro4 and in 
arol, which synthesize precursors to chorismate, do not have any of the defective 
vacuolar phenotypes observed in aro7 strains. An alternative explanation is that Aro7p 
is a bifunctional protein and carries out another function related to vacuole biogenesis, 
althogh there as yet is no experimental evidence to support this hypothesis. It has been 
demonstrated recently that Arolp associates in vitro with microtubules (Barnes et al, 
1992). This could also be the case for Aro7p. In strains lacking a functional Aro7p the 
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mutation could possibly affect microtubular function as a result. In vitro site directed 
mutagenesis of AR07 might help in the elucidation of its function. 
Amino acid pools in some organisms increase if the osmotic strength of the 
medium rises (Csonka, 1989). In yeast phenylalanine and/or tyrosine might be 
sequestered in a similar process. Alternatively, chorismate, which could accumulate in 
aro7 mutants, might have a deleterious effect on osmoregulation and vacuole biogenesis 
directly, or by aiding the excessive accumulation of biochemical intermediates in other 
branches of the pathway. The involvement of aromatic amino acids in osmoregulation 
has not been demonstrated thus far. It appears unlikely that a lack of tyrosine and 
phenylalanine or an excess of tryptophan is responsible for the pleiotropic vacuolar 
defects associated with aro7, because an excess of all aromatic amino acids individually 
or alone does not restore vacuoles in aro7 nor does it lead to vacuolar morphology 
changes in the wild type. Chorismate is an intermediate in ubiquinone, p-aminobenzoate 
and vitamin K biosynthesis. Ubiquinone is a electron acceptor in mitochondria, p-
aminobenzoate a precursor in folic acid biosynthesis, and vitamin K a cofactor in y-
carboxylation reactions. An excess of any of these components due to accumulation of 
chorismate could shift the intermediate equilibrium in a way that factors influencing 
vacuole morphology are expressed or repressed. The effect of an excess of chorismate 
in the wild type was not examined for financial reasons. 
This example of an apparent involvement of a biosynthetic enzyme in sorting of 
vacuolar proteins and organelle biogenesis stresses the complexity and plasticity of the 
processes required for protein sorting. K the fidelity of cellular processes, such as the 
biosynthesis of primary or secondary metabolites is disturbed, it can have a series of 
secondary effects on apparently unrelated processes. This consideration is especially 
important in interpreting mutational analysis of cellular events, since the mutant 
phenotype selected for can be the consequence of a mutation in an functionally 
unrelated gene which changes the fidelity of key cellular processes, or the inactivation 
of a multifunctional enzyme. 
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C H A P T E R S 
FINAL DISCUSSION 
8.1. Osmohomeostasis and the Vacuole 
This study addressed the proposed function of the yeast vacuole in cellular 
osmohomeostasis. The evidence obtained so far suggests that some vacuolar function is 
required for intracellular osmohomeostasis. The namre of the osmoregulatory 
mechanism could not be elucidated, although by isolation and characterization of ssv 
genes and lastly the development of in vitro reconstitution of the osmoregulatory 
vacuolar function this can be accomplished. The ssv mutants isolated in this smdy were 
defective in an immediate osmoregulatory response, which is different to the adaptive 
osmoresistance dependent on the accumulation of glycerol (Blomberg and Adler, 1989). 
Assuming that the osmosensitive phenotype is primarily caused by a vacuolar defect, 
the vacuole must allow survival to otherwise lethal osmotic stress by regulating the 
cytoplasmic water potential before other slower adaptive masures can be taken. One 
likely possibility is that osmotic gated vacuolar membrane channels open during 
osmotic shock to balance the osmotic loss of water from the cytoplasm. No such 
channels have been identified in S. cerevisiae. The presence of a hydrostatic and 
osmotic pressure activated channel in the plant vacuolar membrane has been 
demonstrated (Alexandre and Lassalles, 1991). This channel is activated by both 
hydrostatic pressure on either side, or an osmotic gradient, using sorbitol as an inducing 
agent. The channel was gated under in vivo conditions by a sole change in osmolality, 
without the need of a turgor change. The channel appears to regulate water flux between 
cytosol and the vacuole, and is also permissive to K"*" and to a lesser extent to CI" ions. 
A similar mechanism of osmotic potential gating could exist in yeast vacuoles, which is 
consistent with all preliminary findings in this and other studies. A non-functional water 
potential regulating channel caused by mislocalization of some component due to a 
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vacuolar targeting defect or due to a mutation in a gene(s) encoding the channel 
protein(s) could explain the mutants failure to immediately adapt to osmotic stress even 
before the osmoprotectant glycerol and other de novo synthesized proteins can adapt the 
yeast to the new environment. The fact that some newly synthesized gene products 
together with glycerol are required for long term survival under osmotic stress 
(Blomberg and AdIer, 1989) does not contradict these considertions. Patch-clamp 
studies on the isolated vacuolar membrane from yeast analogous to the approach 
described above (Alexandre and Lassalles, 1991) could demonstrate the presence of a 
similar osmoregulated ion-conducting channel. The proposed existence of an immediate 
osmoregulatory mechanism will prevent immediate cell death under unfavourable 
conditions and allow secondary osmotic responses to be initiated. In the unicellular alga 
Dunaliella salina the primary osmotic response consists of swelling or shrinking of the 
cell which is not surrounded by a rigid cell wall due to very rapid water fluxes. A 
secondary metabolic response is initiated which is mediated by a chloroplastic Pj / 
triose-phosphate shuttle, activating or deactivating chloroplastic enzymes in either 
starch or glycerol synthesis according to the osmolarity of the surrounding medium 
(Bental et al., 1990). Yeast vacuoles respond with swelling or contraction dependent on 
the water pressure in the surrounding environment hinting that at least the vacuole can 
balance turgor pressure. It appears that in different organisms at least two osmotic 
responses exist, an immediate response to mediate turgor adaptation and a secondary 
metabolic response to adapt to the change in osmolarity and provide an osmotic balance 
to allow normal metabolic processes to occur. 
The molecular analysis of 55^7, the gene probably corresponding to the ssv7-\ 
locus, revealed that it represents a nucleotide exchange factor by sequence homology. 
Ssv7p could transmit a signal induced by osmotic changes to a thus far unidentified 
GTPase and initiate a GTP-binding protein mediated immediate osmoregulatory 
response. Considering the anuclear phenotype observed in the ssv7-l mutant, this 
hypothesis appears unlikely. Rather, the osmosensitivity and vacuolar morphology 
defect might result from deregulated transcription as an immediate result of the absence 
of a nuclear membrane. The osmosensitive phenotype might actually represent a 
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conditional phenotype, similar to temperature sensitivity, and not an osmoregulatory 
defect. This finding somewhat questions the isolation procedure of the ^^v mutants, 
because ssv7-l was a "typical" ssv mutant in that it was osmosensitive, had a vacuolar 
morphology defect and also mislocalized a fraction of its p2CPY to the cell surface. 
Other genes in similar pathways could affect vacuole morphology and osmoregulation. 
8.2. Protein Traffic to the Vacuole 
The analysis of vps mutants will aid the elucidation of the sorting mechanisms 
responsible for the recognition of p2CPY and the immediate processes involved in 
retrieval of the protein from the Golgi compartment where sorting occurs. The approach 
taken by two research groups to isolate mutants involved in vacuolar sorting are based 
on the mislocalization of p2CPY (Rothman et at., 1986) or a ppCPY-invertase hybrid 
protein (Bankaitis et al., 1986). A total of approximately 49 different complementation 
groups were obtained affected in the localization of a number of vacuolar proteins 
(Klionsky et al., 1990; Raymond et al., 1992). This has led to the conclusion that their 
putative gene products are involved in the sorting of all soluble vacuolar enzymes. The 
finding that Vps35p is specifically involved in the sorting of CPY but not other vacuolar 
proteins as are a number of ssv genes is a first indication that both approaches will have 
isolated mutants mainly in the specific recognition of CPY but not other soluble 
vacuolar proteins, and components commonly involved in the early sorting processes. 
This is corraborated by the fact that most vps mutant alleles secrete p2CPY but not 
always PrA or PrB to the same degree. Secondly, proteins leaving the Golgi in vacuole 
destined transport vesicles will not be able to fuse back with the Golgi apparatus, 
assuming unidirectionality of specific transport events, resulting in accumulation of 
these vesicles in the cytoplasm (Baker et al., 1990; Bourne, 1988; Rothman and Orci, 
1992). The unidirectionality argument is favoured by considering the findings derived 
from sec mutants. For instance seel mutants will accumulate secretory vesicles but not 
ER or Golgi under restrictive conditions indicative of unidirectionality or kinetically 
favoured transport into the forward direction (Kaiser and Schekman, 1990). Thus all 
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mutants defective in the targeting and fusion of Golgi to vacuole vesicles with the 
vacuole or a post-Golgi compartment will have escaped the mutational analysis. Recent 
evidence confirms that some vacuolar protein precursors are indeed accumulated in 
post-Golgi transport vesicles and are not secreted (Klionsky et al., 1992). 
Second, ten-fold overproduction of CPY results in secretion of the protein via the 
late secretory pathway (Rothman et al., 1986). The PRCl gene, together with other 
vacuolar proteinase genes, undergoes cell cycle specific regulation and is induced ten to 
15 fold in the late logarithmic growth phase (see Chapter 4). Since the standard 
missorting assay uses cells of early to mid log phase, CPY has been considered as a 
vacuolar enzyme because it is not secreted under such conditions. This does not mean 
that CPY is not naturally secreted under certain growth conditions. Thus the isolation of 
mutants which secrete CPY might also include mutants in hypothetical regulatory paths 
that regulate PRCl gene expression. A way to distinguish such mutants from genuine 
missorting mutants would be to determine the levels of mRNA and protein synthesis. 
Taken together the vps mutants isolated so far are not necessarily representative 
protein sorting mutants, but more likely affect specific pathways that are required for 
sorting of such proteins in the Golgi or for vesicle budding from the Golgi (class C) 
mutants and for the regulation of protein expression. Using other vacuolar targeting 
information from different vacuolar proteins will aid the identification of other genes 
responsible for specific sorting. 
New strategies have to be developed to isolate mutants in the Golgi to vacuole 
pathway not relying on a vps phenotype, but on the absence of a vacuolar compartment 
for example, assuming that vesicular flow from the Golgi ensures vacuole maintenance. 
The ssv mutants isolated in this study comprise a new set of putative vacuolar mutants, 
but four complementation groups also have a severe vp^ phenotype. The fact that there 
is little overlap between ssv and vps mutants and that some ssv mutants have an aberrant 
vacuole morphology but are able to correctly localize most of their CPY to the vacuole 
might be characteristic for mutants in a later sorting or targeting pathway. On the other 
hand, a vacuolar acidification defect induced by specific inhibitors of the vacuolar 
ATPase or by deletion of vacuolar ATPase genes results in the partial secretion of 
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vacuolar enzyme precursors (Klionsky et al., 1992; Rothman et al., 1989). This would 
argue against vectorial transport of vacuolar proteins from the Golgi to the vacuole, 
assuming that acidic environment in the Golgi is mainatined. Assuming also the 
presence of intermediate transport vesicles between the distal Golgi and the vacuole 
these results can be explained by the vesicles fusing back to the Golgi compartment if 
the vacuole is not acidic, or that these intermediate vesicles fuse with secretory vesicles. 
Preliminary experimental evidence argues against this model, because acidification 
deficient mutants have vacuoles and can sort vacuolar proteins to the vacuole, albeit less 
efficiently. One possible explanation is that vesicles destined for the vacuole fuse with 
an intermediate pre-vacuolar compartment where sorting receptor recycling takes place. 
The acidic environment might aid the release of the proteins from a sorting receptor, 
and i f this compartment is not acidic the protein-receptor complex might relocalize to 
the Golgi where it disassociates and is secreted because of a putative oversaturation of 
the sorting pathway because most vacuolar proteins are transported back to the sorting 
compartment. In this context it appears attractive to propose the presence of a pre-
vacuolar endosomal compartment acidified by the vacuolar type ATPase because if the 
recycling took place in the vacuole, the proteins might be subject to proteolytic 
cleavage. One way to address this hypothesis would be to engineer a C-terminal 
extention peptide onto CPY which contains a cleavage consensus for PrA. The 
expression of this peptide in a pulse chase labelling experiment in an acidification 
deficient vacuolar ATPase mutant and subsequent immunoprecipitation would allow the 
determination of whether this peptide is cleaved judging from a change in 
electrophoretic mobility. I f the secreted fusion has not cleaved the extention peptide it 
would favour the argument that the recycling takes place in a pre-vacuolar 
compartment. On the other hand, Klionsky et al., 1992, suggest that Pho8p and also 
p2CPY and p2PrA accumulate in vesicles which are unable to fuse with the vacuole. 
This suggests a completely different role for vacuolar acidification. These results could 
be explained that for fusion of post-Golgi transport vesicles with the vacuole one of the 
requirements is an acidic compartment, and i f not present the vesicles might, less 
efficiently, fuse with another acidic compartment - the secretory vesicles. 
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8.3. Structural Integrity of the Vacuole 
Lysosomes in mammalian cells are subject to a reorganization induced by changes 
in pH (Heuser, 1989). A lowering of the extracellular pH is accompanied by a 
movement of lysosomes to the periphery of the cell in a microtubule dependent fashion. 
An increase in pH is accompanied by a movement of the lysosomes to the cell center, 
both processes wich involve probably kinesin and dynein based motors. Changes in pH 
also change the fission/fusion properties of lysosomes or lysosomal vesicles. pH 
dependent changes of vacuolar morphology in yeast have so far not been observed 
possibly because of the difficulties associated with light microscopic analysis of live 
vacuoles. However, other pH dependent processes have been described, such as the 
acidification induced mislocalization of vacuolar proteins (Klionsky et al., 1992). The 
effect of other environmental changes on the yeast vacuole have not yet been assessed, 
and it is possible that vacuolar morphology is subject to for example metabolic 
regulation. Studies in ATP depleted mammalian cells have shown that otherwise 
separate Golgi compartments can connect by tubules (Donaldson et al., 1989). This is 
indicative of a malfunctioning of a process involving mechanisms to separate 
membrane compartments including vesicle budding and fusion. Similarly, the yeast 
vacuole might undergo morphological changes in mutants i f the cytoplasmic 
environment is unfavourable to the stable assembly of vacuoles and finally disrupt or 
vesicularize vacuoles, although the mutation itself does not inactivate a vacuolar gene. 
8.4. Epilogue 
One final question remains - why are there different sorting mechanisms for 
different vacuolar proteins and different import mechanisms and what is the biological 
sense of it? Why does the cell require different sorting mechanisms for proteins with the 
same destination and similar function. The synthesis of proteins involved in sorting and 
targeting is energetically expensive as is translocation and transport. Most vacuolar 
proteases are synthesized under energetically unfavourable conditions like starvation or 
sporulation, and the expense of energy might be unfavourable. The presence of a single 
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sorting mechanism would help to "save energy". On the other hand strains with several 
independent mechanisms for vacuolar protein sorting have a selective advantage if one 
sorting component is inactivated. Also, they might be able to modulate individual 
transport and sorting activities in response to environmental stimuli. 
The biogenesis of the vacuole has been studied by a number of different 
approaches, mainly initiated by the isolation of mutants deficient in a vacuolar function. 
Unfortunately, the isolation and characterization of the gene products involved in the 
biogenesis of the vacuole has not yet allowed us to fully and unambiguously describe 
the pathway(s) and processes involved in describing the sorting and transport processes. 
One of the prime targets for future research is to isolate the transport compartment that 
mediates transport from the Golgi to the vacuole and to prove or disprove that the 
transport is mediated by intermediate transport vesicles. The sole fact that transport 
within the secretory pathway is mediated by vesicular intermediates does not necessitate 
that this is also the case for Golgi to vacuole transport. By analogy, the pulsating 
vacuole in Paramecium sp. derives its contents from morphologically distinctive 
tubules surrounding it (M. Latterich, unpublished observations). The fact that most 
fusion processes observed so far are mediated by the NSF (Secl8p), but the vacuolar 
transport processes do not depend on NSF are intriguing and indicate that this transport 
pathway might be different to the membrane flow in the secretory pathway. Also not 
known is the pathway the vacuolar membrane derives its components from. Under 
normal circumstancs each daughter bud receives some vacuolar material in a regulated 
fashion, and generally it is believed that the vacuole will grow due to the fusion of 
transport vesicles or endocytic vesicles with the pre-formed organelle. If this is the case, 
class C vacuolar mutants should only be deficient in the transport of intermediate 
vesicles from Golgi to vacuole, whereas all class A mutants are chiefly deficient in the 
sorting process. The design of a cell free in vitro transport reaction reconstituting the 
step from Golgi to vacuole should greatly aid the elucidation of the mechanism and to 
test the proposed role of the VPS gene products in this pathway. The transport pathway 
has been reconstituted in gently lysed sphaeroplasts (Vida et al., 1990). So far every 
effort to reconstitute transport in all vps mutants in the presence of wild type cytoplasm 
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has failed even in vps mutants whose gene products are known to be cytoplasmic. This 
is despite the fact that vacuole segregation in segregation defective mutants could be 
restored by addition of wild type cytosol in an in vitro assay (Tom Vida, personal 
communication). This is also different to the situation in the secretory pathway where 
transport can easily be reconstituted in vitro. The phenomenon could have several 
explanations. First, vps mutants could have requirements for components which are not 
sufficiently present under assay conditions. However, transport in the wild type should 
not occur under the same conditions. Second, all vps mutants isolated to date are 
associated with the Golgi dependent sorting process and/or the process of transport 
vesicle formation. This would be a good hypothesis for all VP5 gene products being 
associated with the Golgi, but it still does not account for soluble VPS gene products in 
the pathway. Third, some of the VPS gene products do not participate in transport 
directly, but are required for the biosynthesis of metabolites which can affect the sorting 
process. The sole provision of protein factors in the transport reaction might thus not 
suffice to maintain transport. A provision of intermediate metabolites to the assay might 
then restore transport activity. Fourth, some VPS gene products are inactivated during 
the cell fractionation process. This does not explain why in wild type broken ceUs 
transport does occur. Fifth, the presence of defective VPS gene products may not allow 
wild type VPS gene products to become associated with the sorting process. This does 
not explain why VPS deletion mutants still cannot reconstitute in vitro transport in the 
presence of the wild type gene product. Sixth, some VPS gene products are involved in 
the maintenance of a tubular structure spanning from the Golgi to the vacuole. The 
addition of the wild type gene product will not allow under in vitro conditions the 
formation of the connective tubule. 
As a result of the data obtained in this study together with results from other 
studies describing aspects of vacuole biogenesis, I wish to propose two different models 
which account for all major findings described up to date. These models are in no case 
complete, nor do they reflect the in vivo situation in yeast vacuole biogenesis. They are 
merely intended to provide some stimulus for future investigations into vacuole 
biogenesis from a diffemt perspective, and to be disproven rather than proven. 
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However, they represent alternative models to the existing simple model where Golgi to 
vacuole transport occurs via vesicular intermediates, and when the sorting process is 
hindered secretion occurs. 
Model A - Vesicular Transport Intermediates. According to this model the 
transport from Golgi to vacuole is mediated by transport vesicles which bud off from a 
distal Golgi compartment and fuse with a pre-vacuolar compartment (PVC) which may 
or may not be identical to an endosomal compartment. This compartment is acidified, 
and acidification is required to disassociate receptor ligand complexes, before receptors 
are retrieved in a retrograde vesicle mediated mechanism. The PVC will bud off 
vesicles which fuse with the vacuole. This model makes biological "sense" in that it 
allows receptor recycling to occur from a compartment that has no active proteinases 
present, unlike the vacuole which could "leak" proteinases back to the Golgi if it was 
the recycling compartment. This model is very attractive in that it is consistent with all 
experimental findings. I f deregulated by the absence of components required for vesicle 
budding from the PVC, vacuolar proteins would accumulate in this compartment and 
wil l eventually be transported to the Golgi via the retrograde transport mechanism and 
will be secreted because of over-saturation of the sorting process. This would be the 
case in all class C mutants which do not have a vacuole. The model also accounts for 
the sorting defects of class A and class B vacuolar mutants, because these mutants do 
have vacuoles, and the vacuolar material seems to be derived from the secretory 
pathway by lipid flow which is independent of the sorting of soluble vacuolar proteins, 
because four mutants (class C) defective in vacuolar protein sorting but not endocytosis 
do not produce vacuoles {endl). One could argue that all but four VPS gene products 
are involved in conferting specificity to the sorting process and are defective in 
receptors, or related receptor-retrieval processes. One alternative explanation is that 
fransport-intermediate vesicles in the absence of certain gene products can bypass the 
vacuole and fuse with the plasma membrane. On the other hand, a significant number of 
VPS genes may be involved in intermediate metabolism which when deregulated results 
in aberrant sorting or a bypass of the vacuole. 
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Figure 8.1: Model "A". Transport in S. cerevisiae is mediated by vesicles. EDVs bud 
off from the ER and fuse with the Golgi (1) where recycling of ER proteins 
takes place via a yet unknown route (2). Intra Golgi traffic in anterograde (3) 
and retrograde (4) direction is mediated by vesicles. In the trans Golgi secretory 
proteins leave the Golgi by default (5), and vacuolar proteins are retrieved by 
specific receptors and are transported to the PVC via vesicles (6) which recycle 
back to the Golgi after dissociation of ligands (7). The PVC will bud off vesicles 
to the vacuole (8) contributing to vacuolar biosynthesis. Endocytotic vesicles (9) 
might fuse with the PVC also. 
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Model B - Tubular Goigi to Vacuole Intermediate. This model assumes that 
there are no vesicular intermediates between Golgi and the vacuole, but that a late Golgi 
compartment is connected to the vacuole via a tubular network. This model is attractive 
in that it explains the secretion of all soluble vacuolar proteins when Golgi to vacuole 
transport is disturbed, which would be impossible with intermediate transport vesicles 
assuming the unidirectionality and specificity of vesicle mediated transport as in the 
secretory pathway. This model explains why there is no requirement for NSF in this 
particular pathway. On the other hand the fact that receptor mediated retrieval of 
vacuolar proteins from the Golgi does occur requires a more sophisticated explanation. 
It can be imagined that specific receptors transport their ligands along the tubule to the 
vacuole. I f disturbed by changes in pH or mutations that affect the transport within the 
tubular compartment soluble proteins are secreted, while membrane bound vacuolar 
proteins will accumulate in the tubule. This model requires the presence of a molecular 
sieve or "valve" to stop vacuolar contents leaking into Golgi compartments. A 
morphological analysis of some vpsl and ssvl alleles reveal the presence of "drop" 
shaped compartments surrounding the central vacuole, similar to the cistemae of a 
pulsating vacuole in Paramecium sp., which might reflect overexaggerated Golgi to 
vacuole tubules. 
Experiments directly addressing aspects of the two models, together with the 
development of better fixation protocols that preserve ultra-morphological features of S. 
cerevisiae better than existing methods, will lead to more insight in this exciting 
mechanism of organelle biogenesis. A detailed study of the proposed regulation of 
vacuolar structure and biogenesis by metabolic intermediates will shed some more light 
on the integrative regulation of compartmentalized biochemical pathways, and lastly on 
the mechanism of regulation of organelle structure and function. 
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Figure 8.2: Model "B". Transport from Golgi to the vacuole is mediated by tubules. 
EDVs bud off from the ER and fuse with the Golgi (1) where recycling of ER 
proteins takes place via a yet unknown route (2). Intra Golgi traffic in 
anterograde (3) and retrograde (4) direction is mediated by vesicles. In the trans 
Golgi secretory proteins leave the Golgi by default (5), and vacuolar proteins are 
sorted into protein specific tubules which are in direct connection with the 
vacuole (6). Endocytotic vesicles (7) fuse with an endosomal compartment 
which subsequently is engulfed by the vacuole or fuses with it (8). A similar 
process could mediate the uptake of Golgi to vacuole tubules or vesicles in 
model "A". 
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Also, an improved method to isolate vacuoles from yeast is desirable because the 
use of density gradient flotation methods is a lengthy process which easily can 
inactivate a number of vacuolar constituents (M.D. Watson, unpublished fmdings). The 
identification of a vacuolar membrane protein that assembles on the vacuolar membrane 
and does not take the secretory pathway could help to develop a scheme to affinity 
purify vacuoles with magnetic beads and thus have a purer and newer preparation. 
Finally, "nature" is more creative than the scientific mind of investigators of 
vacuolar structure and function, who already have difficulties in collecting all relevant 
information and establishing a link between vacuole structure and function. In different 
organisms different vacuole-like compartments can have different functions. Apart from 
Paramecium sp. whose pulsating vacuoles take over the role of the "kidney" organelle 
by collecting and exocytosing water that entered the protozoa during pino- and 
endocytosis, vacuoles in Hydractinia symbiolongicarpus regulate the peristaltic 
movement of the digestive tract (stolon) in a timely manner by swelling and subsequent 
contraction to maintain gastrovascular flow (Schierwater et al, 1992): a diverse and 
sophisticated role for a morphologically "simple" single-layer membrane enclosed 
compartment. 
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